Document:

Document

			
	Exhibit 4.1

WEX INC., as Issuer,
AND
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.,
as Trustee
INDENTURE
Dated as of July 1, 2020
6.50% Convertible Senior Notes due 2027
			
	

Table of Contents

Page

						
	Article 1
Definitions
	
	Section 1.01 Definitions
	1
	Section 1.02 References to Interest
	21
	Article 2
Issue, Description, Execution, Registration and Exchange Of Notes
	
	Section 2.01 Designation and Amount
	21
	Section 2.02 Form of Notes
	21
	Section 2.03 Date and Denomination of Notes; Payments of Interest and Defaulted Amounts
	21
	Section 2.04 Execution, Authentication and Delivery of Notes
	23
	Section 2.05 Exchange and Registration of Transfer of Notes; Restrictions on Transfer; Depositary
	23
	Section 2.06 Mutilated, Destroyed, Lost or Stolen Notes
	28
	Section 2.07 Temporary Notes
	28
	Section 2.08 Cancellation of Notes Paid, Converted, Etc
	29
	Section 2.09 CUSIP Numbers
	29
	Section 2.10 Repurchases
	29
	Article 3
Satisfaction and Discharge
	
	Section 3.01 Satisfaction and Discharge
	29
	Article 4
Particular Covenants of the Company
	
	Section 4.01 Payment of Cash Interest and Accreted Principal Amount
	29
	Section 4.02 Maintenance of Office or Agency
	29

	Section 4.03 Appointments to Fill Vacancies in Trustee’s Office
	30
	Section 4.04 Provisions as to Paying Agent
	30

	Section 4.05 Existence
	31
	Section 4.06 Rule 144A Information Requirement and Annual Reports
	31
	Section 4.07 Additional Information Rights
	32

	Section 4.08 Stay, Extension and Usury Laws
	32
	Section 4.09 Compliance Certificate; Statements as to Defaults
	32

	Section 4.10 Additional Amounts.
	32
	Section 4.11 Incurrence of Indebtedness.
	34
	Article 5
Lists of Holders And Reports by the Company and the Trustee
	
	Section 5.01 Lists of Holders
	37
	Section 5.02 Preservation and Disclosure of Lists
	37
	Article 6
Defaults and Remedies
	
	Section 6.01 Events of Default
	37
	Section 6.02 Acceleration; Rescission and Annulment
	38
	Section 6.03 Additional Interest
	39

									
		-1-
	

[AM_ACTIVE 402138650_25]

ActiveUS 180326157v.6

Table of Contents
(continued)
Page

						
	Section 6.04 Payments of Notes on Default; Suit Therefor
	39
	Section 6.05 Application of Monies Collected by Trustee
	40
	Section 6.06 Proceedings by Holders
	41
	Section 6.07 Proceedings by Trustee
	41
	Section 6.08 Remedies Cumulative and Continuing
	42

	Section 6.09 Direction of Proceedings and Waiver of Defaults by Holders of the Required Percentage
	42

	Section 6.10 Notice of Defaults
	42

	Section 6.11 Undertaking to Pay Costs
	42

	Article 7
Concerning the Trustee
	
	Section 7.01 Duties and Responsibilities of Trustee
	43
	Section 7.02 Reliance on Documents, Opinions, Etc
	44

	Section 7.03 No Responsibility for Recitals, Etc
	45

	Section 7.04 Trustee, Paying Agents, Conversion Agents or Note Registrar May Own Notes
	45

	Section 7.05 Monies and Common Stock to Be Held in Trust
	45

	Section 7.06 Compensation and Expenses of Trustee
	45

	Section 7.07 Officer’s Certificate as Evidence
	46

	Section 7.08 Eligibility of Trustee
	46

	Section 7.09 Resignation or Removal of Trustee
	46

	Section 7.10 Acceptance by Successor Trustee
	47

	Section 7.11 Succession by Merger, Etc
	47

	Section 7.12 Trustee’s Application for Instructions from the Company
	47

	Article 8
Concerning the Holders
	
	Section 8.01 Action by Holders
	48

	Section 8.02 Proof of Execution by Holders
	48

	Section 8.03 Who Are Deemed Absolute Owners
	48

	Section 8.04 Company-Owned Notes Disregarded
	48

	Section 8.05 Revocation of Consents; Future Holders Bound
	49

	Article 9
Holders’ Meetings
	
	Section 9.01 Purpose of Meetings
	49

	Section 9.02 Call of Meetings by Trustee
	49

	Section 9.03 Call of Meetings by Company or Holders
	50

	Section 9.04 Qualifications for Voting
	50

	Section 9.05 Regulations
	50

	Section 9.06 Voting
	50

	Section 9.07 No Delay of Rights by Meeting
	51

	Article 10
Supplemental Indentures
	

									
		-2-
	

[AM_ACTIVE 402138650_25]

ActiveUS 180326157v.6

Table of Contents
(continued)
Page

						
	Section 10.01 Supplemental Indentures Without Consent of Holders
	51

	Section 10.02 Supplemental Indentures with Consent of Holders
	52

	Section 10.03 Effect of Supplemental Indentures
	53

	Section 10.04 Notation on Notes
	53

	Section 10.05 Evidence of Compliance of Supplemental Indenture to Be Furnished Trustee
	53

	Article 11
Consolidation, Merger, Sale, Conveyance and Lease
	
	Section 11.01 Company May Consolidate, Etc. on Certain Terms
	53

	Section 11.02 Successor Person to Be Substituted
	53

	Section 11.03 Opinion of Counsel to Be Given to Trustee
	54

	Article 12
Immunity of Incorporators, Stockholders, Officers and Directors
	
	Section 12.01 Indenture and Notes Solely Obligations of the Company
	54

	Article 13
Conversion of Notes
	
	Section 13.01 Conversion Privilege
	54

	Section 13.02 Conversion Procedure; Settlement upon Conversion.
	55
	Section 13.03 Adjustment of Conversion Price
	57

	Section 13.04 Adjustments of Prices
	65

	Section 13.05 Shares to Be Fully Paid
	65

	Section 13.06 Effect of Recapitalizations, Reclassifications and Changes of the Common Stock.
	65

	Section 13.07 Certain Covenants
	67

	Section 13.08 Responsibility of Trustee
	67

	Section 13.10 Notice to Holders Prior to Certain Actions
	67

	Section 13.11 Stockholder Rights Plans
	68

	Article 14
Repurchase of Notes at Option of Holders
	
	Section 14.01 [Intentionally Omitted].
	68

	Section 14.02 Repurchase at Option of Holders Upon a Fundamental Change
	68

	Section 14.03 Withdrawal of Fundamental Change Repurchase Notice
	70

	Section 14.04 Deposit of Fundamental Change Repurchase Price.
	70

	Section 14.05 Covenant to Comply with Applicable Laws Upon Repurchase of Notes
	71

	Article 15
Optional Redemption
	
	Section 15.01 Optional Redemption
	71

	Section 15.02 Notice of Optional Redemption; Selection of Notes
	72

									
		-3-
	

[AM_ACTIVE 402138650_25]

ActiveUS 180326157v.6

Table of Contents
(continued)
Page

						
	Section 15.03 Payment of Notes Called for Redemption
	73

	Section 15.04 Restrictions on Redemption
	73
	Article 16
Miscellaneous Provisions
	
	Section 16.01 Provisions Binding on Company’s Successors
	73

	Section 16.02 Official Acts by Successor Person
	73

	Section 16.03 Addresses for Notices, Etc.
	74

	Section 16.04 Governing Law; Jurisdiction
	74
	Section 16.05 Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee
	74

	Section 16.06 Legal Holidays
	75

	Section 16.07 No Security Interest Created
	75

	Section 16.08 Benefits of Indenture
	75

	Section 16.09 Table of Contents, Headings, Etc
	75
	Section 16.10 Authenticating Agent
	75

	Section 16.11 Execution in Counterparts
	76

	Section 16.12 Severability
	76

	Section 16.13 Waiver of Jury Trial
	76

	Section 16.14 Force Majeure
	77

	Section 16.15 Calculations
	77

	Section 16.16 USA PATRIOT Act
	77

	Section 16.17 Withholding Taxes
	77

	Section 16.18 Agreed Tax Treatment
	77

EXHIBITS
Form of Face of Note A-1

									
		-4-
	

[AM_ACTIVE 402138650_25]

ActiveUS 180326157v.6

INDENTURE dated as of July 1, 2020 between WEX INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in ‎Section 1.01) and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee,” as more fully set forth in ‎Section 1.01).
In order to declare the terms and conditions upon which the Company’s 6.50% Convertible Senior Notes due 2027 (the “Notes”) are, and are to be, authenticated, issued and delivered, and in consideration of the premises and of the purchase and acceptance of the Notes by the Holders thereof, the Company covenants and agrees with the Trustee for the equal and proportionate benefit of the respective Holders from time to time of the Notes (except as otherwise provided below), as follows:
ARTICLE 1:   Definitions

Section 1.01 Definitions. The terms defined in this ‎Section 1.01 (except as herein otherwise expressly provided or unless the context otherwise requires) for all purposes of this Indenture and of any indenture supplemental hereto shall have the respective meanings specified in this ‎Section 1.01. The words “herein,” “hereof,” “hereunder” and words of similar import refer to this Indenture as a whole and not to any particular Article, Section or other subdivision. The terms defined in this Article include the plural as well as the singular.
“Accreted Principal Amount” means at any time with respect to a Note, and subject to the provisions of ‎Section 13.02(h), the Original Principal Amount of $1,000 per Note plus the aggregate of any interest payments accrued and added thereto on each Interest Payment Date (solely to the extent that the Company elects to make a PIK Interest payment on any such date) prior to such time in accordance with the provisions of ‎Section 2.03; provided that the Accreted Principal Amount shall include all accrued interest to but excluding (i) the date on which the Accreted Principal Amount of the Notes is accelerated in accordance with the provisions of ‎Section 6.02, (ii) any Redemption Date in accordance with the provisions of ‎Article 15, (iii) any Fundamental Change Repurchase Date in accordance with the provisions of ‎Article 14, and (iv) any Conversion Date under the circumstances set forth in ‎Section 13.02(h), in each case, as though such date were an Interest Payment Date.
“Acquired Indebtedness” means Indebtedness of a Person existing at the time such Person becomes a Restricted Subsidiary or Indebtedness of a Restricted Subsidiary assumed in connection with an Asset Acquisition by such Restricted Subsidiary; provided such Indebtedness was not Incurred in connection with or in contemplation of such Person becoming a Restricted Subsidiary or such Asset Acquisition.
“Additional Amounts” shall have the meaning specified in ‎Section 4.10(a).
“Additional Interest” means all amounts, if any, payable pursuant to ‎Section 6.03.
“Affiliate” of any specified Person means any other Person directly or indirectly controlling or controlled by or under direct or indirect common control with such specified Person. For the purposes of this definition, “control,” when used with respect to any specified Person means the power to direct or cause the direction of the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing. Notwithstanding anything to the contrary herein, the determination of whether one Person is an “Affiliate” of another Person for purposes of this Indenture shall be made based on the facts at the time such determination is made or required to be made, as the case may be, hereunder.
“Asset Acquisition” means (1) an investment by the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries in any other Person pursuant to which such Person shall become a Restricted Subsidiary or a Regulated Subsidiary or shall be merged into or consolidated with the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries; provided that such Person’s primary business is a Related Business or (2) an acquisition by the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries of the property and assets of any Person other than the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries that constitute substantially all of a division or line of business of such Person that is a Related Business.
1
[AM_ACTIVE 402138650_25]

ActiveUS 180326157v.6

“Asset Sale” means any sale, transfer or other disposition (including by way of merger, consolidation or Sale-Leaseback Transaction) in one transaction or a series of related transactions by the Company or any of its Restricted Subsidiaries to any Person other than the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries of:
1.all or any of the Capital Stock of any Restricted Subsidiary or Regulated Subsidiary;
2.all or substantially all of the property and assets of an operating unit or business of the Company or any of its Restricted Subsidiaries; or
3.any other property and assets (other than the Capital Stock or other Investment in an Unrestricted Subsidiary) of the Company or any of its Restricted Subsidiaries outside the ordinary course of business of the Company or such Restricted Subsidiary and,
4.in each case, that is not governed by the provisions of Article 11 hereof; provided that “Asset Sale” shall not include:
a.sales or other dispositions of Investment Securities, inventory, receivables, leases and other current assets, and any portfolios thereof;
b.sales, transfers or other dispositions of assets with a fair market value not in excess of $10.0 million in any transaction or series of related transactions;
c.any sale, transfer, assignment or other disposition of any property equipment that has become damaged, worn out, obsolete or otherwise unsuitable for use in connection with, or no longer used in connection with, the business of the Company or its Restricted Subsidiaries;
d.an issuance of Capital Stock by a Restricted Subsidiary or the sale, transfer or other disposition by the Company or a Restricted Subsidiary of the Capital Stock of a Restricted Subsidiary or Regulated Subsidiary, in each case to the Company, a Wholly Owned Restricted Subsidiary or a Wholly Owned Regulated Subsidiary;
e.the licensing, sublicensing, lease, assignment or sublease of any real or personal property in the ordinary course of business;
f.any financing transaction with respect to property built or acquired by the Company or any Restricted Subsidiary after the Issue Date to the extent consummated within 365 days of the completion of construction or acquisition of such property, including Sale-Leaseback Transactions and Qualified Securitization Transactions not prohibited by this Indenture;
g.the sale, transfer or other disposition or unwinding of any Hedging Obligations;
h.the sale or other disposition of Securitization Assets, or participations or interests therein, or the issuance or sale of Capital Stock in a Qualified Securitization Entity, in each case in connection with any Qualified Securitization Transaction;
i.any “fee in lieu” or other disposition of assets to any governmental authority or agency that continue in use by the Company or any Restricted Subsidiary, so long as the Company or any Restricted Subsidiary may obtain title to such assets upon reasonable notice by paying a nominal fee;
j.the issuance of Disqualified Stock that is permitted by this Indenture; 
2

k.dispositions in the ordinary course of business consisting of the abandonment of intellectual property which, in the reasonable good faith determination of the Company, is not material to the conduct of the business of the Company or any Restricted Subsidiary;
l.any surrender or waiver of contract rights or the settlement, release, recovery on or surrender of contract, tort or other claims of any kind;
m.Liens, or foreclosure on assets as a result of Liens;
n.the sale or issuance of Capital Stock in a Restricted Subsidiary that is, or is intended to be, a joint venture or partially-owned Restricted Subsidiary to a joint venture partner or investor to the extent that such joint venture partner or investor contributes or transfers cash, cash equivalents or other assets the Fair Market Value of which is at least equivalent to the Fair Market Value of the Capital Stock so sold or issued; or
o.the sale, transfer or other disposition, including any participation, of any interest in a loan, advance or other extension of credit held by the Company or any Restricted Subsidiary.
“Average Life” means, at any date of determination with respect to any indebtedness security, the quotient obtained by dividing (1) the sum of the products of (a) the number of years from such date of determination to the dates of each successive scheduled principal payment of such indebtedness security and (b) the amount of such principal payment by (2) the sum of all such principal payments.
“Bank Regulated Subsidiary” means (i) WEX Bank, (ii) any direct or indirect insured depository institution Subsidiary of the Company that is regulated by foreign, federal or state banking regulators, including, without limitation, the OCC, the Utah Department of Financial Institutions, the FDIC or the Federal Reserve or (iii) any Subsidiary of a Bank Regulated Subsidiary all of the Common Stock of which is owned by such Bank Regulated Subsidiary.
“Board of Directors” means the board of directors of the Company or a committee of such board duly authorized to act for it hereunder, or any equivalent body in a limited liability company serving substantially the same function as a board of directors of a corporation.
“Board Resolution” means a copy of a resolution certified by the Secretary or an Assistant Secretary of the Company to have been duly adopted by the Board of Directors of the Company, and to be in full force and effect on the date of such certification, and delivered to the Trustee.
“Business Day” means, with respect to any Note, any day other than a Saturday, a Sunday or a day on which the Federal Reserve Bank of New York is authorized or required by law or executive order to close or be closed.
“Capital Stock” means, for any entity, any and all shares, interests, rights to purchase, warrants, options, participations or other equivalents of or interests in (however designated) stock issued by that entity, but excluding any debt securities that are convertible into such stock.
“Capitalized Lease” means, as applied to any Person, any lease of any property (whether real, personal or mixed) which, in conformity with GAAP, is required to be accounted for as a capital lease on the balance sheet of such Person.
“Capitalized Lease Obligation” shall mean, at the time any determination thereof is to be made, the amount of the liability in respect of a Capitalized Lease that would at such time be required to be capitalized and reflected as a liability on a balance sheet (excluding the footnotes thereto) prepared in accordance with GAAP.
“CIBC Conversion Cap” shall have the meaning specified in Section 13.02(a). 
3

“Clause A Distribution” shall have the meaning specified in ‎Section 13.03(c).
“Clause B Distribution” shall have the meaning specified in ‎Section 13.03(c).
“Clause C Distribution” shall have the meaning specified in ‎Section 13.03(c).
“close of business” means 5:00 p.m. (New York City time).
“Commission” means the U.S. Securities and Exchange Commission.
“Common Equity” of any Person means Capital Stock of such Person that is generally entitled (a) to vote in the election of directors of such Person or (b) if such Person is not a corporation, to vote or otherwise participate in the selection of the governing body, partners, managers or others that will control the management or policies of such Person.
“Common Stock” means the common stock of the Company, par value $0.01 per share, at the date of this Indenture, subject to ‎Section 13.06.
“Common Stock Deemed Issued” means, with respect to any issuance or sale of Common Stock or Convertible Securities by the Company or its subsidiaries, the sum of (a) the number of shares of Common Stock actually issued in such transaction plus (b) the number of shares of Common Stock issuable upon exercise, conversion or exchange of Convertible Securities issued in such transaction (or issuable upon exercise of other Convertible Securities issued in such transaction), in each case, regardless of whether the Convertible Securities are actually exercisable, convertible or exchangeable at such time. 
“Common Stock Deemed Outstanding” means, at any given time, the sum of (a) the number of shares of Common Stock actually outstanding at such time, plus (b) the number of shares of Common Stock issuable upon exercise, conversion or exchange of Convertible Securities actually outstanding at such time (treating as actually outstanding any Convertible Securities issuable upon exercise of other Convertible Securities actually outstanding at such time), in each case, regardless of whether the Convertible Securities are actually exercisable, convertible or exchangeable at such time; provided, that Common Stock Deemed Outstanding at any given time shall not include shares owned or held by or for the account of the Company or any of its Wholly Owned subsidiaries.
“Company” shall have the meaning specified in the first paragraph of this Indenture, and subject to the provisions of ‎Article 11, shall include its successors and assigns.
“Company Order” means a written order of the Company, signed by the Company’s Chief Executive Officer, President, Chief Financial Officer, Executive or Senior Vice President, any Vice President (whether or not designated by a number or numbers or word or words added before or after the title “Vice President”), the Company’s Treasurer or Assistant Treasurer or the Company’s Secretary or any Assistant Secretary, and delivered to the Trustee.
“Comparable Treasury Issue” means the United States Treasury security or securities selected by the Quotation Agent as having an actual or interpolated maturity comparable to the remaining term of the Notes that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of a comparable maturity to the remaining term of the Notes.
“Comparable Treasury Price” means, with respect to any Fundamental Change Repurchase Date, (a) the arithmetic average (as determined by the Quotation Agent) of the Reference Treasury Dealer Quotations for such Fundamental Change Repurchase Date after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (b) if the Quotation Agent obtains fewer than four (4) Reference Treasury Dealer Quotations, the arithmetic average of all such Reference Treasury Dealer Quotations for such Fundamental Change Repurchase Date.
4

“Consolidated EBITDA” means, for any period, Consolidated Net Income for such period; plus, to the extent such amount was deducted in calculating such Consolidated Net Income:
1.Consolidated Interest Expense;
2.income taxes;
3.depreciation expense;
4.amortization expense; and
5.without duplication for items already excluded, (x) all other non-cash items reducing Consolidated Net Income (including any non-cash items under that certain Tax Receivable Agreement, dated February 22, 2005, among the Company, Cendant Corporation and Cendant Mobility Services Corporation) minus (y) all non-cash items increasing Consolidated Net Income, all as determined on a consolidated basis for the Company, its Restricted Subsidiaries and its Regulated Subsidiaries in conformity with GAAP;
provided that, if any Restricted Subsidiary or Regulated Subsidiary is not a Wholly Owned Restricted Subsidiary or Wholly Owned Regulated Subsidiary, as the case may be, Consolidated EBITDA shall be reduced (to the extent not otherwise reduced in accordance with GAAP) by an amount equal to (A) the amount of the Consolidated Net Income attributable to such Restricted Subsidiary or Regulated Subsidiary multiplied by (B) the percentage of Common Stock of such Restricted Subsidiary or Regulated Subsidiary not owned on the last day of such period by the Company or any of its Restricted Subsidiaries or any of its Wholly Owned Regulated Subsidiaries.
“Consolidated Fixed Charge Coverage Ratio” means, with respect to any Person, the ratio of Consolidated EBITDA of such Person during the most recent four full fiscal quarters (the “Four Quarter Period”), for which financial statements are available, ending on or prior to the date of the transaction giving rise to the need to calculate the Consolidated Fixed Charge Coverage Ratio (the “Transaction Date”), to Consolidated Fixed Charges of such Person for the Four Quarter Period. In addition to and without limitation of the foregoing, for purposes of this definition, Consolidated EBITDA and Consolidated Fixed Charges shall be calculated after giving effect on a pro forma basis for the period of such calculation to:
1.the Incurrence or repayment of any Indebtedness of such Person or any of its Restricted Subsidiaries or Regulated Subsidiaries (and the application of the proceeds thereof) as part of the transaction giving rise to the need to make such calculation and any Incurrence or repayment of other Indebtedness (and the application of the proceeds thereof), other than the Incurrence or repayment of Indebtedness in the ordinary course of business for working capital purposes pursuant to working capital facilities, occurring during the Four Quarter Period or at any time subsequent to the last day of the Four Quarter Period and on or prior to the Transaction Date, as if such Incurrence or repayment, as the case may be (and the application of the proceeds thereof), occurred on the first day of the Four Quarter Period; and
2.any Asset Sales or Asset Acquisitions (including, without limitation, any Asset Acquisition giving rise to the need to make such calculation as a result of such Person or one of its Restricted Subsidiaries or Regulated Subsidiaries (including any Person who becomes a Restricted Subsidiary or Regulated Subsidiaries as a result of the Asset Acquisition) Incurring, assuming or otherwise being liable for Acquired Indebtedness and also including any Consolidated EBITDA attributable to the assets which are the subject of the Asset Acquisition or Asset Sale during the Four Quarter Period) occurring during the Four Quarter Period or at any time subsequent to the last day of the Four Quarter Period and on or prior to the Transaction Date, as if such Asset Sale or Asset Acquisition (including the Incurrence, assumption or liability for any such Acquired Indebtedness) occurred on the first day of the Four Quarter Period.
5

If such Person or any of its Restricted Subsidiaries or Regulated Subsidiaries directly or indirectly guarantees Indebtedness of a third Person, the preceding sentence shall give effect to the Incurrence of such guaranteed Indebtedness as if such Person or any Restricted Subsidiary of such Person had directly Incurred or otherwise assumed such guaranteed Indebtedness. Furthermore, in calculating “Consolidated Fixed Charges”:
1.interest on outstanding Indebtedness determined on a fluctuating basis as of the Transaction Date and which will continue to be so determined thereafter shall be deemed to have accrued at a fixed rate per annum equal to the rate of interest on such Indebtedness in effect on the Transaction Date;
2.if interest on any Indebtedness actually Incurred on the Transaction Date may optionally be determined at an interest rate based upon a factor of a prime or similar rate, a Eurocurrency interbank offered rate, or other rates, then the interest rate in effect on the Transaction Date will be deemed to have been in effect during the Four Quarter Period; and
3.notwithstanding clause (1) above, interest on Indebtedness determined on a fluctuating basis, to the extent such interest is covered by agreements relating to Interest Swap Obligations, shall be deemed to accrue at the rate per annum resulting after giving effect to such agreements.
“Consolidated Fixed Charges” means, with respect to any Person for any period, the sum, without duplication, of (1) Consolidated Interest Expense, plus (2) the product of (A) the amount of all dividend payments on any series of Preferred Stock of such Person (other than (x) dividends paid in Qualified Stock and (y) dividends on the Preferred Stock to the extent they are paid in kind or accrete, except to the extent they constitute Disqualified Stock) paid, accrued or scheduled to be paid or accrued during such period times (B) a fraction, the numerator of which is one and the denominator of which is one minus the then current effective consolidated federal, state and local tax rate of such Person, expressed as a decimal. 
“Consolidated Interest Expense” means, for any period, the aggregate amount of interest  in respect of Indebtedness (including, without limitation, amortization of original issue discount on any Indebtedness and the interest portion of any deferred payment obligation of the type described under clause (4) of the definition of “Indebtedness,” calculated in accordance with the effective interest method of accounting; all commissions, discounts and other fees and charges owed with respect to letters of credit and bankers’ acceptance financing; Indebtedness that is Guaranteed or secured by the Company, any of its Restricted Subsidiaries, or any of its Regulated Subsidiaries), and all but the principal component of rentals in respect of Capitalized Lease Obligations paid, accrued or scheduled to be paid or to be accrued by the Company, its Restricted Subsidiaries and its Regulated Subsidiaries during such period; excluding, however, (1) any amount of such interest of any Restricted Subsidiary or Regulated Subsidiary if the net income of such Restricted Subsidiary or Regulated Subsidiary is excluded in the calculation of Consolidated Net Income pursuant to clause (3) or (4) of the definition thereof (but only in the same proportion as the net income of such Restricted Subsidiary or Regulated Subsidiary is excluded from the calculation of Consolidated Net Income pursuant to clause (3) or (4) of the definition thereof) and (2) any premiums, fees and expenses (and any amortization thereof) payable in connection with the offering of the Notes, all as determined on a consolidated basis (without taking into account Unrestricted Subsidiaries) in conformity with GAAP, and (3) interest payments on trust preferred or similar securities issued by a Regulated Subsidiary to the extent the proceeds of the sale of such securities are invested in a Regulated Subsidiary.
“Consolidated Net Income” means, for any period, the aggregate net income (or loss) of the Company and its Restricted Subsidiaries and Regulated Subsidiaries for such period determined in conformity with GAAP; provided that the following items shall be excluded in computing Consolidated Net Income (without duplication):
1.the net income (or loss) of any Person that is not a Restricted Subsidiary or Regulated Subsidiary, except that the Company’s equity in the net income of any such Person for such period (to the extent not otherwise excluded pursuant to clauses (2) through (6) below) will be included up to the aggregate amount of cash actually distributed by such Person during such period to the Company or to its Restricted Subsidiaries or Regulated Subsidiaries (less minority interest therein) as a dividend or other distribution;
6

2.the net income (or loss) of any Person accrued prior to the date it becomes a Restricted Subsidiary or Regulated Subsidiary or is merged into or consolidated with the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries or all or substantially all of the property and assets of such Person are acquired by the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries;
3.the net income of any Restricted Subsidiary to the extent that the declaration or payment of dividends or similar distributions by such Restricted Subsidiary of such net income is not at the time permitted by the operation of the terms of its charter or any agreement, instrument, judgment, decree, order, statute, rule or governmental regulation applicable to such Restricted Subsidiary;
4.the net income of any Regulated Subsidiary (x) to the extent that the declaration or payment of dividends or similar distributions by such Regulated Subsidiary of such net income is not at the time permitted by the operation of the terms of its charter or any agreement or instrument with a Person, other than such Regulated Subsidiary’s applicable regulatory authorities, or any judgment or decree applicable to such Regulated Subsidiary and (y) other than to the extent that such Regulated Subsidiary reasonably believes, in good faith, that such net income could be distributed, declared or paid as a dividend or similar distribution without causing such Regulated Subsidiary to fail to be at least “adequately capitalized” as defined in the regulations of applicable regulatory authorities, or to meet minimum capital requirements imposed by applicable regulatory authorities;
5.any gains or losses (on an after-tax basis) attributable to Asset Sales or Regulated Sales;
6.all extraordinary gains and extraordinary losses, and unusual items;
7.the cumulative effect of changes in accounting principles;
8.the net after-tax effect of impairment charges related to goodwill and other intangible assets;
9.(i) any net after-tax effect of income (loss) from the early extinguishment or conversion of (a) Indebtedness, (b) Hedging Obligations or (c) other derivative instruments, (ii) any non-cash income (or loss) related to currency gains or losses related to Hedging Obligations pursuant to Financial Accounting Standards Codification No. 815 – Derivatives and Hedging (or such successor provision) and (iii) any non-cash expense, income, gain or loss attributable to the movement in mark to market valuation of Hedging Obligations pursuant to GAAP, shall be excluded; and
10.non-recurring cash charges and non-recurring cash income or gains.
“Consolidated Net Worth” means, at any date of determination, stockholders’ equity as set forth on the most recently available quarterly or annual consolidated balance sheet of the Company and its Restricted Subsidiaries and Regulated Subsidiaries (which shall be as of a date not more than 90 days prior to the date of such computation, and which shall not take into account Unrestricted Subsidiaries), plus, to the extent not included, any Preferred Stock of the Company, less any amounts attributable to Disqualified Stock or any equity security convertible into or exchangeable for Indebtedness, the cost of treasury stock and the principal amount of any promissory notes receivable from the sale of the Capital Stock of the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries, each item to be determined in conformity with GAAP (excluding the effects of foreign currency exchange adjustments under Financial Accounting Standards Board Statement of Financial Accounting Standards No. 52, as replaced by Financial Accounting Standards Codification No. 830 (or any other successor provision)).
“Conversion Agent” shall have the meaning specified in ‎Section 4.02.
7

“Conversion Date” shall have the meaning specified in ‎Section 13.02(c).
“Conversion Obligation” shall have the meaning specified in ‎Section 13.02(a).
“Conversion Price” shall initially mean $200.00, subject to adjustment in accordance with the provisions of ‎Section 13.03.
“Conversion Rate” shall have the meaning specified in ‎Section 13.02(a).
“Convertible Securities” shall have the meaning specified in ‎Section 13.03(f).
“Corporate Trust Office” means the principal office of the Trustee at which at any time its corporate trust business shall be administered, which office at the date of this Indenture is located at 500 Ross Street, 12th Floor, Pittsburgh, PA 15262, or such other address as the Trustee may designate from time to time by notice to the Holders and the Company, or the principal corporate trust office of any successor trustee (or such other address as such successor trustee may designate from time to time by notice to the Holders and the Company).
“Custodian” means the Trustee, as custodian for The Depository Trust Company, with respect to the Global Notes, or any successor entity thereto.
“Credit Facility” means an indebtedness facility or other financing arrangement (including, without limitation, the Credit Facilities, commercial paper facilities, letter of credit facilities or indentures) of the Company, its Restricted Subsidiaries or its Regulated Subsidiaries for working capital or other general corporate purposes, providing for revolving credit loans, term loans, letters of credit, bankers acceptances or other short-term or long-term indebtedness, including any notes, mortgages, guarantees, collateral documents, instruments and agreements executed in connection therewith together with the related documents, as such agreements may be amended (including any amendment and restatement), supplemented, replaced or otherwise modified from time to time (other than, for the avoidance of doubt, the Notes).
“Default” means any event that is, or after notice or passage of time, or both, would be, an Event of Default.
“Defaulted Amounts” means any amounts on any Note (including, without limitation, the Redemption Price, the Fundamental Change Repurchase Price, the Accreted Principal Amount and interest) that are payable but are not punctually paid or duly provided for when due under this Indenture.
“Depositary” means, with respect to each Global Note, the Person specified in ‎Section 2.05(c) as the Depositary with respect to such Notes, until a successor shall have been appointed and become such pursuant to the applicable provisions of this Indenture, and thereafter, “Depositary” shall mean or include such successor.
“Distributed Property” shall have the meaning specified in ‎Section 13.03(c).
“Disqualified Stock” means any class or series of Capital Stock of any Person that by its terms or otherwise is (1) required to be redeemed prior to a date that is 91 days following the Stated Maturity of the Notes, (2) redeemable at the option of the holder of such class or series of Capital Stock at any time prior to the Stated Maturity of the Notes or (3) convertible into or exchangeable for Capital Stock referred to in clause (1) or (2) above or Indebtedness having a scheduled maturity prior to the Stated Maturity of the Notes; provided that any Capital Stock that would not constitute Disqualified Stock but for provisions thereof giving holders thereof the right to require such Person to repurchase or redeem such Capital Stock upon the occurrence of an “asset sale” or “change of control” occurring prior to the Stated Maturity of the Notes shall not constitute Disqualified Stock if the “asset sale” or “change of control” provisions applicable to such Capital Stock are no more favorable to the holders of such Capital Stock than the provisions contained in Article 14 and such Capital Stock specifically provides that such Person will not repurchase or redeem any such stock pursuant to such provision prior to the Company’s repurchase of such Notes as are required to be repurchased pursuant to Article 14.
8

“Effective Date” means with respect to a share split or share combination, as applicable, the first date on which shares of the Common Stock trade on the applicable exchange or in the applicable market, regular way, reflecting such action.
“eNett/Optal Acquisition” means the acquisition by the Company of eNett International (Jersey) Limited, a Jersey limited company (“Everest”), and Optal Limited, a private company limited by shares incorporated in England and Wales (“Olympus”), pursuant to the terms of the Share Purchase Agreement, dated as of January 24, 2020 (as may be amended, restated, amended and restated, waived, supplemented or otherwise modified from time to time, the “eNett/Optal SPA”), by and among Everest, Olympus, Travelport Limited, a Bermuda exempted company, Toro Private Holdings I, Ltd., a private company limited by shares incorporated in England and Wales, the Everest Sellers (as defined therein), the Olympus Sellers (as defined therein) and the Company.
“Event of Default” shall have the meaning specified in ‎Section 6.01.
“Excess Acquisitions” means acquisitions of Common Stock by the relevant Holder after the date hereof other than securities acquired as a result of an employee or designee of such Holder (or any Affiliate of such Holder) serving as a member of the Board of Directors, any payment of interest on the Notes in-kind or adjustment pursuant to the terms of the Notes, reclassification, recapitalization, stock split or combination, exchange or readjustment of such Common Stock, or any stock dividend or stock distribution in respect of such Common Stock.
“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
“Excluded Issuance” means any issuance or sale of: (a) Convertible Securities or shares of Common Stock issued upon the conversion of Convertible Securities and (b) shares of Common Stock or Convertible Securities issued, with respect to (a) and (b) above, (i) directly or upon the exercise or vesting of options, restricted stock units or other equity awards to directors, officers, employees, consultants or agents of the Company in connection with their service as directors of the Company, their employment by the Company or their retention as consultants or agents by the Company, in each case authorized by the Board of Directors and issued pursuant to the Company's 2019 Equity and Incentive Plan or any other employee benefit plan, management incentive plan or compensation related arrangement or award adopted by the Company in the ordinary course and approved by the Board of Directors, (ii) any issuance of Common Stock pursuant to any stock purchase plan or stock ownership plan or similar plan or program approved by the Board of Directors, (iii) pursuant to any underwritten offering of Common Stock or Convertible Securities by the Company pursuant to an effective registration statement under the Securities Act, (iv) pursuant to any offering of Common Stock or Convertible Securities by the Company pursuant to Rule 144A, (v) pursuant to any private placements, subject to customary purchase price discounts not to exceed 9.0%, (vi) as consideration for any merger, consolidation, acquisition or similar transaction to which the Company or any of its subsidiaries is a party, including, without limitation, any “business combination” (as defined in the rules and regulations promulgated by the Securities and Exchange Commission) or otherwise as consideration for a bona fide acquisition of the securities or the assets, business unit, division or business of another Person, (vii) any issuance of shares of equity securities in connection with a bona fide strategic partnership or commercial arrangement with a Person that is not an Affiliate of the Company or any of its subsidiaries (other than (x) any such strategic partnership or commercial arrangement with a private equity firm, sovereign wealth fund, hedge fund or similar financial firm or (y) an issuance the primary purpose of which is a bona fide capital raise), (viii) any issuance of shares of any equity securities or convertible securities to a third party financial institution as an “equity kicker” in connection with a bona fide borrowing by the Company that is primarily a debt financing transaction, (ix) the issuance of Common Stock or Convertible Securities to a Governmental Authority or designee thereof (in each case, excluding a sovereign wealth fund who regularly makes financial investments) in connection with a financing transaction pursuant to a program developed to address COVID-19 (including the impacts thereof), and (x) any issuance of Common Stock in connection with the conversion, exercise or exchange of any Convertible Securities outstanding on the date of this Indenture in accordance with the terms of such Convertible Securities as in effect on the date of this Indenture.
9

“Ex-Dividend Date” means the first date on which shares of the Common Stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive the issuance, dividend or distribution in question, from the Company or, if applicable, from the seller of Common Stock on such exchange or market (in the form of due bills or otherwise) as determined by such exchange or market.
“Fair Market Value” means with respect to any security or other property, the fair market value of such security or other property as determined by the Board of Directors, acting in good faith.
“FATCA” shall have the meaning specified in ‎Section 4.10(a)(i)(D).
“FDIC” means the Federal Deposit Insurance Corporation.
“Federal Reserve” means the Board of Governors of the Federal Reserve System of the United States, together with its constituent banks and agencies.
“Foreign Subsidiary” means any Subsidiary of the Company that is an entity which is a controlled foreign corporation under Section 957 of the Internal Revenue Code or any Subsidiary that is otherwise organized under the laws of a jurisdiction other than the United States, any state thereof, or the District of Columbia.
“Form of Assignment and Transfer” means the “Form of Assignment and Transfer” attached as Attachment 3 to the Form of Note attached hereto as Exhibit A.
“Form of Fundamental Change Repurchase Notice” means the “Form of Fundamental Change Repurchase Notice” attached as Attachment 2 to the Form of Note attached hereto as Exhibit A.
“Form of Note” means the “Form of Note” attached hereto as Exhibit A.
“Form of Notice of Conversion” means the “Form of Notice of Conversion” attached as Attachment 1 to the Form of Note attached hereto as Exhibit A.
“Fundamental Change” shall be deemed to have occurred at the time after the Notes are originally issued if any of the following occurs:
1.a “person” or “group” within the meaning of Section 13(d) of the Exchange Act, other than the Company, its Subsidiaries and the employee benefit plans of the Company and its Subsidiaries, becomes the direct or indirect “beneficial owner,” as defined in Rule 13d-3 under the Exchange Act, of Common Stock representing more than 50% of the voting power of the Common Stock and files a Schedule TO (or any successor schedule, form or report) or any schedule, form or report under the Exchange Act disclosing that fact;
2.the consummation of (A) any recapitalization, reclassification or change of the Common Stock (other than changes resulting from a subdivision, combination or change in par value) as a result of which the Common Stock would be converted into, or exchanged for, stock, other securities, other property or assets; (B) any share exchange, consolidation or merger of the Company pursuant to which the Common Stock will be converted into cash, securities or other property or assets; or (C) any sale, lease or other transfer in one transaction or a series of related transactions of all or substantially all of the consolidated assets of the Company and its Subsidiaries, taken as a whole, to any Person other than one or more of the Company’s Wholly Owned Subsidiaries; provided, however, that neither (i) a transaction described in clause (A) or (B) in which the holders of all classes of the Company’s Common Equity immediately prior to such transaction own, directly or indirectly, more than 50% of all classes of Common Equity of the continuing or surviving Person or transferee or the parent thereof immediately after such transaction in substantially the same proportions as such ownership immediately prior to such transaction nor (ii) any merger of the Company solely for the purpose of changing the Company’s jurisdiction of incorporation that results in a reclassification, conversion or exchange of outstanding shares of the Common Stock solely into shares of common stock of the surviving entity that is Listed Stock (as defined below) and such Listed Stock becomes the Reference Property for the Notes shall be a Fundamental Change pursuant to this clause (b);
10

3.the stockholders of the Company approve any plan or proposal for the liquidation or dissolution of the Company; or
4.the Common Stock (or other common stock, ordinary shares or shares of Common Equity (or American depositary shares representing any of the foregoing) constituting Reference Property) ceases to be listed or quoted on any of The New York Stock Exchange, The NASDAQ Global Select Market or The NASDAQ Global Market (or any of their respective successors). 
If any transaction in which the Common Stock is replaced by the securities of another entity occurs, references to the Company in this definition shall instead be references to such other entity.
For purposes of this definition of “Fundamental Change” above, any transaction that constitutes a Fundamental Change pursuant to both clause (a) and clause (b) of such definition (without giving effect to the proviso in clause (b)) shall be deemed a Fundamental Change solely under clause (b) of such definition (subject to the proviso in clause (b)).
“Fundamental Change Company Notice” shall have the meaning specified in ‎Section 14.02(c).
“Fundamental Change Repurchase Date” shall have the meaning specified in ‎Section 14.02(a).
“Fundamental Change Repurchase Notice” shall have the meaning specified in ‎Section 14.02(b)(i).
“Fundamental Change Repurchase Price” shall have the meaning specified in ‎Section 14.02(a).
“GAAP” means generally accepted accounting principles in the United States of America as in effect as of the Issue Date, including, without limitation, those set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other entity as approved by a significant segment of the accounting profession. All ratios and computations contained or referred to in this Indenture shall be computed in conformity with GAAP applied on a consistent basis.
“Global Note” shall have the meaning specified in ‎Section 2.05(b).
“Governmental Entity” means any court, administrative agency or commission or other governmental authority or instrumentality, whether federal, state, local or foreign, and any applicable self-regulatory organization (including The New York Stock Exchange).
“Guarantee” means any obligation, contingent or otherwise, of any Person directly or indirectly guaranteeing any Indebtedness of any other Person and, without limiting the generality of the foregoing, any obligation, direct or indirect, contingent or otherwise, of such Person (1) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness of such other Person (whether arising by virtue of partnership arrangements, or by agreements to keep-well, to purchase assets, goods, securities or services (unless such purchase arrangements are on arm’s-length terms and are entered into in the ordinary course of business), to take-or-pay, or to maintain financial statement conditions or otherwise) or (2) entered into for purposes of assuring in any other manner the obligee of such Indebtedness of the payment thereof or to protect such obligee against loss in respect thereof (in whole or in part); provided that the term “Guarantee” shall not include endorsements for collection or deposit in the ordinary course of business, letters of credit issued by a Bank Regulated Subsidiary in the ordinary course of its business or other signature guarantees made by a Regulated Subsidiary in the ordinary course of its business. The term “Guarantee” used as a verb has a corresponding meaning.
“Hedging Obligations” means, with respect to any Person, the obligations of such person under (i) any and all rate swap transactions, basis swaps, credit derivative transactions, forward rate transactions, commodity swaps, commodity options, forward commodity contracts, equity or equity index swaps or options, bond or bond price or bond index swaps or options or forward bond or forward bond price or forward bond index transactions, interest rate 
11

options, forward foreign exchange transactions, cap transactions, floor transactions, collar transactions, currency swap transactions, cross-currency rate swap transactions, currency options, spot contracts, or any other similar transactions or any combination of any of the foregoing (including any options to enter into any of the foregoing), whether or not any such transaction is governed by or subject to any master agreement, and (ii) any and all transactions of any kind, and the related confirmations, which are subject to the terms and conditions of, or governed by, any form of master agreement published by the International Swaps and Derivatives Association, Inc., any International Foreign Exchange Master Agreement, or any other master agreement (any such master agreement, together with any related schedules, a “Master Agreement”), including any such obligations or liabilities under any Master Agreement.
“Holder,” as applied to any Note, or other similar terms (but excluding the term “beneficial holder”), means any Person in whose name at the time a particular Note is registered on the Note Register.
“Incremental Equivalent Debt” means Indebtedness incurred by one or more of the Company or any guarantor of the Senior Credit Facilities in the form of one or more series of senior secured first lien notes (but not term loans), junior lien term loans or notes, subordinated term loans or notes or senior unsecured term loans or notes, or any bridge facility, to the extent secured by the same collateral that secures the Senior Credit Facilities.   
“Incur” means, with respect to any Indebtedness, to incur, create, issue, assume, Guarantee or otherwise become liable for or with respect to, or become responsible for, the payment of, contingently or otherwise, such Indebtedness; provided that (1) any Indebtedness of a Person existing at the time such Person becomes a Restricted Subsidiary will be deemed to be Incurred by such Restricted Subsidiary at the time it becomes a Restricted Subsidiary and (2) neither the accrual of interest nor the accretion of original issue discount shall be considered an Incurrence of Indebtedness.
“Indebtedness” means, with respect to any Person at any date of determination (without duplication):
1.all indebtedness of such Person for borrowed money;
2.all obligations of such Person evidenced by bonds, debentures, notes or other similar instruments;
3.all obligations of such Person in respect of letters of credit or other similar instruments (including reimbursement obligations with respect thereto, but excluding letters of credit issued by such Person and excluding obligations with respect to letters of credit (including trade letters of credit) securing obligations (other than obligations described in (1) or (2) above or (5), (6) or (7) below) entered into in the ordinary course of business of such Person to the extent such letters of credit are not drawn upon or, if drawn upon, to the extent such drawing is reimbursed no later than the third Business Day following receipt by such Person of a demand for reimbursement);
4.all obligations of such Person to pay the deferred and unpaid purchase price of property or services, which purchase price is recorded as a liability under GAAP and due more than three months after the date of placing such property in service or taking delivery and title thereto or the completion of such services, except Trade Payables;
5.all Capitalized Lease Obligations of such Person;
6.all Indebtedness of other Persons secured by a Lien on any asset of such Person, whether or not such Indebtedness is assumed by such Person; provided that the amount of such Indebtedness shall be the lesser of (A) the fair market value of such asset at such date of determination and (B) the amount of such Indebtedness;
7.all Indebtedness of other Persons Guaranteed by such Person to the extent such Indebtedness is Guaranteed by such Person;
12

8.Acquired Indebtedness;
9.to the extent not otherwise included in this definition, net obligations under Hedging Obligations (other than Hedging Obligations not entered into for speculative investment purposes and designed to protect the Company or its Restricted Subsidiaries or Regulated Subsidiaries against fluctuations in commodity prices, equity prices, foreign currency exchange rates or interest rates and that do not increase the Indebtedness of the obligor outstanding at any time other than as a result of fluctuations in commodity prices, foreign currency exchange rates or interest rates or by reason of fees, indemnities and compensation payable thereunder); and
10.all obligations to redeem or repurchase Disqualified Stock issued by such Person,
11.provided that Indebtedness shall not include:
a.obligations arising from products and services offered by Regulated Subsidiaries in the ordinary course including, but not limited to, deposits, CDs, prepaid forward contracts, swaps, foreign currency purchases or sales and letters of credit;
b.indebtedness of the Company or any Restricted Subsidiary represented by letters of credit for the account of the Company or such Restricted Subsidiary, as the case may be, in order to provide security for workers’ compensation claims, payment obligations in connection with self-insurance, supporting performance, surety or appeal bonds or similar obligations in the ordinary course of business;
c.indebtedness arising from agreements of the Company or a Restricted Subsidiary providing for indemnification, adjustment of purchase price or similar obligations, in each case, Incurred or assumed in connection with the disposition of any business, assets or a Subsidiary, other than Guarantees of Indebtedness Incurred by any Person acquiring all or any portion of such business, assets or a Subsidiary for the purpose of financing such acquisition;
d.advances from the Federal Home Loan Bank, Federal Reserve Bank (or similar institution), repurchase and reverse repurchase agreements relating to Investment Securities, medium term notes, treasury tax and loan balances, federal discount window obligations, federal funds interbank loans, special direct investment balances, bank notes, commercial paper, term investment option balances, brokered certificates of deposit, dollar rolls, and fed funds purchased, in each case Incurred in the ordinary course of a Regulated Subsidiary’s business;
e.(i) indebtedness or other obligations Incurred by a Regulated Subsidiary the proceeds of which are used to satisfy applicable minimum capital requirements imposed by applicable regulatory authorities of such Regulated Subsidiary and (ii) any Guarantee thereof by the Company where the provision of such Guarantee by the Company is required by the applicable regulatory authority;
f.any obligations under or with respect to a Qualified Securitization Transaction;
g.any liability for federal, state, local or other taxes,
h.performance, surety or appeal bonds provided in the ordinary course of business, or
i.agreements providing for indemnification, adjustment of purchase price or similar obligations, or Guarantees or letters of credit, surety bonds or performance bonds securing any obligations of the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries pursuant to such agreements, in any case Incurred in connection with the disposition of any business, assets or Restricted Subsidiary or Regulated Subsidiary (other than Guarantees of 
13

Indebtedness Incurred by any Person acquiring all or any portion of such business, assets or Restricted Subsidiary or Regulated Subsidiary for the purpose of financing such acquisition), so long as the principal amount does not exceed the gross proceeds actually received by the Company or any Restricted Subsidiary or Regulated Subsidiary in connection with such disposition; and
j.any earn out obligations, including any obligations arising from or in connection with an Asset Acquisition or Investment that are conditioned upon the determination of earning, revenues, proceeds, profits or events after the closing of the transaction, shall not be deemed Indebtedness until such obligations become a liability on the balance sheet of such Person in accordance with GAAP and the amount of any such Indebtedness will be calculated in conformity with GAAP.
The amount of Indebtedness of any Person at any date shall be the outstanding balance at such date of all unconditional obligations as described above and, with respect to contingent obligations, the maximum liability upon the occurrence of the contingency giving rise to the obligation; provided that:
1.the amount outstanding at any time of any Indebtedness issued with original issue discount is the face amount of such Indebtedness less the remaining unamortized portion of the original issue discount of such Indebtedness at such time as determined in conformity with GAAP, and 
2.money borrowed and set aside at the time of the Incurrence of any Indebtedness in order to prefund the payment of the interest on such Indebtedness shall not be deemed to be “Indebtedness” so long as such money is held to secure the payment of such interest.
“Indenture” means this instrument as originally executed or, if amended or supplemented as herein provided, as so amended or supplemented.
“Interest Payment Date” means each January 15 and July 15 of each year, beginning on January 15, 2021 and ending on, and including, the Maturity Date.
“Interest Swap Obligations” means the obligations of any Person pursuant to any arrangement with any other Person, whereby, directly or indirectly, such Person is entitled to receive from time to time periodic payments calculated by applying either a floating or a fixed rate of interest on a stated notional amount in exchange for periodic payments made by such other Person calculated by applying a fixed or a floating rate of interest on the same notional amount and shall include, without limitation, interest rate swaps, caps, floors, collars and similar agreements.
“Investment” in any Person means any direct or indirect advance, loan or other extension of credit (including, without limitation, by way of Guarantee or similar arrangement; but excluding Investment Securities, advances to customers or suppliers in the ordinary course of business that are, in conformity with GAAP, recorded as accounts receivable, prepaid expenses or deposits on the balance sheet of the Company or its Restricted Subsidiaries, the acquisition of receivables or other payment obligations from customers and clients through factoring or other comparable arrangements, the purchase of portfolios of receivables or other payment obligations and endorsements for collection or deposit arising in the ordinary course of business) or capital contribution to (by means of any transfer of cash or other property to others or any payment for property or services for the account or use of others), or any purchase or acquisition of Capital Stock, bonds, notes, debentures or other similar instruments issued by, such Person and shall include (1) the designation of a Restricted Subsidiary as an Unrestricted Subsidiary and (2) the retention of the Capital Stock (or any other Investment) by the Company or any of its Restricted Subsidiaries, of (or in) any Person that has ceased to be a Restricted Subsidiary and/or a Regulated Subsidiary.
“Investment Securities” means marketable securities of a Person (other than an Affiliate or joint venture of the Company or any Restricted Subsidiary or any Regulated Subsidiary), mortgages, credit card and other loan receivables, futures contracts on marketable securities, interest rates and foreign currencies used for the hedging of 
14

marketable securities, mortgages or credit card and other loan receivables purchased, borrowed, sold, loaned or pledged by such Person in the ordinary course of its business. 
“Issue Date” means the original issue date of the Company’s 4.75% senior notes due 2023.
“Last Reported Sale Price” of the Common Stock on any date means the closing sale price per share (or if no closing sale price is reported, the average of the bid and ask prices or, if more than one in either case, the average of the average bid and the average ask prices) on that date as reported in composite transactions for the principal U.S. national or regional securities exchange on which the Common Stock is traded. If the Common Stock is not listed for trading on a U.S. national or regional securities exchange on the relevant date, the “Last Reported Sale Price” shall be the last quoted bid price for the Common Stock in the over-the-counter market on the relevant date as reported by OTC Markets Group Inc. or a similar organization. If the Common Stock is not so quoted, the “Last Reported Sale Price” shall be the average of the mid-point of the last bid and last ask prices for the Common Stock on the relevant date from a nationally recognized independent investment banking firm selected by the Company for this purpose.
“Lien” means any mortgage, pledge, security interest, encumbrance, lien or charge of any kind (including, without limitation, any conditional sale or other title retention agreement).
“Market Disruption Event” means (a) a failure by the primary U.S. national or regional securities exchange or market on which the Common Stock is listed or admitted for trading to open for trading during its regular trading session or (b) the occurrence or existence prior to 1:00 p.m., New York City time, on any Trading Day for the Common Stock for more than one half-hour period in the aggregate during regular trading hours of any suspension or limitation imposed on trading (by reason of movements in price exceeding limits permitted by the relevant stock exchange or otherwise) in the Common Stock or in any options contracts or futures contracts relating to the Common Stock.
“Maturity Date” means July 15, 2027.
“Merger Event” shall have the meaning specified in ‎Section 13.06(a).
“New Notes” shall have the meaning specified in ‎Section 4.11(e).
“Note Register” shall have the meaning specified in ‎Section 2.05(a).
“Note Registrar” shall have the meaning specified in ‎Section 2.05(a).
“Notes” shall have the meaning specified in the first paragraph of the recitals of this Indenture and reference to a “Note” means $1,000 Original Principal Amount of Notes.
“Notice of Conversion” shall have the meaning specified in ‎Section 13.02(b).
“Notice of Redemption” shall have the meaning specified in ‎Section 15.02(a).
“NYSE Conversion Restriction” shall have the meaning specified in Section 13.02(a).
“OCC” means the United States Office of the Comptroller of the Currency.
“Officer” means, with respect to the Company, the President, the Chief Executive Officer, the Chief Financial Officer, the Treasurer, the Secretary, any Executive or Senior Vice President or any Vice President (whether or not designated by a number or numbers or word or words added before or after the title “Vice President”).
15

“Officer’s Certificate,” when used with respect to the Company, means a certificate that is delivered to the Trustee and that is signed by an Officer of the Company, as the case may be. Each such certificate shall include the statements provided for in ‎Section 16.05 if and to the extent required by the provisions of such Section. The Officer giving an Officer’s Certificate pursuant to ‎Section 4.08 shall be the principal executive, financial or accounting officer of the Company.
“open of business” means 9:00 a.m. (New York City time).
“Opinion of Counsel” means an opinion in writing signed by legal counsel, who may be an employee of or counsel to the Company, or other counsel reasonably acceptable to the Trustee, that is delivered to the Trustee, which opinion may contain customary exceptions and qualifications as to the matters set forth therein and which legal counsel may, in providing such opinion, rely upon certifications or other representations as to matters of fact. Each such opinion shall include the statements provided for in ‎Section 16.05 if and to the extent required by the provisions of such ‎Section 16.05.
“Optional Redemption” shall have the meaning specified in ‎Section 15.01.
“Original Principal Amount” means, at any date or time, the $1,000 original principal amount per Note on the date of this Indenture.
“outstanding,” when used with reference to Notes, shall, subject to the provisions of ‎Section 8.04, mean, as of any particular time, all Notes authenticated and delivered by the Trustee under this Indenture, except:
1.Notes theretofore canceled by the Trustee or accepted by the Trustee for cancellation;
2.Notes, or portions thereof, that have become due and payable and in respect of which monies in the necessary amount shall have been deposited in trust with the Trustee or with any Paying Agent (other than the Company) or shall have been set aside and segregated in trust by the Company (if the Company shall act as its own Paying Agent);
3.Notes that have been paid pursuant to ‎Section 2.06 or Notes in lieu of which, or in substitution for which, other Notes shall have been authenticated and delivered pursuant to the terms of ‎Section 2.06 unless proof satisfactory to the Trustee is presented that any such Notes are held by protected purchasers in due course;
4.Notes converted pursuant to ‎Article 13 and required to be cancelled pursuant to ‎Section 2.08;
5.Notes redeemed pursuant to ‎Article 15; and
6.Notes repurchased by the Company pursuant to ‎Section 2.10 after the Company surrenders them for cancellation to the Trustee in accordance with ‎Section 2.08.
“Paying Agent” shall have the meaning specified in ‎Section 4.02.
“Person” means an individual, a corporation, a limited liability company, an association, a partnership, a joint venture, a joint stock company, a trust, an unincorporated organization or a government or an agency or a political subdivision thereof.
“Physical Notes” means permanent certificated Notes in registered form issued in denominations of $1,000 Original Principal Amount and integral multiples thereof.
“PIK Interest” shall have the meaning specified in ‎Section 2.03(b).
“Predecessor Note” of any particular Note means every previous Note evidencing all or a portion of the same debt as that evidenced by such particular Note; and, for the purposes of this definition, any Note authenticated 
16

and delivered under ‎Section 2.06 in lieu of or in exchange for a mutilated, lost, destroyed or stolen Note shall be deemed to evidence the same debt as the mutilated, lost, destroyed or stolen Note that it replaces.
“Preferred Stock” of any Person means any Capital Stock of such Person that has preferential rights to any other Capital Stock of such Person with respect to dividends or redemptions or upon liquidation.
“Pricing Date” shall have the meaning specified in ‎Section 13.03(f).
“Purchase Money Indebtedness” means Indebtedness (1) Incurred to finance the cost (including the cost of improvement or construction and fees and expenses related to the acquisition) of real or personal property acquired after the Issue Date, provided that (a) the amount of such indebtedness does not exceed 100% of such cost, and (b) such Indebtedness is Incurred prior to, at the time of, or within twelve months after the later of the acquisition, the completion of construction or the commencement of full operation of such property; or (2) issued in exchange for, or the net proceeds of which are used to refinance or refund, then outstanding Purchase Money Indebtedness and any refinancings or refundings thereof in accordance with clause (iii) of ‎Section 4.11(a).
“Qualified Securitization Transaction” means a securitization or other sale or financing of Securitization Assets.
“Qualified Stock” means any class or series of Capital Stock of any Person other than Disqualified Stock.
“Quotation Agent” means one of the Reference Treasury Dealers appointed by the Issuer.
“Record Date” means, with respect to any dividend, distribution or other transaction or event in which the holders of Common Stock (or other applicable security) have the right to receive any cash, securities or other property or in which the Common Stock (or such other security) is exchanged for or converted into any combination of cash, securities or other property, the date fixed for determination of holders of the Common Stock (or such other security) entitled to receive such cash, securities or other property (whether such date is fixed by the Board of Directors, by statute, by contract or otherwise).
“Redemption Date” shall have the meaning specified in ‎Section 15.02(a).
“Redemption Price” means, for any Notes to be redeemed pursuant to ‎Section 15.01 100% of the Accreted Principal Amount of such Notes (which for purposes of ‎Article 15 shall include accrued interest thereon to, but excluding, the Redemption Date as though such date were an Interest Payment Date in accordance with the provisions of ‎Section 2.03).
“Reference Property” shall have the meaning specified in ‎Section 13.06(a).
“Reference Treasury Dealer Quotations” means, with respect to any Reference Treasury Dealer and any Fundamental Change Repurchase Date, the average (as determined by the Quotation Agent) of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the Quotation Agent by such Reference Treasury Dealer at 3:30 p.m. New York City time on the third Trading Day preceding such Fundamental Change Repurchase Date.
“Reference Treasury Dealer” means any primary U.S. Government securities dealers in New York City selected by the Company.
“Regular Record Date” means, with respect to any Interest Payment Date, fifteen days immediately preceding the applicable Interest Payment Date (whether or not such day is a Business Day).
“Regulated Sale” means any sale, transfer or other disposition (including by way of merger, consolidation or Sale-Leaseback Transaction) in one transaction or a series of related transactions by any Regulated Subsidiaries to any Person other than the Company or any of its Restricted Subsidiaries or Regulated Subsidiaries of:
17

1.all or any of the Common Stock of any Regulated Subsidiary that constitutes a Significant Subsidiary, or
2.all or substantially all of the property and assets of any Regulated Subsidiary that constitutes a Significant Subsidiary,
in each case, that is not governed by Article 11; provided that “Regulated Sale” shall not include (i) an issuance, sale, transfer or other disposition of Capital Stock by a Regulated Subsidiary to the Company, a Wholly Owned Restricted Subsidiary or a Wholly Owned Regulated Subsidiary or (ii) any sale, transfer or disposition described in clauses (a), (c), (d), (f), (g) (as if it applied to a Regulated Subsidiary), (h), (i), (j), (k), (m), (n), (o) or (q) of the proviso to the definition of Asset Sale.
“Related Business” means any business which is the same as or ancillary or complementary to any business of the Company and its Restricted Subsidiaries and Regulated Subsidiaries that is being conducted on the date hereof, and, with respect to any Regulated Subsidiary, any activity or business in which it is permitted to engage, from time to time, by applicable statute and regulation.
“Relevant Taxing Jurisdiction” shall have the meaning specified in ‎Section 4.10(a).
“Required Percentage” means a majority.
“Responsible Officer” means, when used with respect to the Trustee, any officer within the corporate trust department of the Trustee, including any trust officer or any other officer of the Trustee who customarily performs functions similar to those performed by the Persons who at the time shall be such officers, respectively, or to whom any corporate trust matter is referred because of such person’s knowledge of and familiarity with the particular subject and who shall have direct responsibility for the administration of this Indenture.
“Restricted Securities” shall have the meaning specified in ‎Section 2.05(c).
“Restricted Subsidiary” means any Subsidiary of the Company other than an Unrestricted Subsidiary or a Regulated Subsidiary.
“Regulated Subsidiary” means a Bank Regulated Subsidiary or any other Subsidiary subject to minimum capital requirements or other similar material regulatory requirements imposed by applicable bank regulatory authorities.
“Regulatory Cap” shall have the meaning specified in Section 13.02(a). 
“Rule 144” means Rule 144 as promulgated under the Securities Act.
“Rule 144A” means Rule 144A as promulgated under the Securities Act.
“Sale-Leaseback Transaction” means, with respect to any Person, an arrangement whereby such Person sells or transfers property and then or thereafter leases such property or any substantial part thereof which such Person intends to use for substantially the same purpose or purposes as the property sold or transferred; provided that for purposes of this definition, “property” shall not include Investment Securities.
“Securitization Assets” means credit card receivables, leases, lease receivables, other receivables, royalty and revenue streams, other financial assets, proceeds of the foregoing, and books, records and other related assets incidental to the foregoing.
 “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
18

“Securities Purchase Agreement” means the WEX Inc. Common Stock and 6.50% Convertible Senior Notes Due 2027 Purchase Agreement, dated as of June 29, 2020, among the Company and the Purchasers named therein relating to the purchase and sale of the Notes, as such agreement may be amended, supplemented, modified or restated.
“Senior Credit Facilities” means the credit facilities provided under the Credit Agreement dated as of July 1, 2016, and as amended through the date hereof, among the Company, certain Subsidiaries of the Company party thereto, the lenders party thereto from time to time in their capacities as lenders thereunder, and Bank of America, N.A., as administrative agent, including any notes, mortgages, guarantees, collateral documents, instruments and agreements executed in connection therewith, and any amendments, supplements, modifications, extensions, replacements, renewals, restatements, restructurings, refundings or refinancings thereof and any one or more indentures or credit facilities or commercial paper facilities with banks or other institutional lenders or investors that extend, replace, refund, refinance, renew or defease any part of the loans, notes, other credit facilities or commitments thereunder, including any such replacement, restructuring, refunding or refinancing facility or indenture that increases the amount borrowable thereunder or alters the maturity thereof or adds Restricted Subsidiaries as additional borrowers or guarantors thereunder and whether by the same or any other agent, lender or group of lenders.
“Settlement Amount” shall have the meaning specified in ‎Section 13.02(a)(i).
“Significant Subsidiary” means a Subsidiary of the Company that meets the definition of “significant subsidiary” in ‎Article 1, Rule 1-02(w) of Regulation S-X under the Exchange Act.
“Specified Dollar Amount” means the maximum cash amount per Note to be received upon conversion as specified in the settlement notice related to any converted Notes.
“Spin-Off” shall have the meaning specified in ‎Section 13.03(c).
“Stated Maturity” means, (1) with respect to any Indebtedness, the date specified in such Indebtedness as the fixed date on which the final installment of principal of such indebtedness security is due and payable and (2) with respect to any scheduled installment of principal of or interest on any Indebtedness, the date specified in such Indebtedness as the fixed date on which such installment is due and payable.
“Subsidiary” means, with respect to any Person, any corporation, association, partnership or other business entity of which more than 50% of the total voting power of shares of Capital Stock or other interests (including partnership interests) entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers, general partners or trustees thereof is at the time owned or controlled, directly or indirectly, by (i) such Person; (ii) such Person and one or more Subsidiaries of such Person; or (iii) one or more Subsidiaries of such Person.
“Successor Company” shall have the meaning specified in ‎Section 11.01(a).
“Trade Payables” means, with respect to any Person, any accounts payable or any other indebtedness or monetary obligation to trade creditors created, assumed or Guaranteed by such Person or any of its Subsidiaries arising in the ordinary course of business in connection with the acquisition of goods or services.
“Trading Day” means a day on which (i) trading in the Common Stock (or other security for which a closing sale price must be determined) generally occurs on The New York Stock Exchange or, if the Common Stock (or such other security) is not then listed on The New York Stock Exchange, on the principal other U.S. national or regional securities exchange on which the Common Stock (or such other security) is then listed or, if the Common Stock (or such other security) is not then listed on a U.S. national or regional securities exchange, on the principal other market on which the Common Stock (or such other security) is then traded and (ii) a Last Reported Sale Price for the Common Stock (or such other security) is available on such securities exchange or market, provided that any 
19

day on which a Market Disruption Event occurs shall not be a Trading Day; and provided further that if the Common Stock (or such other security) is not so listed or traded, “Trading Day” means a Business Day.
“transfer” shall have the meaning specified in ‎Section 2.05(c).
“Treasury Rate” means, with respect to any Fundamental Change Repurchase Date, the rate per annum equal to the semiannual equivalent yield to maturity or interpolated (on a day count basis) of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such Fundamental Change Repurchase Date.
“Trigger Event” shall have the meaning specified in ‎Section 13.03(c).
“Trust Indenture Act” means the Trust Indenture Act of 1939, as amended, as it was in force at the date of execution of this Indenture; provided, however, that in the event the Trust Indenture Act of 1939 is amended after the date of this Indenture, the term “Trust Indenture Act” shall mean, to the extent required by such amendment, the Trust Indenture Act of 1939, as so amended.
“Trustee” means the Person named as the “Trustee” in the first paragraph of this Indenture until a successor trustee shall have become such pursuant to the applicable provisions of this Indenture, and thereafter “Trustee” shall mean or include each Person who is then a Trustee hereunder.
“unit of Reference Property” shall have the meaning specified in ‎Section 13.06(a).
“Unrestricted Subsidiary” means (1) any Subsidiary of the Company that at the time of determination shall be designated an Unrestricted Subsidiary by the Board of Directors in the manner provided below; and (2) any Subsidiary of an Unrestricted Subsidiary. The Board of Directors may designate any Restricted Subsidiary or Regulated Subsidiary (including any newly acquired or newly formed Subsidiary of the Company) to be an Unrestricted Subsidiary unless such Subsidiary owns any Capital Stock of, or owns or holds any Lien on any property of, the Company or any Restricted Subsidiary; provided that (A) any Guarantee by the Company or any Restricted Subsidiary of any Indebtedness of the Subsidiary being so designated shall be deemed an “Incurrence” of such Indebtedness by the Company or such Restricted Subsidiary at the time of such designation; (B) either (I) the Subsidiary to be so designated has Total Assets of $1,000 or less or (C) if applicable, the Incurrence of Indebtedness referred to in clause (A) of this proviso would be permitted under ‎Section 4.11. The Board of Directors may designate any Unrestricted Subsidiary to be a Restricted Subsidiary; provided that (a) no default or Event of Default shall have occurred and be continuing at the time of or after giving effect to such designation and (b) all Indebtedness of such Unrestricted Subsidiary outstanding immediately after such designation would, if Incurred at such time, have been permitted to be Incurred (and shall be deemed to have been Incurred) for all purposes of this Indenture. Any such designation by the Board of Directors shall be evidenced to the Trustee by promptly filing with the Trustee a copy of the Board Resolution giving effect to such designation and an Officer’s Certificate certifying that such designation complied with the foregoing provisions.
“Valuation Period” shall have the meaning specified in ‎Section 13.03(c).
“VWAP” means, for a 20 consecutive Trading Day period, the per share volume-weighted average price as displayed under the heading “Bloomberg VWAP” on Bloomberg page “WEX <equity> AQR” (or its equivalent successor if such page is not available) in respect of the period from the scheduled open of trading on the first such Trading Day until the scheduled close of trading of the primary trading session on the 20th such Trading Day (or if such volume-weighted average price is unavailable for any such period, the market value of one share of the Common Stock for such period determined, using a volume-weighted average method, by a nationally recognized independent investment banking firm retained for this purpose by the Company). The “VWAP” shall be determined without regard to after-hours trading or any other trading outside of the regular trading session trading hours. 
20

“Wholly Owned” means, with respect to any Subsidiary of any Person, the ownership all of the outstanding Capital Stock of such Subsidiary (other than directors’ qualifying shares) by such Person or one or more Wholly Owned Subsidiaries of such Person.
Section 1.02 References to Interest. Unless the context otherwise requires, any reference to interest on, or in  respect of, any Note in this Indenture shall be deemed to include Additional Interest if, in such context, Additional Interest is, was or would be payable pursuant to ‎Section 6.03. 
ARTICLE 2:  Issue, Description, Execution, Registration and Exchange Of Notes
Section 2.01 Designation and Amount.. The Notes shall be designated as the “6.50% Convertible Senior Notes due 2027.” The aggregate Original Principal Amount of Notes that may be authenticated and delivered under this Indenture is limited to $310,000,000, except for Notes authenticated and delivered upon registration or transfer of, or in exchange for, or in lieu of other Notes to the extent expressly permitted hereunder.
Section 2.02 Form of Notes. The Notes and the Trustee’s certificate of authentication to be borne by such Notes shall be substantially in the respective forms set forth in Exhibit A, the terms and provisions of which shall constitute, and are hereby expressly incorporated in and made a part of this Indenture. To the extent applicable, the Company and the Trustee, by their execution and delivery of this Indenture, expressly agree to such terms and provisions and to be bound thereby. 
Any Global Note may be endorsed with or have incorporated in the text thereof such legends or recitals or changes not inconsistent with the provisions of this Indenture as may be required by the Custodian or the Depositary, or as may be required to comply with any applicable law or any regulation thereunder or with the rules and regulations of any securities exchange or automated quotation system upon which the Notes may be listed or traded or designated for issuance or to conform with any usage with respect thereto, or to indicate any special limitations or restrictions to which any particular Notes are subject.
Any of the Notes may have such letters, numbers or other marks of identification and such notations, legends or endorsements as the Officer executing the same may approve (execution thereof to be conclusive evidence of such approval) and as are not inconsistent with the provisions of this Indenture, or as may be required to comply with any law or with any rule or regulation made pursuant thereto or with any rule or regulation of any securities exchange or automated quotation system on which the Notes may be listed or designated for issuance, or to conform to usage or to indicate any special limitations or restrictions to which any particular Notes are subject.
Each Global Note shall represent such Original Principal Amount of the outstanding Notes as shall be specified therein and shall provide that it shall represent the aggregate Original Principal Amount of outstanding Notes from time to time endorsed thereon and that the aggregate Original Principal Amount of outstanding Notes represented thereby may from time to time be increased or reduced to reflect redemptions, repurchases, cancellations, conversions, transfers or exchanges permitted hereby. Any endorsement of a Global Note to reflect the amount of any increase or decrease in the amount of outstanding Notes represented thereby shall be made by the Trustee or the Custodian, at the direction of the Trustee, in such manner and upon instructions given by the Holder of such Notes in accordance with this Indenture. Payment of principal (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable) of a Global Note shall be made to the Holder of such Note on the date of payment.
Section 2.03 Date and Denomination of Notes; Payments of Interest and Defaulted Amounts. (a) The Notes shall be issuable in registered form without coupons in denominations of $1,000 Original Principal Amount and integral multiples thereof. Each Note shall be dated the date of its authentication and shall bear interest from the date specified on the face of such Note. Accrued interest on the Notes shall be computed on the basis of a 360-day year composed of twelve 30-day months and, for partial months, on the basis of the number of days actually elapsed in a 30-day month. 
21

(b) Interest will be payable, at the election of the Company, in whole or in part, on each Interest Payment Date (i) as cash interest and/or (ii) as accrued interest to be added as an accretion to the principal amount of the Notes (“PIK Interest”). If the Company elects, in respect of any Interest Payment Date, to pay PIK Interest on the Notes, the Company must make such election in writing to the Trustee at least 10 days prior to such Interest Payment Date, and such election shall be irrevocable once made.  Following receipt of any such election from the Company, the Trustee, in the name and at the expense of the Company, shall cause such notice to be delivered to each Holder on or prior to such Interest Payment Date.  If the Company fails to timely make an election with respect to payment of interest on any Interest Payment Date, then interest shall be payable on such date in cash.
On each Interest Payment Date, the principal amount of each Note shall be the Accreted Principal Amount of such Note immediately prior to such Interest Payment Date and, solely to the extent the Company elects to make a PIK Interest payment, plus the amount of interest accrued on such Accreted Principal Amount during the period beginning on the Interest Payment Date next preceding the applicable Interest Payment Date (or if none, from July 1, 2020) and ending on, but excluding such Interest Payment Date. Accordingly, any reference herein to the principal amount of a Note at any time shall be a reference to its Accreted Principal Amount at such time; provided that, any reference to the payment of accrued and unpaid interest on a Note as of any date shall be deemed to include all interest accrued (if any) from the immediately preceding Interest Payment Date (or if none, from the date of issuance of the Note) which shall be added to the Accreted Principal Amount of such Note as though such date were an Interest Payment Date. Interest shall accrue on the Accreted Principal Amount of each Note at the per annum rate of 6.50%.
On each Interest Payment Date, solely to the extent the Company elects to make a PIK Interest payment, the Company shall be required to notify the Trustee of the then current Accreted Principal Amount per Note.
The Person in whose name any Note (or its Predecessor Note) is registered on the Note Register at the close of business on any Regular Record Date with respect to any Interest Payment Date shall be entitled to receive any interest payable on such Interest Payment Date.  Payment of cash interest, if any, may be made by check mailed to the Holders at their addresses set forth in the Note Register; provided that payment by wire transfer of immediately available funds will be required with respect to principal of and interest (other than PIK Interest) on all Notes the Holders of which will have provided wire transfer instructions to the Company or the Paying Agent. Such payment (other than PIK Interest) will be in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts. If a payment date is not a Business Day, payment shall be made on the next succeeding day that is a Business Day, and no interest shall accrue for the intervening period on any amount that would otherwise have been payable on such payment date if it were a Business Day. 
(C)  Any Defaulted Amounts shall forthwith cease to be payable to the Holder on the relevant payment date but shall accrue interest per annum at the rate borne by the Notes, subject to the enforceability thereof under applicable law, from, and including, such relevant payment date, and such Defaulted Amounts together with such interest thereon shall be paid by the Company, at its election in each case, as provided in clauses ‎(i) or ‎(ii) below:
i.The Company may elect to make payment of or cause the Paying Agent to make payment of any Defaulted Amounts to the Persons in whose names the Notes (or their respective Predecessor Notes) are registered at the close of business on a special record date for the payment of such Defaulted Amounts, which shall be fixed in the following manner. The Company shall notify the Trustee in writing of the amount of the Defaulted Amounts proposed to be paid on each Note and the date of the proposed payment (which shall be not less than 25 days after the receipt by the Trustee of such notice, unless the Trustee shall consent to an earlier date), and at the same time the Company shall deposit with the Trustee an amount of money equal to the aggregate amount to be paid in respect of such Defaulted Amounts or shall make arrangements satisfactory to the Trustee for such deposit on or prior to the date of the proposed payment, such money when deposited to be held in trust for the benefit of the Persons entitled to such Defaulted Amounts as in this clause provided. Thereupon the Company shall fix a special record date for the payment of such Defaulted Amounts which shall be not more than 15 days and not less than 10 days prior to the date of the proposed payment, and not less than 10 days after the receipt by the Trustee of the notice of the proposed payment. The Company shall promptly notify the Trustee of such special record date and the Trustee, in the name 
22

and at the expense of the Company, shall cause notice of the proposed payment of such Defaulted Amounts and the special record date therefor to be delivered to each Holder not less than 10 days prior to such special record date. Notice of the proposed payment of such Defaulted Amounts and the special record date therefor having been so sent, such Defaulted Amounts shall be paid to the Persons in whose names the Notes (or their respective Predecessor Notes) are registered at the close of business on such special record date and shall no longer be payable pursuant to the following clause ‎(ii) of this ‎Section 2.03(c).
ii.The Company may make payment of or cause the Paying Agent to make payment of any Defaulted Amounts in any other lawful manner not inconsistent with the requirements of any securities exchange or automated quotation system on which the Notes may be listed or designated for issuance, and upon such notice as may be required by such exchange or automated quotation system, if, after notice given by the Company to the Trustee of the proposed payment pursuant to this clause, such manner of payment shall be deemed practicable by the Trustee.
Section 2.04 Execution, Authentication and Delivery of Notes. The Notes shall be signed in the name and on behalf of the Company by the manual, electronic or facsimile signature of its Chief Executive Officer, President, Chief Financial Officer, Treasurer, Secretary or any of its Executive or Senior Vice Presidents.
At any time and from time to time after the execution and delivery of this Indenture, the Company may deliver Notes executed by the Company to the Trustee for authentication, together with a Company Order for the authentication and delivery of such Notes, and the Trustee in accordance with such Company Order shall authenticate and deliver such Notes, without any further action by the Company hereunder.
Only such Notes as shall bear thereon a certificate of authentication substantially in the form set forth on the form of Note attached as Exhibit A hereto, executed manually or electronically by an authorized officer of the Trustee (or an authenticating agent appointed by the Trustee as provided by ‎Section 16.10), shall be entitled to the benefits of this Indenture or be valid or obligatory for any purpose. Such certificate by the Trustee (or such an authenticating agent) upon any Note executed by the Company shall be conclusive evidence that the Note so authenticated has been duly authenticated and delivered hereunder and that the Holder is entitled to the benefits of this Indenture.
In case any Officer of the Company who shall have signed any of the Notes shall cease to be such Officer before the Notes so signed shall have been authenticated and delivered by the Trustee, or disposed of by the Company, such Notes nevertheless may be authenticated and delivered or disposed of as though the person who signed such Notes had not ceased to be such Officer of the Company; and any Note may be signed on behalf of the Company by such persons as, at the actual date of the execution of such Note, shall be the Officers of the Company, although at the date of the execution of this Indenture any such person was not such an Officer.
Section 2.05 Exchange and Registration of Transfer of Notes; Restrictions on Transfer; Depositary.  The Company shall cause to be kept at the Corporate Trust Office a register (the register maintained in such office or in any other office or agency of the Company designated pursuant to ‎Section 4.02, the “Note Register”) in which, subject to such reasonable regulations as it may prescribe, the Company shall provide for the registration of Notes and of transfers of Notes. Such register shall be in written form or in any form capable of being converted into written form within a reasonable period of time. The Trustee is hereby initially appointed the “Note Registrar” for the purpose of registering Notes and transfers of Notes as herein provided. The Company may appoint one or more co-Note Registrars in accordance with ‎Section 4.02.
Upon surrender for registration of transfer of any Note to the Note Registrar or any co-Note Registrar, and satisfaction of the requirements for such transfer set forth in this ‎Section 2.05, the Company shall execute, and the Trustee shall authenticate and deliver, in the name of the designated transferee or transferees, one or more new Notes of any authorized denominations and of a like aggregate Original Principal Amount and bearing such restrictive legends as may be required by this Indenture.
23

Notes may be exchanged for other Notes of any authorized denominations and of a like aggregate Original Principal Amount, upon surrender of the Notes to be exchanged at any such office or agency maintained by the Company pursuant to ‎Section 4.02. Whenever any Notes are so surrendered for exchange, the Company shall execute, and the Trustee shall authenticate and deliver, the Notes that the Holder making the exchange is entitled to receive, bearing registration numbers not contemporaneously outstanding.
All Notes presented or surrendered for registration of transfer or for exchange, repurchase or conversion shall (if so required by the Company, the Trustee, the Note Registrar or any co-Note Registrar) be duly endorsed, or be accompanied by a written instrument or instruments of transfer in form satisfactory to the Company and duly executed, by the Holder thereof or its attorney-in-fact duly authorized in writing.
No service charge shall be imposed by the Company, the Trustee, the Note Registrar, any co-Note Registrar or the Paying Agent for any exchange or registration of transfer of Notes, but the Company may require a Holder to pay a sum sufficient to cover any documentary, stamp or similar issue or transfer tax required in connection therewith as a result of the name of the Holder of new Notes issued upon such exchange or registration of transfer being different from the name of the Holder of the old Notes surrendered for exchange or registration of transfer.
None of the Company, the Trustee, the Note Registrar or any co-Note Registrar shall be required to exchange or register a transfer of (i) any Notes surrendered for conversion or, if a portion of any Note is surrendered for conversion, such portion thereof surrendered for conversion, (ii) any Notes, or a portion of any Note, surrendered for repurchase (and not withdrawn) in accordance with ‎Article 14 or (iii) any Notes selected for Optional Redemption in accordance with ‎Article 15, except the unredeemed portion of any Note being redeemed in part.
All Notes issued upon any registration of transfer or exchange of Notes in accordance with this Indenture shall be the valid obligations of the Company, evidencing the same debt, and entitled to the same benefits under this Indenture as the Notes surrendered upon such registration of transfer or exchange.
(b) So long as the Notes are eligible for book-entry settlement with the Depositary, unless otherwise required by law, subject to the fourth paragraph from the end of ‎Section 2.05(c) all Notes shall be represented by one or more Notes in global form (each, a “Global Note”) registered in the name of the Depositary or the nominee of the Depositary. The transfer and exchange of beneficial interests in a Global Note that does not involve the issuance of a Physical Note shall be effected through the Depositary (but not the Trustee or the Custodian) in accordance with this Indenture (including the restrictions on transfer set forth herein) and the procedures of the Depositary therefor.
(c) Every Note that bears or is required under this ‎Section 2.05(c) to bear the legend set forth in this ‎Section 2.05(c) (together with any shares of Common Stock issued upon conversion of the Notes that is required to bear the legend set forth in ‎Section 2.05(d), collectively, the “Restricted Securities”) shall be subject to the restrictions on transfer set forth in this ‎Section 2.05(c) (including the legend set forth below), unless such restrictions on transfer shall be eliminated or otherwise waived by written consent of the Company, and the Holder of each such Restricted Security, by such Holder’s acceptance thereof, agrees to be bound by all such restrictions on transfer. As used in this ‎Section 2.05(c) and in ‎Section 2.05(d), the term “transfer” encompasses any sale, pledge, transfer or other disposition whatsoever of any Restricted Security.
Any certificate evidencing such Note (and all securities issued in exchange therefor or substitution thereof, other than Common Stock, if any, issued upon conversion thereof, which shall bear the legend set forth in ‎Section 2.05(d), if applicable) shall bear a legend in substantially the following form (unless such Notes have been transferred pursuant to a registration statement that has become or been declared effective under the Securities Act and that continues to be effective at the time of such transfer, or sold pursuant to the exemption from registration provided by Rule 144 or any similar provision then in force under the Securities Act, or unless otherwise agreed by the Company with notice in writing to the Trustee):
THIS SECURITY AND THE SHARES OF COMMON STOCK, IF ANY, ISSUABLE UPON CONVERSION OF THIS SECURITY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 
24

1933, AS AMENDED (THE “SECURITIES ACT”), AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF OR OF A BENEFICIAL INTEREST HEREIN, THE ACQUIRER:
(1)  REPRESENTS THAT IT AND ANY ACCOUNT FOR WHICH IT IS ACTING IS A “QUALIFIED INSTITUTIONAL BUYER” (WITHIN THE MEANING OF RULE 144A UNDER THE SECURITIES ACT) AND THAT IT EXERCISES SOLE INVESTMENT DISCRETION WITH RESPECT TO EACH SUCH ACCOUNT, AND
(2)  AGREES FOR THE BENEFIT OF WEX INC. (THE “COMPANY”) THAT IT WILL NOT OFFER, SELL, PLEDGE OR OTHERWISE TRANSFER THIS SECURITY OR ANY BENEFICIAL INTEREST HEREIN, EXCEPT:
(A)  TO THE COMPANY OR ANY SUBSIDIARY THEREOF, OR
(B)  PURSUANT TO A REGISTRATION STATEMENT WHICH HAS BECOME EFFECTIVE UNDER THE SECURITIES ACT, OR
(C)  TO A PERSON THAT IT REASONABLY BELIEVES TO BE A QUALIFIED INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT, OR
(D)  PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT OR ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.
PRIOR TO THE REGISTRATION OF ANY TRANSFER IN ACCORDANCE WITH CLAUSE (2)(D) ABOVE, THE COMPANY AND THE TRUSTEE RESERVE THE RIGHT TO REQUIRE THE DELIVERY OF SUCH LEGAL OPINIONS, CERTIFICATIONS OR OTHER EVIDENCE AS MAY REASONABLY BE REQUIRED IN ORDER TO DETERMINE THAT THE PROPOSED TRANSFER IS BEING MADE IN COMPLIANCE WITH THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS. NO REPRESENTATION IS MADE AS TO THE AVAILABILITY OF ANY EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.
IF THE NOTES ARE HELD BY THE PURCHASER PARTIES OR TRANSFEREES TO WHOM THE PURCHASER PARTIES TRANSFERRED NOTES IN RELIANCE ON SECTIONS 6(b)(i) OR 6(b)(ii) OF THE PURCHASE AGREEMENT:
THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO TRANSFER RESTRICTIONS SET FORTH IN A PURCHASE AGREEMENT, DATED AS OF JUNE 29, 2020, COPIES OF WHICH ARE ON FILE WITH THE SECRETARY OF THE ISSUER.
No transfer of any Note will be registered by the Note Registrar unless the applicable box on the Form of Assignment and Transfer has been checked.
Any Note (or security issued in exchange or substitution therefor) (i) on which the Company has agreed to remove the legend with notice in writing to the Trustee as set forth above in this ‎Section 2.05(c)), (ii) that has been transferred pursuant to a registration statement that has become effective or been declared effective under the Securities Act and that continues to be effective at the time of such transfer or (iii) that has been sold pursuant to the exemption from registration provided by Rule 144 or any similar provision then in force under the Securities Act, may, upon surrender of such Note for exchange to the Note Registrar in accordance with the provisions of this ‎Section 2.05, be exchanged for a new Note or Notes, of like tenor and aggregate Original Principal Amount, which shall not bear the restrictive legend required by this ‎Section 2.05(c) and shall not be assigned a restricted CUSIP number. The Company shall be entitled to instruct the Custodian in writing to so surrender any Global Note 
25

as to which any of the conditions set forth in clause (i) through (iii) of the immediately preceding sentence have been satisfied, and, upon such instruction, the Custodian shall so surrender such Global Note for exchange; and any new Global Note so exchanged therefor shall not bear the restrictive legend specified in this ‎Section 2.05(c) and shall not be assigned a restricted CUSIP number.
Notwithstanding any other provisions of this Indenture (other than the provisions set forth in this ‎Section 2.05(c)), a Global Note may not be transferred as a whole or in part except (i) by the Depositary to a nominee of the Depositary or by a nominee of the Depositary to the Depositary or another nominee of the Depositary or by the Depositary or any such nominee to a successor Depositary or a nominee of such successor Depositary and (ii) for exchange of a Global Note or a portion thereof for one or more Physical Notes in accordance with the second immediately succeeding paragraph.
The Depositary shall be a clearing agency registered under the Exchange Act. The Company initially appoints The Depository Trust Company to act as Depositary with respect to each Global Note. Initially, each Global Note shall be issued to the Depositary, registered in the name of Cede & Co., as the nominee of the Depositary, and deposited with the Trustee as custodian for Cede & Co.
If (i) the Depositary notifies the Company at any time that the Depositary is unwilling or unable to continue as depositary for the Global Notes and a successor depositary is not appointed within 90 days, (ii) the Depositary ceases to be registered as a clearing agency under the Exchange Act and a successor depositary is not appointed within 90 days or (iii) an Event of Default with respect to the Notes has occurred and is continuing and a beneficial owner of any Note requests that its beneficial interest therein be issued as a Physical Note, the Company shall execute, and the Trustee, upon receipt of an Officer’s Certificate and a Company Order for the authentication and delivery of Notes, shall authenticate and deliver (x) in the case of clause (iii), a Physical Note to such beneficial owner in an Original Principal Amount equal to the Original Principal Amount of such Note corresponding to such beneficial owner’s beneficial interest and (y) in the case of clause (i) or (ii), Physical Notes to each beneficial owner of the related Global Notes (or a portion thereof) in an aggregate Original Principal Amount equal to the aggregate Original Principal Amount of such Global Notes in exchange for such Global Notes, and upon delivery of the Global Notes to the Trustee such Global Notes shall be canceled.
Physical Notes issued in exchange for all or a part of the Global Note pursuant to this ‎Section 2.05(c) shall be registered in such names and in such authorized denominations as the Depositary, pursuant to instructions from its direct or indirect participants or otherwise, or, in the case of clause (iii) of the immediately preceding paragraph, the relevant beneficial owner, shall instruct the Trustee. Upon execution and authentication, the Trustee shall deliver such Physical Notes to the Persons in whose names such Physical Notes are so registered.
At such time as all interests in a Global Note have been converted, canceled, repurchased, redeemed or transferred, such Global Note shall be, upon receipt thereof, canceled by the Trustee in accordance with standing procedures and existing instructions between the Depositary and the Custodian. At any time prior to such cancellation, if any interest in a Global Note is exchanged for Physical Notes, converted, canceled, repurchased, redeemed or transferred to a transferee who receives Physical Notes therefor or any Physical Note is exchanged or transferred for part of such Global Note, the principal amount of such Global Note shall, in accordance with the standing procedures and instructions existing between the Depositary and the Custodian, be appropriately reduced or increased, as the case may be, and an endorsement shall be made on such Global Note, by the Trustee or the Custodian, at the direction of the Trustee, to reflect such reduction or increase.
None of the Company, the Trustee or any agent of the Company or the Trustee shall have any responsibility or liability for any aspect of the records relating to or payments made on account of beneficial ownership interests of a Global Note or maintaining, supervising or reviewing any records relating to such beneficial ownership interests. Subject to its compliance with its obligations under this Indenture, the Company shall have no responsibility or liability for any act or omission of the Depositary.
(d) Any stock certificate representing Common Stock issued upon conversion of a Note shall bear a legend in substantially the following form (unless such Common Stock has been transferred pursuant to a registration 
26

statement that has become or been declared effective under the Securities Act and that continues to be effective at the time of such transfer, or pursuant to the exemption from registration provided by Rule 144 or any similar provision then in force under the Securities Act, or such Common Stock has been issued upon conversion of a Note that has transferred pursuant to a registration statement that has become or been declared effective under the Securities Act and that continues to be effective at the time of such transfer, or pursuant to the exemption from registration provided by Rule 144 or any similar provision then in force under the Securities Act, or unless otherwise agreed by the Company with written notice thereof to any transfer agent for the Common Stock):
THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF OR OF A BENEFICIAL INTEREST HEREIN, THE ACQUIRER:
(1)  REPRESENTS THAT IT AND ANY ACCOUNT FOR WHICH IT IS ACTING IS A “QUALIFIED INSTITUTIONAL BUYER” (WITHIN THE MEANING OF RULE 144A UNDER THE SECURITIES ACT) AND THAT IT EXERCISES SOLE INVESTMENT DISCRETION WITH RESPECT TO EACH SUCH ACCOUNT, AND
(2)  AGREES FOR THE BENEFIT OF WEX INC. (THE “COMPANY”) THAT IT WILL NOT OFFER, SELL, PLEDGE OR OTHERWISE TRANSFER THIS SECURITY OR ANY BENEFICIAL INTEREST HEREIN, EXCEPT:
(A)  TO THE COMPANY OR ANY SUBSIDIARY THEREOF, OR
(B)  PURSUANT TO A REGISTRATION STATEMENT WHICH HAS BECOME EFFECTIVE UNDER THE SECURITIES ACT, OR
(C)  TO A PERSON THAT IT REASONABLY BELIEVES TO BE A QUALIFIED INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT, OR
(D)  PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT OR ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.
PRIOR TO THE REGISTRATION OF ANY TRANSFER IN ACCORDANCE WITH CLAUSE (2)(D) ABOVE, THE COMPANY AND THE TRANSFER AGENT FOR THE COMPANY’S COMMON STOCK RESERVE THE RIGHT TO REQUIRE THE DELIVERY OF SUCH LEGAL OPINIONS, CERTIFICATIONS OR OTHER EVIDENCE AS MAY REASONABLY BE REQUIRED IN ORDER TO DETERMINE THAT THE PROPOSED TRANSFER IS BEING MADE IN COMPLIANCE WITH THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS. NO REPRESENTATION IS MADE AS TO THE AVAILABILITY OF ANY EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.
IF THE SECURITIES ARE HELD BY THE PURCHASER PARTIES OR TRANSFEREES TO WHOM THE PURCHASER PARTIES TRANSFERRED SECURITIES IN RELIANCE ON SECTIONS 6(b)(i) OR 6(b)(ii) OF THE PURCHASE AGREEMENT:
THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO TRANSFER RESTRICTIONS SET FORTH IN A PURCHASE AGREEMENT, DATED AS OF JUNE 29, 2020, COPIES OF WHICH ARE ON FILE WITH THE SECRETARY OF THE ISSUER.
Any such Common Stock (i) on which the Company has agreed to remove the legend with notice in writing to the transfer agent as set forth above in this ‎Section 2.05(d), (ii) that has been transferred pursuant to a registration statement that has become or been declared effective under the Securities Act and that continues to be 
27

effective at the time of such transfer or (iii) that has been sold pursuant to the exemption from registration provided by Rule 144 or any similar provision then in force under the Securities Act, may, upon surrender of the certificates representing such Common Stock for exchange in accordance with the procedures of the transfer agent for the Common Stock, be exchanged for a new certificate or certificates for a like aggregate number of shares of Common Stock, which shall not bear the restrictive legend required by this ‎Section 2.05(d).
Section 2.06 Mutilated, Destroyed, Lost or Stolen Notes. In case any Note shall become mutilated or be destroyed, lost or stolen, the Company in its discretion may execute, and upon its written request the Trustee or an authenticating agent appointed by the Trustee shall authenticate and deliver, a new Note, bearing a registration number not contemporaneously outstanding, in exchange and substitution for the mutilated Note, or in lieu of and in substitution for the Note so destroyed, lost or stolen. In every case the applicant for a substituted Note shall furnish to the Company, to the Trustee and, if applicable, to such authenticating agent such security or indemnity as may be required by them to save each of them harmless from any loss, liability, cost or expense caused by or connected with such substitution, and, in every case of destruction, loss or theft, the applicant shall also furnish to the Company, to the Trustee and, if applicable, to such authenticating agent evidence to their satisfaction of the destruction, loss or theft of such Note and of the ownership thereof.
The Trustee or such authenticating agent may authenticate any such substituted Note and deliver the same upon the receipt of such security or indemnity as the Trustee, the Company and, if applicable, such authenticating agent may require. No service charge shall be imposed by the Company, the Trustee, the Note Registrar, any co-Note Registrar or the Paying Agent upon the issuance of any substitute Note, but the Company may require a Holder to pay a sum sufficient to cover any documentary, stamp or similar issue or transfer tax required in connection therewith as a result of the name of the Holder of the new substitute Note being different from the name of the Holder of the old Note that became mutilated or was destroyed, lost or stolen. In case any Note that has matured or is about to mature or has been surrendered for required repurchase or is about to be converted in accordance with ‎Article 13 shall become mutilated or be destroyed, lost or stolen, the Company may, in its sole discretion, instead of issuing a substitute Note, pay or authorize the payment of or convert or authorize the conversion of the same (without surrender thereof except in the case of a mutilated Note), as the case may be, if the applicant for such payment or conversion shall furnish to the Company, to the Trustee and, if applicable, to such authenticating agent such security or indemnity as may be required by them to save each of them harmless for any loss, liability, cost or expense caused by or connected with such substitution, and, in every case of destruction, loss or theft, evidence satisfactory to the Company, the Trustee and, if applicable, any Paying Agent or Conversion Agent evidence of their satisfaction of the destruction, loss or theft of such Note and of the ownership thereof.
Every substitute Note issued pursuant to the provisions of this ‎Section 2.06 by virtue of the fact that any Note is destroyed, lost or stolen shall constitute an additional contractual obligation of the Company, whether or not the destroyed, lost or stolen Note shall be found at any time, and shall be entitled to all the benefits of (but shall be subject to all the limitations set forth in) this Indenture equally and proportionately with any and all other Notes duly issued hereunder. To the extent permitted by law, all Notes shall be held and owned upon the express condition that the foregoing provisions are exclusive with respect to the replacement, payment, redemption, conversion or repurchase of mutilated, destroyed, lost or stolen Notes and shall preclude any and all other rights or remedies notwithstanding any law or statute existing or hereafter enacted to the contrary with respect to the replacement, payment, redemption, conversion or repurchase of negotiable instruments or other securities without their surrender.
Section 2.07 Temporary Notes. Pending the preparation of Physical Notes, the Company may execute and the Trustee or an authenticating agent appointed by the Trustee shall, upon written request of the Company, authenticate and deliver temporary Notes (printed or lithographed). Temporary Notes shall be issuable in any authorized denomination, and substantially in the form of the Physical Notes but with such omissions, insertions and variations as may be appropriate for temporary Notes, all as may be determined by the Company. Every such temporary Note shall be executed by the Company and authenticated by the Trustee or such authenticating agent upon the same conditions and in substantially the same manner, and with the same effect, as the Physical Notes. Without unreasonable delay, the Company shall execute and deliver to the Trustee or such authenticating agent Physical Notes (other than any Global Note) and thereupon any or all temporary Notes (other than any Global Note) may be surrendered in exchange therefor, at each office or agency maintained by the Company pursuant 
28

to ‎Section 4.02 and the Trustee or such authenticating agent shall authenticate and deliver in exchange for such temporary Notes an equal aggregate principal amount of Physical Notes. Such exchange shall be made by the Company at its own expense and without any charge therefor. Until so exchanged, the temporary Notes shall in all respects be entitled to the same benefits and subject to the same limitations under this Indenture as Physical Notes authenticated and delivered hereunder.
Section 2.08 Cancellation of Notes Paid, Converted, Etc. The Company shall cause all Notes surrendered for the purpose of payment at maturity, repurchase upon a Fundamental Change, redemption, registration of transfer or exchange or conversion, if surrendered to the Company or any of its agents, Subsidiaries or Affiliates, in each case, that the Company controls, to be delivered to the Trustee for cancellation. All Notes delivered to the Trustee shall be canceled promptly by it in accordance with its customary procedures. Except for Notes surrendered for transfer or exchange, no Notes shall be authenticated in exchange thereof except as expressly permitted by any of the provisions of this Indenture. The Trustee shall dispose of canceled Notes in accordance with its customary procedures.
Section 2.09 CUSIP Numbers. The Company in issuing the Notes may use “CUSIP” numbers (if then generally in use), and, if so, the Trustee shall use “CUSIP” numbers in all notices issued to Holders as a convenience to such Holders; provided that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Notes or on such notice and that reliance may be placed only on the other identification numbers printed on the Notes. The Company shall promptly notify the Trustee in writing of any change in the “CUSIP” numbers.
Section 2.10 Repurchases. The Company may, to the extent permitted by law, directly or indirectly (regardless of whether such Notes are surrendered to the Company), repurchase Notes in the open market or otherwise, whether by the Company or its Subsidiaries or through a privately negotiated transaction or public tender or exchange offer or through counterparties to private agreements, including by cash-settled swaps or other cash-settled derivatives. Any Notes so repurchased by the Company shall be submitted to the Trustee for cancellation.
ARTICLE 3: Satisfaction and Discharge

Section 3.01 Satisfaction and Discharge. This Indenture shall upon request of the Company contained in an Officer’s Certificate cease to be of further effect, and the Trustee, at the expense of the Company, shall execute proper instruments acknowledging satisfaction and discharge of this Indenture, when (a) (i) all Notes theretofore authenticated and delivered (other than Notes which have been destroyed, lost or stolen and which have been replaced, paid or converted as provided in ‎Section 2.06) have been delivered to the Trustee for cancellation; or (ii) the Company has deposited with the Trustee or delivered to Holders, as applicable, after the Notes have become due and payable, whether on the Maturity Date, any Redemption Date, any Fundamental Change Repurchase Date, upon conversion or otherwise, cash, shares of Common Stock or a combination thereof, as applicable, solely to satisfy the Company’s Conversion Obligation, sufficient to pay all of the outstanding Notes and all other sums due and payable under this Indenture by the Company; and (b) the Company has delivered to the Trustee an Officer’s Certificate and an Opinion of Counsel, each stating that all conditions precedent herein provided for relating to the satisfaction and discharge of this Indenture have been complied with. Notwithstanding the satisfaction and discharge of this Indenture, the obligations of the Company to the Trustee under ‎Section 7.06 shall survive.
ARTICLE 4: Particular Covenants of the Company
Section 4.01 Payment of Cash Interest and Accreted Principal Amount. The Company covenants and agrees that it will cause to be paid all cash interest payments and the Accreted Principal Amount (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable), if any, of each of the Notes at the places, at the respective times and in the manner provided herein and in the Notes.
Section 4.02 Maintenance of Office or Agency. The Company will maintain in the contiguous United States, an office or agency where the Notes may be surrendered for registration of transfer or exchange or for presentation for payment or repurchase (“Paying Agent”) or for conversion (“Conversion Agent”) and where 
29

notices and demands to or upon the Company in respect of the Notes and this Indenture may be served. The Company will give prompt written notice to the Trustee of the location, and any change in the location, of such office or agency. If at any time the Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served at the Corporate Trust Office or the office or agency of the Trustee in the contiguous United States; provided, no service of legal process on the Company may be made at any office of the Trustee.
The Company may also from time to time designate as co-Note Registrars one or more other offices or agencies where the Notes may be presented or surrendered for any or all such purposes and may from time to time rescind such designations; provided that no such designation or rescission shall in any manner relieve the Company of its obligation to maintain an office or agency in the contiguous United States, for such purposes. The Company will give prompt written notice to the Trustee of any such designation or rescission and of any change in the location of any such other office or agency. The terms “Paying Agent” and “Conversion Agent” include any such additional or other offices or agencies, as applicable.
The Company hereby initially designates the Trustee as the Paying Agent, Note Registrar, Custodian and Conversion Agent and the Corporate Trust Office as the office or agency in the Borough of Manhattan, The City of New York, where Notes may be surrendered for registration of transfer or exchange or for presentation for payment or repurchase or for conversion and where notices and demands to or upon the Company in respect of the Notes and this Indenture may be served.
Section 4.03 Appointments to Fill Vacancies in Trustee’s Office. The Company, whenever necessary to avoid or fill a vacancy in the office of Trustee, will appoint, in the manner provided in ‎Section 7.09, a Trustee, so that there shall at all times be a Trustee hereunder.
Section 4.04 Provisions as to Paying Agent. (a) If the Company shall appoint a Paying Agent other than the Trustee, the Company will cause such Paying Agent to execute and deliver to the Trustee an instrument in which such agent shall agree with the Trustee, subject to the provisions of this ‎Section 4.04:
iii.that it will hold all sums held by it as such agent for the payment of the Accreted Principal Amount (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable) of the Notes in trust for the benefit of the Holders of the Notes;
iv.that it will give the Trustee prompt notice of any failure by the Company to make any payment of the Accreted Principal Amount (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable) of the Notes when the same shall be due and payable; and 
v.that at any time during the continuance of an Event of Default, upon request of the Trustee, it will forthwith pay to the Trustee all sums so held in trust.
The Company shall, on or before each due date of the Accreted Principal Amount (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable) of the Notes, deposit with the Paying Agent a sum sufficient to pay such Accreted Principal Amount (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable), and (unless such Paying Agent is the Trustee) the Company will promptly notify the Trustee in writing of any failure to take such action; provided that if such deposit is made on the due date, such deposit must be received by the Paying Agent by 11:00 a.m., New York City time, on such date.
1.If the Company shall act as its own Paying Agent, it will, on or before each due date of the Accreted Principal Amount (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable) of the Notes, set aside, segregate and hold in trust for the benefit of the Holders of the Notes a sum sufficient to pay such Accreted Principal Amount (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable) so becoming due and will promptly notify the Trustee in writing of any failure to take such action and of any failure by the Company to make any payment of the Accreted Principal Amount 
30

(including the Redemption Price and the Fundamental Change Repurchase Price, if applicable) of the Notes when the same shall become due and payable.
2.Anything in this ‎Section 4.04 to the contrary notwithstanding, the Company may, at any time, for the purpose of obtaining a satisfaction and discharge of this Indenture, or for any other reason, pay, cause to be paid or deliver to the Trustee all sums or amounts held in trust by the Company or any Paying Agent hereunder as required by this ‎Section 4.04, such sums or amounts to be held by the Trustee upon the trusts herein contained and upon such payment or delivery by the Company or any Paying Agent to the Trustee, the Company or such Paying Agent shall be released from all further liability but only with respect to such sums or amounts.
3.Any money and Common Stock deposited with the Trustee or any Paying Agent, or then held by the Company, in trust for the payment of the Accreted Principal Amount (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable) and the consideration due upon conversion of any Note and remaining unclaimed for two years after such Accreted Principal Amount (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable) or consideration due upon conversion has become due and payable shall be paid to the Company on request of the Company contained in an Officer’s Certificate, or (if then held by the Company) shall be discharged from such trust; and the Holder of such Note shall thereafter, as an unsecured general creditor, look only to the Company for payment thereof, and all liability of the Trustee or such Paying Agent with respect to such trust money and Common Stock, and all liability of the Company as trustee thereof, shall thereupon cease.
Section 4.05 Existence. Subject to ‎Article 11, the Company shall do or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence.
Section 4.06 Rule 144A Information Requirement and Annual Reports. 
1.At any time the Company is not subject to Section 13 or 15(d) of the Exchange Act, the Company shall, so long as any of the Notes or any shares of Common Stock issuable upon conversion thereof shall, at such time, constitute “restricted securities” within the meaning of Rule 144(a)(3) under the Securities Act, promptly provide to the Trustee and, upon written request, any Holder, beneficial owner or prospective purchaser of such Notes or any shares of Common Stock issuable upon conversion of such Notes, the information required to be delivered pursuant to Rule 144A(d)(4) under the Securities Act to facilitate the resale of such Notes or shares of Common Stock pursuant to Rule 144A.
1.The Company shall file with the Trustee, within 15 days after the same are required to be filed with the Commission, copies of any documents or reports that the Company is required to file with the Commission pursuant to Section 13 or 15(d) of the Exchange Act (excluding, for the avoidance of doubt, any such documents or reports, or portions thereof, subject to confidential treatment and any correspondence with the Commission and giving effect to any grace period provided by Rule 12b-25 under the Exchange Act or any similar or successor grace period or any other extension or deferral period permitted by the Commission from time to time). Any such document or report that the Company files with the Commission via the Commission’s EDGAR system shall be deemed to be filed with the Trustee for purposes of this Section 4.06(b) at the time such documents are filed via the EDGAR system, it being understood that the Trustee shall have no responsibility to determine whether any documents have been filed on the EDGAR system. Notwithstanding anything to the contrary in this Indenture, the Company shall in no event be required to file with, or otherwise provide or disclose to, the Trustee or any Holder any information for which the Company is seeking, or has received, confidential treatment from the Commission.
2.Delivery of the reports and documents described in subsection  (b) above to the Trustee is for informational purposes only, and the Trustee’s receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company’s compliance with any of its covenants hereunder (as to which the Trustee is entitled to conclusively rely on an Officer’s Certificate).
31

Section 4.07 Additional Information Rights. The Company shall provide the Holders with (it being understood that any such document or report that the Company files with the Commission via the Commission’s EDGAR system shall be deemed to have been provided to the Holders for purposes of this Section 4.07):
3.within 90 days after the end of each fiscal year of the Company (or, if longer, by the last day of any extension or deferral period permitted by the Commission from time to time for the filing of Annual Reports on Form 10-K or on any applicable equivalent form), (A) an audited, consolidated balance sheet of the Company and its subsidiaries as of the end of such fiscal year, (B) an audited, consolidated income statement of the Company and its subsidiaries for such fiscal year and (C) an audited, consolidated statement of cash flows of the Company and its subsidiaries for such fiscal year; provided that this requirement shall be deemed to have been satisfied if on or prior to such date the Company files its annual report on Form 10-K for the applicable fiscal year with the Commission; and
4.within 45 days after the end of each of the first three quarters of each fiscal year of the Company (or, if longer, by the last day of any extension or deferral period permitted by the Commission from time to time for the filing of Quarterly Reports on Form 10-Q or on any applicable equivalent form), (A) an unaudited, consolidated balance sheet of the Company and its subsidiaries as of the end of such fiscal quarter, (B) an unaudited, consolidated income statement of the Company and its subsidiaries for such fiscal quarter and (C) an unaudited, consolidated statement of cash flows of the Company and its subsidiaries for such fiscal quarter; provided that this requirement shall be deemed to have been satisfied if on or prior to such date the Company files its quarterly report on Form 10-Q for the applicable fiscal quarter with the Commission.
Section 4.08 Stay, Extension and Usury Laws. The Company covenants (to the extent that it may lawfully do so) that it shall not at any time insist upon, plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law or other law that would prohibit or forgive the Company from paying all or any portion of the Accreted Principal Amount of the Notes as contemplated herein, wherever enacted, now or at any time hereafter in force, or that may affect the covenants or the performance of this Indenture; and the Company (to the extent it may lawfully do so) hereby expressly waives all benefit or advantage of any such law, and covenants that it will not, by resort to any such law, hinder, delay or impede the execution of any power herein granted to the Trustee, but will suffer and permit the execution of every such power as though no such law had been enacted.
Section 4.09 Compliance Certificate; Statements as to Defaults. The Company shall deliver to the Trustee within 120 days after the end of each fiscal year of the Company (beginning with the fiscal year ending on December 31, 2020) an Officer’s Certificate stating whether the signers thereof have knowledge of any failure by the Company to comply with all conditions and covenants then required to be performed under this Indenture during such fiscal year and, if so, specifying each such failure and the nature thereof.
In addition, the Company shall deliver to the Trustee, as soon as possible, and in any event within 30 days after the occurrence of any Event of Default or Default, an Officer’s Certificate setting forth the details of such Event of Default or Default, its status and the action that the Company is taking or proposing to take in respect thereof.
Section 4.10 Additional Amounts.
1.If the Company consolidates with or merges with or into, or sells, conveys, transfers or leases all or substantially all of the Company’s properties and assets to, another company pursuant to ‎Section 11.02, and the Successor Company is not organized and existing under the laws of the United States of America, any State thereof or the District of Columbia, then all payments and deliveries made by, or on behalf of, the Successor Company under or with respect to the Notes, including, but not limited to, payments of interest in cash or the Accreted Principal Amount (including, if applicable, the Redemption Price and the Fundamental Change Repurchase Price) and deliveries of Common Stock or other Reference Property upon conversion, shall be made without withholding or deduction for, or on account of, any present or future taxes, duties, assessments or governmental charges of whatever nature imposed or levied by a taxing authority within any jurisdiction in which the Successor Company is, 
32

for tax purposes, organized or resident or doing business or through which payment is made or deemed made (or any political subdivision or taxing authority thereof or therein) (each, as applicable, a “Relevant Taxing Jurisdiction”), unless such withholding or deduction is required by law or by regulation or governmental policy having the force of law. In the event that any such withholding or deduction is so required, the Successor Company shall pay such additional amounts (the “Additional Amounts”) as may be necessary to ensure that the net amount received by the beneficial owner after such withholding or deduction (and after deducting or withholding any taxes on the Additional Amounts) shall equal the amounts that would have been received by such beneficial owner had no such withholding or deduction been required; provided that no Additional Amounts shall be payable:
(i) for or on account of:
a.any tax, duty, assessment or other governmental charge that would not have been imposed but for:
i.the existence of any present or former connection between the Holder or beneficial owner of such Note and the Relevant Taxing Jurisdiction, other than merely holding such Note or the receipt of payments thereunder, including, without limitation, such Holder or beneficial owner being or having been a national, domiciliary or resident of such Relevant Taxing Jurisdiction or treated as a resident thereof or being or having been physically present or engaged in a trade or business therein or having or having had a permanent establishment therein;
ii.the presentation of such Note (in cases in which presentation is required) more than 30 days after the later of the date on which the payment of interest in cash or the Accreted Principal Amount of (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable) such Note or the delivery of Common Stock or other Reference Property upon conversion of such Note became due and payable pursuant to the terms thereof or was made or duly provided for; or
iii.the failure of the Holder or beneficial owner to comply with a timely request from the Successor Company to provide certification, information, documents or other evidence concerning such Holder’s or beneficial owner’s nationality, residence, identity or connection with the Relevant Taxing Jurisdiction, or to make any declaration or satisfy any other reporting requirement relating to such matters, if and to the extent that due and timely compliance with such request is required by statute, regulation or administrative practice of the Relevant Taxing Jurisdiction in order to reduce or eliminate any withholding or deduction as to which Additional Amounts would have otherwise been payable to such Holder or beneficial owner;
b.any estate, inheritance, gift, sale, transfer, excise, personal property or similar tax, assessment or other governmental charge;
c.any tax, duty, assessment or other governmental charge that is payable otherwise than by withholding or deduction from payments under or with respect to the Notes;
d.any tax, assessment, withholding or deduction required by sections 1471 through 1474 of the United States Internal Revenue Code of 1986, as amended (“FATCA”), any current or future Treasury Regulations or rulings promulgated thereunder, any law, regulation or other official guidance enacted in any jurisdiction implementing FATCA, any intergovernmental agreement between the United States and any other jurisdiction to implement FATCA or any law enacted by such other jurisdiction to give effect to such agreement, or any agreement with the U.S. Internal Revenue Service under FATCA;
e.any tax, duty, assessment or other governmental charge required to be withheld or deducted by any Paying Agent from any payment of interest in cash or the Accreted Principal 
33

Amount of any Notes, if such payment could have been made without such withholding or deduction by at least one other Paying Agent;
f.any taxes imposed by the United States or any political subdivision thereof; or
g.any combination of taxes referred to in the preceding clauses ‎(a), ‎(b), ‎(c), ‎(d), ‎(e), or ‎(f),
(ii) with respect to any payment of interest in cash or the Accreted Principal Amount of (including the Fundamental Change Repurchase Price, if applicable) such Note or the delivery of Common Stock or other Reference Property upon conversion of such Note to a Holder, if the Holder is a fiduciary, partnership or person other than the sole beneficial owner of that payment to the extent that a beneficiary or settlor with respect to the fiduciary, a partner or member of that partnership or a beneficial owner would not have been entitled to such Additional Amounts had that beneficiary, settlor, partner, member or beneficial owner been the Holder thereof.
(b) [reserved].
(c)  If the Successor Company is required to make any deduction or withholding from any payments with respect to the Notes, the Successor Company will deliver to the Trustee official tax receipts evidencing the remittance to the relevant tax authorities of the amounts so withheld or deducted or other evidence reasonably satisfactory to the Trustee.
(d) Any reference in this Indenture or the Notes in any context to the delivery of Common Stock or other Reference Property, in each case, upon conversion of any Note or the payment of the Accreted Principal Amount of (including the Fundamental Change Repurchase Price and Redemption Price, if applicable) any Note or any other amount payable with respect to such Note, shall be deemed to include payment of Additional Amounts to the extent that, in such context, Additional Amounts are, were or would be payable in respect thereof pursuant to this ‎Section 4.09.
Section 4.11 Incurrence of Indebtedness.
(a) The Company will not, and will not permit any of its Restricted Subsidiaries or Regulated Subsidiaries to, Incur any Indebtedness, including Disqualified Stock, and the Company will not permit any Restricted Subsidiary or Regulated Subsidiary to issue Preferred Stock; provided that the Company or any Restricted Subsidiary or any Regulated Subsidiary may Incur Indebtedness, including Disqualified Stock, and any Restricted Subsidiary or Regulated Subsidiary may issue Preferred Stock if, after giving effect to the Incurrence of such Indebtedness and the issuance of Preferred Stock and the receipt and application of the proceeds therefrom, the Company’s Consolidated Fixed Charge Coverage Ratio would be greater than 1.5:1.0.
Notwithstanding the foregoing, the Company and any Restricted Subsidiary and any Regulated Subsidiary may Incur each and all of the following:
(i) Indebtedness of the Company and/or any Restricted Subsidiary under any Credit Facility in an aggregate principal amount at any one time outstanding (with letters of credit constituting Indebtedness being deemed to have a principal amount equal to the maximum potential liability of the Company and its Restricted Subsidiaries thereunder) not to exceed the sum of (a) $3,169.0 million plus (b)(1) in the case of Indebtedness incurred to finance the eNett/Optal Acquisition, $1,357 million or (2) in the case of other Indebtedness, an amount not to exceed (I) the greater of (x) $375,000,000 and (y) 50% of Consolidated EBITDA for the Four Quarter Period most recently then ended calculated on a pro forma basis plus (II) the aggregate amount of all voluntary prepayments and repurchases of term loans under the Senior Credit Facilities (other than voluntary prepayments and repurchases of term loans incurred pursuant to clause (III) below) and voluntary reductions of commitments under the revolving credit facility under the Senior Credit Facilities, in each case made prior to the date of any such incurrence (other than prepayments, repurchases and commitment reductions made with the proceeds of Indebtedness under the Senior Credit Facilities or any other long-term Indebtedness), plus (III) the maximum aggregate principal amount (if any) that could be established or incurred without causing the Consolidated Secured 
34

Leverage Ratio (as calculated in accordance with the terms of the Senior Credit Facilities) as of the last day of the most recently ended Four Quarter Period, calculated on a pro forma basis after giving effect to the incurrence of such additional amount, any acquisition or Investment consummated in connection therewith and all other appropriate pro forma adjustments (but without netting any cash proceeds from such incurrence), to exceed 4.00:1.00, minus (IV) the aggregate principal amount of all incremental term loans and incremental revolving credit facility commitments under the Senior Credit Facilities and Incremental Equivalent Debt theretofore incurred in reliance on clauses (I) and (II) above;
(ii) Indebtedness owed (A) to the Company evidenced by a promissory note or (B) to any Restricted Subsidiary or Regulated Subsidiary; provided that (x) any event which results in any such Restricted Subsidiary or Regulated Subsidiary ceasing to be a Restricted Subsidiary or Regulated Subsidiary or any subsequent transfer of such Indebtedness (other than to the Company or another Restricted Subsidiary or Regulated Subsidiary) shall be deemed, in each case, to constitute an Incurrence of such Indebtedness not permitted by this clause (2) and (y) if the Company is the obligor on such Indebtedness, such Indebtedness must be expressly contractually subordinated in right of payment to the Notes;
(iii) Indebtedness issued in exchange for, or the net proceeds of which are used to refinance or refund, then outstanding Indebtedness (other than Indebtedness outstanding under clause (i), (ii), (vii) or (viii)) and any refinancings thereof in an amount not to exceed the amount so refinanced or refunded (plus premiums, accrued interest, fees and expenses); provided that (a) Indebtedness the proceeds of which are used to refinance or refund the Notes or Indebtedness that is pari passu with, or subordinated in right of payment to, the Notes shall only be permitted under this clause (iii) if (x) in case the Notes are refinanced in part or the Indebtedness to be refinanced is pari passu with the Notes, such new Indebtedness, by its terms or by the terms of any agreement or instrument pursuant to which such new Indebtedness is outstanding, is pari passu with, or subordinate in right of payment to, the remaining Notes, or (y) in case the Indebtedness to be refinanced is subordinated in right of payment to the Notes, such new Indebtedness, by its terms or by the terms of any agreement or instrument pursuant to which such new Indebtedness is issued or remains outstanding, is expressly made subordinate in right of payment to the Notes at least to the extent that the Indebtedness to be refinanced is subordinated to the Notes, (b) such new Indebtedness, determined as of the date of Incurrence of such new Indebtedness, does not mature prior to the Stated Maturity of the Indebtedness to be refinanced or refunded, and the Average Life of such new Indebtedness is at least equal to the remaining Average Life of the Indebtedness to be refinanced or refunded and (c) such new Indebtedness shall not include Indebtedness of the Company or Indebtedness of a Restricted Subsidiary that refinances Indebtedness of a Regulated Subsidiary or Unrestricted Subsidiary;
(iv) Indebtedness of the Company, to the extent the net proceeds thereof are promptly (A) used to purchase Notes tendered pursuant to Article 14, (B) deposited to defease or discharge the Notes as set forth in Article 3 or (C) irrevocably deposited with the Trustee, in trust, for the benefit of the Holders of the Notes, to pay the principal of, premium, if any, and interest due on the Notes to a particular redemption date in connection with an irrevocable notice of redemption;
(v) (x) Indebtedness existing on the date hereof (including the Notes but excluding the Credit Facilities) and (y) Guarantees of Indebtedness of the Company or of any Restricted Subsidiary by the Company or any Restricted Subsidiary;
(vi) (x) Indebtedness, Disqualified Stock or Preferred Stock of the Company or any Restricted Subsidiary Incurred to finance an acquisition or (y) Acquired Indebtedness; provided, however, that, in the case of both of clauses (x) and (y), after giving effect to such acquisition, merger or amalgamation and the Incurrence of such Indebtedness either: (i) the Company would be permitted to Incur at least $1.00 of additional Indebtedness pursuant to the first paragraph of this ‎Section 4.11; or (ii) the Consolidated Fixed Charge Coverage Ratio of the Company would be equal to or greater than the Consolidated Fixed Charge Coverage Ratio immediately prior to giving effect to such acquisition, merger or amalgamation;
(vii) Indebtedness of Foreign Subsidiaries in an aggregate principal amount at any time outstanding not to exceed $5.0 million;
35

(viii) Indebtedness not otherwise permitted hereunder in an aggregate principal amount at any time outstanding not to exceed $50.0 million for the Company and its Restricted Subsidiaries;
(xi) Purchase Money Indebtedness of the Company or any Restricted Subsidiary not to exceed at any one time outstanding the greater of $40.0 million and 5.0% of Consolidated Net Worth;
(x) Indebtedness of any Qualified Securitization Entity in connection with a Qualified Securitization Transaction (which may include Indebtedness incurred to acquire Securitization Assets in preparation for a Qualified Securitization Transaction) and Guarantees by the Company or any of its Restricted Subsidiaries of any such Indebtedness; and
(xi) Indebtedness, Disqualified Stock and Preferred Stock of Regulated Subsidiaries the proceeds of which are entirely invested or used in the business of such Regulated Subsidiary (or any Subsidiary of such Regulated Subsidiary).
(b) Notwithstanding any other provision of this ‎Section 4.11, the maximum amount of Indebtedness that may be Incurred pursuant to this ‎Section 4.11 will not be deemed to be exceeded, with respect to any outstanding Indebtedness due solely to the result of fluctuations in the exchange rates of currencies or due to fluctuations in the value of commodities or securities which underlie such Indebtedness. For the purposes of determining compliance with any restriction on the Incurrence of Indebtedness (x) the U.S. dollar equivalent principal amount of any Indebtedness denominated in a foreign currency shall be calculated based on the relevant currency exchange rate in effect on the date such Indebtedness was Incurred, in the case of term Indebtedness, or first committed, in the case of revolving credit Indebtedness and (y) the principal amount of any Indebtedness which is calculated by reference to any underlying security or commodity shall be calculated based on the relevant closing price of such commodity or security on the date such Indebtedness was Incurred.
© For purposes of determining any particular amount of Indebtedness under this ‎Section 4.11, (x) Indebtedness outstanding under the Credit Facilities on the date hereof shall be treated as Incurred pursuant to clause (i) of  ‎Section 4.11(a) and (y) Guarantees, Liens or obligations with respect to letters of credit supporting Indebtedness otherwise included in the determination of such particular amount shall not be included. For purposes of determining compliance with this ‎Section 4.11(c), if an item of Indebtedness meets the criteria of more than one of the types of Indebtedness described above (other than Indebtedness referred to in clause (x) of the preceding sentence), including under the first paragraph of ‎Section 4.11(a), the Company, in its sole discretion, shall classify, and from time to time may reclassify, such item of Indebtedness.
(d) The Company will not Incur any Indebtedness if such Indebtedness is contractually subordinated in right of payment to any other Indebtedness unless such Indebtedness is also subordinate in right of payment to the Notes to the same extent; provided, however, that no Indebtedness will be deemed to be contractually subordinated in right of payment to any other Indebtedness solely by virtue of being unsecured or by virtue of being secured on a junior priority basis or pursuant to any customary provisions of any intercreditor agreements related to lien subordination (but not payment subordination) of any such junior security interest.
(e) If, after the date hereof, the Company shall issue secured or unsecured notes (“New Notes”) (including, for the avoidance of doubt, any notes contractually subordinated to the Notes) in an underwritten offering that is registered with the Securities and Exchange Commission or in an offering in which the initial purchasers rely on Rule 144A either alone or in combination with Regulation S under the Securities Act for the distribution of securities to investors in an aggregate principal amount equal to or greater than $250 million that includes a negative covenant or covenants relating to the Incurrence of Indebtedness and issuance of Preferred Stock binding on the Company and subsidiaries of the Company that are either Restricted Subsidiaries or Regulated Subsidiaries (in each case, determined as of the time of issuance of the New Notes) the terms of which (including any component definitions used in such negative covenant) are more advantageous to the Company than the terms set forth, or any component definitions used, in this ‎Section 4.11, then (i) the terms of this Section 4.11 (including any component definitions) shall automatically and without any further action by the Company or the Trustee be deemed amended and modified to reflect such more advantageous provisions and (b) in order to more fully effectuate, but not as a 
36

condition to, the foregoing, the Company and the Trustee shall promptly execute a supplemental indenture to incorporate such more advantageous provisions herein.
ARTICLE 5: Lists of Holders And Reports by the Company and the Trustee
Section 5.01 Lists of Holders. The Company covenants and agrees that it will furnish or cause to be furnished to the Trustee, semi-annually, not more than 15 days after each January 15 and July 15 in each year beginning with January 15, 2021, and at such other times as the Trustee may request in writing, within 30 days after receipt by the Company of any such request (or such lesser time as the Trustee may reasonably request in order to enable it to timely provide any notice to be provided by it hereunder), a list in such form as the Trustee may reasonably require of the names and addresses of the Holders as of a date not more than 15 days (or such other date as the Trustee may reasonably request in order to so provide any such notices) prior to the time such information is furnished, except that no such list need be furnished so long as the Trustee is acting as Note Registrar.
Section 5.02 Preservation and Disclosure of Lists. The Trustee shall preserve, in as current a form as is reasonably practicable, all information as to the names and addresses of the Holders contained in the most recent list furnished to it as provided in ‎Section 5.01 or maintained by the Trustee in its capacity as Note Registrar, if so acting. The Trustee may destroy any list furnished to it as provided in ‎Section 5.01 upon receipt of a new list so furnished.
ARTICLE 6: Defaults and Remedies
Section 6.01 Events of Default. Each of the following events shall be an “Event of Default” with respect to the Notes:
(a) default in the payment of the Accreted Principal Amount of any Note when due and payable on the Maturity Date, upon any required repurchase (including any repurchase required under ‎Article 14 hereof or as a result of providing a Notice of Redemption), upon declaration of acceleration or otherwise;
(b) default in the payment of interest on any Note when due and payable on any Interest Payment Date and the default continues for a period of 30 days;
(c) failure by the Company to comply with its obligation to convert the Notes in accordance with this Indenture upon exercise of a Holder’s conversion right and such failure continues for five Business Days from the applicable Conversion Date;
(d) failure by the Company to issue a Fundamental Change Company Notice in accordance with ‎Section 14.02(c) when due;
(e) failure by the Company to comply with any of its other agreements contained in the Notes or this Indenture for 60 days following receipt by the Company of written notice of such failure to comply from the Trustee or the Holders of at least 25% in aggregate Original Principal Amount of the Notes then outstanding;
(f) default by the Company or any Significant Subsidiary of the Company with respect to any mortgage, agreement or other instrument under which there may be outstanding, or by which there may be secured or evidenced, any indebtedness for money borrowed in excess of $50,000,000 (or its foreign currency equivalent) in the aggregate of the Company and/or any such Significant Subsidiary, whether such indebtedness now exists or shall hereafter be created (i) resulting in such indebtedness becoming or being declared due and payable or (ii) constituting a failure to pay the principal of any such debt when due and payable (after the expiration of all applicable grace periods) at its stated maturity, upon required repurchase, upon declaration of acceleration or otherwise, in each case of clauses (i) and (ii), if such failure to pay or default is not cured or waived, or such acceleration is not rescinded or annulled, as applicable, in either case, within 30 days after written notice is delivered to the Company by the Trustee or is delivered to the Company and the Trustee by Holders of at least 25% in aggregate Original Principal Amount of Notes then outstanding, in accordance with this Indenture;
37

(g) a final judgment or judgments for the payment of $50,000,000 (or its foreign currency equivalent) or more (excluding any amounts covered by insurance) in the aggregate rendered against the Company or any Significant Subsidiary of the Company, which judgment is not discharged, paid, bonded, waived or stayed within 60 days after (i) the date on which the right to appeal thereof has expired if no such appeal has commenced, or (ii) the date on which all rights to appeal have been extinguished;
(h) the Company or any Significant Subsidiary shall commence a voluntary case or other proceeding seeking liquidation, reorganization or other relief with respect to the Company or any such Significant Subsidiary or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or seeking the appointment of a trustee, receiver, liquidator, custodian or other similar official of the Company or any such Significant Subsidiary or any substantial part of its property, or shall consent to any such relief or to the appointment of or taking possession by any such official in an involuntary case or other proceeding commenced against it, or shall make a general assignment for the benefit of creditors, or shall fail generally to pay its debts as they become due; or
(i) an involuntary case or other proceeding shall be commenced against the Company or any Significant Subsidiary seeking liquidation, reorganization or other relief with respect to the Company or such Significant Subsidiary or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or seeking the appointment of a trustee, receiver, liquidator, custodian or other similar official of the Company or such Significant Subsidiary or any substantial part of its property, and such involuntary case or other proceeding shall remain undismissed and unstayed for a period of 30 consecutive days.
Section 6.02 Acceleration; Rescission and Annulment. Except to the extent set forth in ‎Section 6.02 hereof, if one or more Events of Default shall have occurred and be continuing (whatever the reason for such Event of Default and whether it shall be voluntary or involuntary or be effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body), then, and in each and every such case (other than an Event of Default specified in ‎Section 6.01(h) or ‎Section 6.01(i) with respect to the Company or any of its Significant Subsidiaries), unless the principal of all of the Notes shall have already become due and payable, the Holders of at least 25% in aggregate Original Principal Amount of the Notes then outstanding determined in accordance with ‎Section 8.04, by notice in writing to the Company (and to the Trustee if given by Holders), may declare 100% of the Accreted Principal Amount of all the Notes and all accrued and unpaid interest thereunder to be due and payable immediately, and upon any such declaration the same shall become and shall automatically be immediately due and payable, anything contained in this Indenture or in the Notes to the contrary notwithstanding. If an Event of Default specified in ‎Section 6.01(h) or ‎Section 6.01(i) with respect to the Company or any of its Significant Subsidiaries occurs and is continuing, 100% of the Accreted Principal Amount of all Notes shall become and shall automatically be immediately due and payable.
The immediately preceding paragraph, however, is subject to the conditions that if, at any time after the principal of the Notes shall have been so declared due and payable, and before any judgment or decree for the payment of the monies due shall have been obtained or entered as hereinafter provided, the Company shall pay or shall deposit with the Trustee a sum sufficient to pay the Accreted Principal Amount of any and all Notes that shall have become due otherwise than by acceleration (with interest on overdue installments of accrued and unpaid interest to the extent that payment of such interest is enforceable under applicable law, and on such principal at the rate borne by the Notes) and amounts due to the Trustee pursuant to ‎Section 7.06, and if (1) rescission would not conflict with any judgment or decree of a court of competent jurisdiction and (2) any and all existing Events of Default under this Indenture, other than the nonpayment of the Accreted Principal Amount of Notes that shall have become due solely by such acceleration, shall have been cured or waived pursuant to ‎Section 6.09, then and in every such case (except as provided in the immediately succeeding sentence) the Holders of the Required Percentage in aggregate Original Principal Amount of the Notes then outstanding, by written notice to the Company and to the Trustee, may waive all existing and past Defaults or Events of Default with respect to the Notes and rescind and annul such declaration and its consequences and such Default shall cease to exist, and any Event of Default arising therefrom shall be deemed to have been cured for every purpose of this Indenture; but no such waiver or rescission and annulment shall extend to or shall affect any subsequent Default or Event of Default, or shall impair any right consequent thereon. Notwithstanding anything to the contrary herein, no such waiver or rescission and annulment shall extend to or shall affect any continuing Default or Event of Default relating to (i) the nonpayment of the 
38

Accreted Principal Amount (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable) of any Notes or (ii) a failure to deliver the consideration due upon conversion of the Notes.
Section 6.03 Additional Interest. Notwithstanding anything in this Indenture or in the Notes to the contrary, to the extent the Company elects, the sole remedy for an Event of Default relating to the Company’s failure to comply with its obligations as set forth in ‎Section 4.06(b) or ‎Section 4.07 shall (i) for the first 180 days after the occurrence of such an Event of Default (beginning on, and including the date on which such an Event of Default first occurs), consist exclusively of the right to receive Additional Interest on the Notes at a rate equal to 0.25% per annum of the Accreted Principal Amount of the Notes outstanding for each day during such 180-day period on which such Event of Default is continuing and (ii) for the period from, and including, the 181st day after the occurrence of such an Event of Default to, and including, the 360th day after the occurrence of such an Event of Default, consist exclusively of the right to receive Additional Interest on the Notes at a rate equal to 0.50% per annum of the Accreted Principal Amount of Notes outstanding for each day during such additional 180-day period on which such an Event of Default is continuing, subject to the second immediately succeeding paragraph. If the Company so elects, such Additional Interest shall be payable in the same manner and on the same dates as interest payable on the Notes is added to the Accreted Principal Amount or paid in cash, in accordance with the provisions of ‎Section 2.03. On the 361st day after such Event of Default (if the Event of Default relating to the Company’s failure to file is not cured or waived prior to such 361st day), the Notes shall be immediately subject to acceleration as provided in ‎Section 6.02. The provisions of this paragraph will not affect the rights of Holders of Notes in the event of the occurrence of any Event of Default other than the Company’s failure to comply with its obligations as set forth in ‎Section 4.06(b) or ‎Section 4.07. In the event the Company does not elect to pay Additional Interest following an Event of Default in accordance with this ‎Section 6.03, the Notes shall be immediately subject to acceleration as provided in ‎Section 6.02.
In no event will the rate of any such Additional Interest payable pursuant to this ‎Section 6.03 accrue at a rate in excess of 0.50% per annum, regardless of the number of events or circumstances giving rise to the requirement to pay such Additional Interest.
In order to elect to pay Additional Interest as the sole remedy during the first 360 days after the occurrence of any Event of Default described in the penultimate preceding paragraph, the Company must notify all Holders of the Notes, the Trustee and the Paying Agent of such election prior to the beginning of such 360-day period. Upon the failure to timely give such notice, the Notes shall be immediately subject to acceleration as provided in ‎Section 6.02.
Section 6.04 Payments of Notes on Default; Suit Therefor. If an Event of Default described in clause ‎(a) or ‎(b) of ‎Section 6.01 shall have occurred and be continuing, the Company shall, upon demand of the Trustee, pay to the Trustee, for the benefit of the Holders of the Notes, the whole amount then due and payable on the Notes for the Accreted Principal Amount, with interest on any overdue Accreted Principal Amount at the rate borne by the Notes at such time, and, in addition thereto, such further amount as shall be sufficient to cover any amounts due to the Trustee under ‎Section 7.06. If the Company shall fail to pay such amounts forthwith upon such demand, the Trustee, in its own name and as trustee of an express trust, may institute a judicial proceeding for the collection of the sums so due and unpaid, may prosecute such proceeding to judgment or final decree and may enforce the same against the Company or any other obligor upon the Notes and collect the moneys adjudged or decreed to be payable in the manner provided by law out of the property of the Company or any other obligor upon the Notes, wherever situated.
In the event there shall be pending proceedings for the bankruptcy or for the reorganization of the Company or any other obligor on the Notes under Title 11 of the United States Code, or any other applicable law, or in case a receiver, assignee or trustee in bankruptcy or reorganization, liquidator, sequestrator or similar official shall have been appointed for or taken possession of the Company or such other obligor, the property of the Company or such other obligor, or in the event of any other judicial proceedings relative to the Company or such other obligor upon the Notes, or to the creditors or property of the Company or such other obligor, the Trustee, irrespective of whether the Accreted Principal Amount of the Notes shall then be due and payable as therein expressed or by declaration or otherwise and irrespective of whether the Trustee shall have made any demand pursuant to the provisions of 
39

this ‎Section 6.04, shall be entitled and empowered, by intervention in such proceedings or otherwise, to file and prove a claim or claims for the whole amount of the Accreted Principal Amount of the Notes, and, in case of any judicial proceedings, to file such proofs of claim and other papers or documents and to take such other actions as it may deem necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel) and of the Holders allowed in such judicial proceedings relative to the Company or any other obligor on the Notes, its or their creditors, or its or their property, and to collect and receive any monies or other property payable or deliverable on any such claims, and to distribute the same after the deduction of any amounts due to the Trustee under ‎Section 7.06; and any receiver, assignee or trustee in bankruptcy or reorganization, liquidator, custodian or similar official is hereby authorized by each of the Holders to make such payments to the Trustee, as administrative expenses, and, in the event that the Trustee shall consent to the making of such payments directly to the Holders, to pay to the Trustee any amount due it for reasonable compensation, expenses, advances and disbursements, including agents and counsel fees, and including any other amounts due to the Trustee under ‎Section 7.06, incurred by it up to the date of such distribution.
Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Holder any plan of reorganization, arrangement, adjustment or composition affecting such Holder or the rights of any Holder thereof, or to authorize the Trustee to vote in respect of the claim of any Holder in any such proceeding.
All rights of action and of asserting claims under this Indenture, or under any of the Notes, may be enforced by the Trustee without the possession of any of the Notes, or the production thereof at any trial or other proceeding relative thereto, and any such suit or proceeding instituted by the Trustee shall be brought in its own name as trustee of an express trust, and any recovery of judgment shall, after provision for the payment of the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, be for the ratable benefit of the Holders of the Notes.
In any proceedings brought by the Trustee (and in any proceedings involving the interpretation of any provision of this Indenture to which the Trustee shall be a party) the Trustee shall be held to represent all the Holders of the Notes, and it shall not be necessary to make any Holders of the Notes parties to any such proceedings.
In case the Trustee shall have proceeded to enforce any right under this Indenture and such proceedings shall have been discontinued or abandoned because of any waiver pursuant to ‎Section 6.09 or any rescission and annulment pursuant to ‎Section 6.02 or for any other reason or shall have been determined adversely to the Trustee, then and in every such case the Company, the Holders and the Trustee shall, subject to any determination in such proceeding, be restored respectively to their several positions and rights hereunder, and all rights, remedies and powers of the Company, the Holders and the Trustee shall continue as though no such proceeding had been instituted.
Section 6.05 Application of Monies Collected by Trustee. Any monies collected by the Trustee pursuant to this ‎Article 6 with respect to the Notes shall be applied in the following order, at the date or dates fixed by the Trustee for the distribution of such monies, upon presentation of the several Notes, and stamping thereon the payment, if only partially paid, and upon surrender thereof, if fully paid:
First, to the payment of all amounts due the Trustee and its agent under this Indenture;
Second, to the payment of the whole amount (including, if applicable, the payment of the Redemption Price and the Fundamental Change Repurchase Price) then owing and unpaid upon the Notes for the Accreted Principal Amount, with interest on the overdue Accreted Principal Amount and in case such monies shall be insufficient to pay in full the whole amounts so due and unpaid upon the Notes, then to the payment of such Accreted Principal Amount (including, if applicable, the Redemption Price and the Fundamental Change Repurchase Price) and interest without preference or priority of Accreted Principal Amount over interest, or of interest over Accreted Principal Amount, or of any Note over any other Note, ratably to the aggregate of such 
40

Accreted Principal Amount (including, if applicable, the Redemption Price and the Fundamental Change Repurchase Price); and
Third, to the payment of the remainder, if any, to the Company.
Section 606 Proceedings by Holders. Except to enforce the right to receive payment of the Accreted Principal Amount (including, if applicable, the Redemption Price and the Fundamental Change Repurchase Price) when due, or the right to receive the consideration due upon conversion, no Holder of any Note shall have any right by virtue of or by availing of any provision of this Indenture to institute any suit, action or proceeding in equity or at law upon or under or with respect to this Indenture, or for the appointment of a receiver, trustee, liquidator, custodian or other similar official, or for any other remedy hereunder, unless:
2.such Holder previously shall have given to the Trustee written notice of an Event of Default and of the continuance thereof, as herein provided;
3.Holders of at least 25% in aggregate Original Principal Amount of the Notes then outstanding shall have made written request upon the Trustee to institute such action, suit or proceeding in its own name as Trustee hereunder;
4.such Holders shall have offered to the Trustee such security or indemnity reasonably satisfactory to it against any loss, liability or expense to be incurred therein or thereby;
5.the Trustee for 60 days after its receipt of such notice, request and offer of such security or indemnity, shall have neglected or refused to institute any such action, suit or proceeding; and
6.no direction that, in the opinion of the Trustee, is inconsistent with such written request shall have been given to the Trustee by the Holders of the Required Percentage in aggregate Original Principal Amount of the Notes then outstanding within such 60-day period and not withdrawn within 10 days of when the Trustee notified the Holders that such direction was inconsistent pursuant to ‎Section 6.09, it being understood and intended, and being expressly covenanted by the taker and Holder of every Note with every other taker and Holder and the Trustee that no one or more Holders shall have any right in any manner whatever by virtue of or by availing of any provision of this Indenture to affect, disturb or prejudice the rights of any other Holder (it being understood that the Trustee shall have no liability or responsibility to determine whether any such action is prejudicial to the Holders), or to obtain or seek to obtain priority over or preference to any other such Holder, or to enforce any right under this Indenture, except in the manner herein provided and for the equal, ratable and common benefit of all Holders (except as otherwise provided herein). For the protection and enforcement of this ‎Section 6.06, each and every Holder and the Trustee shall be entitled to such relief as can be given either at law or in equity.
Notwithstanding any other provision of this Indenture and any provision of any Note, the right of any Holder to receive payment or delivery, as the case may be, of (x) the Accreted Principal Amount (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable) of, (y) the cash interest (if any), and (z) the consideration due upon conversion of, such Note, on or after the respective due dates expressed or provided for in such Note or in this Indenture, or to institute suit for the enforcement of any such payment or delivery, as the case may be, on or after such respective dates against the Company shall not be impaired or affected without the consent of such Holder.
Section 6.07 Proceedings by Trustee. In case of an Event of Default, the Trustee may in its discretion proceed to protect and enforce the rights vested in it by this Indenture by such appropriate judicial proceedings as are necessary to protect and enforce any of such rights, either by suit in equity or by action at law or by proceeding in bankruptcy or otherwise, whether for the specific enforcement of any covenant or agreement contained in this Indenture or in aid of the exercise of any power granted in this Indenture, or to enforce any other legal or equitable right vested in the Trustee by this Indenture or by law.
41

Section 6.08 Remedies Cumulative and Continuing. Except as provided in the last paragraph of ‎Section 2.06, all powers and remedies given by this ‎Article 6 to the Trustee or to the Holders shall, to the extent permitted by law, be deemed cumulative and not exclusive of each other or of any other powers and remedies available to the Trustee or the Holders of the Notes, by judicial proceedings or otherwise, to enforce the performance or observance of the covenants and agreements contained in this Indenture, and no delay or omission of the Trustee or of any Holder of any of the Notes to exercise any right or power accruing during the continuance of any Default or Event of Default shall impair any such right or power, or shall be construed to be a waiver of any such Default or Event of Default or any acquiescence therein; and, subject to the provisions of ‎Section 6.06, every power and remedy given by this ‎Article 6 or by law to the Trustee or to the Holders may be exercised from time to time, and as often as shall be deemed expedient, by the Trustee or by the Holders.
Section 6.09 Direction of Proceedings and Waiver of Defaults by Holders of the Required Percentage. The Holders of the Required Percentage in aggregate Original Principal Amount of the Notes at the time outstanding determined in accordance with ‎Section 8.04 shall have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee or exercising any trust or power conferred on the Trustee with respect to the Notes; provided, however, that (a) such direction shall not be in conflict with any rule of law or with this Indenture, and (b) the Trustee may take any other action deemed proper by the Trustee that is not inconsistent with such direction. The Trustee may refuse to follow any direction that it determines is unduly prejudicial to the rights of any other Holder or that would involve the Trustee in personal liability. The Holders of the Required Percentage in aggregate Original Principal Amount of the Notes at the time outstanding determined in accordance with ‎Section 8.04 may on behalf of the Holders of all of the Notes waive any existing or past Default or Event of Default hereunder and its consequences except (i) a default in the payment of the Accreted Principal Amount (including any Redemption Price and any Fundamental Change Repurchase Price) of the Notes when due that has not been cured, (ii) a failure by the Company to deliver the consideration due upon conversion of the Notes that has not been cured or (iii) a default in respect of a covenant or provision hereof which under ‎Article 10 cannot be modified or amended without the consent of each Holder of an outstanding Note affected. Upon any such waiver the Company, the Trustee and the Holders of the Notes shall be restored to their former positions and rights hereunder; but no such waiver shall extend to any subsequent or other Default or Event of Default or impair any right consequent thereon. Whenever any Default or Event of Default hereunder shall have been waived as permitted by this ‎Section 6.09, said Default or Event of Default shall for all purposes of the Notes and this Indenture be deemed to have been cured and to be not continuing; but no such waiver shall extend to any subsequent or other Default or Event of Default or impair any right consequent thereon.
Section 6.10 Notice of Defaults. The Trustee shall, within 90 days after the occurrence and continuance of a Default of which a Responsible Officer has received written notice of the existence thereof, deliver to all Holders notice of all Defaults known to a Responsible Officer, unless such Defaults shall have been cured or waived before the giving of such notice; provided that, except in the case of a Default in the payment of the Accreted Principal Amount of (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable) any of the Notes or a Default in the delivery of the consideration due upon conversion, the Trustee shall be protected in withholding such notice if and so long as the Trustee in good faith determines that the withholding of such notice is in the interests of the Holders.
Section 6.11 Undertaking to Pay Costs. All parties to this Indenture agree, and each Holder of any Note by its acceptance thereof shall be deemed to have agreed, that any court may, in its discretion, require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee for any action taken or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of such suit and that such court may in its discretion assess reasonable costs, including reasonable attorneys’ fees and expenses, against any party litigant in such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant; provided that the provisions of this ‎Section 6.11 (to the extent permitted by law) shall not apply to any suit instituted by the Trustee, to any suit instituted by any Holder, or group of Holders, holding in the aggregate more than 10% in principal amount of the Notes at the time outstanding determined in accordance with ‎Section 8.04, or to any suit instituted by any Holder for the enforcement of the payment of the Accreted Principal Amount of any Note (including, but not limited to, the Redemption Price and the Fundamental Change Repurchase Price, if applicable) on or after the due date expressed or provided for in such Note or to any suit for the 
42

enforcement of the right to convert any Note, or receive the consideration due upon conversion, in accordance with the provisions of ‎Article 13.

ARTICLE 7 :Concerning the Trustee
Section 7.01 Duties and Responsibilities of Trustee
If an Event of Default has occurred and is continuing, the Trustee shall, prior to the receipt of direction, if any, from the Required Percentage of Holders,  exercise such of the rights and powers vested in it by this Indenture, and use the same degree of care and skill in its exercise, as a prudent person would exercise or use under the circumstances in the conduct of such person’s own affairs; provided that if an Event of Default occurs and is continuing, the Trustee will be under no obligation to exercise any of the rights or powers under this Indenture at the request or direction of any of the Holders unless such Holders have offered to the Trustee indemnity or security reasonably satisfactory to it against any loss, liability or expense that might be incurred by it in compliance with such request or direction.
No provision of this Indenture shall be construed to relieve the Trustee from liability for its own grossly negligent action, its own grossly negligent failure to act or its own willful misconduct, except that:
(a) prior to the occurrence of an Event of Default and after the curing or waiving of all Events of Default that may have occurred:
(i) the duties and obligations of the Trustee shall be determined solely by the express provisions of this Indenture, and the Trustee shall not be liable except for the performance of such duties and obligations as are specifically set forth in this Indenture and no implied covenants or obligations shall be read into this Indenture against the Trustee; and 
(ii) in the absence of gross negligence and willful misconduct on the part of the Trustee, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon any certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture; but, in the case of any such certificates or opinions that by any provisions hereof are specifically required to be furnished to the Trustee, the Trustee shall be under a duty to examine the same to determine whether or not they conform to the requirements of this Indenture (but need not confirm or investigate the accuracy of any mathematical calculations or other facts stated therein);
(b) the Trustee shall not be liable for any error of judgment made in good faith by a Responsible Officer or Officers of the Trustee, unless it shall be proved that the Trustee was grossly negligent in ascertaining the pertinent facts;
(c)  the Trustee shall not be liable with respect to any action taken or omitted to be taken by it in good faith in accordance with the direction of the Holders of not less than the Required Percentage in aggregate Original Principal Amount of the Notes at the time outstanding determined as provided in ‎Section 8.04 relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred upon the Trustee, under this Indenture;
(d) whether or not therein provided, every provision of this Indenture relating to the conduct or affecting the liability of, or affording protection to, the Trustee shall be subject to the provisions of this Section;
(e) the Trustee shall not be liable in respect of any payment (as to the correctness of amount, entitlement to receive or any other matters relating to payment) or notice effected by the Company or any Paying Agent or any records maintained by any co-Note Registrar with respect to the Notes;
43

(f) if any party fails to deliver a notice relating to an event the fact of which, pursuant to this Indenture, requires notice to be sent to the Trustee, the Trustee may conclusively rely on its failure to receive such notice as reason to act as if no such event occurred, unless a Responsible Officer of the Trustee had actual knowledge of such event;
(g) in the absence of written investment direction from the Company, all cash received by the Trustee shall be placed in a non-interest bearing trust account, and in no event shall the Trustee be liable for the selection of investments or for investment losses incurred thereon or for losses incurred as a result of the liquidation of any such investment prior to its maturity date or the failure of the party directing such investments prior to its maturity date or the failure of the party directing such investment to provide timely written investment direction, and the Trustee shall have no obligation to invest or reinvest any amounts held hereunder in the absence of such written investment direction from the Company; and
(h) in the event that the Trustee is also acting as Custodian, Note Registrar, Paying Agent, Conversion Agent or transfer agent hereunder, the rights, indemnities and protections afforded to the Trustee pursuant to this Indenture shall also be afforded to such Custodian, Note Registrar, Paying Agent, Conversion Agent or transfer agent.
No provision of this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur financial liability in the performance of any of its duties or in the exercise of any of its rights or powers.

Section 7.02 Reliance on Documents, Opinions, Etc.
Except as otherwise provided in ‎Section 7.01:

(a) the Trustee may conclusively rely and shall be fully protected in acting upon any resolution, certificate, statement, instrument, opinion, report, notice, request, consent, order, bond, note, coupon or other paper or document believed by it in good faith to be genuine and to have been signed or presented by the proper party or parties;
(b) any request, direction, order or demand of the Company mentioned herein shall be sufficiently evidenced by an Officer’s Certificate (unless other evidence in respect thereof be herein specifically prescribed); and any Board Resolution may be evidenced to the Trustee by a copy thereof certified by the Secretary or an Assistant Secretary of the Company;
(c) before the Trustee acts or refrains from acting, it may require an Officer’s Certificate or an Opinion of Counsel or both. The Trustee will not be liable for any action it takes or omits to take in good faith in reliance on such Officer’s Certificate or Opinion of Counsel. The Trustee may consult with counsel of its selection and require an Opinion of Counsel and any advice of such counsel or Opinion of Counsel shall be full and complete authorization and protection in respect of any action taken or omitted by it hereunder in good faith and in reliance on such advice or Opinion of Counsel;
(d) the Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture or other paper or document, but the Trustee, in its discretion, may make such further inquiry or investigation into such facts or matters as it may see fit, and, if the Trustee shall determine to make such further inquiry or investigation, it shall be entitled to examine the books, records and premises of the Company, personally or by agent or attorney at the expense of the Company and shall incur no liability of any kind by reason of such inquiry or investigation;
(e) the Trustee may execute any of the trusts or powers hereunder or perform any duties hereunder either directly or by or through agents, custodians, nominees or attorneys and the Trustee shall not be responsible for any misconduct or negligence on the part of any agent, custodian, nominee or attorney appointed by it with due care hereunder;
(f) the permissive rights of the Trustee enumerated herein shall not be construed as duties;
(g) the Trustee shall not be deemed to have notice of any Default or Event of Default unless a Responsible Officer of the Trustee has written notice of any event which is in fact such a default is received by the Trustee at the Corporate Trust Office of the Trustee, and such notice references the Notes and this Indenture;
44

(h) the rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder, and each agent, custodian and other Person employed to act hereunder;
(i)the Trustee shall not be required to give any bond or surety in respect of the performance of its powers and duties hereunder; and
(j) the Trustee may request that the Company deliver a certificate setting forth the names of individuals and/or titles of officers authorized at such time to take specified actions pursuant to this Indenture.
In no event shall the Trustee be liable for any special, punitive, indirect or consequential loss or damage of any kind whatsoever (including but not limited to lost profits), even if the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action other than any such loss or damage caused by the Trustee’s willful misconduct or gross negligence. The Trustee shall not be charged with knowledge of any Default or Event of Default with respect to the Notes, unless written notice of such Default or Event of Default shall have been given to a Responsible Officer of the Trustee by the Company or by any Holder of the Notes.
Section 7.03 No Responsibility for Recitals, Etc. The recitals contained herein and in the Notes (except in the Trustee’s certificate of authentication) shall be taken as the statements of the Company, and the Trustee assumes no responsibility for the correctness of the same. The Trustee makes no representations as to the validity or sufficiency of this Indenture or of the Notes. The Trustee shall not be accountable for the use or application by the Company of any Notes or the proceeds of any Notes authenticated and delivered by the Trustee in conformity with the provisions of this Indenture.
Section 7.04 Trustee, Paying Agents, Conversion Agents or Note Registrar May Own Notes. The Trustee, any Paying Agent, any Conversion Agent or Note Registrar, in its individual or any other capacity, may become the owner or pledgee of Notes with the same rights it would have if it were not the Trustee, Paying Agent, Conversion Agent or Note Registrar.
Section 7.05 Monies and Common Stock to Be Held in Trust. All monies and Common Stock received by the Trustee shall, until used or applied as herein provided, be held in trust for the purposes for which they were received. Money and Common Stock held by the Trustee in trust hereunder need not be segregated from other funds except to the extent required by law. The Trustee shall be under no liability for interest on any money or Common Stock received by it hereunder except as may be agreed in writing from time to time by the Company and the Trustee.
Section 7.06 Compensation and Expenses of Trustee. The Company covenants and agrees to pay to the Trustee from time to time, and the Trustee shall be entitled to, such compensation for all services rendered by it hereunder in any capacity (which shall not be limited by any provision of law in regard to the compensation of a trustee of an express trust) as mutually agreed to in writing between the Trustee and the Company, and the Company will pay or reimburse the Trustee upon its request for all reasonable expenses, disbursements and advances reasonably incurred or made by the Trustee in accordance with any of the provisions of this Indenture in any capacity thereunder (including the reasonable compensation and the expenses and disbursements of its agents and counsel and of all Persons not regularly in its employ) except any such expense, disbursement or advance as shall have been caused by its gross negligence or willful misconduct. The Company also covenants to indemnify the Trustee in any capacity under this Indenture and any other document or transaction entered into in connection herewith and its agents and any authenticating agent for, and to hold them harmless against, any loss, claim (whether asserted by the Company, a Holder or any other Person), damage, liability or expense incurred without gross negligence or willful misconduct on the part of the Trustee, its officers, directors, agents or employees, or such agent or authenticating agent, as the case may be, and arising out of or in connection with the acceptance or administration of this Indenture or in any other capacity hereunder, including the costs and expenses of defending themselves against any claim of liability in the premises or in enforcing the terms of this Indenture, including this provision. The obligations of the Company under this ‎Section 7.06 to compensate or indemnify the Trustee and to pay or reimburse the Trustee for expenses, disbursements and advances shall be secured by a senior claim to which the Notes are hereby made subordinate on all money or property held or collected by the Trustee, except, subject to the effect of ‎Section 6.05, funds held in trust herewith for the benefit of the Holders of particular Notes. The Trustee’s right to receive payment of any amounts due under this ‎Section 7.06 shall not be subordinate to any other liability or indebtedness of the Company. The obligation of the 
45

Company under this ‎Section 7.06 shall survive the satisfaction and discharge of this Indenture and the earlier resignation or removal or the Trustee. The Company need not pay for any settlement made without its consent, which consent shall not be unreasonably withheld. The indemnification provided in this ‎Section 7.06 shall extend to the officers, directors, agents and employees of the Trustee.
Without prejudice to any other rights available to the Trustee under applicable law, when the Trustee and its agents and any authenticating agent incur expenses or render services after an Event of Default specified in ‎Section 6.01(h) or ‎Section 6.01(i) occurs, the expenses and the compensation for the services are intended to constitute expenses of administration under any bankruptcy, insolvency or similar laws.
Section 7.07 Officer’s Certificate as Evidence. Except as otherwise provided in ‎Section 7.01, whenever in the administration of the provisions of this Indenture the Trustee shall deem it necessary or desirable that a matter be proved or established prior to taking or omitting any action hereunder, such matter (unless other evidence in respect thereof be herein specifically prescribed) may, in the absence of gross negligence or willful misconduct on the part of the Trustee, be deemed to be conclusively proved and established by an Officer’s Certificate delivered to the Trustee, and such Officer’s Certificate, in the absence of gross negligence and willful misconduct on the part of the Trustee, shall be full warrant to the Trustee for any action taken or omitted by it under the provisions of this Indenture upon the faith thereof.
Section 7.08 Eligibility of Trustee. There shall at all times be a Trustee hereunder which shall be a Person that is eligible pursuant to the Trust Indenture Act (as if the Trust Indenture Act were applicable hereto) to act as such and has a combined capital and surplus of at least $50,000,000. If such Person publishes reports of condition at least annually, pursuant to law or to the requirements of any supervising or examining authority, then for the purposes of this Section, the combined capital and surplus of such Person shall be deemed to be its combined capital and surplus as set forth in its most recent report of condition so published. If at any time the Trustee shall cease to be eligible in accordance with the provisions of this Section, it shall resign immediately in the manner and with the effect hereinafter specified in this Article.
Section 7.09Resignation or Removal of Trustee.  The Trustee may at any time resign by giving written notice of such resignation to the Company and by delivering notice thereof to the Holders. Upon receiving such notice of resignation, the Company shall promptly appoint a successor trustee by written instrument, in duplicate, executed by order of the Company, one copy of which instrument shall be delivered to the resigning Trustee and one copy to the successor trustee. If no successor trustee shall have been so appointed and have accepted appointment within 45 days after the delivery of such notice of resignation to the Holders, the resigning Trustee may, upon ten Business Days’ notice to the Company and the Holders, petition any court of competent jurisdiction for the appointment of a successor trustee (at the Company’s expense), or any Holder who has been a bona fide holder of a Note or Notes for at least six months (or since the date of this Indenture) may, subject to the provisions of ‎Section 6.11, on behalf of himself or herself and all others similarly situated, petition any such court for the appointment of a successor trustee. Such court may thereupon, after such notice, if any, as it may deem proper and prescribe, appoint a successor trustee.
(b) In case at any time any of the following shall occur:
(i) the Trustee shall cease to be eligible in accordance with the provisions of ‎Section 7.08 and shall fail to resign after written request therefor by the Company or by any such Holder, or 
(ii) the Trustee shall become incapable of acting, or shall be adjudged a bankrupt or insolvent, or a receiver of the Trustee or of its property shall be appointed, or any public officer shall take charge or control of the Trustee or of its property or affairs for the purpose of rehabilitation, conservation or liquidation, 
then, in either case, the Company may by a Board Resolution remove the Trustee and appoint a successor trustee by written instrument, in duplicate, executed by order of the Company, one copy of which instrument shall be delivered to the Trustee so removed and one copy to the successor trustee, or, subject to the provisions of ‎Section 6.11, any Holder who has been a bona fide holder of a Note or Notes for at least six months (or since the date of this Indenture) may, on behalf of himself or herself and all others similarly situated, petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor trustee. Such court may thereupon, after such notice, if any, as it may deem proper and prescribe, remove the Trustee and appoint a successor trustee.
46

(c)  The Holders of the Required Percentage in aggregate Original Principal Amount of the Notes at the time outstanding, as determined in accordance with ‎Section 8.04, may at any time remove the Trustee upon thirty (30) days prior written notice and nominate a successor trustee that shall be deemed appointed as successor trustee unless within ten days after notice to the Company of such nomination the Company objects thereto, in which case the Trustee so removed or any Holder, upon the terms and conditions and otherwise as in ‎Section 7.09(a) provided, may petition any court of competent jurisdiction for an appointment of a successor trustee.
(d) Any resignation or removal of the Trustee and appointment of a successor trustee pursuant to any of the provisions of this ‎Section 7.09 shall become effective upon acceptance of appointment by the successor trustee as provided in ‎Section 7.10.
Section 7.10 Acceptance by Successor Trustee. Any successor trustee appointed as provided in ‎Section 7.09 shall execute, acknowledge and deliver to the Company and to its predecessor trustee an instrument accepting such appointment hereunder, and thereupon the resignation or removal of the predecessor trustee shall become effective and such successor trustee, without any further act, deed or conveyance, shall become vested with all the rights, powers, duties and obligations of its predecessor hereunder, with like effect as if originally named as Trustee herein; but, nevertheless, on the written request of the Company or of the successor trustee, the trustee ceasing to act shall, upon payment of any amounts then due it pursuant to the provisions of ‎Section 7.06, execute and deliver an instrument transferring to such successor trustee all the rights and powers of the trustee so ceasing to act. Upon request of any such successor trustee, the Company shall execute any and all instruments in writing for more fully and certainly vesting in and confirming to such successor trustee all such rights and powers. Any trustee ceasing to act shall, nevertheless, retain a senior claim to which the Notes are hereby made subordinate on all money or property held or collected by such trustee as such, except for funds held in trust for the benefit of Holders of particular Notes, to secure any amounts then due it pursuant to the provisions of ‎Section 7.06.
No successor trustee shall accept appointment as provided in this ‎Section 7.10 unless at the time of such acceptance such successor trustee shall be eligible under the provisions of ‎Section 7.08.
Upon acceptance of appointment by a successor trustee as provided in this ‎Section 7.10, each of the Company and the successor trustee, at the written direction and at the expense of the Company shall send or cause to be sent a notice of the succession of such trustee hereunder to the Holders at their addresses as they shall appear on the Note Register. If the Company fails to send such notice within ten days after acceptance of appointment by the successor trustee, the successor trustee shall cause such notice to be sent at the expense of the Company.
Section 7.11 Succession by Merger, Etc. Any corporation or other entity into which the Trustee may be merged or converted or with which it may be consolidated, or any corporation or other entity resulting from any merger, conversion or consolidation to which the Trustee shall be a party, or any corporation or other entity succeeding to all or substantially all of the corporate trust business of the Trustee (including the administration of this Indenture), shall be the successor to the Trustee hereunder without the execution or filing of any paper or any further act on the part of any of the parties hereto; provided that in the case of any corporation or other entity succeeding to all or substantially all of the corporate trust business of the Trustee such corporation or other entity shall be eligible under the provisions of ‎Section 7.08.
In case at the time such successor to the Trustee shall succeed to the trusts created by this Indenture, any of the Notes shall have been authenticated but not delivered, any such successor to the Trustee may adopt the certificate of authentication of any predecessor trustee or authenticating agent appointed by such predecessor trustee, and deliver such Notes so authenticated; and in case at that time any of the Notes shall not have been authenticated, any successor to the Trustee or an authenticating agent appointed by such successor trustee may authenticate such Notes either in the name of any predecessor trustee hereunder or in the name of the successor trustee; and in all such cases such certificates shall have the full force which it is anywhere in the Notes or in this Indenture provided that the certificate of the Trustee shall have; provided, however, that the right to adopt the certificate of authentication of any predecessor trustee or to authenticate Notes in the name of any predecessor trustee shall apply only to its successor or successors by merger, conversion or consolidation.
Section 7.12 Trustee’s Application for Instructions from the Company. Any application by the Trustee for written instructions from the Company (other than with regard to any action proposed to be taken or omitted to be taken by 
47

the Trustee that affects the rights of the Holders of the Notes under this Indenture) may, at the option of the Trustee, set forth in writing any action proposed to be taken or omitted by the Trustee under this Indenture and the date on and/or after which such action shall be taken or such omission shall be effective. The Trustee shall not be liable to the Company for any action taken by, or omission of, the Trustee in accordance with a proposal included in such application on or after the date specified in such application (which date shall not be less than three Business Days after the date any officer that the Company has indicated to the Trustee should receive such application actually receives such application, unless any such officer shall have consented in writing to any earlier date), unless, prior to taking any such action (or the effective date in the case of any omission), the Trustee shall have received written instructions in accordance with this Indenture in response to such application specifying the action to be taken or omitted.
ARTICLE 8: Concerning the Holders
Section 8.01 Action by Holders. Whenever in this Indenture it is provided that the Holders of a specified percentage of the aggregate principal amount of the Notes (whether expressed as such or as Original Principal Amount or Accreted Principal Amount) may take any action (including the making of any demand or request, the giving of any notice, consent or waiver or the taking of any other action), the fact that at the time of taking any such action, the Holders of such specified percentage have joined therein may be evidenced (a) by any instrument or any number of instruments of similar tenor executed by Holders in person or by agent or proxy appointed in writing, or (b) by the record of the Holders voting in favor thereof at any meeting of Holders, or (c) by a combination of such instrument or instruments and any such record of such a meeting of Holders. Whenever the Company solicits the taking of any action by the Holders of the Notes, the Company may, but shall not be required to, fix in advance of such solicitation, a date as the record date for determining Holders entitled to take such action. The record date if one is selected shall be not more than fifteen days prior to the date of commencement of solicitation of such action.
Section 8.02 Proof of Execution by Holders. Subject to the provisions of ‎Section 7.01 and ‎Section 7.02, proof of the execution of any instrument by a Holder or its agent or proxy shall be sufficient if made in accordance with such reasonable rules and regulations as may be prescribed by the Trustee or in such manner as shall be satisfactory to the Trustee. The holding of Notes shall be proved by the Note Register or by a certificate of the Note Registrar. 
Secion 8.03 Who Are Deemed Absolute Owners. The Company, the Trustee, any authenticating agent, any Paying Agent, any Conversion Agent and any Note Registrar may deem the Person in whose name a Note shall be registered upon the Note Register to be, and may treat it as, the absolute owner of such Note (whether or not such Note shall be overdue and notwithstanding any notation of ownership or other writing thereon made by any Person other than the Company or any Note Registrar) for the purpose of receiving payment of or on account of the Accreted Principal Amount (including any Redemption Price and any Fundamental Change Repurchase Price) of such Note, for conversion of such Note and for all other purposes; and neither the Company nor the Trustee nor any Paying Agent nor any Conversion Agent nor any Note Registrar shall be affected by any notice to the contrary. All such payments or deliveries so made to any Holder for the time being, or upon its order, shall be valid, and, to the extent of the sums or Common Stock so paid or delivered, effectual to satisfy and discharge the liability for monies payable or shares deliverable upon any such Note. Notwithstanding anything to the contrary in this Indenture or the Notes following an Event of Default, any holder of a beneficial interest in a Global Note may directly enforce against the Company, without the consent, solicitation, proxy, authorization or any other action of the Depositary or any other Person, such holder’s right to exchange such beneficial interest for a Note in certificated form in accordance with the provisions of this Indenture.
Section 8.04 Company-Owned Notes Disregarded. In determining whether the Holders of the requisite aggregate principal amount of Notes (whether expressed as such or as Original Principal Amount or Accreted Principal Amount) have concurred in any direction, consent, waiver or other action under this Indenture, Notes that are owned by the Company, by any Subsidiary thereof or by any Affiliate of the Company or any Subsidiary thereof shall be disregarded and deemed not to be outstanding for the purpose of any such determination; provided that for the purposes of determining whether the Trustee shall be protected in relying on any such direction, consent, waiver or other action only Notes that a Responsible Officer knows are so owned shall be so disregarded. Notes so owned that have been pledged in good faith may be regarded as outstanding for the purposes of this ‎Section 8.04 if the pledgee shall establish to the satisfaction of the Trustee the pledgee’s right to so act with respect to such Notes and that the pledgee is not the Company, a Subsidiary thereof or an Affiliate of the Company or a Subsidiary thereof. In the case of a dispute as to such right, any decision by the Trustee 
48

taken upon the advice of counsel shall be full protection to the Trustee. Upon request of the Trustee, the Company shall furnish to the Trustee promptly an Officer’s Certificate listing and identifying all Notes, if any, known by the Company to be owned or held by or for the account of any of the above described Persons; and, subject to ‎Section 7.01, the Trustee shall be entitled to accept such Officer’s Certificate as conclusive evidence of the facts therein set forth and of the fact that all Notes not listed therein are outstanding for the purpose of any such determination. Notwithstanding Section 316(a)(1) of the Trust Indenture Act (which, for the avoidance of doubt, shall not apply to this Indenture unless and until this Indenture is qualified under the Trust Indenture Act) or anything herein to the contrary, to the fullest extent permitted by law, no Notes owned or beneficially owned by any of the Purchasers (as defined in the Securities Purchase Agreement) or any of their respective Affiliates shall be deemed to be owned by the Company, by any Subsidiary thereof or by any Affiliate of the Company or any Subsidiary thereof.
Section 8.05 Revocation of Consents; Future Holders Bound
At any time prior to (but not after) the evidencing to the Trustee, as provided in ‎Section 8.01, of the taking of any action by the Holders of the percentage of the aggregate principal amount of the Notes specified in this Indenture in connection with such action, any Holder of a Note that is shown by the evidence to be included in the Notes the Holders of which have consented to such action may, by filing written notice with the Trustee at its Corporate Trust Office and upon proof of holding as provided in ‎Section 8.02, revoke such action so far as concerns such Note. Except as aforesaid, any such action taken by the Holder of any Note shall be conclusive and binding upon such Holder and upon all future Holders and owners of such Note and of any Notes issued in exchange or substitution therefor or upon registration of transfer thereof, irrespective of whether any notation in regard thereto is made upon such Note or any Note issued in exchange or substitution therefor or upon registration of transfer thereof.
ARTICLE 9: Holders’ Meetings
Section 9.01 Purpose of Meetings
A meeting of Holders may be called at any time and from time to time pursuant to the provisions of this ‎Article 9 for any of the following purposes:
(a) to give any notice to the Company or to the Trustee or to give any directions to the Trustee permitted under this Indenture, or to consent to the waiving of any Default or Event of Default hereunder (in each case, as permitted under this Indenture) and its consequences, or to take any other action authorized to be taken by Holders pursuant to any of the provisions of ‎Article 6;
(b) to remove the Trustee and nominate a successor trustee pursuant to the provisions of ‎Article 7;
(c) to consent to the execution of an indenture or indentures supplemental hereto pursuant to the provisions of ‎Section 10.02; or
(d) to take any other action authorized to be taken by or on behalf of the Holders of any specified aggregate principal amount of the Notes under any other provision of this Indenture or under applicable law.
Section 9.02 Call of Meetings by Trustee
The Trustee may at any time call a meeting of Holders to take any action specified in ‎Section 9.01, to be held at such time and at such place as the Trustee shall determine. Notice of every meeting of the Holders, setting forth the time and the place of such meeting and in general terms the action proposed to be taken at such meeting and the establishment of any record date pursuant to ‎Section 8.01, shall be delivered to Holders. Such notice shall also be delivered to the Company. Such notices shall be delivered not less than 20 nor more than 90 days prior to the date fixed for the meeting.
Any meeting of Holders shall be valid without notice if the Holders of all Notes then outstanding are present in person or by proxy or if notice is waived before or after the meeting by the Holders of all Notes then 
49

outstanding, and if the Company and the Trustee are either present by duly authorized representatives or have, before or after the meeting, waived notice.
Section 9.03 Call of Meetings by Company or Holders
In case at any time the Company, pursuant to a Board Resolution, or the Holders of at least 10% of the aggregate principal amount of the Notes then outstanding, shall have requested the Trustee to call a meeting of Holders, by written request setting forth in reasonable detail the action proposed to be taken at the meeting, and the Trustee shall not have delivered the notice of such meeting within 20 days after receipt of such request, then the Company or such Holders may determine the time and the place for such meeting and may call such meeting to take any action authorized in ‎Section 9.01, by delivering notice thereof as provided in ‎Section 9.02.
Section 9.04 Qualifications for Voting
To be entitled to vote at any meeting of Holders a Person shall (a) be a Holder of one or more Notes on the record date pertaining to such meeting or (b) be a Person appointed by an instrument in writing as proxy by a Holder of one or more Notes on the record date pertaining to such meeting. The only Persons who shall be entitled to be present or to speak at any meeting of Holders shall be the Persons entitled to vote at such meeting and their counsel and any representatives of the Trustee and its counsel and any representatives of the Company and its counsel.
Section 9.05 Regulations
Notwithstanding any other provisions of this Indenture, the Trustee may make such reasonable regulations as it may deem advisable for any meeting of Holders, in regard to proof of the holding of Notes and of the appointment of proxies, and in regard to the appointment and duties of inspectors of votes, the submission and examination of proxies, certificates and other evidence of the right to vote, and such other matters concerning the conduct of the meeting as it shall think fit.
The Trustee shall, by an instrument in writing, appoint a temporary chairman of the meeting, unless the meeting shall have been called by the Company or by Holders as provided in ‎Section 9.03, in which case the Company or the Holders calling the meeting, as the case may be, shall in like manner appoint a temporary chairman. A permanent chairman and a permanent secretary of the meeting shall be elected by vote of the Holders of the Required Percentage in aggregate Original Principal Amount of the Notes represented at the meeting and entitled to vote at the meeting.
Subject to the provisions of ‎Section 8.04, at any meeting of Holders each Holder or proxyholder shall be entitled to one vote for each $1,000 Original Principal Amount of Notes held or represented by him or her; provided, however, that no vote shall be cast or counted at any meeting in respect of any Note challenged as not outstanding and ruled by the chairman of the meeting to be not outstanding. The chairman of the meeting shall have no right to vote other than by virtue of Notes held by it or instruments in writing as aforesaid duly designating it as the proxy to vote on behalf of other Holders. Any meeting of Holders duly called pursuant to the provisions of ‎Section 9.02 or ‎Section 9.03 may be adjourned from time to time by the Holders of the Required Percentage in aggregate Original Principal Amount of Notes represented at the meeting, whether or not constituting a quorum, and the meeting may be held as so adjourned without further notice.
Section 9.06 Voting
The vote upon any resolution submitted to any meeting of Holders shall be by written ballot on which shall be subscribed the signatures of the Holders or of their representatives by proxy and the outstanding aggregate Original Principal Amount of the Notes held or represented by them. The permanent chairman of the meeting shall appoint two inspectors of votes who shall count all votes cast at the meeting for or against any resolution and who shall make and file with the secretary of the meeting their verified written reports in duplicate of all votes cast at the meeting. A record in duplicate of the proceedings of each meeting of Holders shall be prepared by the secretary of the meeting and there shall be attached to said record the original reports of the inspectors of votes on any vote by 
50

ballot taken thereat and affidavits by one or more Persons having knowledge of the facts setting forth a copy of the notice of the meeting and showing that said notice was delivered as provided in ‎Section 9.02. The record shall show the aggregate Original Principal Amount of the Notes voting in favor of or against any resolution. The record shall be signed and verified by the affidavits of the permanent chairman and secretary of the meeting and one of the duplicates shall be delivered to the Company and the other to the Trustee to be preserved by the Trustee, the latter to have attached thereto the ballots voted at the meeting.
Any record so signed and verified shall be conclusive evidence of the matters therein stated.
Section 9.07 No Delay of Rights by Meeting
Nothing contained in this ‎Article 9 shall be deemed or construed to authorize or permit, by reason of any call of a meeting of Holders or any rights expressly or impliedly conferred hereunder to make such call, any hindrance or delay in the exercise of any right or rights conferred upon or reserved to the Trustee or to the Holders under any of the provisions of this Indenture or of the Notes.
ARTICLE 10: Supplemental Indentures
Section 10.01 Supplemental Indentures Without Consent of Holders
The Company, when authorized by the resolutions of the Board of Directors, and the Trustee, at the Company’s expense, may from time to time and at any time enter into an indenture or indentures supplemental hereto for one or more of the following purposes:
(a) to cure any ambiguity, omission, defect or inconsistency;
(b) to provide for the assumption by a Successor Company of the obligations of the Company under this Indenture pursuant to ‎Article 11;
(c) to add guarantees with respect to the Notes;
(d) to secure the Notes;
(e) to add to the covenants of the Company or to add to the Events of Default of the Company for the benefit of the Holders or surrender any right or power conferred upon the Company;
(f) to make any change that does not adversely affect the rights of any Holder;
(g) in connection with any Merger Event, provide that the notes are convertible into Reference Property, subject to the provisions of ‎Section 13.02, and make such related changes to the terms of the Notes and conversion rights of the Holders to the extent expressly required by ‎Section 13.06;
(h) provide for the acceptance of appointment by a successor trustee or facilitate the administration of the trusts under this Indenture by more than one trustee;
(i) comply with the rules of the Depositary;
(j) to amend ‎Section 4.11 pursuant to ‎Section 4.11(e); or
(k) comply with any requirement of the Securities and Exchange Commission in connection with the qualification of this Indenture under the Trust Indenture Act.
Upon the written request of the Company, the Trustee is hereby authorized to join with the Company in the execution of any such supplemental indenture, to make any further appropriate agreements and stipulations that may 
51

be therein contained, but the Trustee shall not be obligated to, but may in its discretion, enter into any supplemental indenture that affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise.
Any supplemental indenture authorized by the provisions of this ‎Section 10.01 may be executed by the Company and the Trustee without the consent of the Holders of any of the Notes at the time outstanding, notwithstanding any of the provisions of ‎Section 10.02.
Section 10.02 Supplemental Indentures with Consent of Holders
With the consent (evidenced as provided in ‎Article 8) of the Holders of the Required Percentage in aggregate Original Principal Amount of the Notes then outstanding (determined in accordance with ‎Article 8 and including, without limitation, consents obtained in connection with a repurchase of, or tender or exchange offer for, Notes), Company, when authorized by the resolutions of the Board of Directors, and the Trustee, at the Company’s expense, may from time to time and at any time enter into an indenture or indentures supplemental hereto for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of this Indenture or any supplemental indenture or of modifying in any manner the rights of the Holders; provided, however, that, without the consent of each Holder of an outstanding Note affected, no such supplemental indenture shall:
(a) reduce the amount of Notes whose Holders must consent to an amendment;
(b) reduce the rate of or extend the stated time for the accretion of interest on any Note in accordance with the provisions of ‎Section 2.03;
(c) change the Original Principal Amount of, reduce the Accreted Principal Amount of or extend the Maturity Date of any Note;
(d) make any change that adversely affects the conversion rights of any Notes;
(e) reduce the Redemption Price or the Fundamental Change Repurchase Price of any Note or amend or modify in any manner adverse to the Holders the Company’s obligation to make such payments, whether through an amendment or waiver of provisions in the covenants, definitions or otherwise;
(f) make any Note payable in a currency other than that stated in the Note;
(g) change the ranking of the Notes;
(h) change the provisions set forth in ‎Section 4.09 in a manner adverse to the Holders or beneficial owners of the Notes;
(i) make any change in this ‎Article 10 that requires each Holder’s consent or in the waiver provisions in ‎Section 6.02 or ‎Section 6.09; or
Upon the written request of the Company, and upon the filing with the Trustee of evidence of the consent of Holders as aforesaid and subject to ‎Section 10.05, the Trustee shall join with the Company in the execution of such supplemental indenture unless such supplemental indenture affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion, but shall not be obligated to, enter into such supplemental indenture.
Holders do not need under this ‎Section 10.02 to approve the particular form of any proposed supplemental indenture. It shall be sufficient if such Holders approve the substance thereof. After any such supplemental indenture becomes effective, the Company shall deliver to the Holders a notice briefly describing such supplemental indenture. However, the failure to give such notice to all the Holders, or any defect in the notice, will not impair or affect the validity of the supplemental indenture.
52

Section 10.03 Effect of Supplemental Indentures
Upon the execution of any supplemental indenture pursuant to the provisions of this ‎Article 10, this Indenture shall be and be deemed to be modified and amended in accordance therewith and the respective rights, limitation of rights, obligations, duties and immunities under this Indenture of the Trustee, the Company and the Holders shall thereafter be determined, exercised and enforced hereunder subject in all respects to such modifications and amendments and all the terms and conditions of any such supplemental indenture shall be and be deemed to be part of the terms and conditions of this Indenture for any and all purposes.
Section 10.04 Notation on Notes
Notes authenticated and delivered after the execution of any supplemental indenture pursuant to the provisions of this ‎Article 10 may, at the Company’s expense, bear a notation in form approved by the Trustee as to any matter provided for in such supplemental indenture. If the Company or the Trustee shall so determine, new Notes so modified as to conform, in the opinion of the Trustee and the Board of Directors, to any modification of this Indenture contained in any such supplemental indenture may, at the Company’s expense, be prepared and executed by the Company, authenticated by the Trustee (or an authenticating agent duly appointed by the Trustee pursuant to ‎Section 16.10) and delivered in exchange for the Notes then outstanding, upon surrender of such Notes then outstanding.
Section 10.05 Evidence of Compliance of Supplemental Indenture to Be Furnished Trustee
In addition to the documents required by ‎Section 16.05, the Trustee shall receive an Officer’s Certificate and an Opinion of Counsel as conclusive evidence that any supplemental indenture executed pursuant hereto complies with the requirements of this ‎Article 10 and is permitted or authorized by this Indenture and is the legal, valid and binding obligation of the Company, enforceable against it in accordance with its terms.
ARTICLE 11: Consolidation, Merger, Sale, Conveyance and Lease
Section 11.01 Company May Consolidate, Etc. on Certain Terms
Subject to the provisions of ‎Section 11.02, the Company shall not consolidate with, merge with or into, or sell, convey, transfer or lease all or substantially all of its properties and assets to another Person, unless:
(a) the resulting, surviving or transferee Person (the “Successor Company”), if not the Company, shall be (i) a corporation organized and existing under the laws of the United States of America, any State thereof or the District of Columbia or (ii) a corporation or entity that is treated as a corporation for U.S. federal income tax purposes organized and existing under the laws of the Cayman Islands, the British Virgin Islands, the Islands of Bermuda, the Netherlands, Belgium, Switzerland, Luxembourg, the Republic of Ireland, Canada or the United Kingdom, and the Successor Company (if not the Company) shall expressly assume, by supplemental indenture all of the obligations of the Company under the Notes and this Indenture (including, for the avoidance of doubt, the obligation to pay Additional Amounts, as set forth in ‎Section 4.09); and
(b) immediately after giving effect to such transaction, no Default or Event of Default shall have occurred and be continuing under this Indenture.
For purposes of this ‎Section 11.01, the sale, conveyance, transfer or lease of all or substantially all of the properties and assets of one or more Subsidiaries of the Company to another Person, which properties and assets, if held by the Company instead of such Subsidiaries, would constitute all or substantially all of the properties and assets of the Company on a consolidated basis, shall be deemed to be the sale, conveyance, transfer or lease of all or substantially all of the properties and assets of the Company to another Person.
Section 11.02 Successor Person to Be Substituted
53

In case of any such consolidation, merger, sale, conveyance, transfer or lease and upon the assumption by the Successor Company, by supplemental indenture, executed and delivered to the Trustee and satisfactory in form to the Trustee, of the due and punctual payment of the Accreted Principal Amount of all of the Notes, the due and punctual delivery or payment, as the case may be, of any consideration due upon conversion of the Notes and the due and punctual performance of all of the covenants and conditions of this Indenture to be performed by the Company, such Successor Company (if not the Company) shall succeed to and, except in the case of a lease of all or substantially all of the Company’s properties and assets, shall be substituted for the Company, with the same effect as if it had been named herein as the party of the first part, and the Company (except in the case of a lease of all or substantially all of the Company’s property and assets) shall be discharged from the obligations of the Company under the Notes and this Indenture. Such Successor Company thereupon may cause to be signed, and may issue either in its own name or in the name of the Company any or all of the Notes issuable hereunder which theretofore shall not have been signed by the Company and delivered to the Trustee; and, upon the order of such Successor Company instead of the Company and subject to all the terms, conditions and limitations in this Indenture prescribed, the Trustee shall authenticate and shall deliver, or cause to be authenticated and delivered, any Notes that previously shall have been signed and delivered by the Officers of the Company to the Trustee for authentication, and any Notes that such Successor Company thereafter shall cause to be signed and delivered to the Trustee for that purpose. All the Notes so issued shall in all respects have the same legal rank and benefit under this Indenture as the Notes theretofore or thereafter issued in accordance with the terms of this Indenture as though all of such Notes had been issued at the date of the execution hereof.  In the event of any such consolidation, merger, sale, conveyance or transfer (but not in the case of a lease), upon compliance with this ‎Article 11 the Person named as the “Company” in the first paragraph of this Indenture (or any successor that shall thereafter have become such in the manner prescribed in this ‎Article 11) may be dissolved, wound up and liquidated at any time thereafter and, except in the case of a lease, such Person shall be released from its liabilities as obligor and maker of the Notes and from its obligations under this Indenture and the Notes.
In case of any such consolidation, merger, sale, conveyance, transfer or lease, such changes in phraseology and form (but not in substance) may be made in the Notes thereafter to be issued as may be appropriate.
Section 11.03 Opinion of Counsel to Be Given to Trustee
. No such consolidation, merger, sale, conveyance, transfer or lease shall be effective unless the Trustee shall receive an Officer’s Certificate and an Opinion of Counsel as conclusive evidence that any such consolidation, merger, sale, conveyance, transfer or lease and any such assumption and, if a supplemental indenture is required in connection with such transaction, such supplemental indenture, complies with the provisions of this ‎Article 11.
ARTICLE 12: Immunity of Incorporators, Stockholders, Officers and Directors
Section 12.01 Indenture and Notes Solely Obligations of the Company 
No recourse for the payment of the Accreted Principal Amount of any, nor for any claim based thereon or otherwise in respect thereof, and no recourse under or upon any obligation, covenant or agreement of the Company in this Indenture or in any supplemental indenture or in any Note, nor because of the creation of any indebtedness represented thereby, shall be had against any incorporator, stockholder, employee, agent, Officer, director, manager, member, partner or Subsidiary, as such, past, present or future, of the Company or of any successor Person, either directly or through the Company or any successor Person, whether by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly understood that all such liability is hereby expressly waived and released as a condition of, and as a consideration for, the execution of this Indenture and the issue of the Notes.
ARTICLE 13: Conversion of Notes
Section 13.01 Conversion Privilege
. 
54

(a)  Subject to and upon compliance with the provisions of this ‎Article 13, each Holder of a Note shall have the right, at such Holder’s option, to convert such Note at any time prior to the close of business on the second Business Day immediately preceding the Maturity Date.
Section 13.02 Conversion Procedure; Settlement upon Conversion.
(a) Subject to this ‎Section 13.02 and ‎Section 13.06(a), upon conversion of any Note, the Company shall pay or deliver, as the case may be, to the converting Holder, in respect of each Note being converted, cash (“Cash Settlement”), shares of Common Stock, together with cash, if applicable, in lieu of delivering any fractional share of Common Stock in accordance with subsection ‎(j) of this ‎Section 13.02 (“Physical Settlement”) or a combination of cash and shares of Common Stock, together with cash, if applicable, in lieu of delivering any fractional share of Common Stock in accordance with subsection ‎(j) of this ‎Section 13.02 (“Combination Settlement”), at its election, as set forth in this ‎Section 13.02 (such obligation to deliver shares of Common Stock or cash pursuant to this ‎Section 13.02, the “Conversion Obligation”).
(i) The cash, shares of Common Stock or combination of cash and shares of Common Stock in respect of any conversion of Notes (the “Settlement Amount”) shall be computed as follows:
(A) if the Company elects to satisfy its Conversion Obligation in respect of such conversion by Physical Settlement, the number of shares of Common Stock to be delivered under this ‎Section 13.02 in respect of any such Note shall be equal to the quotient obtained by dividing (x) the Accreted Principal Amount of such Note on the relevant Conversion Date (subject to ‎Section 13.02(h)) by (y) the Conversion Price in effect on such Conversion Date in accordance with the settlement provisions of this ‎Section 13.02 (such quotient, rounded to the nearest 1/10,000 of a share of Common Stock, the “Conversion Rate”).
(B) if the Company elects to satisfy its Conversion Obligation in respect of such conversion by Cash Settlement, the Company shall pay to the converting Holder, in respect of any Notes being converted, cash in an amount equal to the product of (i) the VWAP of the Common Stock for the period ending on, and including, the Trading Day immediately preceding the date of the Notice of Conversion multiplied by (ii) the Conversion Rate for such Note.
(C) if the Company elects (or is deemed to have elected) to satisfy its Conversion Obligation in respect of such conversion by Combination Settlement, the Company shall deliver, in respect of each Note being converted, (i) a Settlement Amount equal to the amount specified in ‎Section 13.02(a)(i)(A) multiplied by the percentage of the Settlement Amount that the Company has elected to deliver in shares of Common Stock and (ii) the amount specified in ‎Section 13.02(a)(i)(B) multiplied by the percentage of the Settlement Amount that the Company has elected to deliver in cash. The Company agrees, for United States federal income tax purposes, to treat any Combination Settlement as a recapitalization in part to the extent of any Common Stock delivered and a sale in part to the extent of any cash delivered.
(ii) To the extent that Physical Settlement or Combination Settlement (or the possibility that a Holder could receive Physical Settlement or Combination Settlement, including as a result of any anti-dilution adjustment) would require the Company to obtain shareholder approval (including under New York Stock Exchange Rule 312.04), then notwithstanding the foregoing or anything else in this Indenture to the contrary, unless and until such shareholder approval is obtained,  the Company shall elect Cash Settlement. To the extent that Physical Settlement or Combination Settlement (or the possibility that a Holder could receive Physical Settlement or Combination Settlement, including as a result of any anti-dilution adjustment) would require the Company or any Holder to obtain any regulatory approvals or consents from any Governmental Entity (including if the Holder, together with any group of persons acting in concert therewith, would own, control, or hold with power to vote (as determined in accordance with the Change in Bank Control Act of 1978, as amended, and the regulations implemented thereunder by the Federal Deposit Insurance Corporation in 12 C.F.R. §§ 303.80-.88), more than 9.9% of the outstanding shares of any class of voting securities or to otherwise control the Company) (the “CIBC Conversion Cap” and the maximum amount of shares of Common Stock that may be issued without the requirement to obtain any such 
55

regulatory approvals or consents from any Governmental Entity, including pursuant to the Hart-Scott-Rodino Antitrust Improvements Act of 1976, the “Regulatory Cap”), then:
(A) to the extent the CIBC Conversion Cap or the Regulatory Cap would be exceeded solely as a result of Excess Acquisitions by a Holder, such Holder shall not have the right to convert Notes solely to the extent that Physical Settlement of such conversion would exceed the CIBC Conversion Cap or the Regulatory Cap; and
(B) to the extent the CIBC Conversion Cap or the Regulatory Cap would be exceeded as a result (in whole or in part) of events other than Excess Acquisitions by a Holder (including, without limitation, any reduction in the number of shares of Common Stock outstanding as a result of any action taken by the Company), the Company shall elect Cash Settlement with result to amounts that exceed the CIBC Conversion Cap or the Regulatory Cap.
If a Holder has made Excess Acquisitions, the extent to which the CIBC Conversion Cap or the Regulatory Cap would be exceeded as a result of such Excess Acquisitions shall be deemed to be limited to  the number of shares of Common Stock acquired in such Excess Acquisitions.
(iii) The Company shall inform a converting Holder of the Company’s election with regard to the method of fulfillment of its Conversion Obligation no later than two Trading Days after the day a Notice of Conversion is provided by such Holder and shall settle such conversion no later than three Trading Days after the day a Notice of Conversion is provided by such Holder.
(b) Subject to ‎Section 13.02(e), before any Holder of a Note shall be entitled to convert a Note as set forth above, such Holder shall (i) in the case of a Global Note, comply with the procedures of the Depositary in effect at that time and (ii) in the case of a Physical Note (1) complete, manually sign and deliver an irrevocable notice to the Conversion Agent as set forth in the Form of Notice of Conversion (or a facsimile thereof) (a “Notice of Conversion”) at the office of the Conversion Agent and state in writing the number of Notes to be converted and the name or names (with addresses) in which such Holder wishes the certificate or certificates for any shares of Common Stock to be delivered upon settlement of the Conversion Obligation to be registered, (2) surrender such Notes, duly endorsed to the Company or in blank (and accompanied by appropriate endorsement and transfer documents), at the office of the Conversion Agent, (3) if required, pay all applicable transfer or similar taxes, if any, pursuant to ‎Section 13.02(e), and (4) if required, furnish appropriate endorsements and transfer documents. The Trustee (and if different, the Conversion Agent) shall notify the Company of any conversion pursuant to this ‎Article 13 on the Conversion Date for such conversion. No Notice of Conversion with respect to any Notes may be surrendered by a Holder thereof if such Holder has also delivered a Fundamental Change Repurchase Notice to the Company in respect of such Notes and has not validly withdrawn such Fundamental Change Repurchase Notice in accordance with ‎Section 14.03.
If more than one Note shall be surrendered for conversion at one time by the same Holder, the Conversion Obligation with respect to such Notes shall be computed on the basis of the aggregate number of Notes (or specified portions thereof to the extent permitted thereby) so surrendered.
(c) A Note shall be deemed to have been converted immediately prior to the close of business on the date (the “Conversion Date”) that the Holder has complied with the requirements set forth in subsection ‎(b) above. The Company shall pay or deliver, as the case may be, the consideration due in respect of the Conversion Obligation on the third Business Day immediately following the relevant Conversion Date. The Company shall issue or cause to be issued, and deliver (if applicable) to the Conversion Agent or to such Holder, or such Holder’s nominee or nominees, the full number of shares of Common Stock to which such Holder shall be entitled, in certificate form or in book-entry format, in satisfaction of the Company’s Conversion Obligation.
(d) In case any Note certificate shall be surrendered for partial conversion, the Company shall execute and the Trustee shall authenticate and deliver to or upon the written order of the Holder of the Note certificate so surrendered a new Note certificate in authorized denominations in an aggregate Original Principal Amount equal to the unconverted portion of the surrendered Note certificate, without payment of any service charge by the converting Holder but, if required by the 
56

Company or Trustee, with payment of a sum sufficient to cover any documentary, stamp or similar issue or transfer tax or similar governmental charge required by law or that may be imposed in connection therewith as a result of the name of the Holder of the new Note certificate issued upon such conversion being different from the name of the Holder of the old Note certificate surrendered for such conversion.
(e) If a Holder submits a Note for conversion, the Company shall pay any documentary, stamp or similar issue or transfer tax due on the issue of the shares of Common Stock upon conversion, unless the tax is due because the Holder requests such shares to be issued in a name other than the Holder’s name, in which case the Holder shall pay that tax. The Conversion Agent may refuse to deliver the certificates representing the Common Stock being issued in a name other than the Holder’s name until the Trustee receives a sum sufficient to pay any tax that is due by such Holder in accordance with the immediately preceding sentence.
(f) Except as provided in ‎Section 13.03, no adjustment shall be made for dividends on any shares of Common Stock issued upon the conversion of any Note as provided in this ‎Article 13.
(g) Upon the conversion of an interest in a Global Note, the Trustee, or the Custodian at the direction of the Trustee, shall make a notation on such Global Note as to the reduction in the Original Principal Amount represented thereby. The Company shall notify the Trustee in writing of any conversion of Notes effected through any Conversion Agent other than the Trustee.
(h) Upon conversion, a Holder shall not receive any separate cash payment for accrued interest. The Company’s settlement of the full Conversion Obligation shall be deemed to satisfy in full its obligation to pay the Accreted Principal Amount of the Note and accrued interest, if any, from and including the Interest Payment Date next preceding the relevant Conversion Date to, but not including, such Conversion Date. As a result, accrued interest, if any, from and including the Interest Payment Date next preceding the relevant Conversion Date to, but not including, such Conversion Date shall be deemed to be paid in full rather than cancelled, extinguished or forfeited. Upon a conversion of Notes into a combination of cash and shares of Common Stock, accrued and unpaid interest will be deemed to be paid first out of the cash paid upon such conversion. Notwithstanding the foregoing, (1) for conversions after the close of business on the Regular Record Date immediately preceding the Maturity Date; (2) if the Company has specified a Fundamental Change Repurchase Date that is on or after the Regular Record Date immediately preceding an Interest Payment Date and on or prior to such Interest Payment Date; or (3) if the Company has specified a Redemption Date that is on or after the Regular Record Date immediately preceding an Interest Payment Date and on or prior to such Interest Payment Date, the Accreted Principal Amount of any Note converted shall, in each case, be increased by the interest that would have accreted to the Accreted Principal Amount in accordance with the provisions of ‎Section 2.03 as though the relevant Conversion Date were an Interest Payment Date.
(i) The Person in whose name any shares of Common Stock shall be issuable upon conversion shall be treated as a stockholder of record as of the close of business on the relevant Conversion Date. Upon a conversion of Notes, such Person shall no longer be a Holder of such Notes surrendered for conversion.
(j) Notwithstanding anything to the contrary in the foregoing in ‎Section 13.02(a) or otherwise, the Company shall not issue any fractional share of Common Stock upon conversion of the Notes and shall instead pay cash in lieu of delivering any fractional share of Common Stock issuable upon conversion based on the VWAP of the Common Stock for the period ending on, and including, the Trading Day immediately preceding the relevant Conversion Date.
Section 13.03 Adjustment of Conversion Price
The Conversion Price shall be adjusted from time to time by the Company if any of the following events occurs, except that the Company shall not make any adjustments to the Conversion Price if Holders of the Notes participate (other than in the case of (x) a share split or share combination or (y) a tender or exchange offer), at the same time and upon the same terms as holders of the Common Stock and solely as a result of holding the Notes, in any of the transactions described in this ‎Section 13.03, without having to convert their Notes, as if they held a number of shares of Common Stock equal to the applicable Conversion Rate at such time, multiplied by the aggregate Accreted Principal Amount (expressed in thousands) of Notes held by such Holder.
57

(a) If the Company exclusively issues shares of Common Stock as a dividend or distribution on shares of the Common Stock, or if the Company effects a share split or share combination, the Conversion Price shall be adjusted based on the following formula:
CP1 = CP0 x (OSo/OS1)

where,
									
	CP0
	=	the Conversion Price in effect immediately prior to the open of business on the Ex-Dividend Date of such dividend or distribution, or immediately prior to the open of business on the Effective Date of such share split or share combination, as applicable;
	CP1
	=	the Conversion Price in effect immediately after the open of business on such Ex-Dividend Date or Effective Date;
	OS0
	=	the number of shares of Common Stock outstanding immediately prior to the open of business on such Ex-Dividend Date or Effective Date (before giving effect to any such dividend, distribution, split or combination); and
	OS1
	=	the number of shares of Common Stock outstanding immediately after giving effect to such dividend, distribution, share split or share combination.

Any adjustment made under this ‎Section 13.03(a) shall become effective immediately after the open of business on the Ex-Dividend Date for such dividend or distribution, or immediately after the open of business on the Effective Date for such share split or share combination, as applicable. If any dividend or distribution of the type described in this ‎Section 13.03(a) is declared but not so paid or made, or any share split or combination of the type described in this ‎Section 13.03(a) is announced but the outstanding shares of Common Stock are not split or combined, as the case may be, the Conversion Price shall be immediately readjusted, effective as of the date the Board of Directors determines not to pay such dividend or distribution, or not to split or combine the outstanding shares of Common Stock, as the case may be, to the Conversion Price that would then be in effect if such dividend or distribution had not been declared or such share split or combination had not been announced.
(b) If the Company issues to all or substantially all holders of the Common Stock any rights, options or warrants (other than pursuant to a stockholders rights plan) entitling them, for a period of not more than 45 calendar days after the announcement date of such issuance, to subscribe for or purchase shares of Common Stock at a price per share that is less than the VWAP of the Common Stock for the period ending on, and including, the Trading Day immediately preceding the date of announcement of such issuance, the Conversion Price shall be decreased based on the following formula:
CP1 = CP0 X ((OSo + Y)/(OSo + X))

where,
58

									
	CP0
	=	the Conversion Price in effect immediately prior to the open of business on the Ex-Dividend Date for such issuance;
	CP1
	=	the Conversion Price in effect immediately after the open of business on such Ex-Dividend Date;
	OS0
	=	the number of shares of Common Stock outstanding immediately prior to the open of business on such Ex-Dividend Date;
	X	=	the total number of shares of Common Stock issuable pursuant to such rights, options or warrants; and
	Y	=	the number of shares of Common Stock equal to the aggregate price payable to exercise such rights, options or warrants, divided by the VWAP of the Common Stock for the period ending on, and including, the Trading Day immediately preceding the date of announcement of the issuance of such rights, options or warrants.

Any decrease made under this ‎Section 13.03(b) shall be made successively whenever any such rights, options or warrants are issued and shall become effective immediately after the open of business on the Ex-Dividend Date for such issuance. To the extent that shares of Common Stock are not delivered after the expiration of such rights, options or warrants, the Conversion Price shall be increased to the Conversion Price that would then be in effect had the decrease with respect to the issuance of such rights, options or warrants been made on the basis of delivery of only the number of shares of Common Stock actually delivered. If no such rights, options or warrants are issued, or if no such rights, options or warrants are exercised prior to their expiration, the Conversion Price shall be increased to the Conversion Price that would then be in effect if such Ex-Dividend Date for such issuance had not occurred.
For purposes of this ‎Section 13.03(b), in determining whether any rights, options or warrants entitle the holders to subscribe for or purchase shares of Common Stock at a price per share that is less than such VWAP of the Common Stock immediately preceding the date of announcement for such issuance, and in determining the aggregate offering price of such shares of Common Stock, there shall be taken into account any consideration received by the Company for such rights, options or warrants and any amount payable on exercise or conversion thereof, the value of such consideration, if other than cash, to be determined by the Company in good faith. Except in the case of an increase of the Conversion Price pursuant to the immediately preceding paragraph, the Conversion Price shall not be increased pursuant to this ‎Section 13.03(b).
(c) If the Company distributes shares of its Capital Stock, evidences of its indebtedness, other assets or property of the Company or rights, options or warrants to acquire its Capital Stock or other securities, to all or substantially all holders of the Common Stock, excluding (i) dividends, distributions or issuances described in ‎Section 13.03(a) or ‎Section 13.03(b), (ii) rights issued under a stockholders rights plan prior to separation thereof from the shares of Common Stock in the circumstances described in ‎Section 13.11, (iii) dividends or distributions paid exclusively in cash described in ‎Section 13.03(d), (iv) distributions of Reference Property upon conversion of, or in exchange for, Common Stock in a transaction described in ‎Section 13.06(a), and (v) Spin-Offs as to which the provisions set forth below in this ‎Section 13.03(c) shall apply (any of such shares of Capital Stock, evidences of indebtedness, other assets or property or rights, options or warrants to acquire Capital Stock or other securities, the “Distributed Property”), then the Conversion Price shall be decreased based on the following formula:
CP1 = CP0 x ((SP0 - FMV)/SP0)

where,
59

									
	CP0
	=	the Conversion Price in effect immediately prior to the open of business on the Ex-Dividend Date for such distribution;
	CP1
	=	the Conversion Price in effect immediately after the open of business on such Ex-Dividend Date;
	SP0
	=	the VWAP of the Common Stock for the period ending on, and including, the Trading Day immediately preceding the Ex-Dividend Date for such distribution; and

	FMV	=	the Fair Market Value of the Distributed Property with respect to each outstanding share of Common Stock on the Ex-Dividend Date for such distribution.

Any decrease made under the portion of this ‎Section 13.03(c) above shall become effective immediately after the open of business on the Ex-Dividend Date for such distribution. If such distribution is not so paid or made, the Conversion Price shall be increased to the Conversion Price that would then be in effect if such distribution had not been declared. Notwithstanding the foregoing, if “FMV” (as defined above) is equal to or greater than “SP0” (as defined above), in lieu of the foregoing decrease, each Holder of a Note shall receive, in respect of each such Note, at the same time and upon the same terms as holders of the Common Stock receive the Distributed Property, the amount and kind of Distributed Property such Holder would have received if such Holder owned a number of shares of Common Stock equal to the Conversion Rate in effect on the Ex-Dividend Date for the distribution. If the Board of Directors determines the “FMV” (as defined above) of any distribution for purposes of this ‎Section 13.03(c) by reference to the actual or when-issued trading market for any securities, it shall in doing so consider the prices in such market over the same period used in computing the Last Reported Sale Prices of the Common Stock over the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the Ex-Dividend Date for such distribution.
With respect to an adjustment pursuant to this ‎Section 13.03(c) where there has been a payment of a dividend or other distribution on the Common Stock of shares of Capital Stock of any class or series, or similar equity interest, of or relating to a Subsidiary or other business unit of the Company, that are, or, when issued, will be, listed or admitted for trading on a U.S. national securities exchange (a “Spin-Off”), the Conversion Price shall be decreased based on the following formula:

CP1 = CP0 x (MP0/(MP0 + FMV))

where,
									
	CP0
	=	the Conversion Price in effect immediately prior to the end of the Valuation Period;
	CP1
	=	the Conversion Price in effect immediately after the end of the Valuation Period;
	FMV	=	the VWAP of the Capital Stock or similar equity interest distributed to holders of the Common Stock applicable to one share of Common Stock (determined by reference to the definition of Last Reported Sale Price as set forth in ‎Section 1.01 as if references therein to Common Stock were to such Capital Stock or similar equity interest) for the period after, and including, the Ex-Dividend Date of the Spin-Off (the “Valuation Period”); and

	MP0
	=	the VWAP of the Common Stock over the Valuation Period.

The decrease to the Conversion Price under the preceding paragraph shall occur on the last Trading Day of the Valuation Period; provided that if the relevant Conversion Date occurs during the Valuation Period, references in the portion of this ‎Section 13.03(c) related to Spin-Offs to 10 Trading Days shall be deemed to be replaced with such lesser number of Trading Days as have elapsed between the Ex-Dividend Date of such Spin-Off and the Conversion Date in determining the Conversion Price.
60

For purposes of this ‎Section 13.03(c) (and subject in all respect to ‎Section 13.11), rights, options or warrants distributed by the Company to all holders of the Common Stock entitling them to subscribe for or purchase shares of the Company’s Capital Stock, including Common Stock (either initially or under certain circumstances), which rights, options or warrants, until the occurrence of a specified event or events (“Trigger Event”): (i) are deemed to be transferred with such Common Stock; (ii) are not exercisable; and (iii) are also issued in respect of future issuances of Common Stock, shall be deemed not to have been distributed for purposes of this ‎Section 13.03(c) (and no adjustment to the Conversion Price under this ‎Section 13.03(c) will be required) until the occurrence of the earliest Trigger Event, whereupon such rights, options or warrants shall be deemed to have been distributed and an appropriate adjustment (if any is required) to the Conversion Price shall be made under this ‎Section 13.03(c). If any such right, option or warrant, including any such existing rights, options or warrants distributed prior to the date of this Indenture, are subject to events, upon the occurrence of which such rights, options or warrants become exercisable to purchase different securities, evidences of indebtedness or other assets, then the date of the occurrence of any and each such event shall be deemed to be the date of distribution and Ex-Dividend Date with respect to new rights, options or warrants with such rights (in which case the existing rights, options or warrants shall be deemed to terminate and expire on such date without exercise by any of the holders thereof). In addition, in the event of any distribution (or deemed distribution) of rights, options or warrants, or any Trigger Event or other event (of the type described in the immediately preceding sentence) with respect thereto that was counted for purposes of calculating a distribution amount for which an adjustment to the Conversion Price under this ‎Section 13.03(c) was made, (1) in the case of any such rights, options or warrants that shall all have been redeemed or purchased without exercise by any holders thereof, upon such final redemption or purchase (x) the Conversion Price shall be readjusted as if such rights, options or warrants had not been issued and (y) the Conversion Price shall then again be readjusted to give effect to such distribution, deemed distribution or Trigger Event, as the case may be, as though it were a cash distribution, equal to the per share redemption or purchase price received by a holder or holders of Common Stock with respect to such rights, options or warrants (assuming such holder had retained such rights, options or warrants), made to all holders of Common Stock as of the date of such redemption or purchase, and (2) in the case of such rights, options or warrants that shall have expired or been terminated without exercise by any holders thereof, the Conversion Price shall be readjusted as if such rights, options and warrants had not been issued.
For purposes of ‎Section 13.03(a), ‎Section 13.03(b) and this ‎Section 13.03(c), if any dividend or distribution to which this ‎Section 13.03(c) is applicable also includes one or both of:
(A)  a dividend or distribution of shares of Common Stock to which ‎Section 13.03(a) is applicable (the “Clause A Distribution”); or
(B)  a dividend or distribution of rights, options or warrants to which ‎Section 13.03(b) is applicable (the “Clause B Distribution”), 
then, in either case, (1) such dividend or distribution, other than the Clause A Distribution and the Clause B Distribution, shall be deemed to be a dividend or distribution to which this ‎Section 13.03(c) is applicable (the “Clause C Distribution”) and any Conversion Price adjustment required by this ‎Section 13.03(c) with respect to such Clause C Distribution shall then be made, and (2) the Clause A Distribution and Clause B Distribution shall be deemed to immediately follow the Clause C Distribution and any Conversion Price adjustment required by ‎Section 13.03(a) and ‎Section 13.03(b) with respect thereto shall then be made, except that, if determined by the Company (I) the “Ex-Dividend Date” of the Clause A Distribution and the Clause B Distribution shall be deemed to be the Ex-Dividend Date of the Clause C Distribution and (II) any shares of Common Stock included in the Clause A Distribution or Clause B Distribution shall be deemed not to be “outstanding immediately prior to the open of business on such Ex-Dividend Date or Effective Date” within the meaning of ‎Section 13.03(a) or “outstanding immediately prior to the open of business on such Ex-Dividend Date” within the meaning of ‎Section 13.03(b).
The Conversion Price shall not be increased pursuant to this ‎Section 13.03(c).
61

(d) If any cash dividend or distribution is made to all or substantially all holders of the Common Stock, the Conversion Price shall be adjusted based on the following formula:
CP1= CP0 x ((SP0 - C)/SP0)
where,
									
	CP0
	=	the Conversion Price in effect immediately prior to the open of business on the Ex-Dividend Date for such dividend or distribution;
	CP1
	=	the Conversion Price in effect immediately after the open of business on the Ex-Dividend Date for such dividend or distribution;
	SP0
	=	the Last Reported Sale Price of the Common Stock on the Trading Day immediately preceding the Ex-Dividend Date for such dividend or distribution; and
	C	=	the amount in cash per share the Company distributes to all or substantially all holders of the Common Stock.

Any decrease pursuant to this ‎Section 13.03(d) shall become effective immediately after the open of business on the Ex-Dividend Date for such dividend or distribution. If such dividend or distribution is not so paid, the Conversion Price shall be increased, effective as of the date the Board of Directors determines not to make or pay such dividend or distribution, to be the Conversion Price that would then be in effect if such dividend or distribution had not been declared. Notwithstanding the foregoing, if “C” (as defined above) is equal to or greater than “SP0” (as defined above), in lieu of the foregoing decrease, each Holder of a Note shall receive, for each Note it holds, at the same time and upon the same terms as holders of Common Stock, the amount of cash that such Holder would have received if such Holder owned a number of shares of Common Stock equal to the Conversion Rate on the Ex-Dividend Date for such cash dividend or distribution.
(e) If the Company or any of its Subsidiaries make a payment in respect of a tender or exchange offer for the Common Stock that is subject to the then-applicable tender offer rules under the Exchange Act (other than an odd-lot tender offer), to the extent that the cash and value of any other consideration included in the payment per share of Common Stock exceeds the VWAP of the Common Stock for the period commencing on, and including, the Trading Day next succeeding the last date on which tenders or exchanges may be made pursuant to such tender or exchange offer, the Conversion Price shall be decreased based on the following formula:
CP1 = CPo x ((OSo x SP1)/(AC+ (SP1 x OS1))

where,
62

									
	CP0
	=	the Conversion Price in effect immediately prior to the close of business on the 10th Trading Day immediately following, and including, the Trading Day next succeeding the date such tender or exchange offer expires;
	CP1
	=	the Conversion Price in effect immediately after the close of business on the 10th Trading Day immediately following, and including, the Trading Day next succeeding the date such tender or exchange offer expires;
	AC	=	the aggregate value of all cash and any other consideration (as determined by the Company in good faith) paid or payable for shares of Common Stock purchased in such tender or exchange offer;
	OS0
	=	the number of shares of Common Stock outstanding immediately prior to the date such tender or exchange offer expires (prior to giving effect to the purchase of all shares of Common Stock accepted for purchase or exchange in such tender or exchange offer);
	OS1
	=	the number of shares of Common Stock outstanding immediately after the date such tender or exchange offer expires (after giving effect to the purchase of all shares of Common Stock accepted for purchase or exchange in such tender or exchange offer); and
	SP1
	=	the VWAP of the Common Stock for the period commencing on, and including, the Trading Day next succeeding the date such tender or exchange offer expires.

The decrease to the Conversion Price under this ‎Section 13.03(e) shall occur at the close of business on the 10th Trading Day immediately following, and including, the Trading Day next succeeding the date such tender or exchange offer expires; provided that in respect of any conversion of Notes if the relevant Conversion Date occurs during the 10 Trading Days immediately following, and including, the Trading Day next succeeding the expiration date of any tender or exchange offer, references in this ‎Section 13.03(e) with respect to 10 Trading Days shall be deemed replaced with such lesser number of Trading Days as have elapsed between the date that such tender or exchange offer expires and the Conversion Date in determining the Conversion Price.
In the event that the Company or one of its Subsidiaries is obligated to purchase Common Stock pursuant to any such tender offer or exchange offer described in this clause ‎(e) but the Company or such Subsidiary is permanently prevented by applicable law from effecting any such purchase or any such purchase is rescinded, the applicable Conversion Price shall be increased to be the Conversion Price that would then be in effect if such tender or exchange offer had not been made or had not been made only in respect of the purchases that have been effected.
(f) If the Company issues or sells shares of its Common Stock or rights, options, warrants, convertible notes, convertible preferred stock or other instruments that can be exercised or exchanged for its Common Stock (“Convertible Securities”), excluding (i) dividends, distributions or issuances described in ‎Section 13.03(a) or ‎Section 13.03(b), (ii) rights issued under a stockholders rights plan prior to separation thereof from the shares of Common Stock in the circumstances described in ‎Section 13.11, (iii) dividends or distributions paid exclusively in cash described in ‎Section 13.03(d), (iv) distributions of Reference Property upon conversion of, or in exchange for, Common Stock in a transaction described in ‎Section 13.06(a), (v) distributions described in ‎Section 13.03(c), and (vi) Excluded Issuances, without consideration or for consideration per share (or having an exercise or conversion price per share) of Common Stock less than either (x) the Conversion Price in effect immediately prior to such issuance or sale or (y) if such consideration per share is not less than the Conversion Price in effect immediately prior to such issuance or sale, the VWAP of the Common Stock for the period preceding the date of the agreement on pricing such shares (or such Convertible Securities) (the “Pricing Date”), the Conversion Price shall be decreased based on the following formula:

CP1 = CP0 x ((OS + (AC/SP))/(OS+IS))

where,
63

									
	AC	=	the Fair Market Value of aggregate consideration received for such issuance or sale;
	CP0
	=	the Conversion Price in effect immediately prior to the close of business on the Pricing Date;
	CP1
	=	the Conversion Price in effect immediately after to the close of business on the Pricing Date;
	IS	=	Common Stock Deemed Issued;
	OS	=	Common Stock Deemed Outstanding immediately prior to such sale or issuance;
	SP	=	either (x) CP0 or (y) if the consideration per share (or, in the case of Convertible Securities, the exercise or conversion price per share of Common Stock) in such issuance or sale is not less than the Conversion Price in effect immediately prior to such issuance or sale, the VWAP of the Common Stock for the period ending on, and including, the Trading Day immediately prior to such issuance or sale (or deemed issuance or sale); and

(g) Notwithstanding this ‎Section 13.03 or any other provision of this Indenture or the Notes, if a Conversion Price adjustment becomes effective on any Ex-Dividend Date, and a Holder that has converted its Notes on or after such Ex-Dividend Date and on or prior to the related Record Date would be treated as the record holder of shares of Common Stock as of the related Conversion Date as described under ‎Section 13.02(i) based on an adjusted Conversion Price for such Ex-Dividend Date, then, notwithstanding the Conversion Price adjustment provisions in this ‎Section 13.03, the Conversion Price adjustment relating to such Ex-Dividend Date shall not be made for such converting Holder. Instead, such Holder shall be treated as if such Holder were the record owner of shares of the Common Stock on an unadjusted basis and participate in the related dividend, distribution or other event giving rise to such adjustment.
(h)  Except as stated herein, the Company shall not adjust the Conversion Price for the issuance of shares of Common Stock or any securities convertible into or exchangeable for Common Stock or the right to purchase shares of Common Stock or such convertible or exchangeable securities.
(i) In addition to those adjustments required by clauses ‎(a), ‎(b), ‎(c), ‎(d), ‎(e) and ‎(f) of this ‎Section 13.03, and to the extent permitted by applicable law and subject to the applicable rules of any exchange on which any of the Company’s securities are then listed, the Company from time to time may (but is not required to) decrease the Conversion Price by any amount for a period of at least 20 Business Days (i) if the Company determines that such decrease would be in the Company’s best interest or (ii) to avoid or diminish any income tax to holders of Common Stock or rights to purchase shares of Common Stock in connection with a dividend or distribution of shares of Common Stock (or rights to acquire shares of Common Stock) or similar event. Whenever the Conversion Price is decreased pursuant to the preceding sentence, the Company shall deliver to the Holder of each Note a notice of the decrease at least 15 days prior to the date the decreased Conversion Price takes effect, and such notice shall state the decreased Conversion Price and the period during which it will be in effect.
(j) Except as described in this ‎Section 13.03, the Conversion Price shall not be required to be adjusted for any transaction or event. Without limiting the foregoing, the Conversion Price shall not be required to be adjusted:
(i) upon the issuance of any shares of Common Stock pursuant to any present or future plan providing for the reinvestment of dividends or interest payable on the Company’s securities and the investment of additional optional amounts in shares of Common Stock under any plan;
(ii) upon the issuance of any shares of Common Stock or options or rights to purchase those shares pursuant to any present or future employee, director or consultant benefit plan or program of or assumed by the Company or any of the Company’s Subsidiaries;
(iii) upon the issuance of any shares of Common Stock pursuant to any option, warrant, right or exercisable, exchangeable or convertible security not described in clause ‎(ii) of this subsection and outstanding as of the date the Notes were first issued;
(iv) for a third-party tender offer; other than as described in ‎Section 13.03(e);
(v) solely for a change in the par value of the Common Stock; or 
64

(vi) for accrued and unpaid interest, if any.
(k) All calculations and other determinations under this ‎Article 13 shall be made by the Company and shall be made to the nearest one-ten thousandth (1/10,000th) of a US dollar. The Company shall not be required to make an adjustment in the Conversion Price unless the adjustment would require a change of at least 1% in the Conversion Price. However, the Company shall carry forward any adjustments that are less than 1% of the Conversion Price and make such carried forward adjustments (1) upon conversion of any Note, on the relevant Conversion Date and (2) on each anniversary of the original issue date of the Notes, in each case, without duplication and regardless of whether the aggregate adjustment is less than 1%.
(l) Whenever the Conversion Price is adjusted as herein provided, the Company shall promptly file with the Trustee (and the Conversion Agent if not the Trustee) an Officer’s Certificate setting forth the Conversion Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment. Unless and until a Responsible Officer of the Trustee shall have received such Officer’s Certificate, the Trustee shall not be deemed to have knowledge of any adjustment of the Conversion Price and may assume without inquiry that the last Conversion Price of which it has knowledge is still in effect. Promptly after delivery of such certificate, the Company shall prepare a notice of such adjustment of the Conversion Price setting forth the adjusted Conversion Price and the date on which each adjustment becomes effective and shall deliver such notice of such adjustment of the Conversion Price to each Holder. Failure to deliver such notice shall not affect the legality or validity of any such adjustment.
(m) For purposes of this ‎Section 13.03, the number of shares of Common Stock at any time outstanding shall not include shares of Common Stock held in the treasury of the Company so long as the Company does not pay any dividend or make any distribution on the Common Stock held in the treasury of the Company, but shall include shares of Common Stock issuable in respect of scrip certificates issued in lieu of fractions of shares of Common Stock.
Section 13.04 Adjustments of Prices
Whenever any provision of this Indenture requires the Company to calculate the Last Reported Sale Prices or VWAP over a span of multiple days, the Company shall make adjustments in its good faith judgment to each to account for any adjustment to the Conversion Price that becomes effective, or any event requiring an adjustment to the Conversion Price where the Ex-Dividend Date, Effective Date or expiration date, as the case may be, of the event occurs, at any time during the period when the Last Reported Sale Prices or VWAP are to be calculated.
For the avoidance of doubt, the adjustments made pursuant to this ‎Section 13.04 shall be made solely to the extent that the Company determines in its good faith judgment that any such adjustment is appropriate, without duplication of any adjustment made pursuant to ‎Section 13.03.
Section 13.05 Shares to Be Fully Paid
The Company shall provide, free from preemptive rights, out of its authorized but unissued shares or shares held in treasury, sufficient shares of Common Stock to provide for conversion of the Notes from time to time as such Notes are presented for conversion.
Section 13.06 Effect of Recapitalizations, Reclassifications and Changes of the Common Stock.
(a) In the case of:
(i) any recapitalization, reclassification or change of the Common Stock (other than changes in par value or from no par value or resulting from a subdivision or combination),
(ii) any consolidation, merger, combination or similar transaction involving the Company,
(iii) any sale, lease or other transfer to a third party of the consolidated assets of the Company and the Company’s Subsidiaries substantially as an entirety or 
65

(iv) any statutory share exchange,
in each case, as a result of which the Common Stock would be converted into, or exchanged for, stock, other securities, other property or assets (including cash or any combination thereof) (any such event, a “Merger Event”), then, at and after the effective time of such Merger Event, the right to convert each $1,000 of Accreted Principal Amount of Notes shall be changed into a right to convert such Accreted Principal Amount of Notes into the kind and amount of shares of stock, other securities or other property or assets (including cash or any combination thereof) that a holder of a number of shares of Common Stock equal to the Conversion Rate for $1,000 of Accreted Principal Amount of Notes immediately prior to such Merger Event would have owned or been entitled to receive (the “Reference Property,” with each “unit of Reference Property” meaning the kind and amount of Reference Property that a holder of one share of Common Stock is entitled to receive) upon such Merger Event and, prior to or at the effective time of such Merger Event, the Company or the successor or purchasing Person, as the case may be, shall execute with the Trustee a supplemental indenture permitted under ‎Section 10.01(g) providing for such change in the right to convert each $1,000 Accreted Principal Amount of Notes.
If the Merger Event causes the Common Stock to be converted into, or exchanged for, the right to receive more than a single type of consideration (determined based in part upon any form of stockholder election), then (i) the Reference Property into which the Notes will be convertible shall be deemed to be (x) the weighted average of the types and amounts of consideration received by the holders of Common Stock that affirmatively make such an election or (y) if no holders of Common Stock affirmatively make such an election, the types and amounts of consideration actually received by the holders of Common Stock, and (ii) the unit of Reference Property for purposes of the immediately preceding paragraph shall refer to the consideration referred to in clause (i) attributable to one share of Common Stock. If the holders of the Common Stock receive only cash in such Merger Event, then for all conversions for which the relevant Conversion Date occurs after the effective date of such Merger Event (A) the consideration due upon conversion of each $1,000 Accreted Principal Amount of Notes shall be solely cash in an amount equal to the Conversion Rate for $1,000 of Accreted Principal Amount of Notes in effect on the Conversion Date, multiplied by the price paid per share of Common Stock in such Merger Event and (B) the Company shall satisfy the Conversion Obligation by paying cash to converting Holders on the second Business Day immediately following the relevant Conversion Date. The Company shall notify Holders, the Trustee and the Conversion Agent (if other than the Trustee) of such weighted average as soon as reasonably practicable after such determination is made.
Such supplemental indenture described in the second immediately preceding paragraph shall provide for anti-dilution and other adjustments that shall be as nearly equivalent as is possible to the adjustments provided for in this ‎Article 13. If, in the case of any Merger Event, the Reference Property includes shares of stock, securities or other property or assets (including cash or any combination thereof) of a Person other than the successor or purchasing Person, as the case may be, in such Merger Event, then such supplemental indenture shall also be executed by such other Person and shall contain such additional provisions to protect the interests of the Holders of the Notes as the Company shall reasonably consider necessary by reason of the foregoing, including the provisions providing for the purchase rights set forth in ‎Article 14.
(b) When the Company executes a supplemental indenture pursuant to subsection ‎(a) of this ‎‎Section 13.06, the Company shall promptly file with the Trustee an Officer’s Certificate briefly stating the reasons therefor, the kind or amount of cash, securities or property or asset that will comprise a unit of Reference Property after any such Merger Event, any adjustment to be made with respect thereto and that all conditions precedent have been complied with, and shall promptly deliver notice thereof to all Holders. The Company shall cause notice of the execution of such supplemental indenture to be delivered to each Holder within 20 days after execution thereof. Failure to deliver such notice shall not affect the legality or validity of such supplemental indenture.
(c) The Company shall not become a party to any Merger Event unless its terms are consistent with this ‎Section 13.06. None of the foregoing provisions shall affect the right of a holder of Notes to convert its Notes into shares of Common Stock as set forth in ‎Section 13.01 and ‎Section 13.02 prior to the effective date of such Merger Event.
66

(d) The above provisions of this Section shall similarly apply to successive Merger Events.
Section 13.07 Certain Covenants
 (a) The Company covenants that all shares of Common Stock issued upon conversion of Notes will be fully paid and non-assessable by the Company and free from all taxes, liens and charges with respect to the issue thereof.
(b) The Company covenants that, if any shares of Common Stock to be provided for the purpose of conversion of Notes hereunder require registration with or approval of any governmental authority under any federal or state law before such shares of Common Stock may be validly issued upon conversion, the Company will, to the extent then permitted by the rules and interpretations of the Commission, secure such registration or approval, as the case may be.
(c) The Company further covenants that if at any time the Common Stock shall be listed on any national securities exchange or automated quotation system, the Company will use commercially reasonable efforts to list and keep listed, so long as the Common Stock shall be so listed on such exchange or automated quotation system, any shares of Common Stock issuable upon conversion of the Notes.
Section 13.08 Responsibility of Trustee
The Trustee and any other Conversion Agent shall not at any time be under any duty or responsibility to any Holder to determine the Conversion Price (or any adjustment thereto) or whether any facts exist that may require any adjustment (including any decrease) of the Conversion Price, or with respect to the nature or extent or calculation of any such adjustment when made, or with respect to the method employed, or herein or in any supplemental indenture provided to be employed, in making the same. The Trustee and any other Conversion Agent shall not be accountable with respect to the validity or value (or the kind or amount) of any shares of Common Stock, or of any securities, property or cash that may at any time be issued or delivered upon the conversion of any Note; and the Trustee and any other Conversion Agent make no representations with respect thereto. Neither the Trustee nor any Conversion Agent shall be responsible for any failure of the Company to issue, transfer or deliver any shares of Common Stock or stock certificates or other securities or property or cash upon the surrender of any Note for the purpose of conversion or to comply with any of the duties, responsibilities or covenants of the Company contained in this Article. Without limiting the generality of the foregoing, neither the Trustee nor any Conversion Agent shall be under any responsibility to determine the correctness of any provisions contained in any supplemental indenture entered into pursuant to ‎Section 13.06 relating either to the kind or amount of shares of stock or securities or property (including cash) receivable by Holders upon the conversion of their Notes after any event referred to in such ‎Section 13.06 or to any adjustment to be made with respect thereto, but, subject to the provisions of ‎Section 7.01, may accept (without any independent investigation) as conclusive evidence of the correctness of any such provisions, and shall be protected in relying upon, the Officer’s Certificate (which the Company shall be obligated to file with the Trustee prior to the execution of any such supplemental indenture) with respect thereto.
Section 13.10 Notice to Holders Prior to Certain Actions
In case of any:
(a) action by the Company or one of its Subsidiaries that would require an adjustment in the Conversion Price pursuant to ‎Section 13.03 or ‎Section 13.11;
(b) Merger Event; or
(c) voluntary or involuntary dissolution, liquidation or winding-up of the Company or any of its Subsidiaries; 
then, in each case (unless notice of such event is otherwise required pursuant to another provision of this Indenture), the Company shall cause to be filed with the Trustee and the Conversion Agent (if other than the Trustee) and to be sent to each Holder at its address appearing on the Note Register, as promptly as possible but in any event at least 20 days prior to the applicable date hereinafter specified, a notice stating (i) the date on which a record is to be taken for 
67

the purpose of such action by the Company or one of its Subsidiaries or, if a record is not to be taken, the date as of which the holders of Common Stock of record are to be determined for the purposes of such action by the Company or one of its Subsidiaries, or (ii) the date on which such Merger Event, dissolution, liquidation or winding-up is expected to become effective or occur, and the date as of which it is expected that holders of Common Stock of record shall be entitled to exchange their Common Stock for securities or other property deliverable upon such Merger Event, dissolution, liquidation or winding-up. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such action by the Company or one of its Subsidiaries, Merger Event, dissolution, liquidation or winding-up.
Section 13.11 Stockholder Rights Plans
If the Company has a stockholder rights plan in effect upon conversion of the Notes, each share of Common Stock, if any, issued upon such conversion shall be entitled to receive the appropriate number of rights, if any, and the certificates representing shares of the Common Stock issued upon such conversion shall bear such legends, if any, in each case as may be provided by the terms of any such stockholder rights plan, as the same may be amended from time to time. However, if, prior to any conversion of Notes, the rights have separated from the shares of Common Stock in accordance with the provisions of the applicable stockholder rights plan, the Conversion Price shall be adjusted at the time of separation as if the Company distributed to all or substantially all holders of the Common Stock Distributed Property as provided in ‎Section 13.03(c), subject to readjustment in the event of the expiration, termination or redemption of such rights.
Article 14: Repurchase of Notes at Option of Holders
Secion 14.01 [Intentionally Omitted].
Section 14.02 Repurchase at Option of Holders Upon a Fundamental Change
If a Fundamental Change occurs at any time, each Holder shall have the right, at such Holder’s option, to require the Company to repurchase for consideration in cash any or all of such Holder’s Notes, or any portion thereof that is equal to $1,000 or an integral multiple of $1,000, on the date (the “Fundamental Change Repurchase Date”) specified by the Company that is not less than 20 calendar days or more than 35 calendar days following the date of the Fundamental Change Company Notice at a repurchase price (the “Fundamental Change Repurchase Price”) equal to the sum of (x) 105% of the Accreted Principal Amount of such Notes (which for purposes of ‎Article 14 shall include accrued interest thereon to, but excluding, the Fundamental Change Repurchase Date as though such date were an Interest Payment Date in accordance with the provisions of ‎Section 2.03) and (y) the sum of the present values of the scheduled payments of interest that would have been made (assuming such interest payments were paid in cash) on the Notes to be repurchased had such Notes remained outstanding from the Fundamental Change Repurchase Date through the Maturity Date, discounted to the Fundamental Change Repurchase Date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 50 basis points. For the avoidance of doubt, the occurrence of a Fundamental Change shall not affect the Holder’s right to convert any Notes in accordance with ‎Article 13 hereof.
The Fundamental Change Repurchase Date shall be subject to postponement in order to allow the Company to comply with applicable law as a result of changes to such applicable law occurring after the date of this Indenture.
(b) Repurchases of Notes under this ‎Section 14.02 shall be made, at the option of the Holder thereof, upon:
(i) delivery to the Paying Agent by a Holder of a duly completed notice (the “Fundamental Change Repurchase Notice”) in the form set forth in Attachment 2 to the Form of Note attached hereto as Exhibit A, if the Notes are Physical Notes, or in compliance with the Depositary’s procedures for surrendering interests in Global Notes, if the Notes are Global Notes, in each case on or before the close of business on the Business Day immediately preceding the Fundamental Change Repurchase Date; and 
68

(ii) delivery of the Notes, if the Notes are Physical Notes, to the Paying Agent at any time after delivery of the Fundamental Change Repurchase Notice (together with all necessary endorsements for transfer) and on or prior to the close of business on the Business Day immediately preceding the Fundamental Change Repurchase Date at the office of the Paying Agent, or book-entry transfer of the Notes, if the Notes are Global Notes, in compliance with the procedures of the Depositary, in each case such delivery being a condition to receipt by the Holder of the Fundamental Change Repurchase Price therefor.
The Fundamental Change Repurchase Notice in respect of any Notes to be repurchased shall state:
i.in the case of Physical Notes, the certificate numbers of the Notes to be delivered for repurchase;
ii.the Accreted Principal Amount to be repurchased; and 
iii.that the Notes are to be repurchased by the Company pursuant to the applicable provisions of the Notes and this Indenture; provided, however, that if the Notes are Global Notes, the Fundamental Change Repurchase Notice must comply with appropriate Depositary procedures.
Notwithstanding anything herein to the contrary, any Holder delivering to the Paying Agent the Fundamental Change Repurchase Notice contemplated by this ‎Section 14.02 shall have the right to withdraw, in whole or in part, such Fundamental Change Repurchase Notice at any time prior to the close of business on the Business Day immediately preceding the Fundamental Change Repurchase Date by delivery of a written notice of withdrawal to the Paying Agent in accordance with ‎Section 14.03.
The Paying Agent shall promptly notify the Company of the receipt by it of any Fundamental Change Repurchase Notice or written notice of withdrawal thereof.
(c) On or before the 20th calendar day after the occurrence of the effective date of a Fundamental Change, the Company shall provide to all Holders of Notes and the Trustee and the Paying Agent (in the case of a Paying Agent other than the Trustee) a notice (the “Fundamental Change Company Notice”) of the occurrence of the effective date of the Fundamental Change and of the repurchase right at the option of the Holders arising as a result thereof. In the case of Physical Notes, such notice shall be by first class mail or, in the case of Global Notes, such notice shall be delivered in accordance with the applicable procedures of the Depositary. Each Fundamental Change Company Notice shall specify:
(i) the events causing the Fundamental Change;
(ii) the date of the Fundamental Change;
(iii) the last date on which a Holder may exercise the repurchase right pursuant to this ‎Article 14;
(iv) the Fundamental Change Repurchase Price;
(v) the Fundamental Change Repurchase Date;
(vi) the name and address of the Paying Agent and the Conversion Agent, if applicable;
(vii) the then applicable Conversion Price;
(viii) that the Notes with respect to which a Fundamental Change Repurchase Notice has been delivered by a Holder may be converted only if the Holder withdraws the Fundamental Change Repurchase Notice in accordance with the terms of this Indenture; and 
(ix) the procedures that Holders pursuant to this ‎Article 14 must follow to require the Company to repurchase their Notes; 
69

provided, however, that, if the Notes are Global Notes, the Holders (and holders of a beneficial interest in such Global Notes) must comply with the applicable procedures of the Depositary.
No failure of the Company to give the foregoing notices and no defect therein shall limit the Holders’ repurchase rights or affect the validity of the proceedings for the repurchase of the Notes pursuant to this ‎Section 14.02.
At the Company’s request, the Trustee shall give such notice in the Company’s name and at the Company’s expense; provided, however, that, in all cases, the text of such Fundamental Change Company Notice shall be prepared by the Company.
(d) Notwithstanding the foregoing, the Company shall not be required to purchase, or to make an offer to purchase, the Notes upon a Fundamental Change if a third party makes such an offer in the same manner, at the same time and otherwise in compliance with the requirements for an offer made by the Company as set forth above, and such third party purchases all Notes properly surrendered and not validly withdrawn under its offer in the same manner, at the same time and otherwise in compliance with the requirements for an offer made by the Company as set forth above.
(e) Notwithstanding the foregoing, the Company shall not be required to give such notice or repurchase the Notes as described above upon a Fundamental Change pursuant to clause (b) of the definition thereof if such Fundamental Change results in the Notes becoming convertible (pursuant to ‎Section 13.06) into an amount of cash per Note greater than the Fundamental Change Repurchase Price (assuming the maximum amount of accrued interest would be payable based on the latest possible Fundamental Change Repurchase Date).
(f) Notwithstanding the foregoing, no Notes may be repurchased by the Company on any date at the option of the Holders upon a Fundamental Change if the Accreted Principal Amount of the Notes has been accelerated, and such acceleration has not been rescinded, on or prior to such date (except in the case of an acceleration resulting from a Default by the Company in the payment of the Fundamental Change Repurchase Price with respect to such Notes). The Paying Agent will promptly return to the respective Holders thereof any Physical Notes held by it during the acceleration of the Notes (except in the case of an acceleration resulting from a Default by the Company in the payment of the Fundamental Change Repurchase Price with respect to such Notes), or any instructions for book-entry transfer of the Notes in compliance with the procedures of the Depositary shall be deemed to have been cancelled, and, upon such return or cancellation, as the case may be, the Fundamental Change Repurchase Notice with respect thereto shall be deemed to have been withdrawn.
Section 14.03 Withdrawal of Fundamental Change Repurchase Notice
(a) A Fundamental Change Repurchase Notice may be withdrawn (in whole or in part) by means of a written notice of withdrawal delivered to the office of the Paying Agent in accordance with this ‎Section 14.03 at any time prior to the close of business on the Business Day immediately preceding the Fundamental Change Repurchase Date, specifying:
(i) the Accreted Principal Amount with respect to which such notice of withdrawal is being submitted (which must be in integral multiples of $1,000),
(ii) if Physical Notes have been issued, the certificate number of the Note in respect of which such notice of withdrawal is being submitted, and 
(iii) the Accreted Principal Amount, if any (which must be in integral multiples of $1,000), that remain subject to the original Fundamental Change Repurchase Notice, which portion must be in integral multiples of $1,000; 
provided, however, that if the Notes are Global Notes, the notice must comply with appropriate procedures of the Depositary.
Section 14.04 Deposit of Fundamental Change Repurchase Price. 
70

(a) The Company will deposit with the Trustee (or other Paying Agent appointed by the Company, or if the Company is acting as its own Paying Agent, set aside, segregate and hold in trust as provided in ‎Section 4.04) on or prior to 11:00 a.m., New York City time, on the Fundamental Change Repurchase Date an amount of money sufficient to repurchase all of the Notes to be repurchased at the appropriate Fundamental Change Repurchase Price. Subject to receipt of funds and/or Notes by the Trustee (or other Paying Agent appointed by the Company), payment for Notes surrendered for repurchase (and not withdrawn prior to the close of business on the Business Day immediately preceding the Fundamental Change Repurchase Date) will be made on the later of (i) the Fundamental Change Repurchase Date (provided the Holder has satisfied the conditions in ‎Section 14.02) and (ii) the time of book-entry transfer or the delivery of such Note to the Trustee (or other Paying Agent appointed by the Company) by the Holder thereof in the manner required by ‎Section 14.02 by mailing checks for the amount payable to the Holders of such Notes entitled thereto as they shall appear in the Note Register; provided, however, that payments to the Depositary shall be made by wire transfer of immediately available funds to the account of the Depositary or its nominee. The Trustee shall, promptly after such payment and upon written demand by the Company, return to the Company any funds in excess of the Fundamental Change Repurchase Price.
(b) If by 11:00 a.m. New York City time, on the Fundamental Change Repurchase Date, the Trustee (or other Paying Agent appointed by the Company) holds money sufficient to make payment on all the Notes or portions thereof that are to be repurchased on such Fundamental Change Repurchase Date, then, with respect to the Notes that have been properly surrendered for repurchase and have not been validly withdrawn, (i) such Notes will cease to be outstanding, (ii) interest will cease to accrue on such Notes (whether or not book-entry transfer of the Notes has been made or the Notes have been delivered to the Trustee or Paying Agent) and (iii) all other rights of the Holders of such Notes will terminate (other than the right to receive the Fundamental Change Repurchase Price).
(c) Upon surrender of a Physical Note that is to be repurchased in part pursuant to ‎Section 14.02, the Company shall execute and the Trustee shall authenticate and deliver to the Holder a new Note in an authorized denomination equal in principal amount to the unrepurchased portion of the Note surrendered.
Section 14.05 Covenant to Comply with Applicable Laws Upon Repurchase of Notes
In connection with any repurchase offer pursuant to a Fundamental Change Repurchase Notice, the Company will, if required:
(a) comply with any tender offer rules under the Exchange Act that may then be applicable;
(b) file a Schedule TO or any other required schedule under the Exchange Act; and
(c) otherwise comply with all federal and state securities laws in connection with any offer by the Company to  repurchase the Notes;
in each case, so as to permit the rights and obligations under this ‎Article 14 to be exercised in the time and in the manner specified in this ‎Article 14. To the extent that the provisions of any securities laws or regulations conflict with the provisions of this Indenture relating to the Company’s obligations to purchase the Notes upon a Fundamental Change, the Company shall comply with the applicable securities laws and regulations and shall not be deemed to have breached its obligations under such provisions of this Indenture by virtue of such conflict.
ARTICLE 15: Optional Redemption 
Section 15.01 Optional Redemption
No sinking fund is provided for the Notes. The Notes shall not be redeemable by the Company prior to the third anniversary of the original issue date of the Notes. On or after the third anniversary of the original issue date of the Notes, the Company may redeem, at its option, (an “Optional Redemption”), for cash, all or any portion of the Notes, at the Redemption Price, only if the Last Reported Sale Price of the Common Stock has been at least 200% of the Conversion Price then in effect for at least 20 Trading Days (whether or not consecutive), during any 30 
71

consecutive Trading Day period, including at least one of the last five Trading Days of such period, ending on, and including, the second Trading Day immediately preceding the date on which the Company provides the Notice of Redemption in accordance with ‎Section 15.02.
Holders may surrender Notes subject to Optional Redemption for conversion in accordance with Section 13.02 at any time prior to the close of business on the second Business Day immediately preceding the Redemption Date (unless the Company fails to pay the Redemption Price, in which case a Holder of Notes subject to Optional Redemption may convert such Notes until the Business Day immediately preceding the date on which the Redemption Price has been paid or duly provided for).
Section 15.02 Notice of Optional Redemption; Selection of Notes
In case the Company exercises its Optional Redemption right to redeem all or, as the case may be, any part of the Notes pursuant to ‎Section 15.01, it shall fix a date for redemption (each, a “Redemption Date”) and it shall deliver or cause to be delivered a notice of such Optional Redemption (a “Notice of Redemption”) not less than 30 nor more than 60 calendar days prior to the Redemption Date to the Trustee, the Paying Agent (if other than the Trustee) and each Holder of Notes. The Redemption Date must be a Business Day. 
(b) Each Notice of Redemption shall identify the provision of this Indenture permitting Optional Redemption and shall specify:
(i) the Redemption Date;
(ii) the Redemption Price;
(iii) that on the Redemption Date, the Redemption Price will become due and payable upon each Note to be redeemed, and that interest thereon, if any, shall cease to accrue on and after the Redemption Date unless the Company defaults in the payment of the Redemption Price;
(iv)the place or places where such Notes subject to Optional Redemption are to be surrendered for payment of the Redemption Price;
(v) that Holders may surrender Notes subject to such Optional Redemption for conversion at any time prior to the close of business on the second Business Day immediately preceding the Redemption Date (unless the Company fails to pay the Redemption Price, in which case a Holder of Notes subject to such Optional Redemption may convert such Notes until the Business Day immediately preceding the date on which the Redemption Price has been paid or duly provided for);
(vi) the procedures a converting Holder must follow to convert its Notes subject to Optional Redemption;
(vii) the Conversion Price;
(viii) the CUSIP, ISIN or other similar numbers, if any, assigned to such Notes subject to Optional Redemption and that no representation is made as to the correctness or accuracy of the CUSIP or ISIN number listed in such notice or printed on the Notes; and 
(ix) in case the Notes are to be redeemed whole, the number of Notes to be redeemed on the Redemption Date.
A Notice of Redemption shall be irrevocable. At the Company’s prior written request, the Trustee shall give the Notice of Redemption in the Company’s name and at its expense; provided, however, that the Company shall have delivered to the Trustee not later than the close of business five (5) Business Days prior to the date the Notice of Redemption is to be sent (unless a shorter period shall be satisfactory to the Trustee), an Officer’s 
72

Certificate and a Company Order requesting that the Trustee give such Notice of Redemption together with the Notice of Redemption to be given setting forth the information to be stated therein as provided in the preceding paragraph. The Notice of Redemption, if given in the manner herein provided, shall be conclusively presumed to have been duly given, whether or not the Holder receives such notice. In any case, failure to give such Notice of Redemption or any defect in the Notice of Redemption to the Holder of any Note designated for Optional Redemption as a whole or in part shall not affect the validity of the proceedings for the Optional Redemption of any other Note.
© If fewer than all of the outstanding Notes are to be redeemed, (i) if the Notes to be redeemed are Physical Notes, the Trustee shall select the Notes or portions thereof to be redeemed (in Original Principal Amounts of $1,000 or integral multiples of the $1,000 Original Principal Amount in excess thereof) by lot or on a pro rata basis or by another method the Trustee considers to be fair and appropriate, and in the case of the Global Note, in accordance with, and subject to, the applicable procedures of the Depositary. If any Note selected for partial redemption is submitted for conversion in part after such selection, the portion of the Note submitted for conversion shall be deemed (so far as may be possible) to be the portion selected for redemption.
Section 15.03 Payment of Notes Called for Redemption
(a) If any Notice of Redemption has been given in respect of the Notes in accordance with ‎Section 15.02, the Notes shall become due and payable on the Redemption Date at the place or places stated in the Notice of Redemption and at the applicable Redemption Price. On presentation and surrender of the Notes at the place or places stated in the Notice of Redemption, the Notes shall be paid and redeemed by the Company at the applicable Redemption Price.
(b) Prior to 11:00 a.m., New York City time, on the Redemption Date, the Company shall deposit with the Paying Agent or, if the Company or a Subsidiary of the Company is acting as the Paying Agent, shall segregate and hold in trust as provided in ‎Section 7.05 an amount of cash (in immediately available funds if deposited on the Redemption Date), sufficient to pay the Redemption Price of all of the Notes to be redeemed on such Redemption Date. Subject to receipt of funds by the Paying Agent, payment for the Notes to be redeemed shall be made on the Redemption Date for such Notes. The Paying Agent shall, promptly after such payment and upon written demand by the Company, return to the Company any funds in excess of the Redemption Price.

Section 15.04 Restrictions on Redemption
The Company may not redeem any Notes on any date if the principal amount of the Notes has been accelerated in accordance with the terms of this Indenture, and such acceleration has not been rescinded on or prior to the Redemption Date (except in the case of an acceleration resulting from a Default by the Company in the payment of the Redemption Price with respect to such Notes).
ARTICLE 16: Miscellaneous Provisions
Section 16.01 Provisions Binding on Company’s Successors
All the covenants, stipulations, promises and agreements of the Company contained in this Indenture shall bind its successors and assigns whether so expressed or not.
Section 16.02 Official Acts by Successor Person
Any act or proceeding by any provision of this Indenture authorized or required to be done or performed by any board, committee or Officer of the Company shall and may be done and performed with like force and effect by the like board, committee or officer of any corporation or other entity that shall at the time be the lawful sole successor of the Company.
73

Section 16.03 Addresses for Notices, Etc.
Any notice or demand that by any provision of this Indenture is required or permitted to be given or served by the Trustee or by the Holders on the Company shall be deemed to have been sufficiently given or made, for all purposes if given or served by being deposited postage prepaid by registered or certified mail in a post office letter box addressed (until another address is filed by the Company with the Trustee) to WEX Inc., 1 Hancock St., Portland, ME, Attention: General Counsel. Any notice, direction, request or demand hereunder to or upon the Trustee shall be deemed to have been sufficiently given or made, for all purposes, if given or served by being deposited postage prepaid by registered or certified mail in a post office letter box addressed to the Corporate Trust Office or sent electronically in PDF format to the email address of the Responsible Officer.
The Trustee, by notice to the Company, may designate additional or different addresses for subsequent notices or communications.
Any notice or communication delivered or to be delivered to a Holder of Physical Notes shall be mailed to it by first class mail, postage prepaid, at its address as it appears on the Note Register and shall be sufficiently given to it if so mailed within the time prescribed. Any notice or communication delivered or to be delivered to a Holder of Global Notes shall be delivered in accordance with the applicable procedures of the Depositary and shall be sufficiently given to it if so delivered within the time prescribed.
Failure to mail or deliver a notice or communication to a Holder or any defect in it shall not affect its sufficiency with respect to other Holders. If a notice or communication is mailed in the manner provided above, it is duly given, whether or not the addressee receives it.
In case by reason of the suspension of regular mail service or by reason of any other cause it shall be impracticable to give such notice to Holders by mail, then such notification as shall be made with the approval of the Trustee shall constitute a sufficient notification for every purpose hereunder.
Section 16.04 Governing Law; Jurisdiction
THIS INDENTURE AND EACH NOTE, AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS INDENTURE AND EACH NOTE, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK (WITHOUT REGARD TO THE CONFLICTS OF LAWS PROVISIONS THEREOF).
The Company irrevocably consents and agrees, for the benefit of the Holders from time to time of the Notes and the Trustee, that any legal action, suit or proceeding against it with respect to obligations, liabilities or any other matter arising out of or in connection with this Indenture or the Notes may be brought in the courts of the State of New York or the courts of the United States located in the Borough of Manhattan, New York City, New York and, until amounts due and to become due in respect of the Notes have been paid, hereby irrevocably consents and submits to the non-exclusive jurisdiction of each such court in personam, generally and unconditionally with respect to any action, suit or proceeding for itself in respect of its properties, assets and revenues.
The Company irrevocably and unconditionally waives, to the fullest extent permitted by law, any objection which it may now or hereafter have to the laying of venue of any of the aforesaid actions, suits or proceedings arising out of or in connection with this Indenture brought in the courts of the State of New York or the courts of the United States located in the Borough of Manhattan, New York City, New York and hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such action, suit or proceeding brought in any such court has been brought in an inconvenient forum.
Section 16.05 Evidence of Compliance with Conditions Precedent; Certificates and Opinions of Counsel to Trustee
74

Upon any application or demand by the Company to the Trustee to take any action under any of the provisions of this Indenture, the Company shall, if requested by the Trustee, furnish to the Trustee an Officer’s Certificate stating that such action is permitted by the terms of this Indenture.
Each Officer’s Certificate provided for, by or on behalf of the Company in this Indenture and delivered to the Trustee with respect to compliance with this Indenture (other than the Officer’s Certificates provided for in ‎Section 4.08) shall include (a) a statement that the person signing such certificate is familiar with the requested action and this Indenture; (b) a brief statement as to the nature and scope of the examination or investigation upon which the statement contained in such certificate is based; (c) a statement that, in the judgment of such person, he or she has made such examination or investigation as is necessary to enable him or her to express an informed judgment as to whether or not such action is permitted by this Indenture; and (d) a statement as to whether or not, in the judgment of such person, such action is permitted by this Indenture and that all covenants and conditions precedent related thereto have been complied with.
Notwithstanding anything to the contrary in this ‎Section 16.05, if any provision in this Indenture specifically provides that the Trustee shall or may receive an Opinion of Counsel in connection with any action to be taken by the Trustee or the Company hereunder, the Trustee shall be entitled to, or entitled to request, such Opinion of Counsel.
Section 16.06 Legal Holidays
In any case where any Fundamental Change Repurchase Date, Maturity Date, Redemption Date is not a Business Day, then any action to be taken on such date need not be taken on such date, but may be taken on the next succeeding Business Day with the same force and effect as if taken on such date, and no interest shall accrue in respect of the delay.
Section 16.07 No Security Interest Created
Nothing in this Indenture or in the Notes, expressed or implied, shall be construed to constitute a security interest under the Uniform Commercial Code or similar legislation, as now or hereafter enacted and in effect, in any jurisdiction.
Section 16.08 Benefits of Indenture
Nothing in this Indenture or in the Notes, expressed or implied, shall give to any Person, other than the Holders, the parties hereto, any Paying Agent, any Conversion Agent, any authenticating agent, any Note Registrar and their successors hereunder, any benefit or any legal or equitable right, remedy or claim under this Indenture.
Section 16.09 Table of Contents, Headings, Etc
The table of contents and the titles and headings of the articles and sections of this Indenture have been inserted for convenience of reference only, are not to be considered a part hereof, and shall in no way modify or restrict any of the terms or provisions hereof.
Section 16.10 Authenticating Agent
The Trustee may appoint an authenticating agent that shall be authorized to act on its behalf and subject to its direction in the authentication and delivery of Notes in connection with the original issuance thereof and transfers and exchanges of Notes hereunder, including under ‎Section 2.04, ‎Section 2.05, ‎Section 2.06, ‎Section 2.07, ‎Section 10.04 and ‎Section 14.04 as fully to all intents and purposes as though the authenticating agent had been expressly authorized by this Indenture and those Sections to authenticate and deliver Notes. For all purposes of this Indenture, the authentication and delivery of Notes by the authenticating agent shall be deemed to be authentication and delivery of such Notes “by the Trustee” and a certificate of authentication executed on behalf of the Trustee by an authenticating agent shall be deemed to satisfy any requirement hereunder or in the Notes for the 
75

Trustee’s certificate of authentication. Such authenticating agent shall at all times be a Person eligible to serve as trustee hereunder pursuant to ‎Section 7.08.
Any corporation or other entity into which any authenticating agent may be merged or converted or with which it may be consolidated, or any corporation or other entity resulting from any merger, consolidation or conversion to which any authenticating agent shall be a party, or any corporation or other entity succeeding to the corporate trust business of any authenticating agent, shall be the successor of the authenticating agent hereunder, if such successor corporation or other entity is otherwise eligible under this ‎Section 16.10, without the execution or filing of any paper or any further act on the part of the parties hereto or the authenticating agent or such successor corporation or other entity.
Any authenticating agent may at any time resign by giving written notice of resignation to the Trustee and to the Company. The Trustee may at any time terminate the agency of any authenticating agent by giving written notice of termination to such authenticating agent and to the Company. Upon receiving such a notice of resignation or upon such a termination, or in case at any time any authenticating agent shall cease to be eligible under this Section, the Trustee may appoint a successor authenticating agent (which may be the Trustee), shall give written notice of such appointment to the Company and shall deliver notice of such appointment to all Holders as the names and addresses of such Holders appear on the Note Register.
The Company agrees to pay to the authenticating agent from time to time reasonable compensation for its services although the Company may terminate the authenticating agent, if it determines such agent’s fees to be unreasonable.
The provisions of ‎Section 7.02, ‎Section 7.03, ‎Section 7.04, ‎Section 8.03 and this ‎Section 16.10 shall be applicable to any authenticating agent.
If an authenticating agent is appointed pursuant to this ‎Section 16.10, the Notes may have endorsed thereon, in addition to the Trustee’s certificate of authentication, an alternative certificate of authentication in the following form:
        ,
as Authenticating Agent, certifies that this is one of the Notes described 
in the within-named Indenture.
							
	By:		
			Authorized Officer

Section 16.11 Execution in Counterparts
This Indenture may be executed in any number of original or electronic counterparts, each of which shall be deemed effective as if they were an original, but such counterparts shall together constitute but one and the same instrument. The exchange of copies of this Indenture and of electronic signatures or signature pages by email, facsimile, PDF or such other electronic means of transmission shall constitute effective execution and delivery of this Indenture as to the parties hereto and may be used in lieu of the original Indenture for all purposes. Signatures, including electronic signatures, of the parties hereto transmitted by email, facsimile, PDF or such other electronic means shall be deemed to be effective as if they were original signatures for all purposes.
Section 16.12 Severability
In the event any provision of this Indenture or in the Notes shall be invalid, illegal or unenforceable, then (to the extent permitted by law) the validity, legality or enforceability of the remaining provisions shall not in any way be affected or impaired.
Section 16.13 Waiver of Jury Trial
76

EACH OF THE COMPANY, THE TRUSTEE AND EACH HOLDER OF THE NOTES BY ACCEPTANCE HEREOF, HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE, THE NOTES OR THE TRANSACTIONS CONTEMPLATED HEREBY.
Section 16.14 Force Majeure
In no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out of or caused by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services; it being understood that the Trustee shall use reasonable efforts that are consistent with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances.
Section 16.15 Calculations
Except as otherwise provided herein, the Company shall be responsible for making all calculations called for under the Notes. These calculations include, but are not limited to, determinations of the Last Reported Sale Prices of the Common Stock, VWAP of the Common Stock, accruals of interest to be added to the Accreted Principal Amount of the Notes, Additional Interest and the Conversion Price of the Notes. The Company shall make all these calculations in good faith and, absent manifest error, the Company’s calculations shall be final and binding on Holders of Notes. The Company shall provide a schedule of its calculations to each of the Trustee and the Conversion Agent, and each of the Trustee and Conversion Agent is entitled to rely conclusively upon the accuracy of the Company’s calculations without independent verification. The Trustee will forward the Company’s calculations to any Holder of Notes upon the request of that Holder at the sole cost and expense of the Company.
Section 16.16 USA PATRIOT Act
The parties hereto acknowledge that in accordance with Section 326 of the USA PATRIOT Act, the Trustee, like all financial institutions and in order to help fight the funding of terrorism and money laundering, is required to obtain, verify, and record information that identifies each person or legal entity that establishes a relationship or opens an account with the Trustee. The parties to this Indenture agree that they will provide the Trustee with such information as it may request in order for the Trustee to satisfy the requirements of the USA PATRIOT Act.
Section 16.17 Withholding Taxes
If the Company or other applicable withholding agent pays withholding taxes or backup withholding on behalf of the Holder or beneficial owner as a result of an adjustment to the Conversion Price, the Company or other applicable withholding agent may, at its option, set off such payments against payments of cash and shares of Common Stock on the Note.
Section 16.18 Agreed Tax Treatment
. The Company agrees, for United States federal income tax purposes, to treat the Notes as indebtedness that is not subject to Treasury Regulations Section 1.1275-4 (Contingent payment debt instruments), unless otherwise required pursuant to a final “determination” within the meaning of Section 1313(a) of the Code (or any corresponding or similar provision of state, local or non-U.S. law).
[Remainder of page intentionally left blank]

77

IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed as of the date first written above.
											
	WEX INC., as Issuer				
	By: /s/ Roberto Simon 
				
	Name: Roberto Simon				
	Title:   Chief Financial Officer

				
					
					
					
					
	

The Bank of New York Mellon Trust Company N.A., as Trustee
				
	By:  /s/ Julie Hoffman-Ramos 
				
	Name: Julie Hoffman-Ramos				
	Title: Vice President – Senior Transaction 
Manager
				
					
					
					

[AM_ACTIVE 402138650_25]

ActiveUS 180326157v.6

EXHIBIT A

i.
 [FORM OF FACE OF NOTE] 
[CONFORM TO LEGENDS SET FORTH IN INDENTURE WHEN FINAL]
[INCLUDE FOLLOWING LEGEND IF A GLOBAL NOTE]
[UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE, OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT HEREUNDER IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.]
[INCLUDE FOLLOWING LEGEND IF A RESTRICTED SECURITY]
[THIS SECURITY AND THE SHARES OF COMMON STOCK, IF ANY, ISSUABLE UPON CONVERSION OF THIS SECURITY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF OR OF A BENEFICIAL INTEREST HEREIN, THE ACQUIRER:
(1) REPRESENTS THAT IT AND ANY ACCOUNT FOR WHICH IT IS ACTING IS A “QUALIFIED INSTITUTIONAL BUYER” (WITHIN THE MEANING OF RULE 144A UNDER THE SECURITIES ACT) AND THAT IT EXERCISES SOLE INVESTMENT DISCRETION WITH RESPECT TO EACH SUCH ACCOUNT, AND
(2) AGREES FOR THE BENEFIT OF WEX INC. (THE “COMPANY”) THAT IT WILL NOT OFFER, SELL, PLEDGE OR OTHERWISE TRANSFER THIS SECURITY OR ANY BENEFICIAL INTEREST HEREIN, EXCEPT:
(A) TO THE COMPANY OR ANY SUBSIDIARY THEREOF, OR
(B) PURSUANT TO A REGISTRATION STATEMENT WHICH HAS BECOME EFFECTIVE UNDER THE SECURITIES ACT, OR
(C) TO A PERSON THAT IT REASONABLY BELIEVES TO BE A QUALIFIED INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT, OR
 (D) PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT OR ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.
PRIOR TO THE REGISTRATION OF ANY TRANSFER IN ACCORDANCE WITH CLAUSE (2)(D) ABOVE, THE COMPANY AND THE TRUSTEE RESERVE THE RIGHT TO REQUIRE THE DELIVERY OF SUCH LEGAL OPINIONS, CERTIFICATIONS OR OTHER EVIDENCE AS MAY REASONABLY BE REQUIRED IN ORDER TO DETERMINE THAT THE PROPOSED TRANSFER IS BEING MADE IN COMPLIANCE WITH THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS. NO 

REPRESENTATION IS MADE AS TO THE AVAILABILITY OF ANY EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.]
[THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO TRANSFER RESTRICTIONS SET FORTH IN A PURCHASE AGREEMENT, DATED AS OF JUNE 29, 2020, COPIES OF WHICH ARE ON FILE WITH THE SECRETARY OF THE COMPANY.]
FOR PURPOSES OF SECTIONS 1272, 1273 AND 1275 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED, AND THE RULES AND REGULATIONS THEREUNDER, THIS NOTE IS BEING ISSUED WITH ORIGINAL ISSUE DISCOUNT; PLEASE CONTACT ROBERTO SIMON, CHIEF FINANCIAL OFFICER, WEX INC., 1 HANCOCK STREET, PORTLAND, MAINE 04101, TELEPHONE: 1-207-773-8171, TO OBTAIN INFORMATION REGARDING THE ISSUE PRICE, THE AMOUNT OF ORIGINAL ISSUE DISCOUNT AND THE YIELD TO MATURITY.

2
[AM_ACTIVE 402138650_25]

ActiveUS 180326157v.6

WEX Inc.
6.50% Convertible Senior Note due 2027
						
	No. [            ]	[Initial Original Principal Amount] $[                    ]1

	CUSIP No. [                ]	

WEX Inc., a corporation duly organized and validly existing under the laws of the State of Delaware (the “Company,” which term includes any successor corporation or other entity under the Indenture referred to on the reverse hereof), for value received hereby promises to pay to [CEDE & CO.]2 [                    ]3, or registered assigns, the Accreted Principal Amount hereof [in respect of the Original Principal Amount of Notes set forth in the “Schedule of Exchanges of Notes” attached hereto]4 on July 15, 2027. The Original Principal Amount hereof, taken together with the Original Principal Amounts of all other outstanding Notes, shall not exceed $310,000,000 in aggregate at any time.
This Note shall bear interest at the rate of 6.50% per annum from July 1, 2020. Interest will be payable, at the election of the Company in accordance with the terms of the Indenture, in whole or, to the extent consistent with the procedures of the Depositary, in part (i) as cash interest and/or (ii) as accrued interest to be added as an accretion to the principal amount of the Notes on each Interest Payment Date. Interest shall accrete to the Accreted Principal Amount, or cash interest payments will be made, on each Interest Payment Date as set forth in ‎Section 2.03 of the Indenture. Additional Interest will accrete to the Accreted Principal Amount as set forth in ‎Section 6.03 of the within-mentioned Indenture, and any reference to interest on, or in respect of, any Note therein shall be deemed to include Additional Interest if, in such context, Additional Interest is, was or would be payable in the form of an accretion to the Accreted Principal Amount pursuant to ‎Section 6.03, and any express mention of the payment of Additional Interest in any provision therein shall not be construed as excluding Additional Interest in those provisions thereof where such express mention is not made.
Any Defaulted Amounts shall accrue interest per annum at the rate borne by the Notes, subject to the enforceability thereof under applicable law, from, and including, the relevant payment date to, but excluding, the date on which such Defaulted Amounts shall have been paid by the Company, at its election, in accordance with ‎Section 2.03(c) of the Indenture.
The Company shall pay or cause the Paying Agent to pay the Accreted Principal Amount on this Note, if and so long as such Note is a Global Note, in immediately available funds to the Depositary or its nominee, as the case may be, as the registered Holder of such Note. As provided in and subject to the provisions of the Indenture, the Company shall pay or cause the Paying Agent to pay the Accreted Principal Amount of any Notes (other than Notes that are Global Notes) at the office or agency designated by the Company for that purpose. The Company has initially designated the Trustee as its Paying Agent and Note Registrar in respect of the Notes and its agency in the Borough of Manhattan, The City of New York, as a place where Notes may be presented for payment or for registration of transfer and exchange.
Reference is made to the further provisions of this Note set forth on the reverse hereof, including, without limitation, provisions giving the Holder of this Note the right to convert this Note on the terms and subject to the limitations set forth in the Indenture. Such further provisions shall for all purposes have the same effect as though fully set forth at this place.
This Note, and any claim, controversy or dispute arising under or related to this Note, shall be construed in accordance with and governed by the laws of the State of New York (without regard to the conflicts of laws provisions thereof).

1 Include if a global note.
2 Include if a global note.
3 Include if a physical note.
4 Include if a global note.
3
[AM_ACTIVE 402138650_25]

ActiveUS 180326157v.6

In the case of any conflict between this Note and the Indenture, the provisions of the Indenture shall control and govern.
This Note shall not be valid or become obligatory for any purpose until the certificate of authentication hereon shall have been signed manually or electronically by the Trustee or a duly authorized authenticating agent under the Indenture.
[Remainder of page intentionally left blank]

4
[AM_ACTIVE 402138650_25]

ActiveUS 180326157v.6

IN WITNESS WHEREOF, the Company has caused this Note to be duly executed.
							
	WEX INC.,		
	By: 
		
	Name:		
	Title:		
			
			
			

			
	The Bank of New York Mellon Trust Company, N.A., as Trustee, certifies that this is one of the Notes described in the within-named Indenture
	By: 

	Authorized Signatory

5
[AM_ACTIVE 402138650_25]

ActiveUS 180326157v.6

[FORM OF REVERSE OF NOTE]
WEX Inc.
6.50% Convertible Senior Note due 2027

This Note is one of a duly authorized issue of Notes of the Company, designated as its 6.50% Convertible Senior Notes due 2027 (the “Notes”), limited to the aggregate Original Principal Amount of $310,000,000 all issued or to be issued under and pursuant to an Indenture dated as of July 1, 2020 (the “Indenture”), among the Company and The Bank of New York Mellon Trust Company, N.A. (the “Trustee”), to which Indenture and all indentures supplemental thereto reference is hereby made for a description of the rights, limitations of rights, obligations, duties and immunities thereunder of the Trustee, the Company and the Holders of the Notes. Capitalized terms used in this Note and not defined in this Note shall have the respective meanings set forth in the Indenture.
In case certain Events of Default shall have occurred and be continuing, the Accreted Principal Amount of all Notes may be declared, by either the Trustee or Holders of at least 25% in aggregate Original Principal Amount of Notes then outstanding, and upon said declaration shall become, due and payable, in the manner, with the effect and subject to the conditions and certain exceptions set forth in the Indenture.
Subject to the terms and conditions of the Indenture, the Company will make all payments and deliveries in respect of the Fundamental Change Repurchase Price on the Fundamental Change Repurchase Date (if applicable), the Redemption Price on any Redemption Date (if applicable) and the Accreted Principal Amount on the Maturity Date, as the case may be, to the Holder who surrenders a Note to a Paying Agent to collect such payments in respect of the Note. The Company will pay cash amounts in money of the United States that at the time of payment is legal tender for payment of public and private debts.
The Indenture contains provisions permitting the Company and the Trustee in certain circumstances, without the consent of the Holders of the Notes, and in certain other circumstances, with the consent of the Holders of not less than the Required Percentage in aggregate Original Principal Amount of the Notes at the time outstanding, evidenced as in the Indenture provided, to execute supplemental indentures modifying the terms of the Indenture and the Notes as described therein. It is also provided in the Indenture that, subject to certain exceptions, the Holders of the Required Percentage in aggregate Original Principal Amount of the Notes at the time outstanding may on behalf of the Holders of all of the Notes waive any existing or past Default or Event of Default under the Indenture and its consequences.
No reference herein to the Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay or deliver, as the case may be, the Accreted Principal Amount (including the Redemption Price and the Fundamental Change Repurchase Price, if applicable) of, the consideration due upon conversion of, and any cash interest payments due under, this Note at the place, at the respective times, at the rate and in the lawful money and/or shares of Common Stock, as the case may be, herein prescribed.
The Notes are issuable in registered form without coupons in denominations of $1,000 Original Principal Amount and integral multiples thereof. At the office or agency of the Company referred to on the face hereof, and in the manner and subject to the limitations provided in the Indenture, Notes may be exchanged for a like aggregate Original Principal Amount of Notes of other authorized denominations, without payment of any service charge but, if required by the Company or Trustee, with payment of a sum sufficient to cover any transfer or similar tax that may be imposed in connection therewith as a result of the name of the Holder of the new Notes issued upon such exchange of Notes being different from the name of the Holder of the old Notes surrendered for such exchange.
The Notes are not subject to redemption prior to July 1, 2023. The Notes shall be redeemable at the Company’s option on or after July 1, 2023 in accordance with the terms and subject to the conditions specified in the Indenture. No sinking fund is provided for the Notes.
6
[AM_ACTIVE 402138650_25]

ActiveUS 180326157v.6

Upon the occurrence of a Fundamental Change, the Holder has the right, at such Holder’s option and subject to the limitations set forth in the Indenture, to require the Company to repurchase for cash all of such Holder’s Notes or any portion thereof (in Original Principal Amounts of $1,000 or integral multiples thereof) on the Fundamental Change Repurchase Date at a price equal to the Fundamental Change Repurchase Price.
Subject to the provisions of the Indenture, the Holder hereof has the right, at its option, at any time prior to the close of business on the second Business Day immediately preceding the Maturity Date, to convert any Notes or portion thereof that is $1,000 Original Principal Amount or any integral multiple thereof, into shares of Common Stock, cash or a combination thereof, at the Company’s election, and at the Conversion Price specified in the Indenture, as adjusted from time to time as provided in the Indenture.

7
[AM_ACTIVE 402138650_25]

ActiveUS 180326157v.6

ABBREVIATIONS
The following abbreviations, when used in the inscription of the face of this Note, shall be construed as though they were written out in full according to applicable laws or regulations:
TEN COM = as tenants in common
UNIF GIFT MIN ACT = Uniform Gifts to Minors Act CUST = Custodian TEN ENT = as tenants by the entireties
JT TEN = joint tenants with right of survivorship and not as tenants in common
Additional abbreviations may also be used though not in the above list.

8
[AM_ACTIVE 402138650_25]

ActiveUS 180326157v.6

SCHEDULE A5
SCHEDULE OF EXCHANGES OF NOTES
WEX Inc.
6.50% Convertible Senior Notes due 2027

The initial Original Principal Amount of this Global Note is              DOLLARS ($[                    ]). The following increases or decreases in this Global Note have been made:
															
	Date of exchange	Amount of decrease in Original Principal Amount of this Global Note	Amount of increase in Original Principal Amount of this Global Note	Original Principal Amount of this Global Note following such decrease or increase	Signature of authorized signatory of Trustee or Custodian
					
					
					
					
					
					
					
					
					
					
					
					
					
					
					
					
					
					
					
					
					
					
					
					
					
					
					

5 Include if a global note.
9
[AM_ACTIVE 402138650_25]

ActiveUS 180326157v.6

ATTACHMENT 1

 [FORM OF NOTICE OF CONVERSION]
To: WEX Inc.
1 Hancock St.
Portland, ME 04101
Attention: Roberto Simon

The undersigned registered owner of this Note hereby exercises the option to convert this Note, or the portion hereof (that is $1,000 Principal Amount or an integral multiple thereof) below designated, into shares of Common, cash or a combination thereof, at the Company’s election, in accordance with the terms of the Indenture referred to in this Note, and directs that the shares of Common Stock issuable and deliverable upon such conversion, together with any cash in lieu of any fractional share, and any Notes representing any unconverted Original Principal Amount hereof, be issued and delivered to the registered Holder hereof unless a different name has been indicated below. If any shares of Common Stock or any portion of this Note not converted are to be issued in the name of a Person other than the undersigned, the undersigned will pay all documentary, stamp or similar issue or transfer taxes, if any in accordance with ‎Section 13.02(d) and ‎Section 13.02(e) of the Indenture. Any amount required to be paid to the undersigned on account of interest accompanies this Note. Capitalized terms used herein but not defined shall have the meanings ascribed to such terms in the Indenture.
						
	Dated: 
	
		
		Signature(s)
	        
Signature Guarantee 
	
	Signature(s) must be guaranteed by an eligible Guarantor Institution (banks, stock brokers, savings and loan associations and credit unions) with membership in an approved signature guarantee medallion program pursuant to Securities and Exchange Commission Rule 17Ad-15 if shares of Common Stock are to be issued, or Notes are to be delivered, other than to and in the name of the registered holder.	
	Fill in for registration of shares if to be issued, and Notes if to be delivered, other than to and in the name of the registered holder:	
	        
(Name)
	
	        
(Street Address)
	
	        
City, State and Zip Code)
Please print name and address
	
		
		Accreted Principal Amount to be converted (if less than all):$            ,000
		NOTICE: The above signature(s) of the Holder(s) hereof must correspond with the name as written upon the face of the Note in every particular without alteration or enlargement or any change whatever.
		        
Social Security or Other Taxpayer
Identification Number

1
[AM_ACTIVE 402138650_25]

ActiveUS 180326157v.6

ATTACHMENT 2

 [FORM OF FUNDAMENTAL CHANGE REPURCHASE NOTICE]
To: WEX Inc.
1Hancock St.
Portland, ME 04101
Attention: Roberto Simon

The undersigned registered owner of this Note hereby acknowledges receipt of a notice from WEX Inc. (the “Company”) as to the occurrence of a Fundamental Change with respect to the Company and specifying the Fundamental Change Repurchase Date and requests and instructs the Company to pay to the registered holder hereof in accordance with ‎Section 14.02 of the Indenture referred to in this Note the entire Accreted Principal Amount of this Note, or the portion thereof (that is $1,000 Original Principal Amount or an integral multiple thereof) below designated. Capitalized terms used herein but not defined shall have the meanings ascribed to such terms in the Indenture.
In the case of Physical Notes, the certificate numbers of the Notes to be repurchased are as set forth below:
Dated:   
			
	
	Signature(s)
	
	Social Security or Other Taxpayer
Identification Number

	
	Accreted Principal Amount to be repaid (if less than all): $                ,000
	
	NOTICE: The above signature(s) of the Holder(s) hereof must correspond with the name as written upon the face of the Note in every particular without alteration or enlargement or any change whatever.

1
[AM_ACTIVE 402138650_25]

ActiveUS 180326157v.6

ATTACHMENT 3

 [FORM OF ASSIGNMENT AND TRANSFER] 
For value received                                          hereby sell(s), assign(s) and transfer(s) unto                          (Please insert social security or Taxpayer Identification Number of assignee) the within Note, and hereby irrevocably constitutes and appoints                                  attorney to transfer the said Note on the books of the Company, with full power of substitution in the premises.
In connection with any transfer of the within Note, the undersigned confirms that such Note is being transferred:
•To WEX Inc. or a subsidiary thereof; or
•Pursuant to a registration statement that has become or been declared effective under the Securities Act of 1933, as amended; or
•Pursuant to and in compliance with Rule 144A under the Securities Act of 1933, as amended; or
•Pursuant to and in compliance with Rule 144 under the Securities Act of 1933, as amended, or any other available exemption from the registration requirements of the Securities Act of 1933, as amended.
			
	
	Dated: 

	
	
	Signature(s)
	
	Signature Guarantee
	
	Signature(s) must be guaranteed by an eligible
Guarantor Institution (banks, stock brokers,
savings and loan associations and credit unions)
with membership in an approved signature
guarantee medallion program pursuant to
Securities and Exchange Commission Rule
17Ad-15 if Notes are to be delivered, other than to
and in the name of the registered holder.

NOTICE: The signature on the assignment must correspond with the name as written upon the face of the Note in every particular without alteration or enlargement or any change whateverExhibit

Exhibit 10.1

WEX INC.
COMMON STOCK 
and
6.50% CONVERTIBLE SENIOR NOTES DUE 2027
PURCHASE AGREEMENT
dated as of
June 29, 2020

TABLE OF CONTENTS
		
	Article 1 DEFINITIONS AND INTERPRETATION
	1

		
	1.1
	Defined Terms    1

		
	1.2
	Interpretation    8

		
	Article 2 THE TRANSACTIONS
	8

		
	2.1
	Sale and Purchase of the Initial Shares and the Notes    8

		
	2.2
	Payment of the Purchase Price    8

		
	2.3
	Underlying Securities    9

		
	Article 3 CLOSING AND CLOSING CONDITIONS
	9

		
	3.1
	Time and Place of the Closing    9

		
	3.2
	Actions at the Closing    9

		
	3.3
	Conditions Precedent to Obligations of the Purchaser    9

		
	3.4
	Conditions Precedent to Obligations of the Company    10

		
	Article 4 REPRESENTATIONS AND WARRANTIES OF THE COMPANY
	11

		
	4.1
	No Registration Required; Rule 144A Eligibility    11

		
	4.2
	No Integration of Offerings or General Solicitation    12

		
	4.3
	Company SEC Documents; Undisclosed Liabilities.    12

		
	4.4
	Authorization; The Purchase Agreement    13

		
	4.5
	Use of Proceeds    13

		
	4.6
	The Notes    13

		
	4.7
	The Indenture    13

		
	4.8
	Registration Rights Agreement; Registration Rights    13

		
	4.9
	The Initial Shares and the Underlying Securities    13

		
	4.10
	Absence of Certain Changes    14

		
	4.11
	Absence of Litigation or Adverse Matters    14

		
	4.12
	Incorporation and Good Standing of the Company and each of its Subsidiaries    14

		
	4.13
	Capitalization    14

		
	4.14
	Certain Material Indebtedness    15

		
	4.15
	No Manipulation    15

		
	4.16
	Non-Contravention of Existing Instruments; No Further Authorizations or Approvals Required    15

		
	4.17
	No Violation    16

		
	4.18
	Company is Not an “Investment Company”    16

		
	4.19
	Independent Accountants    16

		
	4.20
	Compliance with Applicable Laws    16

		
	4.21
	Tax Compliance    17

		
	4.22
	Brokers    17

		
	4.23
	Solvency    18

		
	4.24
	No Other Company Representations or Warranties    18

		
	4.25
	No Other Investor Representations or Warranties    18

		
	Article 5 REPRESENTATIONS AND WARRANTIES OF THE PURCHASER
	18

		
	5.1
	Organization, Authority and Power    18

		
	5.2
	Valid and Binding Obligations    18

		
	5.3
	Securities Law Matters    19

		
	5.4
	Financing    19

		
	5.5
	Non-Contravention of Existing Instruments; No Further Authorizations or Approvals Required    19

		
	5.6
	Brokers    20

i

		
	5.7
	Non-Reliance on Company Estimates, Projections, Forecasts, Forward-Looking Statements and Business Plans    20

		
	5.8
	Ownership of Company Securities.    20

		
	5.9
	Bank Holding Company Status.    20

		
	5.10
	No Other Investor Representations or Warranties    20

		
	5.11
	No Other Company Representations or Warranties    20

		
	Article 6 ADDITIONAL COVENANTS
	21

		
	6.1
	No Integration    21

		
	6.2
	Transfer Agent    21

		
	6.3
	Available Securities of Common Stock    21

		
	6.4
	No Restricted Resales    21

		
	6.5
	Regulatory Filings    21

		
	6.6
	Board Rights    22

		
	6.7
	Section 16 Matters    24

		
	6.8
	Efforts    24

		
	6.9
	Standstill    25

		
	6.10
	Transfer Restrictions    26

		
	6.11
	Preemptive Rights    27

		
	6.12
	Public Disclosure    30

		
	6.13
	Confidentiality    30

		
	6.14
	Financing Cooperation    31

		
	6.15
	Legend    32

		
	6.16
	Negative Covenants    32

		
	6.17
	Information Rights    33

		
	6.18
	Avoidance of Control    33

		
	Article 7 TERMINATION
	34

		
	7.1
	Termination    34

		
	7.2
	Effect of Termination    34

		
	Article 8 MISCELLANEOUS
	34

		
	8.1
	Notices    35

		
	8.2
	Survival    35

		
	8.3
	Entire Agreement; Amendments    36

		
	8.4
	Successors and Assigns    36

		
	8.5
	Governing Law    36

		
	8.6
	Jury Trial    36

		
	8.7
	Expenses, Etc    36

		
	8.8
	Captions    36

		
	8.9
	Severability    36

		
	8.10
	Counterparts    37

		
	8.11
	No Waiver    37

		
	8.12
	Damages Waiver; Specific Performance    37

		
	8.13
	No Third Party Beneficiaries; No Recourse    37

		
	8.14
	Other Activities    38

		
	8.16
	Sponsor    38

Exhibit A:    Form of Indenture
Exhibit B:    Form of Registration Rights Agreement
Exhibit C:    Form of Opinion of Wilmer Cutler Pickering Hale and Dorr LLP

ii

COMMON STOCK AND 6.50% CONVERTIBLE SENIOR NOTES DUE 2027 PURCHASE AGREEMENT 
This Common Stock and 6.50% Convertible Senior Notes due 2027 Purchase Agreement, dated as of June 29, 2020, is entered into by and among WEX Inc., a Delaware corporation (the “Company”), and WP Bronco Holdings, LLC, a Delaware limited liability company (the “Purchaser”) (the Company and the Purchaser being sometimes hereinafter referred to individually as a “Party” and collectively as the “Parties”). 

RECITALS
WHEREAS, the Company desires to issue, sell and deliver to the Purchaser, and the Purchaser desires to purchase and acquire from the Company, $310,000,000 in aggregate principal amount of the Company’s 6.50% Convertible Senior Notes due 2027 (referred to herein as a “Note” individually or the “Notes” collectively), to be issued at the Closing in accordance with the terms and conditions of the Indenture to be entered into as of the Closing by the Company and the Trustee substantially in the form attached hereto as Exhibit A (the “Indenture”) and this Agreement;
WHEREAS, the Company also desires to issue, sell and deliver to the Purchaser, and the Purchaser desires to purchase and acquire from the Company, 577,254 shares of Common Stock (the “Initial Shares”), to be issued at the Closing in accordance with the terms and conditions of this Agreement;
WHEREAS, in connection with the transactions contemplated hereby, at the Closing, the Company and the Purchaser desire to enter into that certain Registration Rights Agreement substantially in the form attached hereto as Exhibit B (the “Registration Rights Agreement”), which provides for certain rights and obligations of the Company and the Purchaser following the Closing; and
WHEREAS, concurrently with the execution and delivery of this Agreement, and as a condition and material inducement to the Company’s willingness to enter into this Agreement, the Purchaser has received a commitment letter, dated as of the date of this Agreement (the “Equity Commitment Letter”), from the Equity Investors pursuant to which the Equity Investors have committed, subject to the terms and conditions thereof, to invest in the Purchaser, directly or indirectly, the cash amounts set forth therein for the purpose of funding the Purchase Price at the Closing.
NOW, THEREFORE, in consideration of the mutual covenants and agreements in this Agreement and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties, intending to be legally bound, agree as follows: 

Article 1 
 DEFINITIONS AND INTERPRETATION
		
	1.1
	Defined Terms. Capitalized terms used in this Agreement (including in the preamble and the Recitals hereto) without other definition shall have the following meanings, unless the context clearly requires otherwise:

“Activist Shareholder” means, as of any date of determination, a Person (other than the Purchaser Parties and their respective Affiliates) that has, directly or indirectly through its Affiliates, whether individually or as a member of a “group” (as defined in Section 13(d)(3) of the Exchange Act), within the three-year period immediately preceding such date of determination (i) called or publicly sought to call a meeting of the stockholders or other equityholders of any Person not publicly approved (at the time of the first such action) by the board of directors or similar governing body of such Person, (ii) publicly initiated any proposal for action by stockholders or other equityholders of any Person initially publicly opposed by the board of directors or similar governing body of such Person, (iii) publicly sought election to, or to place a director or representative on, the board of directors or similar governing body of a Person, or publicly sought the removal of a director or other representative from such board of directors or 

1

similar governing body, in each case which election or removal was not recommended or approved publicly (at the time such election or removal is first sought) by the board of directors or (iv) publicly disclosed any intention, plan or arrangement to do any of the foregoing.
“Affiliate” means, as to any Person, any other Person that, directly or indirectly, controls, or is controlled by, or is under common control with, such first Person; provided, however, (i) that the Company and its subsidiaries, on the one hand, and any Purchaser Party or any of its Affiliates or any of the Persons described in clause (ii), on the other hand, shall not be deemed to be Affiliates of each other and (ii) no Purchaser Party shall be considered an Affiliate of any investment fund affiliated with the Sponsor or any other “portfolio company” (as such term is customarily used among private equity investors) of any investment fund affiliated with the Sponsor, nor shall any investment fund affiliated with the Sponsor or any other portfolio company of any investment fund affiliated with the Sponsor be considered to be an Affiliate of any Purchaser Party. For this purpose, “control” (including its correlative meanings, “controlling”, “controlled by” and “under common control with”), with respect to the relationship between or among two or more Persons, means the possession, directly or indirectly, of the power to direct or cause the direction of the affairs or management of a Person, whether through the ownership of voting securities, as trustee or executor, by contract or otherwise.
“Agreement” means this Common Stock and 6.50% Convertible Senior Notes due 2027 Purchase Agreement, including all Exhibits, Schedules and other attachments hereto.
“Anti-Corruption Laws” has the meaning ascribed to such term in Section ‎4.20(b) hereof.
“Balance Sheet Date” has the meaning ascribed to such term in Section ‎4.3(c) hereof.
“Board Designee” has the meaning ascribed to such term in Section ‎6.6.1 hereof.
“Board Indemnitee” has the meaning ascribed to such term in Section ‎6.6.4 hereof.
“Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in New York, New York are required or authorized by Law to close.
“Capitalization Date” has the meaning ascribed to such term in Section ‎4.13(a) hereof.
“Closing” has the meaning ascribed to such term in Section ‎3.1 hereof.
“Closing Actions” has the meaning ascribed to such term in Section ‎3.2 hereof.
“Closing Date” has the meaning ascribed to such term in Section ‎3.1 hereof.
“Closing Date Securities” means the Initial Shares together with the Notes.
“Code” means the Internal Revenue Code of 1986, as amended, and the regulations and published interpretations thereunder.
“Common Stock” means the common stock of the Company, par value $0.01 per share.
“Company” has the meaning ascribed to such term in the preamble to this Agreement.
“Company Board” means the board of directors of the Company. 
“Company DSU” means a deferred stock unit with respect to Common Stock as described in the Public Filings.
“Company PBRSU” means a performance-based restricted stock unit with respect to Common Stock as described in the Public Filings.
“Company RSU” means a restricted stock unit with respect to Common Stock as described in the Public Filings.

2

“Company SEC Documents” has the meaning ascribed to such term in Section ‎4.3(a) hereof.
“Company Securities” has the meaning ascribed to such term in Section ‎4.13‎(b) hereof.
“Company Stock Option” means an option to purchase shares of Common Stock as described in the Public Filings.
“Company Stock Plans” means the Company 2019 Equity and Incentive Plan, which replaced the 2010 Equity and Incentive Plan, as amended from time to time. 
“Competitor” means (i) Siris Capital Group, LLC, any successor thereto, its affiliated investment funds and their respective affiliates (“affiliated” and “affiliates” for this purpose having the meaning ascribed to such terms under Rule 12b-2 of the Exchange Act), (ii) Elliott Management Corporation, any successor thereto, its affiliated investment funds and their respective affiliates (“affiliated” and “affiliates” for this purpose having the meaning ascribed to such terms under Rule 12b-2 of the Exchange Act) and (iii) any Person that is or becomes primarily engaged in any business that directly or indirectly competes with the Company’s payment solutions business across any geographic market. For the avoidance of doubt, clause (iii) shall not include any Permitted Counterparty. 
“Confidential Information” has the meaning ascribed to such term in Section ‎6.13 hereof.
“Confidentiality Agreement” means that certain Nondisclosure Agreement entered into between the Company and Warburg Pincus LLC, dated as of October 10, 2018 and as further amended on June 17, 2020. 
“Control” has the meaning ascribed to such term in the definition of “Affiliate”. 
“Convertible Securities” has the meaning ascribed to such term in the Indenture.
“DOJ” has the meaning ascribed to such term in Section ‎6.5 hereof.
“DTC” means the Depository Trust Company.
“Effect” has the meaning ascribed to such term in the definition of “Material Adverse Effect”.
“Equity-Linked Securities” means (a) a debt security issued by the Company which is convertible into equity interests of the Company or its subsidiaries (and cash in lieu of fractional shares) and/or cash in an amount determined by reference to the price of equity interests of the Company or (b) a debt security that is issued in specific conjunction with (e.g., as a collective unit or stapled, irrespective of whether such instruments are separable by the holders thereof) call options, warrants or rights to purchase (or substantially equivalent derivative transactions) that are exercisable for equity interests of the Company or its subsidiaries and/or cash in an amount determined by reference to the price of equity interests of the Company.
“Equity Commitment Letter” has the meaning ascribed to such term in the Recitals to this Agreement.
“Equity Investors” means Warburg Pincus (Callisto) Global Growth (Cayman), L.P., Warburg Pincus (Europa) Global Growth (Cayman), L.P.; Warburg Pincus Global Growth-B (Cayman), L.P.; Warburg Pincus Global Growth-E (Cayman), L.P.; Warburg Pincus Global Growth Partners (Cayman), L.P.; WP Global Growth Partners (Cayman), L.P.; Warburg Pincus Financial Sector (Cayman), L.P.; Warburg Pincus Financial Sector-D (Cayman), L.P.; Warburg Pincus Financial Sector Partners (Cayman), L.P., collectively.
“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC promulgated thereunder.
“Export Control Laws” means the EC Regulation 428/2009 and the implementing laws and regulations of the EU member states; the U.S. Export Administration Act, U.S. Export Administration Regulations, U.S. Arms Export Control Act, U.S. International Traffic in Arms Regulations, and their respective implementing rules and regulations; the U.K. Export Control Act 2002 (as amended and extended by the Export Control Order 2008) and 

3

its implementing rules and regulations; and other similar export control laws or restrictions applicable to the Company, its subsidiaries and their respective operations from time to time.
“FINRA” means the United States Financial Industry Regulatory Authority.
“Fraud” means, of a Person, a misrepresentation of or with respect to a representation or warranty set forth in this Agreement by such Person that constitutes actual and intentional common law fraud (and not constructive fraud or negligent misrepresentation).
“FTC” has the meaning ascribed to such term in Section ‎6.5 hereof.
“Fund Indemnitors” has the meaning ascribed to such term in Section ‎6.6.4 hereof.
“GAAP” means generally accepted accounting principles in the United States, consistently applied and as in effect from time to time. 
“Governmental Entity” means any court, administrative agency or commission or other governmental authority or instrumentality, whether federal, state, local or foreign, and any applicable self-regulatory organization (including the NYSE).
“Hedging Transaction” means any short sale of, granting any option for the purchase of, or entering into any hedging or similar transaction (including, without limitation, any swap or forward sale agreement and whether any such transaction is settled in securities, cash, a combination thereof or otherwise) with the purpose or effect of offsetting any loss which results or may result from a decline in the market price of any shares of Common Stock or the Notes, or otherwise establishing or increasing, directly or indirectly, a put equivalent position, as defined in Rule 16a-1(h) under the Exchange Act, with respect to the Common Stock or any other capital stock of the Company or the Notes; provided, however, that, for the avoidance of doubt, a Permitted Transaction shall not be deemed to be a Hedging Transaction.
“HSR Act” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.
“Indemnification Obligations” has the meaning ascribed to such term in Section ‎6.6.4 hereof.
“Indenture” has the meaning ascribed to such term in the Recitals.
“Ineligible Acquirer” has the meaning ascribed to such term in Section ‎6.10.
“Initial Shares” has the meaning ascribed to such term in the Recitals.
“Issuer Agreement” has the meaning ascribed to such term in Section ‎6.14 hereof.
“Law” means any federal, national, state, county, municipal, provincial, local, foreign or multinational, treaty, statute, constitution, common law, ordinance, code, decree, order, judgment, rule, regulation, ruling, published policy or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Entity and any award, order or decision of an arbitrator or arbitration panel with jurisdiction over the parties and subject matter of the dispute. 
“Material Adverse Effect” means any change, event, development, occurrence or effect (each, an “Effect”) that, individually or in the aggregate, has had a material adverse effect on the business, financial condition or results of operations of the Company and its subsidiaries, taken as a whole; provided that no Effect to the extent arising out of or resulting from the following will be taken into account when determining whether a Material Adverse Effect has occurred (subject to the limitations set forth below):
		
	(i)
	changes in general economic conditions, or changes in conditions in the global or international economy generally;

4

		
	(ii)
	general changes in conditions in the financial markets, credit markets, debt markets or capital markets, including (A) changes in interest rates or credit ratings; (B) changes in exchange rates for the currencies of any country; or (C) any suspension of trading in securities (whether equity, debt, derivative or hybrid securities) generally on any securities exchange or over-the-counter market;

		
	(iii)
	general changes in operating, business, regulatory or other conditions in the industries or markets or geographical areas in which the Company and its subsidiaries conduct business;

		
	(iv)
	changes in regulatory, legislative or political conditions;

		
	(v)
	any acts of God, natural disasters or any geopolitical conditions, outbreak of hostilities, acts of war (whether or not declared), sabotage, cyberterrorism (including by means of cyber-attack by or sponsored by a Governmental Entity), terrorism or military actions (including any escalation or general worsening of any such hostilities, acts of war, sabotage, cyberterrorism, terrorism or military actions);

		
	(vi)
	any epidemics or pandemics (including, for the avoidance of doubt, the outbreak of SARS-CoV-2 or COVID-19 and any evolutions thereof or related or associated epidemics, pandemics or disease outbreaks);

		
	(vii)
	the announcement, pendency or consummation of this Agreement or the identity of the Purchaser, in each case including the impact thereof on the relationships, contractual or otherwise, of the Company and its subsidiaries with customers, suppliers, lenders, lessors, business partners, employees, regulators, Governmental Entities or vendors (it being understood and agreed that this clause (vii) shall not apply to any representation or warranty to the extent such representation or warranty expressly addresses the consequences resulting from this Agreement or the consummation of the Transactions, including the representations and warranties contained in Section ‎4.16 hereof);

		
	(viii)
	changes or proposed changes in GAAP or other accounting standards or principles or in any applicable Laws (or the enforcement or interpretation of any of the foregoing);

		
	(ix)
	changes in the price or trading volume of the Common Stock or any other equity or debt securities of the Company or any of its subsidiaries, in and of itself (it being understood and agreed that, unless subject to another exclusion set forth in this definition, the facts and circumstances giving rise to such a change may be taken into account in determining whether a Material Adverse Effect has occurred); 

		
	(x)
	any failure, in and of itself, by the Company and its subsidiaries to meet (A) any public estimates or expectations of the Company’s revenue, earnings or other financial performance or results of operations for any period or (B) any budgets, plans, projections or forecasts of its revenues, earnings or other financial performance or results of operations (it being understood and agreed that, in each case, unless subject to another exclusion set forth in this definition, the underlying cause of any such failure may be taken into consideration when determining whether a Material Adverse Effect has occurred); and 

		
	(xi)
	seasonal changes in the results of operations of the Company and its subsidiaries; 

except, in the case of each of clauses (i), (ii), (iii), (iv), (v), (vi) and (viii), to the extent such Effect has had a disproportionate adverse effect on the Company and its subsidiaries, taken as a whole, relative to other companies operating in the industries in which the Company and its subsidiaries conduct business. 

5

“Money Laundering Laws” has the meaning ascribed to such term in Section ‎4.20(f) hereof.
“New Securities” has the meaning ascribed to such term in Section ‎6.11‎(a) hereof.
“Non-Recourse Party” has the meaning ascribed to such term in Section ‎8.13 hereof.
“Note” has the meaning ascribed to such term in the Recitals to this Agreement.
“NYSE” means the New York Stock Exchange.
“OFAC” means the Office of Foreign Assets Control of the United States Treasury Department.
“Original Principal Amount” means the original principal amount per Note of $1,000.
“Ownership Threshold” has the meaning ascribed to such term in Section ‎6.6.1 hereof.
“Party” or “Parties” has the meaning ascribed to such term in the preamble to this Agreement.
“Permitted Counterparty” has the meaning ascribed to such term in Section ‎6.10(b)(v) hereof. 
“Permitted Transaction” has the meaning ascribed to such term in Section ‎6.10(b)(v) hereof. 
“Permitted Transferee” means (i) an Affiliate or subsidiary of the Purchaser or the Sponsor, (ii) any investment fund, vehicle, holding company or similar entity with respect to which a member of the Sponsor Group serves as a general partner, managing member, manager or advisor or (iii) any successor entity of any Person referred to in clauses (i) or (ii); provided, however, that in no event shall any “portfolio company” (as such term is customarily used among private equity investors) of any Person or any entity controlled by any portfolio company of any Person constitute a “Permitted Transferee”. 
“Person” means any individual, corporation, limited liability company, limited or general partnership, joint venture, association, joint-stock company, trust, unincorporated organization, government or any agency or political subdivision thereof, or any other form of entity or any group comprised of two or more of the foregoing. 
“Preemptive Rights Excluded Issuance” means any issuance or sale of shares of Common Stock or Convertible 
Securities issued (i) directly or upon the exercise or vesting of options, restricted stock units or other equity awards to directors, officers, employees, consultants or agents of the Company in connection with their service as directors of the Company, their employment by the Company or their retention as consultants or agents by the Company, in each case authorized by the Company Board and issued pursuant to the Company's 2019 Equity and Incentive Plan or any other employee benefit plan, management incentive plan or compensation related arrangement or award adopted by the Company in the ordinary course and approved by the Company Board, (ii) pursuant to any stock purchase plan or stock ownership plan or similar plan or program approved by the Company Board, (iii) as consideration for any merger, consolidation, acquisition or similar transaction to which the Company or any of its subsidiaries is a party, including, without limitation, any “business combination” (as defined in the rules and regulations promulgated by the Securities and Exchange Commission) or otherwise as consideration for a bona fide acquisition of the securities or the assets, business unit, division or business of another Person, (iv) in connection with a bona fide strategic partnership or commercial arrangement with a Person that is not an Affiliate of the Company or any of its subsidiaries (other than (x) any such strategic partnership or commercial arrangement with a private equity firm, sovereign wealth fund, hedge fund or similar financial firm or sponsor or (y) an issuance the primary purpose of which is a bona fide capital raise), (v) to a third party financial institution as an “equity kicker” in connection with a bona fide borrowing by the Company that is primarily a debt financing transaction, (vi) to a Governmental Entity or designee thereof (in each case, excluding a sovereign wealth fund who regularly makes financial investments) in connection with a financing transaction pursuant to a program developed to address COVID-19 (including the impacts thereof), (vii) in connection with the conversion, exercise or exchange of any Convertible Securities outstanding on the date of this Agreement in accordance with the terms of such Convertible Securities as in effect on the date of this Agreement, and (viii) under a stockholders rights plan. 

6

“Preemptive Rights Portion” has the meaning ascribed to such term in Section ‎6.11‎(b) hereof.
“Preemptive Securities” has the meaning ascribed to such term in Section ‎6.11‎(a) hereof.
“Preferred Stock” means the preferred stock of the Company, par value $0.01 per share.
“Public Filings” means, collectively, (i) the Company’s annual report on Form 10-K for the year ended December 31, 2019 (including any information incorporated by reference therein), (ii) the Company’s quarterly report on Form 10-Q for the fiscal quarter ended March 31, 2020, (iii) the definitive proxy on Schedule 14A filed by the Company on April 22, 2020 and (iv) the Company’s current reports on Form 8-K filed from January 1, 2020 through the date of this Agreement. 
“Purchase Price” has the meaning ascribed to such term in Section ‎2.2 hereof. 
“Purchaser” has the meaning ascribed to such term in the preamble to this Agreement.
“Purchaser Material Adverse Effect” means any Effect that, individually or in the aggregate, would or would reasonably be expected to, prevent or materially delay (i) the consummation by the Purchaser of any of the Transactions or (ii) the compliance by the Purchaser with its obligations under this Agreement.
“Purchaser Parties” means the Purchaser and the Permitted Transferees of the Purchaser to whom Closing Date Securities or Underlying Securities are transferred in accordance with the terms hereof. 
“Registration Rights Agreement” has the meaning ascribed to such term in the Recitals to this Agreement. 
“Regulatory Event” has the meaning ascribed to such term in Section ‎6.5 hereof.
“Rule 312.03(b)” has the meaning ascribed to such term in Section ‎3.3.2 hereof.
“Sanctions” has the meaning ascribed to such term in Section ‎4.20‎(d) hereof.
“SEC” means the U.S. Securities and Exchange Commission, or any other U.S. federal agency at the time administering the Securities Act.
“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations of the SEC thereunder.
“Shares” means the Initial Shares together with the Underlying Securities.
“Solvent” has the meaning ascribed to such term in Section ‎4.23 hereof.
“Sponsor” means Warburg Pincus LLC.
“Sponsor Group” means the Sponsor and its subsidiaries and Affiliates. 
“subsidiary” means with respect to any Person and at any time, any entity at such time, directly or indirectly, (i) wholly or majority owned by such Person or any other subsidiary of such Person or (ii) Controlled by such Person or any other subsidiary of such Person.
 “Termination Time” means 11:59 P.M. (New York City time) on July 31, 2020. 
“Transfer” means to sell, transfer, assign, pledge, encumber, hypothecate or similarly dispose of, either voluntarily or involuntarily, or to enter into any contract, option or other arrangement or understanding with respect to the sale, transfer, assignment, pledge, encumbrance, hypothecation or similar disposition of, any shares of equity securities beneficially owned by a Person or any interest in any shares of equity securities beneficially owned by a Person; provided, however, that, notwithstanding anything to the contrary in this Agreement, “Transfer” shall not include (i) the conversion of one or more Notes into shares of Common Stock pursuant to the Indenture, (ii) the redemption or other acquisition of Closing Date Securities or Underlying Securities by the Company or (iii) the transfer of any 

7

limited partnership interests or other equity interests in a Purchaser Party (or any direct or indirect parent entity of such Purchaser Party) so long as following any such transfer the Purchaser Party is directly or indirectly controlled and managed by the Sponsor Group.
“Transaction Documents” means this Agreement, the Indenture, the Confidentiality Agreement, the Registration Rights Agreement, the Equity Commitment Letter and all other documents, certificates or agreements executed in connection with the transactions contemplated by this Agreement, the Indenture, the Registration Rights Agreement and the Equity Commitment Letter. 
“Transactions” has the meaning ascribed to such term in Section ‎2.1 hereof.
“Trustee” has the meaning ascribed to such term in the Indenture.
“Underlying Securities” has the meaning ascribed to such term in Section ‎2.3 hereof.
		
	1.2
	Interpretation. Except where otherwise expressly provided or unless the context otherwise necessarily requires, in this Agreement (including in the Recitals hereto):

		
	(a)
	Reference to a given Article, Section, Subsection, clause, or Exhibit is a reference to an Article, Section, Subsection, clause, or Exhibit of this Agreement.

		
	(b)
	The terms “hereof”, “herein”, “hereto”, “hereunder” and “herewith” refer to this Agreement as a whole.

		
	(c)
	Reference to a given agreement, instrument, document or law is a reference to that agreement, instrument, document or law as modified, amended, supplemented and restated through the date as of which such reference is made, and, as to any law, any successor law.

		
	(d)
	Reference to a person includes its predecessors, successors and permitted assigns.

		
	(e)
	The singular includes the plural and the masculine includes the feminine, and vice versa.

		
	(f)
	“Includes” or “including” means “including, for example and without limitation.”

		
	(g)
	References to “days” means calendar days.

		
	(h)
	Any item disclosed by a Party on any schedule to this Agreement shall be deemed to be disclosed and incorporated by reference into each other schedule to this Agreement delivered by such Party, as though fully set forth therein, in each case, to the extent its relevance to such other schedule is reasonably apparent on its face.

ARTICLE 2     
 
THE TRANSACTIONS
		
	2.1
	Sale and Purchase of the Initial Shares and the Notes. Subject to the terms and conditions hereof, at the Closing (i) the Company agrees to issue and sell to the Purchaser, and the Purchaser agrees to purchase and acquire $310,000,000 in aggregate original principal amount of Notes, at a purchase price of $299,150,000 in the aggregate for such Notes, (ii) the Company agrees to issue and sell to the Purchaser, and the Purchaser agrees to purchase and acquire, 577,254 shares of Common Stock, at a purchase price of $90,000,000 in the aggregate for such shares of Common Stock, and (iii) the Parties shall take or cause to be taken the other actions described in Section ‎3.2 (collectively, the “Transactions”). 

		
	2.2
	Payment of the Purchase Price. The aggregate amount payable by the Purchaser for the Closing Date Securities to be purchased by the Purchaser hereunder at the Closing is referred to herein as the “Purchase Price”. Promptly following the execution of this Agreement, the Company shall notify the Purchaser in 

8

writing of the account to which payment of the Purchase Price shall be made at the Closing. The Purchaser shall pay the Purchase Price in immediately available funds at the Closing in accordance with Section ‎3.2.2, subject to the satisfaction or waiver of the conditions to Closing contained herein.
		
	2.3
	Underlying Securities. The Notes will be convertible into shares of Common Stock, cash or a combination thereof on the terms and subject to the conditions set forth in the Indenture. The shares of Common Stock into which the Notes are convertible are referred to herein as the “Underlying Securities.” 

ARTICLE 3     
 
CLOSING AND CLOSING CONDITIONS
		
	3.1
	Time and Place of the Closing. Subject to the terms and conditions hereof, the closing of the Transactions contemplated by Section ‎2.1 (the “Closing”) shall take place at the offices of Wilmer Cutler Pickering Hale and Dorr LLP, at 10:00 A.M., New York time, on the second Business Day after fulfillment or waiver of the closing conditions, or at such other time on the same or such other date as the Company and the Purchaser mutually agree (the actual date of the Closing is referred to herein as the “Closing Date”); provided, without consent of the Purchaser, in its sole discretion, the Closing shall occur no earlier than July 2, 2020.

		
	3.2
	Actions at the Closing. At the Closing, the Company and the Purchaser shall take or cause to be taken the following actions (the “Closing Actions”):

		
	3.2.1
	Delivery of the Closing Date Securities. In exchange for the payment referenced in Section ‎3.2.2 below, the Company shall deliver to the Purchaser the Closing Date Securities to be purchased by the Purchaser hereunder.

		
	3.2.2
	Payment of Purchase Price. The Purchaser shall pay the Purchase Price to the Company by wire transfer in immediately available funds to the account provided to the Purchaser in writing prior to the Closing.

		
	3.2.3
	Additional Actions. The Parties shall execute and deliver, or cause to be executed and delivered, all other documents, and take such other actions, in each case as shall be necessary or appropriate, to consummate the Transactions contemplated hereby, all in accordance with the provisions of this Agreement.

		
	3.3
	Conditions Precedent to Obligations of the Purchaser. The obligation of the Purchaser to consummate the purchase of the Closing Date Securities to be purchased by the Purchaser at Closing shall be subject to satisfaction of each of the following conditions, any of which conditions may be waived by the Purchaser in its sole discretion: 

		
	3.3.1
	Opinion. The Company shall cause to be delivered to the Purchaser the opinion of Wilmer Cutler Pickering Hale and Dorr LLP, special counsel for the Company, dated as of the Closing Date, substantially in the form set forth as Exhibit C to this Agreement.

		
	3.3.2
	NYSE Supplemental Listing of Underlying Securities. The sale by the Company of the Closing Date Securities to the Purchaser and the purchase of the Closing Date Securities by the Purchaser shall comply with Section 312.03(b) of the NYSE Listed Company Manual (“Rule 312.03(b)”), as a result of the effectiveness of the NYSE’s waiver of the application of Rule 312.03(b) or otherwise.

		
	3.3.3
	Indenture. The Purchaser shall have received an executed original copy of the Indenture duly executed by the Company and the Trustee.

		
	3.3.4
	Registration Rights Agreement. The Purchaser shall have received an executed original copy of the Registration Rights Agreement duly executed by the Company.

9

		
	3.3.5
	Good Standing Certificate. The Company shall cause to be delivered to the Purchaser a certificate of the Secretary of State of the State of Delaware, dated not more than three Business Days prior to the Closing Date, to the effect that the Company is validly existing and in good standing under the laws of the State of Delaware.

		
	3.3.6
	Secretary’s Certificate. The Company shall cause to be delivered to the Purchaser a certificate of the Secretary or Assistant Secretary of the Company, certifying as to (1) the Company’s charter documents and By-Laws, (2) Company Board resolutions authorizing and approving the Transaction Documents and the issuance of the Closing Date Securities and the Underlying Securities, and (3) the incumbency of the officer authorized to execute this Agreement, the Indenture, the Registration Rights Agreement and the certificates evidencing the Closing Date Securities and the Underlying Securities, setting forth the name and title and bearing the signatures of such officer. 

		
	3.3.7
	Performance of Closing Actions. The Company shall have performed in all material respects all of the covenants and agreements required to be performed by it at or before the Closing, under this Agreement and the Indenture.

		
	3.3.8
	Listing. The NYSE shall have approved the listing of the Underlying Securities, subject to official notice of issuance.

		
	3.3.9
	Representations and Warranties. The representations and warranties of the Company (i) set forth in Sections ‎4.1, ‎4.2, ‎4.10(b) and ‎4.12(a) shall be true and correct in all respects as of the date of this Agreement and as of the Closing Date with the same effect as though made on and as of such date (except to the extent expressly made as of an earlier date, in which case as of such earlier date), (ii) set forth in Sections ‎4.4, ‎4.6, ‎4.7, ‎4.8, ‎4.9, ‎4.13, ‎4.17(a), ‎4.22, and ‎4.23 shall be true and correct (disregarding all qualifications or limitations as to “materiality”, “Material Adverse Effect” and words of similar import set forth therein) in all material respects as of the date of this Agreement and as of the Closing Date with the same effect as though made on and as of such date (except to the extent expressly made as of an earlier date, in which case as of such earlier date) and (iii) set forth in Article 4, other than in the Sections specified in clauses (i) or (ii) of this Section ‎3.3.9, shall be true and correct (disregarding all qualifications or limitations as to “materiality”, “Material Adverse Effect” and words of similar import set forth therein) as of the date of this Agreement and as of the Closing Date with the same effect as though made on and as of such date (except to the extent expressly made as of an earlier date, in which case as of such earlier date), except, in the case of this clause (iii), where the failure to be true and correct has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.

		
	3.3.10
	Certificate. The Purchaser shall have received a certificate, signed on behalf of the Company by a duly authorized officer thereof, certifying that the conditions set forth in Sections ‎3.3.7 and ‎3.3.9 have been satisfied.

		
	3.3.11
	Board Designee.  James C. Neary shall be a member of the Company Board.

		
	3.3.12
	No Adverse Order. There shall be no injunction of any nature of any Governmental Entity of competent jurisdiction or any Law that is in effect that restrains, prohibits or prevents the consummation of the Transactions contemplated hereby, that directs that the Transactions contemplated hereby not be consummated, or which has the effect of rendering it unlawful to consummate the Transactions contemplated hereby.

		
	3.4
	Conditions Precedent to Obligations of the Company. The obligation of the Company to issue the Closing Date Securities to the Purchaser at the Closing shall be subject to satisfaction of each of the following conditions any of which conditions may be waived by the Company in its sole discretion:

10

		
	3.4.1
	NYSE Supplemental Listing of Underlying Securities. The sale by the Company of the Closing Date Securities to the Purchaser and the purchase of the Closing Date Securities by the Purchaser shall comply with Section 312.03(b) of the NYSE Listed Company Manual (“Rule 312.03(b)”), as a result of the effectiveness of the NYSE’s waiver of the application of Rule 312.03(b) or otherwise.

		
	3.4.2
	Registration Rights Agreement. The Company shall have received an executed original copy of the Registration Rights Agreement duly executed by the Purchaser.

		
	3.4.3
	Performance of Closing Actions. The Purchaser shall have performed in all material respects all the covenants and agreements required to be performed by it at or before Closing under this Agreement.

		
	3.4.4
	Withholding Certificates. The Purchaser shall at the Closing, and subsequently as requested by the Company, provide to the Company a duly completed and valid IRS Form W-9 or W-8 (of the type applicable to the Purchaser), as applicable, executed in its name or, if the Purchaser is a single-member entity that is disregarded for U.S. federal income tax purposes, the name of its single owner.

		
	3.4.5
	Representations and Warranties. The representations and warranties of the Purchaser set forth in ‎Article 5 of this Agreement shall be true and correct in all material respects as of the date of this Agreement and as of the Closing Date, as applicable, with the same effect as though made on and as of such date (except to the extent expressly made as of an earlier date, in which case as of such earlier date).

		
	3.4.6
	No Adverse Order. There shall be no injunction of any nature of any governmental authority of competent jurisdiction or any Law that is in effect that explicitly restrains, prohibits or prevents the consummation of the Transactions contemplated hereby, that directs that the Transactions contemplated hereby not be consummated, or which has the effect of rendering it unlawful to consummate the Transactions contemplated hereby.

		
	3.4.7
	Certificate. The Company shall have received a certificate, signed on behalf of the Purchaser by a duly authorized officer thereof, certifying that the conditions set forth in Section ‎3.4.3 and Section ‎3.4.5 have been satisfied.

ARTICLE 4 
 
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
Except as disclosed (i) in any disclosure schedules delivered by the Company to the Purchaser in connection with the execution of this Agreement or (ii) with respect to the representations and warranties other than those set forth in Sections ‎4.1, ‎4.2, ‎4.4, ‎4.6, ‎4.7, ‎4.8, ‎4.9, ‎4.15 and ‎4.16(b) in the Company SEC Documents (excluding in each case any disclosures set forth in the risk factors or “forward-looking statements” sections of such filings, and any other disclosures included therein to the extent they are predictive or forward-looking in nature), the Company hereby represents and warrants to the Purchaser that: 
		
	4.1
	No Registration Required; Rule 144A Eligibility. Subject to the accuracy in all material respects of the representations and warranties set forth in ‎Article 5 hereof, it is not necessary in connection with the offer, sale, issuance and delivery of the Closing Date Securities and Underlying Securities to the Purchaser in the manner contemplated by this Agreement to register the Closing Date Securities and Underlying Securities under the Securities Act. The Notes satisfy the eligibility requirements of Rule 144A(d)(3) under the Securities Act.  The Company is subject to the reporting requirements of Section 13(a) of the Exchange Act.

11

		
	4.2
	No Integration of Offerings or General Solicitation. None of the Company, its Affiliates or, to the knowledge of the Company, any Person acting on its or any of their behalf has, directly or indirectly, sold, solicited any offer to buy or offered to sell, or will, directly or indirectly, sell, solicit any offer to buy or offer to sell, any security (as defined in the Securities Act) which is or would be integrated with the offering and sale of the Closing Date Securities in a manner that would require the Closing Date Securities to be registered under the Securities Act. None of the Company, its Affiliates, or any Person acting on its or any of their behalf has engaged or will engage, in connection with the offering of the Closing Date Securities, in any form of general solicitation or general advertising within the meaning of Rule 502 under the Securities Act.

		
	4.3
	Company SEC Documents; Undisclosed Liabilities. 

		
	(a)
	The Company has filed with the SEC, on a timely basis, all required reports, schedules, forms, statements and other documents required to be filed by the Company with the SEC pursuant to the Exchange Act since January 1, 2018 (collectively, and including the Public Filings, the “Company SEC Documents”). As of their respective SEC filing dates, the Company SEC Documents complied in all material respects with the requirements of the Securities Act, the Exchange Act and/or the Sarbanes-Oxley Act of 2002 (and the regulations promulgated thereunder), as the case may be, applicable to such Company SEC Documents, and none of the Company SEC Documents as of such respective dates (or, if amended prior to the date of this Agreement, the date of the filing of such amendment, with respect to the disclosures that are amended) contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.

		
	(b)
	The consolidated financial statements of the Company and its subsidiaries (including all related notes or schedules) included or incorporated by reference in the Company SEC Documents complied as to form, as of their respective dates of filing with the SEC, in all material respects with the published rules and regulations of the SEC with respect thereto, have been prepared in accordance with GAAP (except, in the case of unaudited quarterly statements, as permitted by Form 10-Q of the SEC or other rules and regulations of the SEC) applied on a consistent basis during the periods involved (except (i) as may be indicated in the notes thereto or (ii) as permitted by Regulation S-X) and present fairly, in all material respects, the consolidated financial position of the Company and its consolidated subsidiaries as of the dates thereof and the consolidated results of their operations and cash flows for the periods shown (subject, in the case of unaudited quarterly financial statements, to normal year-end adjustments).

		
	(c)
	Neither the Company nor any of its subsidiaries has any liabilities of any nature (whether accrued, absolute, contingent or otherwise) that would be required under GAAP, as in effect on the date hereof, to be reflected on a consolidated balance sheet of the Company (including the notes thereto) except liabilities (i) reflected or reserved against in the balance sheet (or the notes thereto) of the Company and its subsidiaries as of March 31, 2020 (the “Balance Sheet Date”) included in the Public Filings, (ii) incurred after the Balance Sheet Date in the ordinary course of business and that do not arise from any material breach of a material contract, (iii) incurred in connection with the Transactions in accordance with the terms hereof, (iv) that have been discharged or paid prior to the date of this Agreement or (v) that have not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.

		
	(d)
	The Company has established and maintains, and at all times since January 1, 2018 has maintained, disclosure controls and procedures and a system of internal controls over financial reporting (as such terms are defined in paragraphs (e) and (f), respectively, of Rule 13a-15 under the Exchange Act) as required by Rule 13a-15 under the Exchange Act relating to the Company and its consolidated subsidiaries. There are no “material weaknesses” (as defined by the Public Company Accounting Oversight Board) in the design or operation of the Company’s internal controls over, and procedures relating to, financial reporting which would reasonably be expected to adversely affect in any material respect the Company’s ability to record, process, summarize and report financial data, in each case which has not been subsequently remediated. To the knowledge of the Company, since January 1, 2018, there has not been any fraud, whether or not material, that involves management or other employees of the Company or any of its subsidiaries who have 

12

a significant role in the Company’s internal controls over financial reporting. As of the date of this Agreement, to the knowledge of the Company, there is no reason that its outside auditors and its chief executive officer and chief financial officer will not be able to give the certifications and attestations required pursuant to the rules and regulations adopted pursuant to Section 404 of the Sarbanes- Oxley Act of 2002, without qualification, when next due. Since March 31, 2020, there has been no material change in the Company’s internal control over financial reporting.
		
	4.4
	Authorization; The Purchase Agreement. The execution, delivery and performance of this Agreement and the Transactions Documents and the consummation of the Transactions by the Company have been duly authorized by all requisite action by the Company under the Certificate of Incorporation and By-Laws of the Company and all applicable Law. This Agreement has been duly authorized, executed and delivered by the Company, and, assuming due authorization, execution and delivery by the Purchaser, is a valid and binding agreement of the Company, enforceable against the Company in accordance with its terms, except as the enforcement thereof may be limited by bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other similar Laws relating to or affecting the rights and remedies of creditors or by general equitable principles. 

		
	4.5
	Use of Proceeds. The Company shall use the proceeds from the offer and sale of the Closing Date Securities to pay fees and expenses associated with the offering of the Closing Date Securities and Underlying Securities and for working capital and general corporate purposes.

		
	4.6
	The Notes. The Notes have been duly authorized, and, at the Closing Date, will have been duly executed and delivered by the Company, and, assuming due authorization, execution and delivery by the Trustee, will be valid and binding obligations of the Company, enforceable against the Company in accordance with their terms, except as the enforcement thereof may be limited by bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other similar Laws relating to or affecting the rights and remedies of creditors or by general equitable principles.

		
	4.7
	The Indenture.  The Indenture has been duly authorized by the Company, and at the Closing Date, will have been duly executed and delivered by the Company, and, assuming due authorization, execution and delivery by the Trustee, will be a valid and binding agreement of the Company, enforceable against the Company in accordance with its terms, except as the enforcement thereof may be limited by bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other similar Laws relating to or affecting the rights and remedies of creditors or by general equitable principles. After giving effect to transactions contemplated by the Transaction Documents, the Purchaser Parties will not be Affiliates (as defined in the Indenture) of the Company.

		
	4.8
	Registration Rights Agreement; Registration Rights. The Registration Rights Agreement has been duly authorized by the Company and at the Closing Date, will have been duly executed and delivered by the Company, and, assuming due authorization, execution and delivery by the Purchaser, will be a valid and binding agreement of the Company, enforceable against the Company in accordance with its terms, except as the enforcement thereof may be limited by bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other similar Laws relating to or affecting the rights and remedies of creditors or by general equitable principles and except as rights to indemnification under the Registration Rights Agreement may be limited by applicable Law. 

		
	4.9
	The Initial Shares and the Underlying Securities. The Initial Shares and the Underlying Securities (after giving effect to the maximum possible principal amount) have been duly and validly authorized and reserved for issuance and, when issued and delivered in accordance with the provisions of this Agreement or the Indenture, as the case may be, will be duly and validly issued and fully paid and non-assessable, and the issuance of such shares of Common Stock will not be subject to any preemptive rights. The issuance of the Initial Shares and the Underlying Securities do not require any vote or other action or approval of the holders of any capital stock of or other equity interests in the Company under applicable Law or the Certificate of Incorporation or By-Laws of the Company.

13

		
	4.10
	Absence of Certain Changes. 

		
	(a) 
	Since March 31, 2020, except for the execution and performance of this Agreement and any other agreements contemplated hereby and the discussions, negotiations and transactions related hereto, the business of the Company and its subsidiaries has been carried on and conducted in all material respects in the ordinary course of business. 

		
	(b) 
	Since December 31, 2019, there has not been any Material Adverse Effect or any Effect that would, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

		
	4.11
	Absence of Litigation or Adverse Matters. As of the date of this Agreement, there (i) is no proceeding before or by any Governmental Entity or any other Person, pending, or to the Company’s knowledge, threatened or contemplated by any Governmental Entity or any other Person, against or affecting the Company or any of its subsidiaries or any of their respective businesses or assets, (ii) is no outstanding judgment against or affecting the Company or any of its subsidiaries or any of their respective businesses or assets, and (iii) has been no breach by the Company or any of its subsidiaries of any material contract, in each case that has had or would be reasonably likely to have a Material Adverse Effect.

		
	4.12
	Incorporation and Good Standing of the Company and each of its Subsidiaries. The Company (a) has been duly incorporated and is validly existing as a corporation in good standing under the Laws of the State of Delaware, with power and authority to own its properties and conduct its business as described in the Public Filings, and (b) has been duly qualified as a foreign corporation for the transaction of business and is in good standing under the Laws of each other jurisdiction in which it owns or leases properties or conducts any business so as to require such qualification, except, in the case of this clause (b), to the extent that failure to be so qualified has not had and would not reasonably be expected to have a Material Adverse Effect. Each subsidiary of the Company has been duly incorporated or formed and is validly existing as a corporation or limited liability company in good standing under the Laws of its jurisdiction of incorporation, with power and authority (corporate and other) to own its properties and conduct its business as described in the Public Filings, except to the extent that failure to be in good standing has not had and would not reasonably be expected to have a Material Adverse Effect.

		
	4.13
	Capitalization

		
	(a)
	The authorized capital stock of the Company consists of 175,000,000 shares of Common Stock and 10,000,000 shares of Preferred Stock. At the close of business on June 20, 2020 (the “Capitalization Date”), (i) 43,520,379 shares of Common Stock were issued and outstanding, (ii) 427,764 Company RSUs were outstanding, (iii) 464,363 Company PBRSUs were outstanding, (iv) 1,122,736 shares of Common Stock were subject to outstanding Company Stock Options, (v) 69,452 shares of Common Stock were subject to outstanding Company DSUs and (vi) no shares of Preferred Stock were issued or outstanding.

		
	(b)
	Except as described in this Section ‎4.13, there are (i) no outstanding shares of capital stock of, or other equity or voting interests of any character in, the Company as of the date hereof other than shares that have become outstanding after the Capitalization Date which were reserved for issuance as of the Capitalization Date as contemplated by Section ‎4.13‎(a), (ii) no outstanding securities of the Company convertible into or exercisable or exchangeable for shares of capital stock of, or other equity or voting interests of any character in, the Company, (iii) no outstanding obligations, options, warrants, rights, pledges, calls, puts, phantom equity, preemptive rights, or other rights, commitments, agreements or arrangements of any character to acquire from the Company, or that obligate the Company to issue, any capital stock of, or other equity or voting interests (or voting debt) in, or any securities convertible into or exercisable or exchangeable for shares of capital stock of, or other equity or voting interests (or voting debt) in, the Company other than obligations under the Company Stock Plans in the ordinary course of business, (iv) no obligations of the Company to grant, extend or enter into any subscription, warrant, right, convertible or exchangeable security or other similar agreement or commitment relating to any capital stock of, or other equity or voting interests (or voting debt) in, the Company (the items in clauses (i), (ii), (iii) and (iv) being referred to collectively as “Company Securities”) and (v) no 

14

outstanding agreements of any kind which obligate the Company or any of its subsidiaries to repurchase, redeem or otherwise acquire any Company Securities (other than pursuant to the cashless exercise of Company Stock Options or the forfeiture or withholding of taxes with respect to Company RSUs, Company PBRSUs, Company Stock Options or Company DSUs), or obligate the Company to grant, extend or enter into any such agreements relating to any Company Securities, including any agreements granting any preemptive rights, subscription rights, anti-dilutive rights, rights of first refusal or similar rights with respect to any Company Securities. Except as disclosed in Public Filings, none of the Company or any subsidiary of the Company is a party to any stockholders’ agreement, voting trust agreement, registration rights agreement or other similar agreement or understanding relating to any Company Securities or any other agreement relating to the disposition, voting or dividends with respect to any Company Securities. All outstanding shares of Common Stock have been duly authorized and validly issued and are fully paid, nonassessable and were not issued in violation of any purchase option, call option, right of first refusal, subscription right, preemptive or similar rights of a third Person, the Company Certificate of Incorporation, By-Laws or any agreement to which the Company is a party. All of the outstanding shares of capital stock or equity interests of the Company’s subsidiaries have been duly authorized, validly issued, fully paid and non-assessable and none of such capital stock or equity interests are subject to or were issued in violation of any applicable Laws and are not subject to and have not been issued in violation of any stockholders agreement, or any preemptive rights, rights of first refusal or similar rights of any Person, except as would not reasonably be expected to be material to the Company and its subsidiaries, taken as a whole. 
		
	4.14
	Certain Material Indebtedness. Neither the Company nor any of its subsidiaries is, as of the date of this Agreement, in default in the payment of any material indebtedness for borrowed money or in default in any material respect under any agreement relating to its material indebtedness for borrowed money.

		
	4.15
	No Manipulation. Prior to the date hereof, neither the Company nor any of its Affiliates has taken any action which is designed to or which has constituted or which would reasonably be expected to cause or result, under the Exchange Act or otherwise, in stabilization or manipulation of the price of any security of the Company in connection with the offering of the Closing Date Securities (including the issuance of the Underlying Securities upon conversion thereof).

		
	4.16
	Non-Contravention of Existing Instruments; No Further Authorizations or Approvals Required. The issue and sale of the Closing Date Securities and the issuance of the Underlying Securities upon conversion thereof, the execution, delivery and compliance by the Company with all of the provisions of the Notes, the Indenture and this Agreement and the consummation of the transactions herein and therein contemplated (a) will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement, lease or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company or any of its subsidiaries is subject, (b) will not violate (1) the provisions of the Certificate of Incorporation or By-Laws of the Company or similar organizational documents of any of its subsidiaries or (2) any applicable Law, except, in the case of (a) or (b)(1) above, for conflicts, breaches or violations that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect or a material effect on the Company’s ability to consummate the Transactions in a timely manner. No consent, approval, authorization, order, registration or qualification of or with any Governmental Entity is required for the issue and sale of the Closing Date Securities, including the issuance of the Underlying Securities upon conversion thereof or the consummation by the Company of the Transactions as contemplated by this Agreement, the Indenture or the Closing Date Securities, except such consents, approvals, authorizations, orders, registrations or qualifications whose failure to be obtained would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect or a material effect on the Company’s ability to consummate the Transactions in a timely manner or as may be required under (i) state securities or ”blue sky” Laws in connection with the purchase and distribution of the Closing Date Securities (including the issuance of the Underlying Securities upon conversion of the Notes) by the Purchaser, (ii) the HSR Act with respect to the 

15

issuance of the Underlying Securities upon conversion of the Notes by the Purchaser or (iii) the NYSE approval of the Supplemental Listing Application in connection with the listing of the Underlying Securities. 
		
	4.17
	No Violation. Neither the Company nor any of its subsidiaries is (a) in violation of its Certificate of Incorporation or By-Laws or similar organizational documents or (b) in default in the performance or observance of any material obligation, agreement, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement, lease or other agreement or instrument to which it is a party or by which it or any of its properties may be bound, except, in the case of (b), for such defaults as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect or a material effect on the Company’s ability to consummate the Transactions in a timely manner.

		
	4.18
	Company is Not an “Investment Company”. The Company is not and, after giving effect to the transactions contemplated by the offering and sale of the Closing Date Securities (including the issuance of the Underlying Securities upon conversion thereof) and the application of the proceeds thereof, will not be, an “investment company”, as such term is defined in the Investment Company Act of 1940, as amended (the “Investment Company Act”).

		
	4.19
	Independent Accountants. Deloitte & Touche LLP, who has certified certain financial statements of the Company and its subsidiaries, is an independent public accountant as required by the Act and the rules and regulations of the SEC thereunder.

		
	4.20
	Compliance with Applicable Laws; Permits

		
	(a)
	The Company and each of its subsidiaries are, and since January 1, 2018 have been, in compliance with all Laws, in each case, that are applicable to the Company or any of its subsidiaries, except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company and each of its subsidiaries hold all licenses, franchises, permits, certificates, approvals and authorizations from Governmental Entities necessary for the lawful conduct of their respective businesses, except where the failure to hold the same would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

		
	(b)
	The Company, each of its subsidiaries, and each of their respective officers, directors, employees and, to the Company’s knowledge, agents acting on their behalf is, and for the last five (5) years has been, in compliance in all material respects with (i) the Foreign Corrupt Practices Act of 1977 and any rules and regulations promulgated thereunder, (ii) the United Kingdom Bribery Act, (iii) anti-bribery legislation promulgated by the European Union and implemented by its member states, (iv) legislation adopted in furtherance of the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions and (v) any other Laws applicable to the Company and its subsidiaries that address the prevention of corruption, bribery or terrorism (collectively, the “Anti-Corruption Laws”). None of the Company, any of its subsidiaries or any director, officer, or, to the Company’s knowledge, any agent, employee, or other Person associated with or acting on behalf of the Company or its subsidiaries within the last five (5) years has offered, promised, provided, or authorized the provision of any money or other thing of value, directly or indirectly, to any Person to improperly influence official action or secure an improper advantage, or to encourage the recipient to breach a duty of good faith or loyalty or the policies of his/her employer in any material respect, nor has violated or is in violation of any provision of any Anti-Corruption Laws in any material respect.

		
	(c)
	The Company, each of its subsidiaries, and, to the Company’s knowledge, each of their respective officers, directors, employees agents acting on their behalf is, and for the last five (5) years has been, in compliance in all material respects with Export Control Laws. 

		
	(d)
	The Company, each of its subsidiaries, and each of their officers, directors, employees and, to the Company’s knowledge, agents acting on their behalf is, and, for the last five (5) years has been, in 

16

compliance in all material respects with all sanctions Laws or other financial restrictions administered by (i) the United States (including without limitation the Office of Foreign Assets Control of the United States Treasury Department (“OFAC”), including OFAC’s Specially Designated Nationals and Blocked Persons List, and the U.S. Department of State), (ii) the European Union and enforced by its member states, (iii) the United Nations, (iv) Her Majesty’s Treasury or (v) other similar Governmental Entities with regulatory authority over the Company, its subsidiaries and their respective operations from time to time (collectively, “Sanctions”). None of the Company, any of its subsidiaries, or any director, officer, or to the Company’s knowledge, agent, or employee of the Company or any of its subsidiaries is currently the subject or the target of any Sanctions, nor is the Company or any of its subsidiaries (x) located, organized or resident in a country or territory that is the subject or target of Sanctions, including, without limitation, Cuba, Iran, North Korea, Syria and Crimea, or (y) majority-owned or controlled by a Person that is the subject of Sanctions.
		
	(e)
	To the Company’s knowledge, the Company and its subsidiaries have not engaged in, nor are now engaged in, any dealings or transactions with or for the benefit of any Person located, organized, or ordinarily resident in Cuba, Iran, North Korea, Sudan, Syria, or Crimea, in each case directly or indirectly, including through agents or other Persons acting on its behalf.

		
	(f)
	To the Company’s knowledge, the operations of the Company and its subsidiaries are and have been conducted at all times in the past five (5) years in compliance in all material respects with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the applicable money laundering statutes of all jurisdictions where the Company and its subsidiaries conduct business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the “Money Laundering Laws”).

		
	(g)
	The Company and its subsidiaries will not use the proceeds from the Transactions (i) in furtherance of an offer, payment, promise to pay or authorization of the payment or giving of money or anything else of value, to any Person in violation of any Anti-Corruption Laws, or (ii) to fund or facilitate any activities of or business with any Person, or in any country or territory, that, at the time of such funding, is the subject or the target of Sanctions.

		
	(h)
	The Company and its subsidiaries have complied, and are presently in compliance, with their privacy policies, their other third-party obligations and all applicable Laws regarding the collection, use, transfer, storage, protection, disposal and disclosure by the Company and its subsidiaries of personally identifiable information, except where the failure to have complied or be in compliance would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

		
	4.21
	Tax Compliance. Except as described in the Public Filings, the Company and each of its subsidiaries have filed all federal, state, local and foreign tax returns required to be filed through the date of this Agreement or have requested extensions thereof (except where the failure to file would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect) and have paid all taxes required to be paid thereon (except for cases in which the failure to file or pay would not have a Material Adverse Effect, or except as currently being contested in good faith and for which reserves, if required by GAAP, have been created in the financial statements of the Company) and no tax deficiency has been determined adversely to the Company or any of its subsidiaries which remains unpaid and has had (nor does the Company or any of its subsidiaries have any notice or knowledge of any tax deficiency which remains unpaid and could reasonably be expected to be determined adversely to the Company or its subsidiaries and which could reasonably be expected to have), individually or in the aggregate, a Material Adverse Effect.

		
	4.22
	Brokers. Except for BofA Securities, Inc., there is no broker, finder or other party that is entitled to receive from the Company any brokerage or finder’s fee or other fee or commission as a result of any transactions contemplated by this Agreement.

17

		
	4.23
	Solvency. The Company is, and immediately after the Closing Date will be, Solvent. As used herein, the term “Solvent” means, with respect to any Person on a particular date, that on such date (i) the fair market value of the assets of such Person is greater than the total amount of liabilities (including contingent liabilities) of such Person, (ii) the present fair salable value of the assets of such Person is greater than the amount that will be required to pay the probable liabilities of such Person on its debts as they become absolute and matured, (iii) such Person is able to realize upon its assets and pay its debts and other liabilities, including contingent obligations, as they mature and (iv) such Person does not have unreasonably small capital. 

		
	4.24
	No Other Company Representations or Warranties. Except for the representations and warranties made by the Company in this ‎Article 4 and in any certificate or other document delivered in connection with any Transaction Document, neither the Company nor any other Person acting on its behalf makes any other express or implied representation or warranty with respect to the Company or any of its subsidiaries or their respective businesses, operations, properties, assets, liabilities, condition (financial or otherwise) or prospects, notwithstanding the delivery or disclosure to the Purchaser or its representatives of any documentation, forecasts or other information with respect to any one or more of the foregoing, and the Purchaser acknowledges the foregoing. In particular, and without limiting the generality of the foregoing, except for the representations and warranties made by the Company in this ‎Article 4 and in any certificate or other document delivered in connection with any Transaction Document, neither the Company nor any other Person makes or has made any express or implied representation or warranty to the Purchaser or its representatives with respect to (a) any financial projection, forecast, estimate, budget or prospect information relating to the Company, any of its subsidiaries or their respective businesses or (b) any oral or written information presented to the Purchaser or its representatives in the course of its due diligence investigation of the Company, the negotiation of this Agreement or the course of the Transactions or any other transactions or potential transactions involving the Company and the Purchaser.

		
	4.25
	No Other Investor Representations or Warranties. Except for the representations and warranties expressly set forth in ‎Article 5 and in any certificate or other document delivered in connection with any Transaction Document, the Company hereby acknowledges that neither the Purchaser nor any other Person, has made or is making any other express or implied representation or warranty with respect to the Purchaser or any of its subsidiaries or their respective businesses, operations, assets, liabilities, condition (financial or otherwise) or prospects, including with respect to any information provided or made available to the Company or any of its representatives or any information developed by the Company or any of its representatives.

ARTICLE 5 
 
REPRESENTATIONS AND WARRANTIES OF THE PURCHASER
The Purchaser hereby represents and warrants to the Company that:
		
	5.1
	Organization, Authority and Power. The Purchaser is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization and has the requisite power and authority to enter into this Agreement, to consummate each of the transactions and undertakings contemplated hereby, and to perform all the terms and conditions hereof to be performed by it. The execution, delivery and performance of this Agreement and the Registration Rights Agreement and consummation of each of the transactions and undertakings contemplated hereby and thereby have been duly authorized by all requisite action on its part under the Purchaser’s constituent or governing documents and applicable Law.

		
	5.2
	Valid and Binding Obligations. This Agreement has been, and the Registration Rights Agreement will be, duly and validly executed and delivered, and, assuming due authorization, execution and delivery by the Company, this Agreement is, and the Registration Rights Agreement will be, enforceable against the Purchaser in accordance with the terms thereof except as the enforcement thereof may be limited by bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other similar Laws relating to or affecting the rights and remedies of creditors or by general equitable principles.

18

		
	5.3
	Securities Law Matters. The Purchaser hereby acknowledges that the offer and sale of the Closing Date Securities to the Purchaser are being made as a private placement pursuant to Section 4(a)(2) of the Securities Act and are not being registered under the Securities Act. The Purchaser hereby acknowledges that neither the offer and sale of the Closing Date Securities nor the offer and sale of the Underlying Securities have been registered under the Securities Act, or registered or qualified under any state securities laws, and the Closing Date Securities and the Underlying Securities cannot be resold without registration thereunder or exemption therefrom. The Purchaser is an “accredited investor,” as such term is defined in Rule 501(a)(1), (2), (3) or (7) of Regulation D under the Securities Act, and will acquire the Closing Date Securities and Underlying Securities for its own account, not as a nominee or agent, and not with a view to a sale or distribution thereof in violation of the Securities Act, any applicable state “blue sky” Laws or any other applicable securities laws, and the Purchaser has no present intention of selling, granting any participation in, or otherwise distributing the Closing Date Securities or the Underlying Securities in violation of securities Laws. The Purchaser has sufficient knowledge and experience in financial and business matters to enable it to evaluate the risks of investment in the Closing Date Securities and Underlying Securities, is purchasing the Closing Date Securities with a full understanding of all of the terms, conditions and risks thereof, and at the Closing will bear and have the ability to bear the economic risk of this investment for an indefinite period of time, including, but not limited to, loss of the Purchaser’s entire investment therein. The Purchaser has carefully reviewed any disclosure documents used in the offering of the Closing Date Securities and has been furnished with all other materials that it considers relevant to an investment in the Closing Date Securities, has had a full opportunity to ask questions of and receive answers from the Company or any Person or Persons acting on behalf of the Company concerning the terms and conditions of an investment in the Closing Date Securities. The Purchaser understands and agrees to the terms and conditions under which the Closing Date Securities and the Underlying Securities are being offered.

		
	5.4
	Financing. The Equity Investors have delivered to the Company true and complete copies of the Equity Commitment Letter, pursuant to which the Equity Investors have committed, subject to the terms and conditions thereof, to invest the amounts set forth therein in Purchaser and which Equity Commitment Letter provides that the Company is a third-party beneficiary thereof to the extent specified therein. As of the date of this Agreement, the Equity Commitment Letter is in full force and effect and constitutes the enforceable, legal, valid and binding obligations of each of the parties thereto. At the Closing, assuming receipt of the funds under the Equity Commitment Letter, the Purchaser will have available funds necessary to consummate the Transactions and pay the Purchase Price on the terms and conditions contemplated by this Agreement. As of the date of this Agreement, the Purchaser is not aware of any reason why funds sufficient to pay the Purchase Price will not be available on the Closing Date.

		
	5.5
	Non-Contravention of Existing Instruments; No Further Authorizations or Approvals Required. The issue and sale of the Closing Date Securities and the issuance of the Underlying Securities upon conversion thereof, the execution, delivery and compliance by the Purchaser with all of the provisions of the Notes, the Indenture and this Agreement and the consummation of the transactions herein and therein contemplated (a) will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement, lease or other agreement or instrument to which the Purchaser or any of its subsidiaries is a party or by which the Purchaser or any of its subsidiaries is bound or to which any of the property or assets of the Purchaser is subject, (b) will not violate (1) the provisions of the organizational documents of the Purchaser or (2) any applicable Law, except, in the case of (a) or (b)(1) above, for conflicts, breaches or violations that would not, individually or in the aggregate, reasonably be expected to have a Purchaser Material Adverse Effect. No consent, approval, authorization, order, registration or qualification of or with any Governmental Entity is required for the issue and sale of the Closing Date Securities, including the issuance of the Underlying Securities upon conversion thereof or the consummation by the Purchaser of the Transactions as contemplated by this Agreement, the Indenture or the Closing Date Securities, except such consents, approvals, authorizations, orders, registrations or qualifications whose failure to be obtained would not, individually or in the aggregate, reasonably be expected to have a Purchaser Material Adverse Effect or as may be required under (i) state securities or ”blue sky” Laws in connection with the purchase and distribution of the Closing Date 

19

Securities (including the issuance of the Underlying Securities upon conversion of the Notes) by the Purchaser or (ii) the HSR Act with respect to the issuance of the Underlying Securities upon conversion of the Notes by the Purchaser.  No HSR clearance or approval is required to be obtained by the Purchaser in connection with its acquisition of the Notes at the Closing.
		
	5.6
	Brokers.  No broker, investment banker, financial advisor or other Person is entitled to any broker’s, finder’s, financial advisor’s or other similar fee or commission, or the reimbursement of expenses in connection therewith, in connection with the Transactions based upon arrangements made by or on behalf of the Purchaser, the Purchaser Parties or any of their respective subsidiaries, except for Persons, if any, whose fees and expenses will be paid by the Purchaser.

		
	5.7
	Non-Reliance on Company Estimates, Projections, Forecasts, Forward-Looking Statements and Business Plans. In connection with the due diligence investigation of the Company by the Purchaser, the Purchaser Parties and their representatives, the Purchaser, the Purchaser Parties and their representatives have received and may continue to receive from the Company and its representatives certain estimates, projections, forecasts and other forward-looking information, as well as certain business plan information containing such information, regarding the Company and its Subsidiaries and their businesses and operations.  The Purchaser hereby acknowledges that there are uncertainties inherent in attempting to make such estimates, projections, forecasts and other forward-looking statements, as well as in such business plans, with which the Purchaser is familiar, that the Purchaser is making its own evaluation of the adequacy and accuracy of all estimates, projections, forecasts and other forward-looking information, as well as such business plans, so furnished to the Purchaser (including the reasonableness of the assumptions underlying such estimates, projections, forecasts, forward-looking information or business plans), and that the Company makes no representations or warranties with respect to any such information. For the avoidance of doubt, nothing set forth in this Section ‎5.7 shall be construed to limit any of the representations and warranties expressly set forth in Article 4 hereof.

		
	5.8
	Ownership of Company Securities.  As of the date hereof and immediately prior to the Closing, none of the Purchaser nor any funds advised by the Sponsor owns any Common Stock or Convertible Securities. 

		
	5.9
	Bank Holding Company Status.  Assuming the accuracy of the representations made by the Company in Section ‎4.13, the Purchaser, either alone or together with any group of Persons acting in concert therewith, for purposes of any applicable banking regulation or Law (including the Change in Bank Control Act of 1978, as amended, and the regulations implemented thereunder by the Federal Deposit Insurance Corporation in 12 C.F.R. §§ 303.80-.88), will not, directly or indirectly, own, control or have the power to vote, immediately after giving effect to its purchase of the Initial Shares and the Notes pursuant to this Agreement and assuming the conversion of such Notes, in excess of 9.99% of the outstanding shares of any class of the Company’s voting securities.

		
	5.10
	No Other Investor Representations or Warranties. Except for the representations and warranties made by the Purchaser in this ‎Article 5 and in any certificate or other document delivered in connection with any Transaction Document, neither the Purchaser nor any other Person acting on its behalf makes any other express or implied representation or warranty with respect to the Purchaser or any of its Affiliates or their respective businesses, operations, properties, assets, liabilities, condition (financial or otherwise) or prospects, notwithstanding the delivery or disclosure to the Company or its representatives of any documentation, forecasts or other information with respect to any one or more of the foregoing, and the Company acknowledges the foregoing. 

		
	5.11
	No Other Company Representations or Warranties. Except for the representations and warranties expressly set forth in ‎Article 4 and in any certificate or other document delivered in connection with any Transaction Document, the Purchaser hereby acknowledges that neither the Company nor any of its subsidiaries, nor any other Person, (a) has made or is making any other express or implied representation or warranty with respect to the Common Stock, the Company or any of its subsidiaries or their respective 

20

businesses, operations, assets, liabilities, condition (financial or otherwise) or prospects, including with respect to any information provided or made available to the Purchaser or any of its representatives or any information developed by the Purchaser or any of its representatives or (b) will have or be subject to any liability or indemnification obligation to the Purchaser resulting from the delivery, dissemination or any other distribution to the Purchaser or any of its representatives, or the use by the Purchaser or any of its representatives, of any information, documents, estimates, projections, forecasts or other forward-looking information, business plans or other material developed by or provided or made available to the Purchaser or any of its representatives, including in due diligence materials, or management presentations (formal or informal), in anticipation or contemplation of any of the Transactions. In evaluating the suitability of an investment in the Company, the Purchaser has not relied upon any representations or other information other than the representations and warranties of the Company set forth in Article 4.

ARTICLE 6     
 
ADDITIONAL COVENANTS
		
	6.1
	No Integration. The Company agrees that it will not and will cause its Affiliates not to sell, offer for sale or solicit offers to buy any security of the Company of any class if, as a result of the doctrine of “integration” referred to in Rule 502 under the Securities Act, such sale, offer for sale or solicitation of an offer to buy would render invalid (for the purpose of the sale of the Closing Date Securities (including the issuance of the Underlying Securities upon conversion thereof) by the Company to the Purchaser) the exemption from the registration requirements of the Securities Act provided by Section 4(a)(2) thereof or otherwise.

		
	6.2
	Transfer Agent. The Company shall engage and maintain, at its expense, a registrar and transfer agent for the Closing Date Securities, the Underlying Securities and the Common Stock.

		
	6.3
	Available Securities of Common Stock. At any time the Notes are outstanding, the Company shall from time to time take all lawful action within its control to cause the authorized capital stock of the Company to include a sufficient number of authorized but unissued shares of Common Stock to satisfy the conversion requirements of all Notes then outstanding, assuming Physical Settlement (as defined in the Indenture).

		
	6.4
	No Restricted Resales. The Company will not, and will not permit any of its affiliates (as defined in Rule 144 under the Securities Act) that it controls at such time, to resell any of the Closing Date Securities (including the issuance of the Underlying Securities upon conversion thereof) which constitute “restricted securities” under Rule 144 that have been reacquired by any of them, except for Closing Date Securities or Underlying Securities purchased by the Company or any such affiliates and resold in a transaction registered under the Securities Act.

		
	6.5
	Regulatory Filings. The Company and the Purchaser shall, as promptly as practicable after a good faith request from the Purchaser (each a “Regulatory Event”), (i) make or cause their Affiliates to make any required filings with the U.S. Federal Trade Commission (“FTC”) and Department of Justice (“DOJ”) under the HSR Act with respect to the potential issuance of the Underlying Securities in a conversion and any sale of the Initial Shares or such Underlying Securities following a conversion, (ii) make or cause their Affiliates to make any filing or notice required under any other antitrust or competition Law or any other applicable Law in each case as reasonably requested by the Purchaser in connection with any such issuance or sale, (iii) provide any supplemental information requested by any Governmental Entity in connection with the HSR Act or such other antitrust, competition or other Laws or regulations as promptly as practicable after such request is made, and (iv) use their reasonable best efforts to obtain, or cause to be obtained, all consents, authorizations, orders and approvals from all Governmental Entities that may be or become necessary in connection with such issuance or sale; provided that nothing in this Section ‎6.5 shall require, or be construed to require, the Company, the Purchaser, any member of the Sponsor Group or any of their respective Affiliates to (A) agree to (x) sell, hold, divest, license, discontinue, separate or limit, 

21

before or after the Closing Date, any assets, businesses or interests of any such Person; (y) any material conditions relating to, or changes or restrictions in, the operations of any such assets, businesses or interests; or (z) any material modification or waiver of the terms and conditions of this Agreement, (B) otherwise effect, offer or negotiate any of the foregoing or (C) litigate with any Governmental Entity; and provided, further, that the Company and the Purchaser shall take the foregoing actions (subject to the preceding proviso) to cause the clearance under the HSR Act or such other applicable Law to be re-obtained or extended, as applicable, without restriction until all of the Notes have been converted into the Underlying Securities and all such sales have been effected. The Company and the Purchaser shall, and each shall cause its Affiliates to, furnish to the other such information and assistance as the other may reasonably request in connection with its preparation of any filing or submission which is necessary under the HSR Act or such other applicable Law or which is otherwise requested by the FTC or DOJ or other Governmental Entity and shall keep each other apprised of the status of any communications with, and inquiries or requests for additional information from, the FTC and DOJ or other Governmental Entity. 
		
	6.6
	Board Rights

		
	6.6.1
	The Purchaser agrees with the Company, and the Company agrees with the Purchaser, that for so long as the Purchaser Parties, collectively, continue to beneficially own at least fifty percent (50%) of the Shares, determined on an as-converted basis with respect to the Notes, that it initially received at Closing pursuant to this Agreement (the “Ownership Threshold”), then the Purchaser shall have the right to designate one person for election to the Company Board (a “Board Designee”); provided, however, that the Board Designee shall (x) be qualified to serve as a member of the Company Board under applicable legal and regulatory requirements and (y) satisfy all director qualifications in effect from time to time that apply to all nominees for the Company Board; and provided, further, that in each case any proposed Board Designee shall make himself or herself reasonably available for interviews, consent to such reasonable reference and background checks or other reasonable investigations and provide such information (including information necessary to determine the nominee’s independence status under various requirements and institutional investor guidelines as well as information necessary to determine any disclosure obligations of the Company) as the Company Board or its Corporate Governance Committee may reasonably request. The Company shall include any Board Designee designated by the Purchaser in accordance with this Section ‎6.6.1 in the Company’s slate of nominees in any applicable meeting of the Company’s stockholders at which the term of such Board Designee shall expire and shall recommend that the holders of Common Stock vote in favor of any such Board Designee’s election and shall support any Board Designee in a manner no less rigorous and favorable than the manner in which the Company supports its other nominees. Subject to the applicable legal and regulatory requirements (including the listing requirements of the NYSE), the Board Designee shall be entitled to sit on the Compensation Committee and the Finance Committee of the Company Board. For the avoidance of doubt, (a) the Ownership Threshold set forth above in this Section ‎6.6.1 shall only include the Shares, determined on an as-converted basis with respect to the Notes, and in no event shall include any other securities subsequently acquired by the Purchaser or its Affiliates and (b) if at any time the Purchaser Parties do not satisfy the Ownership Threshold, the rights set forth in this Section ‎6.6.1 with respect to the Purchaser shall cease and the acquisition of additional securities of the Company shall not impact or otherwise reinstate any such rights. In the event that the Board Designee ceases to be a member of the Company Board, the Purchaser may select another Person as a nominee for Board Designee to fill the vacancy created thereby and, subject to the requirements in this Section ‎6.6.1, such nominee shall become the Board Designee and shall be promptly appointed by the Company Board to fill such vacancy.  Upon the occurrence of the Ownership Threshold ceasing to be satisfied, the Company may request the then-seated Board Designee to resign and, if the Company makes such request, the Purchaser shall cause such Board Designee to resign promptly.  For the avoidance of doubt, the Purchaser and the Company agree that James C. Neary shall be the Board Designee as of the Closing.

22

		
	6.6.2
	At any time that the Board Designee has been elected as a member of the Company Board in accordance with this Section ‎6.6, the Company agrees to have in effect, at the expense of the Company, a director and officer liability insurance policy for the benefit of the Company and such Board Designee to the same extent as the Company provides such insurance covering the other members of the Company Board. Promptly upon the receipt of an invoice therefor, the Company shall reimburse the Board Designee (or the employer of such Board Designee, if applicable) for the reasonable, documented out-of-pocket costs and expenses of such Board Designee in attending meetings of the Company Board and/or any committee thereof; provided that any such reimbursement pursuant to this Section ‎6.6.2 shall be subject to the Company’s travel and expense policies and in conformity with the reimbursement of documented out-of-pocket costs and expense of other members of the Company Board.

		
	6.6.3
	The Purchaser shall cause the Board Designee to comply with all Company policies, procedures, processes, codes, rules, standards and guidelines applicable to members of the Company Board, including the Company’s standards of conduct, securities trading policies, director confidentiality policies and corporate governance guidelines, and preserve the confidentiality of Company business and information, including discussions or matters considered in meetings of the Company Board or its committees; provided that no such policies, procedures, processes, codes, rules, standards or guidelines shall restrict any Transfer of Closing Date Securities or Underlying Securities by the Purchaser Parties or their Affiliates (other than with respect to the Board Designee solely in his or her individual capacity) except as in effect on the date of this Agreement or as provided herein or in the other Transaction Documents, impose confidentiality obligations on the Board Designee with respect to the sharing of information by the Board Designee with the Purchaser Parties (subject to such information being and remaining subject to the confidentiality obligations of the Purchaser Parties hereunder and under the Confidentiality Agreement) other than as set forth herein or as required under applicable Law (including, without limitation, pursuant to the Board Designee’s fiduciary duties to the Company and its stockholders), or impose any share ownership requirement for the Board Designee.  Notwithstanding the foregoing, the Board Designee shall not participate in, and shall, at the request of the Company Board, recuse himself or herself from, and the Purchaser shall cause him or her not to participate in, and to recuse himself or herself from, any Company Board deliberations and actions relating to the Company’s relationship with the Purchaser Parties, or matters related to the Transactions.

		
	6.6.4
	The Company hereby acknowledges that, in addition to the rights provided to the Board Designee pursuant to this Agreement, the Certificate of Incorporation and By-Laws of the Company and any indemnification agreements that such Board Designee may enter into with the Company from time to time to (collectively, the “Indemnification Obligations”) (as beneficiaries of such rights each Board Designee is herein referred to as a “Board Indemnitee”), the Board Indemnitees may have certain rights to indemnification and/or advancement of expenses provided by, and/or insurance obtained by, the Sponsor Group, whether now or in the future (collectively, the “Fund Indemnitors”).  Notwithstanding anything to the contrary in any of the Indemnification Obligations or this Agreement, the Company hereby agrees that, with respect to its indemnification and advancement obligations to any Board Designee under the Indemnification Obligations or this Agreement or other applicable contract, the Company (i) is the indemnitor of first resort (i.e., its obligations to indemnify the Board Indemnitees are primary and any obligation of the Fund Indemnitors or their insurers to advance expenses or to provide indemnification for the same expenses or liabilities incurred by any of the Board Indemnitees (or any Affiliate thereof) is secondary and excess), (ii) shall be required to advance the full amount of expenses incurred by each Board Indemnitee and shall be liable for the full amount of all expenses, judgments, penalties, fines and amounts paid in settlement by each Board Indemnitee or on such Person’s behalf, in each case to the extent legally permitted and required by this Agreement and the Indemnification Obligations, without regard to any rights such Board Indemnitees may have against the Fund Indemnitors or their insurers, and (iii) irrevocably waives, relinquishes and releases the Fund Indemnitors and such insurers from any and all claims against the Fund 

23

Indemnitors or such insurers for contribution, by way of subrogation or any other recovery of any kind in respect thereof.  In furtherance and not in limitation of the foregoing, the Company agrees that in the event that any Fund Indemnitor or its insurer should advance any expenses or make any payment to a Board Indemnitee for matters subject to advancement or indemnification by the Company pursuant to an Indemnification Obligation or this Agreement or other applicable contract, the Company shall promptly reimburse such Fund Indemnitor or insurer to the extent of its obligations under the Indemnification Obligations or this Agreement and that such Fund Indemnitor or insurer shall be subrogated to all of the claims or rights of such Board Indemnitee under the Indemnification Obligations, this Agreement or such other contract, including to the payment of expenses in an action to collect.  The Company agrees that the Board Indemnitees are third party beneficiaries of this Section ‎6.6.4, able to enforce this Section ‎6.6.4 according to its terms as if a party hereto.  The Company agrees that any Fund Indemnitor not a party hereto shall be an express third party beneficiary of this Section ‎6.6.4, able to enforce such clause according to its terms as if it were a party hereto.  Nothing contained in the Indemnification Obligations shall limit the scope of this Section ‎6.6.4 or the other terms set forth in this Agreement or the rights of the Fund Indemnitors hereunder.
		
	6.7
	Section 16 Matters. If the Company becomes a party to a consolidation, merger or other similar transaction that may result in the Purchaser, or its Affiliates and/or its Board Designee being deemed to have made a disposition of equity securities of the Company or derivatives thereof for purposes of Section 16 of the Exchange Act, and if a Board Designee is serving on the Company Board at such time or has served on the Company Board during the preceding six months (i) the Company Board will pre-approve such disposition of equity securities of the Company or derivatives thereof for the express purpose of exempting the Purchaser’s, its Affiliates’ and its Board Designee’s interests (to the extent the Purchaser or its Affiliates may be deemed to be “directors by deputization”) in such transaction from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder and (ii) if the transaction involves (A) a merger or consolidation to which the Company is a party and the Common Stock is, in whole or in part, converted into or exchanged for equity securities of a different issuer, (B) a potential acquisition by a Purchaser, the Purchaser’s Affiliates, and/or the Board Designee of equity securities of such other issuer or derivatives thereof and (C) an Affiliate or other designee of the Purchaser or its Affiliates will serve on the board of directors (or its equivalent) of such other issuer, then if the Company requires that the other issuer pre-approve any acquisition of equity securities or derivatives thereof for the express purpose of exempting the interests of any director or officer of the Company or any of its subsidiaries in such transactions from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder, the Company shall require that such other issuer pre-approve any such acquisitions of equity securities or derivatives thereof for the express purpose of exempting the interests of such Purchaser’s, its Affiliates’ and its Board Designee’s (for the Purchaser and/or its Affiliates, to the extent such Persons may be deemed to be “directors by deputization” of such other issuer) in such transactions from Section 16(b) of the Exchange Act pursuant to Rule 16b-3 thereunder. The Company also agrees that the Company Board shall take any additional reasonable action as is requested by the Purchaser to cause the exemption of the Transactions and any other transactions expressly contemplated by this Agreement and the other Transaction Documents (including the issuance of any additional Notes or payment in kind of interest under the Indenture) from the liability provisions of Section 16(b) of the Exchange Act pursuant to Rule 16b-3 so long as the Purchaser has the right to appoint a Board Designee under Section ‎6.6.1 or any such Board Designee serves on the Company Board or is subject to Section 16 of the Exchange Act. The Purchaser agrees to cooperate with the Company and to promptly provide such information reasonably required by the Company in connection with the performance of its obligations under this Section ‎6.7.

		
	6.8
	Efforts. Subject to the terms and conditions of this Agreement and applicable Law, each of the Parties hereto shall use its reasonable best efforts to take, or cause to be taken, all actions, and to do, or cause to be done, all things reasonably necessary, proper or advisable under applicable Laws and regulations or otherwise to consummate and make effective the Transactions contemplated by this Agreement, as soon as practicable and, in any event, prior to the Termination Time, including such actions or things as any other 

24

Party hereto may reasonably request in order to cause any of the conditions to such other Party’s obligation to consummate the Transactions to be satisfied.
		
	6.9
	Standstill. The Purchaser agrees that following the Closing until 90 days after the first day on which no Board Designee serves on the Company Board and the Purchaser has no rights under Section ‎6.6.1 hereof to designate a Board Designee, without the prior written approval or invitation of the Company Board, the Purchaser will not, directly or indirectly, and will cause its Affiliates and representatives (acting in such capacity) not to: 

		
	(a)
	effect or seek, offer or propose (whether publicly or otherwise) to effect, or cause or participate in or in any way advise, assist or knowingly encourage any other Person to effect or seek, offer or propose (whether publicly or otherwise) to effect or participate in, (i) any acquisition of any voting securities (or beneficial ownership thereof) or assets of the Company, or any rights to acquire any such voting securities (including derivative securities representing the right to vote or economic benefit of any such securities) or assets (other than any acquisition of director shares granted by the Company to any Board Designee in his or her capacity as a director of the Company); (ii) any tender or exchange offer, merger or other business combination involving the Company, (iii) any recapitalization, restructuring, liquidation, dissolution or other extraordinary transaction with respect to the Company or (iv) any "solicitation" of “proxies" (as such terms are used in the proxy rules of the SEC) or consents to vote any voting securities of the Company;

		
	(b)
	form, join or in any way participate in a "group" (as defined under the Exchange Act) with others other than the Purchaser Parties and their respective Affiliates with respect to any voting securities of the Company;

		
	(c)
	otherwise act, alone or in concert with others, to seek to control or influence the management, the Company Board or policies of the Company;

		
	(d)
	take any action which might force the Company to make a public announcement regarding any of the types of matters set forth in (a) above; or

		
	(e)
	enter into any discussions or arrangements with any third party other than the Purchaser Parties and their respective Affiliates and representatives with respect to any of the foregoing matters set forth in (a) through (d) above; 

provided, however, that, nothing in Section ‎6.9 will limit the Purchaser’s ability to enter into any Permitted Transaction or perform its obligations thereunder or Transfer the Notes or the Shares (subject to Section ‎6.10), limit or restrict any transfer pursuant to a Permitted Transaction or any foreclosure thereunder or transfer in lieu of a margin call or other requirement to post collateral or a foreclosure thereunder; provided, further, that nothing in this Section ‎6.9 will (1) limit the Purchaser’s ability to vote the Shares or convert the Notes, participate in rights offerings made by the Company to all holders of Common Stock, receive any dividends or similar distributions with respect to any securities of the Company, tender shares of Common Stock into any tender or exchange offer that is approved by the Company Board or exercise any other of its rights as a holder of Notes or Shares to the extent such other rights are not explicitly addressed by clauses (a) through (e) of this Section ‎6.9, (2) limit the Purchaser’s ability to engage in a transaction pursuant to Section ‎6.11, or (3) limit the ability of the Purchaser Parties to exercise any rights under Section ‎6.6 or limit the ability of the Board Designee to vote or otherwise exercise his or her legal duties or otherwise act in his or her capacity as a member of the Company Board. Subject to the following sentence, the Purchaser also agrees during such period not to request the Company (or its directors, officers, employees or agents), directly or indirectly, to amend or waive any provision of this Section ‎6.9 (including this sentence).  This Section ‎6.9 shall not prohibit the Purchaser from making and submitting a proposal on a confidential basis directly to the Company’s Chief Executive Officer or Board Chair (including requesting that the Company amend or waive any provision of this Section ‎6.9 in connection with such confidential proposal); provided that any such proposal or request does not require the Company or any other Person to make a public disclosure regarding such proposal or request.  The provisions of this Section ‎6.9 shall be inoperative and 

25

of no force or effect if any Person or "group" (as such term is used in the Exchange Act) other than one including the Purchaser Parties or their respective Affiliates enters into a definitive agreement to acquire (or publicly offers to acquire in an offer that has been recommended by the Company Board) more than 50% of the outstanding voting securities of the Company (or its subsidiaries) or assets of the Company or its subsidiaries representing more than 50% of the consolidated earning power of the Company and its subsidiaries.
		
	6.10
	Transfer Restrictions. 

		
	(a)
	Except as otherwise permitted by Section ‎6.10(b), prior to the twelve (12) month anniversary of the Closing, the Purchaser Parties will not Transfer any Notes or Shares without the prior written consent of the Company.

		
	(b)
	Notwithstanding Section ‎6.10‎(a), the Purchaser Parties shall be permitted to make the following Transfers of any portion or all of their Notes or Shares at any time:

		
	(i)
	Transfers to any Permitted Transferees, but only if the transferee agrees in writing prior to such Transfer for the express benefit of the Company (in form and substance reasonably satisfactory to the Company and with a copy thereof to be furnished to the Company) to be bound by the terms of Section ‎6.9 of this Agreement and this Section ‎6.10;

		
	(ii)
	Transfers consisting of pro rata distributions by the Purchaser Parties to their respective limited partners or other investors, but only if the transferee agrees in writing prior to such Transfer for the express benefit of the Company (in form and substance reasonably satisfactory to the Company and with a copy thereof to be furnished to the Company) to be bound by the terms of Section ‎6.9 of this Agreement and this Section ‎6.10;

		
	(iii)
	Transfers pursuant to a merger, tender offer or exchange offer or other business combination, acquisition of assets or similar transaction or any change of control transaction involving the Company or any subsidiary of the Company that, in each case, is approved by the Company Board; 

		
	(iv)
	Transfers after commencement by the Company or a significant subsidiary (as such term is defined in Rule 12b-2 under the Exchange Act) of the Company of bankruptcy, insolvency or other similar proceedings; 

		
	(v)
	Transfers in connection with a swap or bona fide loan or other financing arrangement, in each case entered into with a nationally or internationally recognized financial institution (any such transaction, subject to compliance with the last paragraph of this Section 6.10(b), a “Permitted Transaction”, and any such financial institution or its Affiliate, collectively with any trustee or agent acting on its behalf in respect of a Permitted Transaction with respect to such Permitted Transaction, a “Permitted Counterparty”), pursuant to a pledge to a Permitted Counterparty to secure such a Permitted Transaction, and any margin call or other requirement to post collateral with respect to such Permitted Transaction or foreclosure by such Permitted Counterparty or transfer to such Permitted Counterparty in lieu of any margin call or other requirement to post collateral or foreclosure and, in the case of any such transfer to a Permitted Counterparty or foreclosure by a Permitted Counterparty, any subsequent sale of the securities by such Permitted Counterparty. The Parties acknowledge and agree that, except as provided in the last paragraph of this Section 6.10(b), nothing contained in this Agreement, the Indenture or the Registration Rights Agreement shall prohibit or otherwise restrict the ability of any Permitted Counterparty to take the actions described in the immediately preceding sentence; and

		
	(vi)
	Transfers that occur after the twelve (12) month anniversary of the Closing;

26

The Purchaser Parties shall be permitted to make Transfers of any portion or all of their Notes or Shares at any time after the twelve (12) month anniversary of the Closing, provided, however, that the Purchaser shall not, at any time (whether before or after the twelve (12) month anniversary of Closing), (1) Transfer any Common Stock of the Company or Notes in any single transfer or series of related transfers, except in connection with a transaction in which no ultimate purchaser (other than an Affiliate of any Purchaser Party) would acquire, or following such Transfer would be the beneficial owner (within the meaning of Rule 13d-3 under the Exchange Act) of, 5% or more of the then-outstanding shares of Common Stock of the Company or (2) Transfer any Common Stock or Notes to a Competitor or Activist Shareholder; provided, further, that any Transfer effected through a registered underwritten offering or through a bona fide sale to the public without registration effected pursuant to Rule 144 under the Securities Act or Section 4(a)(1) of the Securities Act, including in any Transfer to a broker-dealer in a block sale or any brokerage transaction effected through the facilities of the New York Stock Exchange shall be deemed not to violate the immediately preceding proviso to the extent that neither the Purchaser nor any Person acting on the Purchaser’s behalf has (i) prearranged the resale of the Notes or Underlying Securities, as applicable, to a Person that would beneficially own (within the meaning of Rule 13d-3 under the Exchange Act) 5% or more of the then-outstanding shares of Common Stock, a Competitor or Activist Shareholder (any such ineligible acquirer of shares, an “Ineligible Acquirer”) nor (ii) has reason to know, after the exercise of reasonable care, that the acquirer of such securities is an Ineligible Acquirer.  In addition, for so long as any Purchaser Party owns Notes or Shares, no Purchaser Party shall engage in any Hedging Transaction. In connection with any Transfer permitted by this Section ‎6.10(b), the Company will provide reasonable and customary levels of assistance and enter into any customary agreements to the extent reasonably requested by the Purchaser in order to allow the Purchaser to effectuate such Transfer.
In connection with, and as a condition to, any Permitted Transaction, the Purchaser Parties shall cause the relevant Permitted Counterparty to agree (which agreement shall include the Company as a party or an express third party beneficiary) that the Permitted Counterparty shall not, nor shall it direct any other Person to, enter into Hedging Transactions for the purpose of hedging such Permitted Transaction on or with respect to which the underlying securities comprise, in the aggregate, more than one million shares of Common Stock at any one time, it being understood that such limitation on the Permitted Counterparty’s hedging activity shall not limit any activity of the Permitted Counterparty that is not for the purpose of hedging the Permitted Transaction; provided that such limitation on the Permitted Counterparty’s hedging activity shall cease to be applicable if an event of default or event that with the passage of time or giving of notice would be an event of default has occurred under such Permitted Transaction. Any purported Permitted Transaction that does not comply with this paragraph shall not be deemed to be a “Permitted Transaction”.
		
	(c)
	Any attempted Transfer in violation of this Section ‎6.10 shall be null and void ab initio.

		
	6.11
	Preemptive Rights. 

		
	(a)
	From and after the Closing and so long as the Ownership Threshold is collectively satisfied by the Purchaser Parties, if the Company issues or makes any public or non-public offering of any capital stock of, other equity or voting interests in, or Equity-Linked Securities of, the Company or any of its subsidiaries or any securities that are convertible or exchangeable into (or exercisable for) capital stock of, other equity or voting interests in, or Equity-Linked Securities of, the Company or any of its subsidiaries (collectively “Preemptive Securities”), including, for the purposes of this Section ‎6.11, warrants, options or other such rights (other than a Preemptive Rights Excluded Issuance), the Purchaser and each Purchaser Party shall be afforded the opportunity to acquire from the Company the Purchaser Parties’ Preemptive Rights Portion of such securities issued or offered by the Company or any of its subsidiaries (“New Securities”) for the same price as that offered to the other purchasers of such New Securities; provided, that the Purchaser Parties shall not be entitled to acquire any New Securities pursuant to this Section ‎6.11 to the extent the issuance of such New Securities to the Purchaser Parties would require approval of the stockholders of the Company as a result of any such Purchaser Party’s status, if applicable, as an 

27

Affiliate of the Company or pursuant to the rules and listing standards of the NYSE (including NYSE Listed Company Manual Section 312.03), in which case the Company may consummate the proposed issuance of New Securities to other Persons prior to obtaining approval of the stockholders of the Company (subject to compliance by the Company with Section ‎‎6.11(f) below).
		
	(b)
	Subject to the foregoing proviso in Section ‎‎6.11(a), the amount of New Securities that each Purchaser Party shall be entitled to purchase in the aggregate shall be determined by multiplying (1) the total number of such offered shares of New Securities by (2) a fraction, the numerator of which is the number of Shares (in the aggregate and considering the Notes as Shares on an as converted basis) held by such Purchaser Party, immediately prior to such issuance or offering, and the denominator of which is the aggregate number of shares of Common Stock outstanding (on an as converted basis) as of immediately prior to such issuance or offering (the “Preemptive Rights Portion”). The Purchaser Parties may assign their rights to acquire New Securities pursuant to this Section ‎6.11 to any Permitted Transferee; provided that such Permitted Transferee agrees in writing for the express benefit of the Company (in form and substance reasonably satisfactory to the Company and with a copy thereof to be furnished to the Company) to be bound by the terms of this Agreement.

		
	(c)
	If the Company proposes to issue or offer New Securities, it shall, subject to the right of the Company to comply with Section ‎6.11(h) in lieu of this Section ‎‎6.11(c), give the Purchaser written notice of its intention, describing the anticipated price (or range of anticipated prices), anticipated amount of New Securities and other material terms and timing upon which the Company proposes to issue or offer the same (including, in the case of a registered public offering and to the extent possible, a copy of the prospectus included in the registration statement filed with respect to such offering) at least seven (7) Business Days prior to such issuance (or, in the case of a registered public offering, at least seven (7) Business Days prior to the commencement of the marketing of such registered public offering) (provided that, to the extent the terms of such offering cannot reasonably be provided seven (7) Business Days prior to such issuance or commencement of marketing, notice of such terms may be given as promptly as reasonably practicable but in any event prior to such issuance). The Company may provide such notice to the Purchaser Parties on a confidential basis prior to public disclosure of such offering. Other than in the case of a registered public offering, the Purchaser Parties may notify the Company in writing at any time on or prior to the second (2nd) Business Day immediately preceding the date of such issuance (or, if notice of all such terms has not been given prior to the second (2nd) Business Day immediately preceding the date of such issuance, at any time prior to such issuance) whether any of the Purchaser Parties will exercise such preemptive rights and as to the amount of New Securities the Purchaser Parties desires to purchase, up to the maximum amount calculated pursuant to Section ‎6.11(b). In the case of a registered public offering, the Purchaser Parties shall notify the Company in writing at any time prior to the second (2nd) Business Day immediately preceding the date of commencement of the marketing of such registered public offering (or, if notice of all such terms has not been given prior to the second (2nd) Business Day immediately preceding the date of commencement the marketing of such registered public offering, at any time prior to the date of commencement of such registered public offering) whether any of the Purchaser Parties will exercise such preemptive rights and as to the amount of New Securities the Purchaser Parties desires to purchase, up to the maximum amount calculated pursuant to Section ‎6.11(b). Such notice to the Company shall constitute a binding commitment by the Purchaser Parties to purchase the amount of New Securities so specified at the price and other terms set forth in the Company’s notice to it. Subject to receipt of the requisite notice of such issuance by the Company, the failure of the Purchaser Parties to respond prior to the time a response is required pursuant to this Section ‎‎6.11‎(c) shall be deemed to be a waiver of the Purchaser Parties’ purchase rights under this Section ‎‎6.11 only with respect to the offering described in the applicable notice.

		
	(d)
	Each Purchaser Party shall purchase the New Securities that it has elected to purchase under this Section ‎6.11 concurrently with the closing of the related issuance of such New Securities by the 

28

Company (or on such later date as may be agreed to by the Company); provided, that if such related issuance is prior to the tenth (10th) Business Day following the date on which such Purchaser Party has notified the Company that it has elected to purchase New Securities pursuant to this Section ‎‎6.11, then each Purchaser Party shall purchase such New Securities within ten (10) Business Days following the date of the related issuance; and provided further that in the event any such purchase requires expiration of any waiting period mandated by, or any approvals or consents of, any Governmental Entity, such purchase by the Purchaser Parties shall occur promptly following the expiration of such waiting period and receipt of such approvals and consents (and the Company shall provide reasonable and customary assistance in connection with any necessary filings and proceedings in connection therewith). If the proposed issuance by the Company of securities which gave rise to the exercise by the Purchaser Parties of its preemptive rights pursuant to this Section ‎6.11 shall be terminated or abandoned by the Company without the issuance of any New Securities or if any necessary consents or approvals of any Governmental Entity are not obtained by the Purchaser Parties, then the purchase rights of the Purchaser Parties pursuant to this Section ‎6.11 shall also terminate as to such proposed issuance by the Company (but not any subsequent or future issuance), and any funds in respect thereof paid to the Company by the Purchaser Parties in respect thereof shall be promptly refunded in full.
		
	(e)
	In the case of the offering of securities for consideration in whole or in part other than cash, including securities acquired in exchange therefor (other than securities by their terms so exchangeable), the consideration other than cash shall be deemed to be the fair value thereof as reasonably determined by the Company.

		
	(f)
	In the event that the Purchaser Parties are not entitled to acquire any New Securities pursuant to this Section ‎6.11 because such issuance would require the Company to obtain stockholder approval in respect of the issuance of such New Securities to the Purchaser Parties as a result of any such Purchaser Party’s status, if applicable, as an Affiliate of the Company or pursuant to the rules and listing standards of the NYSE (including NYSE Listed Company Manual Section 312.03(c)), the Company shall, upon the Purchaser’s reasonable request delivered to the Company in writing within seven (7) Business Days following its receipt of the written notice of such issuance to the Purchaser Parties pursuant to Section ‎6.11(c), at the Purchaser’s election, (i) waive the restrictions set forth in Section ‎6.9 solely to the extent necessary to permit any Purchaser Party to acquire such number of New Securities equivalent to its Preemptive Rights Portion of such issuance such Purchaser Party would have been entitled to purchase had it been entitled to acquire such New Securities pursuant to Section ‎‎‎6.11(a)-‎(c); (ii) consider and discuss in good faith modifications proposed by the Purchaser Parties to the terms and conditions of such portion of the New Securities which would otherwise be issued to the Purchaser Parties such that the Company would not be required to obtain stockholder approval in respect of the issuance of such New Securities as so modified; and/or (iii) solely to the extent that stockholder approval is required in connection with the issuance of New Securities to Persons other than the Purchaser Parties, use commercially reasonable efforts to seek stockholder approval in respect of the issuance of any New Securities to the Purchaser Parties.

		
	(g)
	The election by any Purchaser Party to not exercise its subscription rights under this Section ‎6.11 in any one instance shall not affect its rights as to any subsequent proposed issuance.

		
	(h)
	Notwithstanding anything in this Section ‎6.11 to the contrary, the Company will not be deemed to have breached this Section ‎6.11 if not later than twenty (20) Business Days following the issuance of any New Securities in contravention of this Section ‎6.11‎‎, the Company or the transferee of such New Securities offers to sell a portion of such equity securities or additional equity securities of the type(s) in question to each Purchaser Party in an amount such that, taking into account such previously-issued New Securities and any such additional New Securities, each Purchaser Party will have had the right to purchase or subscribe for New Securities in a manner consistent with the 

29

allocation and other terms and upon the same economic and other terms provided for in this Section ‎6.11. 
		
	(i)
	The Company and the Purchaser Parties shall use their reasonable best efforts to effect the exercise of the Purchaser Parties’ rights pursuant to this Section ‎6.11, including, except to the extent otherwise contemplated in this Section ‎6.11, securing any required approvals or consents.

		
	6.12
	Public Disclosure.  The Purchaser Parties and the Company shall, and shall cause their Affiliates to, consult with each other before issuing, and give each other the opportunity to review and comment upon, any press release or other public statements with respect to the Transaction Documents or the Transactions, and shall not, and shall cause their Affiliates not to, issue any such press release or make any such public statement prior to such consultation, except as may be required by applicable Law; provided that the initial announcement with respect to the Transaction Documents or the Transactions shall be mutually agreed between the Purchaser Parties and the Company. Notwithstanding the forgoing, this Section ‎6.12 shall not apply to any press release or other public statement made by the Company or the Purchaser Parties (a) which does not contain any information relating to the Transactions that has not been previously announced or made public in accordance with the terms of this Agreement or (b) is made in the ordinary course of business and does not relate specifically to the signing of the Transaction Documents or the Transactions. Subject to the terms of the Confidentiality Agreement and Section ‎6.13, in no event shall this Section ‎6.12 limit disclosure (i) by any Purchaser Party and their respective Affiliates of ordinary course communications regarding this Agreement and the Transactions to its existing or prospective general and limited partners, equityholders, members, managers and investors of any Affiliates of such Person, including disclosing information about the Transactions on their websites in the ordinary course of business consistent with past practice or as part of any sales and Transfers to any Permitted Transferee or (ii) by the Company in any legal proceeding to which it is a party.

		
	6.13
	Confidentiality. The Purchaser Parties will, and will direct their Affiliates and representatives who actually receive Confidential Information to, keep confidential any information (including oral, written and electronic information) concerning the Company, its subsidiaries or its Affiliates that may be furnished to any Purchaser Party, its Affiliates or its or their respective representatives by or on behalf of the Company or any of its representatives pursuant to the Transaction Documents (“Confidential Information”) and to use the Confidential Information solely for the purposes of monitoring, administering or managing the Purchaser Parties’ investment in the Company made pursuant to this Agreement; provided that Confidential Information will not include information that (a) is or becomes available to the public other than as a result of a breach of any confidentiality obligation to the Company by any Purchaser Party or its Affiliates or their respective representatives, (b) becomes available to any Purchaser Party or its Affiliates or their respective representatives from a source other than the Company or its representatives; provided that such source is not known by such Purchaser Party or its Affiliates be subject to an obligation of confidentiality, (c) at the time of disclosure is already in the possession of a Purchaser Party or its Affiliates or their respective representatives on a non-confidential basis, (d) was independently developed by any Purchaser Party or its Affiliates or their respective representatives without the use of or reference to any Confidential Information, or (e) is approved for release by written authorization of the Company, but only to the extent of and subject to such conditions as may be imposed in such written authorization; provided that a Purchaser Party may disclose Confidential Information (i) to its attorneys, accountants, consultants and financial and other professional advisors to the extent necessary to obtain their services in connection with its investment in the Company (provided that the recipients of such Confidential Information are directed to abide by the confidentiality and non-disclosure obligations contained herein and Purchaser shall be responsible for any failure of such recipients to abide by the confidentiality and non-disclosure obligations contained herein), (ii) to any prospective purchaser of Shares and the Notes from such Purchaser Party, or prospective financing sources in connection with any Permitted Transaction, in each case, as long as such prospective purchaser or lender, as applicable, agrees to be bound by similar confidentiality or non-disclosure terms as are contained in this Agreement (with the Company as an express third party beneficiary of such agreement), (iii) to any Affiliate, partner, member, limited partners, prospective partners or co-investors or related investment fund of such Purchaser Parties and their Affiliates and their respective 

30

directors, officers, employees, consultants, financing sources and representatives, in each case in the ordinary course of business (provided that the recipients of such Confidential Information are directed to abide by the confidentiality and non-disclosure obligations contained herein and Purchaser shall be responsible for any failure of such recipients to abide by the confidentiality and non-disclosure obligations contained herein), and (iv) as may otherwise be required by Law or legal, judicial or regulatory process; provided that such Purchaser Party (x) will provide the Company with reasonably prompt written notice of any such requirement so that the Company may seek, with such Purchaser Party’s reasonable cooperation, a protective order or other appropriate remedy, and (y) will disclose only that portion of the Confidential Information which is legally required to be disclosed in the opinion of counsel of such Purchaser Party.  Notwithstanding anything herein or in the Confidentiality Agreement to the contrary, the Parties agree that, automatically upon the occurrence of the Closing, the Confidentiality Agreement shall be deemed to have been terminated by all parties thereto and shall become null and void and have no further force or effect with no liability on the part of any Person thereunder; provided however, that, upon such termination, all “Confidential Information” (as defined under the Confidentiality Agreement) shall be deemed to be Confidential Information for purposes of this Section ‎6.13 and such termination shall not excuse any breach of the Confidentiality Agreement prior to such termination. 
		
	6.14
	Financing Cooperation. If requested by the Purchaser Parties, the Company will provide the following cooperation in connection with the Purchaser Parties entering into any Permitted Transaction: (i) entering into an issuer agreement (an “Issuer Agreement”) with each Permitted Counterparty in a form reasonably satisfactory to the Company that is customary for similar financings and not inconsistent with this Agreement or the Company’s obligations under Law (which agreement may include, without limitation, agreements and obligations of the Company relating to procedures and specified time periods for effecting Transfers and/or conversions upon foreclosure; agreements to not hinder or delay exercises of remedies on foreclosure; acknowledgments regarding corporate policy, if applicable; an agreement by the Company to commit, if requested by the relevant Permitted Counterparty, to electing either cash, physical settlement or a specified combination of cash and physical settlement, with respect to any conversion of the Notes by the Permitted Counterparty following a foreclosure in respect of such Permitted Transaction (provided that the Company shall be permitted to change its election once each calendar quarter with respect to conversions that occur in the subsequent calendar quarter); and certain acknowledgments regarding securities Law status of the pledge arrangements and shall otherwise be consistent with the last paragraph of Section 6.10(b)), (ii) using commercially reasonable efforts to (A) remove any restrictive legends on Closing Date Securities and Underlying Securities and depositing such pledged Closing Date Securities or Underlying Securities in book entry form on the books of DTC when eligible to do so (and providing any necessary indemnities to the transfer agent in connection therewith) or (B) without limiting the generality of clause (A), if such Closing Date Securities or Underlying Securities are eligible for resale under Rule 144A, depositing such pledged Closing Date Securities or Underlying Securities in book entry form on the books of DTC or other depository with customary Rule 144A restrictive legends in lieu of the legends specified in Section ‎6.15, (iii) if so requested by any such Permitted Counterparty, re-registering the pledged Closing Date Securities and Underlying Securities in the name of the relevant Permitted Counterparty or custodian or similar party to a Permitted Transaction, (iv) entering into customary triparty agreements in a form reasonably satisfactory to the Company with each Permitted Counterparty and the Purchaser Parties relating to the delivery of the Closing Date Securities or Underlying Securities to the relevant Permitted Counterparty for crediting to any relevant collateral account and (v) such other cooperation and assistance as the Purchaser Parties may reasonably request that will not unreasonably disrupt the operation of the Company’s business and not inconsistent with this Agreement or the Company’s obligations under Law. Notwithstanding anything to the contrary in the preceding sentence, the Company’s obligation to deliver an Issuer Agreement is conditioned on the Purchaser certifying to the Company in writing that (A) the agreement with respect to which the Issuer Agreement is being delivered constitutes a Permitted Transaction being entered into in accordance with this Agreement, the execution of such Permitted Transaction and the terms thereof do not violate the terms of this Agreement and the Purchaser will pledge or Transfer the Closing Date Securities and/or Underlying Securities to the Permitted Counterparty(ies) pursuant to the terms of the Permitted Transaction, (B) to the extent applicable, whether the registration rights under the Registration Rights Agreement are being assigned to the Permitted Counterparty(ies) under 

31

that Permitted Transaction and (C) the Purchaser Parties acknowledge and agree that the Company will be relying on such certificate when entering into the Issuer Agreement and any inaccuracy in such certificate will be deemed a breach of this Agreement. The Purchaser Parties acknowledge and agree that the statements and agreements of the Company in an Issuer Agreement are solely for the benefit of the applicable Permitted Counterparty(ies) party thereto and that in any dispute between the Company and the Purchaser Parties under this Agreement the Purchaser Parties shall not be entitled to use the statements and agreements of the Company in an Issuer Agreement against the Company. 
		
	6.15
	Legend.  

All certificates or other instruments representing the Closing Date Securities or Underlying Securities will bear a legend substantially to the following effect: 
THE SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE TRANSFERRED, SOLD OR OTHERWISE DISPOSED OF EXCEPT WHILE A REGISTRATION STATEMENT RELATING THERETO IS IN EFFECT UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT OR SUCH LAWS. 
THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO TRANSFER RESTRICTIONS SET FORTH IN A PURCHASER AGREEMENT, DATED AS OF JUNE 29, 2020, COPIES OF WHICH ARE ON FILE WITH THE SECRETARY OF THE ISSUER.
Upon request of the applicable Purchaser Party, (i) upon receipt by the Company of an opinion of counsel reasonably satisfactory to the Company to the effect that such legend is no longer required under the Securities Act and applicable state securities Laws, the Company shall promptly cause the first paragraph of the legend to be removed from any certificate for Closing Date Securities or Underlying Securities to be Transferred in accordance with the terms of this Agreement and (ii) the Company shall cause the second paragraph of the legend to be removed promptly following the expiration of such transfer restrictions set forth in this Agreement (and, for the avoidance of doubt, immediately prior to any termination of this Agreement). 
		
	6.16
	Negative Covenants.  Except as required by applicable Law or as expressly contemplated, required or permitted by this Agreement, (i) during the period from the date of this Agreement until the Closing Date (or such earlier date on which this Agreement is terminated pursuant to Section ‎7.1), (1) unless the Purchaser Parties otherwise consent in writing (such consent not to be unreasonably withheld, delayed or conditioned) the Company shall, and shall cause its subsidiaries to, use their commercially reasonable efforts to operate their businesses in all material respects in the ordinary course of business and to maintain and preserve in all material respects its existing relationships with its customers, employees, independent contractors and other business relationships having material business dealings with the Company or any of its subsidiaries and (2) unless the Purchaser Parties otherwise consent in writing (such consent not to be unreasonably withheld, delayed or conditioned), the Company shall not and shall cause its subsidiaries not to:

		
	(a)
	other than the authorization and issuance of the Closing Date Securities and the Underlying Securities to the Purchaser and the consummation of the other Transactions, issue, sell or grant any shares of its capital stock or other equity or voting interests, or any securities or rights convertible into, exchangeable or exercisable for, or evidencing the right to subscribe for any shares of its capital stock or other equity or voting interests, or any rights, warrants or options to purchase any shares of its capital stock or other equity or voting interests; provided that the Company may issue or grant shares of Common Stock or other securities (i) in the ordinary course of business pursuant to the terms of a Company Stock Plan or (ii) pursuant to other binding obligations in effect on the date of this Agreement; 

32

		
	(b)
	redeem, purchase or otherwise acquire any of its outstanding shares of capital stock or other equity or voting interests, or any rights, warrants or options to acquire any shares of its capital stock or other equity or voting interests (other than pursuant to the cashless exercise of Company Stock Options or the forfeiture or withholding of taxes with respect to Company Stock Options or restricted stock units or pursuant to other binding obligations on the date hereof); 

		
	(c)
	solely with respect to the Company, establish a record date for, declare, set aside for payment or pay any dividend on, or make any other distribution in respect of, any shares of its capital stock or other equity or voting interests;

		
	(d)
	split, combine, subdivide, recapitalize, reclassify or like change to any shares of its capital stock or other equity or voting interests; 

		
	(e)
	amend or supplement the Company’s Certificate of Incorporation or By-Laws or take or authorize any action to wind up its affairs or dissolve;

		
	(f)
	make any material change in the Company’s or its subsidiaries’ financial accounting principles, except as required by changes in GAAP (or any interpretation thereof) or in applicable Law; or 

		
	(g)
	agree or commit to do any of the foregoing.

		
	6.17
	Information Rights. For so long as the Purchaser Parties, collectively, satisfy the Ownership Threshold, the Company shall provide the Purchaser Parties (A) to the extent reasonably requested by the Purchaser Parties or its representatives, reasonable access to management of the Company to discuss the Company’s affairs, finances and accounts and matters related to capital structure and financing, upon reasonable notice and at such reasonable times as the Purchaser Parties or its representatives may reasonably request and the Company and its subsidiaries shall consider in good faith any suggestions made by the Purchaser Parties with respect to the matters discussed, including with respect to the capital structure and financing of the Company and its subsidiaries; provided that any activity pursuant to this Section ‎6.17 shall be conducted in a manner as not to interfere unreasonably with the conduct of the business of the Company and its subsidiaries, provided that the Company shall not be obligated to provide such access or share any information or materials in connection with the same if the Company determines, in its reasonable judgment, that doing so would reasonably be expected to (i) result in the disclosure of trade secrets or competitively sensitive information to third parties, (ii) violate applicable Law or obligation of confidentiality owing to a third party, (iii) jeopardize the protection of an attorney-client privilege, attorney work product protection or other legal privilege, or (iv) expose the Company to risk of liability for disclosure of personal information; provided that the Company and the Purchaser Parties shall use their commercially reasonable efforts to identify alternative means of disclosure of information to the Purchaser Parties in a manner that would not cause the results set forth in the foregoing clauses (i) through (iv).

		
	6.18
	Avoidance of Control. The Purchaser (together with any group of persons acting in concert therewith (as determined in accordance with the Change in Bank Control Act of 1978, as amended, and the regulations implemented thereunder by the Federal Deposit Insurance Corporation in 12 C.F.R. §§ 303.80-.88)) shall not be permitted to, and shall not take any action within its control that would result in the ability to, purchase or exercise any voting rights of any securities in excess of 9.9% of the outstanding shares of any class of voting securities of the Company. In the event the Purchaser (i) breaches its obligations under this Section ‎6.18or believes that it is reasonably likely to breach these obligations or (ii) otherwise has or believes it would be reasonably likely to exceed the 9.9% threshold specified in the immediately preceding sentence, it shall promptly notify the Company and the parties shall cooperate in good faith to modify ownership or make other arrangements or take any other action, in each case, as is necessary to cure or avoid such breach or cure or avoid otherwise exceeding such 9.9% threshold. For the avoidance of doubt, nothing in this Section ‎6.18 shall be construed to limit any Purchaser Party’s rights under any Transaction Documents or as a holder of Shares or Notes or any successor securities. 

33

ARTICLE 7     
 
TERMINATION
		
	7.1
	Termination. This Agreement may be terminated at any time prior to the Closing, only in the following manner:

		
	(a)
	By mutual written agreement of the Company and the Purchaser; 

		
	(b)
	By the Company or the Purchaser, upon written notice to the other, if the Closing shall not have occurred at or prior to the Termination Time; provided, however, that, termination under this provision shall not be available to a Party if the Closing has not occurred primarily as a result of the breach of this Agreement by such Party;

		
	(c)
	by the Purchaser, if the Company shall have breached any of its representations or warranties or failed to perform any of its covenants or agreements set forth in this Agreement, which breach or failure to perform (i) would give rise to the failure of a condition set forth in Section ‎3.3.7 or ‎3.3.9 and (ii) is incapable of being cured prior to the Termination Time, or if capable of being cured, shall not have been cured within ten (10) calendar days (but in no event later than the Termination Time) following receipt by the Company of written notice of such breach or failure to perform from the Purchaser stating the Purchaser’s intention to terminate this Agreement pursuant to this Section ‎7.1(c) and the basis for such termination; provided that the Purchaser shall not have the right to terminate this Agreement pursuant to this Section ‎7.1(c) if the Purchaser is then in material breach of any of its representations, warranties, covenants or agreements hereunder which breach would give rise to the failure of a condition set forth in Section ‎3.4.3 or Section ‎3.4.5; or

		
	(d)
	by the Company, if the Purchaser shall have breached any of its representations or warranties or failed to perform any of its covenants or agreements set forth in this Agreement, which breach or failure to perform (i) would give rise to the failure of a condition set forth in Section ‎3.4.3 or Section ‎3.4.5 and (ii) is incapable of being cured prior to the Termination Time, or if capable of being cured, shall not have been cured within ten (10) calendar days (but in no event later than the Termination Time) following receipt by the Purchaser of written notice of such breach or failure to perform from the Company stating the Company’s intention to terminate this Agreement pursuant to this Section ‎7.1‎(d) and the basis for such termination; provided that the Company shall not have the right to terminate this Agreement pursuant to this Section ‎7.1‎(d) if the Company is then in material breach of any of its representations, warranties, covenants or agreements hereunder which breach would give rise to the failure of a condition set forth in Section ‎3.3.7 or ‎3.3.9.

		
	7.2
	Effect of Termination. In the event of any termination of this Agreement pursuant to Section ‎7.1, upon the effectiveness of such termination, this Agreement shall become null and void and have no further effect, with no liability on the part of the Company or the Purchaser, or their respective Affiliates, with respect to this Agreement, except (a) for the terms of Section ‎6.12, this Section ‎7.2 and ‎Article 8, which shall survive the termination of this Agreement and (b) that nothing in this Section ‎7.2 shall relieve any Party from liability or damages incurred or suffered by any other Party resulting from any (x) Fraud by such first Party or (y) intentional failure of such first Party to perform a covenant hereof; provided that, notwithstanding any other provision set forth in this Agreement, neither the Purchaser, on the one hand, nor the Company, on the other hand, shall have any such liability in excess of the Purchase Price. As used in the foregoing sentence, “intentional” shall mean an act or omission by such Party which such Party actually knew, or reasonably should have known, would constitute a breach of this Agreement by such Party. For the avoidance of doubt, the Confidentiality Agreement shall survive any termination of this Agreement pursuant to Section ‎7.1.

ARTICLE 8 
 
MISCELLANEOUS

34

		
	8.1
	Notices. Any notice, statement, demand, claim, offer or other written instrument required or permitted to be given pursuant to this Agreement shall be in writing and shall be sent by electronic mail (with receipt confirmed by the recipient), hand messenger delivery, overnight courier service, or certified mail (receipt requested) to the other Party at the address set forth below:

		
	(a)
	If to the Company, to it at:

WEX Inc. 
1 Hancock Street 
Portland, ME 04101 
Attention:  Hilary Rapkin 
Email:  Hilary.Rapkin@wexinc.com
with a copy to:
Wilmer Cutler Pickering Hale and Dorr LLP 
60 State Street 
Boston, MA 02109 
Attention:  Glenn Pollner, Andrew Bonnes and Justin Ochs 
Email: Glenn.Pollner@wilmerhale.com 
           Andrew.Bonnes@wilmerhale.com 
           Justin.Ochs@wilmerhale.com  

		
	(b)
	If to the Purchaser, to it at:

c/o Warburg Pincus LLC
450 Lexington Avenue
New York, NY 10017
Attention: General Counsel
Telecopy: (212) 878-9351
Email: notices@warburgpincus.com
with a copy to:
Cleary Gottlieb Steen & Hamilton LLP 
One Liberty Plaza 
New York, NY 10006 
Attention: David Lopez and David Leinwand 
Facsimile No.: (212) 225-3999 
Email:    dlopez@cgsh.com
dleinwand@cgsh.com 
            
Each Party shall have the right to change the place to which notices shall be sent or delivered or to specify one additional address to which copies of notices may be sent, in either case by similar notice sent or delivered in like manner to the other Party. All such notices, requests and other communications shall be deemed received on the date of actual receipt by the recipient thereof if received prior to 5:00 p.m. local time in the place of receipt and such day is a Business Day in the place of receipt. Otherwise, any such notice, request or communication shall be deemed not to have been received until the next succeeding Business Day in the place of receipt.
            
		
	8.2
	Survival. All covenants and agreements contained herein, other than those which by their terms apply in whole or in part at or after the Closing (which shall survive the Closing indefinitely), shall terminate as of the Closing (or the earlier termination of this Agreement), provided that nothing herein shall relieve any 

35

Party of liability for any breach of such covenant or agreement before such termination. Except for the representations and warranties contained in Sections ‎4.1, ‎4.2, ‎4.6, ‎4.7, ‎4.8, ‎4.9, ‎4.12(a), and ‎4.18 hereof, which shall survive the Closing until expiration of the applicable statute of limitations and then shall terminate, the representations and warranties made in this Agreement shall survive for twelve (12) months following the Closing Date and shall then terminate; provided that nothing herein shall relieve any Party of liability for (i) any inaccuracy or breach of such representation or warranty to the extent that any good faith allegation of such inaccuracy or breach is made in writing prior to such termination or (ii) Fraud.
		
	8.3
	Entire Agreement; Amendments. The Transaction Documents, collectively, constitute the entire agreement and supersede all prior agreements and understandings, both written and oral, of the Parties with respect to the subject matter hereof. Any oral representations or modifications concerning this instrument shall be of no force or effect unless contained in a subsequent written modification signed by the Party to be charged. This Agreement may be amended, waived or modified only by a written instrument executed by the Parties.

		
	8.4
	Successors and Assigns. This Agreement shall be binding upon, and shall inure to the benefit of, and shall be enforceable by, the Parties and their respective successors and permitted assigns. Neither this Agreement, nor any right hereunder, may be assigned by any Party without the prior written consent of the other Party; except that consent shall not be required for an assignment by the Purchaser to any subsidiary or Affiliate of the Purchaser or to any member of the Sponsor Group or any other Person that would be a Permitted Transferee, provided that no such assignment shall relieve Purchaser of any of its obligations hereunder.

		
	8.5
	Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF NEW YORK APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED IN SUCH STATE WITHOUT REGARD TO CONFLICTS OF LAW PRINCIPLES THEREOF THAT WOULD REQUIRE THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION. The Parties agree that any suit or proceeding arising in respect of this Agreement engagement will be tried exclusively in the U.S. District Court for the Southern District of New York or, if that court does not have subject matter jurisdiction, in any state court located in The City and County of New York and the Parties agree to submit to the jurisdiction of, and to venue in, such courts.

		
	8.6
	Jury Trial. THE COMPANY AND THE PURCHASER HEREBY IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

		
	8.7
	Expenses, Etc. The Purchaser shall not bear any of the expenses incurred by the Company in connection with this Agreement and the Transactions contemplated hereby. The Company shall reimburse all of the Purchaser’s reasonable and documented third-party expenses incurred in connection with this Agreement and the Transactions contemplated hereby not to exceed $1,000,000 in the aggregate.

		
	8.8
	Captions. The captions contained in this Agreement are for convenience and reference only and in no way define, describe, extend or limit the scope or intent of this Agreement or the intent of any provision contained herein.

		
	8.9
	Severability. The invalidity or unenforceability of any section, paragraph or provision of this Agreement shall not affect the validity or enforceability of any other section, paragraph or provision hereof. If any section, paragraph or provision of this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and only such minor changes) as are necessary to make it valid and enforceable.

36

		
	8.10
	Counterparts. This Agreement may be executed in one or more counterparts, including by facsimile, electronic or PDF signature, each of which shall constitute an original but all of which, taken together, shall constitute but one agreement.

		
	8.11
	No Waiver. The failure of a Party to enforce any of the provisions of this Agreement or to require compliance with any of its terms at any time during the pendency of this Agreement shall in no way affect the validity of this Agreement, or any part hereof, and unless agreed to in a writing executed by such Party, shall not be deemed a waiver of the right of such Party thereafter to enforce any and each such provision.

		
	8.12
	Damages Waiver; Specific Performance. In connection with any breach of this Agreement, no Party shall be liable for any special, punitive, exemplary, indirect or incidental damages or any other damages to the extent such damages were not reasonably foreseeable. The Parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. Accordingly, each Party agrees that in the event of any breach or threatened breach by any Party of any covenant or obligation contained in this Agreement, the non-breaching Party shall be entitled (in addition to any other remedy that may be available to it, whether in law or equity) to obtain (i) a decree or order of specific performance to enforce the observance and performance of such covenant or obligation, and (ii) an injunction restraining such breach or threatened breach. Each of the Parties agrees that it will not oppose the granting of an injunction, specific performance and other equitable relief on the basis that any other Party has an adequate remedy at law or that any award of specific performance is not an appropriate remedy for any reason at law or in equity. Any Party seeking an order or injunction to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement shall not be required to provide any bond or other security in connection with any such order or injunction. 

		
	8.13
	No Third Party Beneficiaries; No Recourse. No provision of this Agreement shall confer upon any Person other than the Parties and their permitted assigns any rights or remedies hereunder, except that (i) the Board Indemnitees and Fund Indemnitors shall be third-party beneficiaries of Section ‎6.6.4, (ii) the Non-Recourse Parties shall be third party beneficiaries of this Section ‎8.13, (iii) any Person referred to in Section ‎8.15 shall be a third-party beneficiary of such Section and (iv) any Person referred to in Section ‎8.16 shall be a third-party beneficiary of such Section. This Agreement may only be enforced against, and any claims or causes of action that may be based upon, arise out of or relate to this Agreement, or the negotiation, execution or performance of this Agreement may only be made against the entities that executed this Agreement and are expressly identified as Parties, including entities that become Parties after the date of this Agreement, and other than the Parties, no former, current or future equityholders, controlling Persons, directors, officers, employees, general or limited partner, member, manager, advisor, agents, successors, assigns or Affiliates of any Party or any former, current or future equityholder, controlling Person, director, officer, employee, general or limited partner, member, manager, advisor, agent successors, assigns or Affiliate of any of the foregoing (each, a “Non-Recourse Party”) shall have any liability for any obligations or liabilities of the Parties to this Agreement or for any claim (whether in tort, contract or otherwise) based on, in respect of, or by reason of, the transactions contemplated hereby or in respect of any representations (whether written or oral) made or alleged to be made in connection herewith, and no personal liability shall attach to, be imposed upon or otherwise be incurred by the Non-Recourse Parties through the Purchaser or otherwise, whether by or through attempted piercing of the corporate (or partnership or limited liability company) veil, by the enforcement of any assessment or by any legal or equitable proceeding, by virtue of any statute, regulation or applicable Law, or otherwise, except for the Company’s right to specifically enforce the Equity Commitment Letter solely to the extent set forth therein and in accordance with the terms thereof. Without limiting the rights of any Party against the other Parties or the Company’s right to enforce the Equity Commitment Letter solely to the extent set forth therein and in accordance with the terms thereof, in no event shall any Party or any of its Affiliates seek to specifically enforce this Agreement against, make any claims for breach of this Agreement against, or seek to recover monetary damages from, any Non-Recourse Party.

37

		
	8.14
	Other Activities. Notwithstanding anything in this Agreement, none of the provisions of this Agreement shall in any way limit the Purchaser or any of its Affiliates or any member of the Sponsor Group from engaging in any brokerage, investment advisory, financial advisory, anti-raid advisory, principaling, merger advisory, financing, asset management, trading, market making, arbitrage, investment activity and other similar activities conducted in the ordinary course of their business. 

		
	8.15
	Business Opportunities. Notwithstanding anything herein to the contrary and to the fullest extent permitted by Section 122(17) of the Delaware General Corporation Law (or any successor provision) and except as provided herein or as may be otherwise expressly agreed in writing by the Company and the Purchaser, the Company, on behalf of itself and its subsidiaries, renounces any interest or expectancy of the Company and its subsidiaries in, or in being offered an opportunity to participate in, business opportunities, that are from time to time presented to the Purchaser or members of the Sponsor Group or any of their respective officers, representatives, directors, agents, stockholders, members, partners, Affiliates, subsidiaries, or any of their respective designees on the Company Board and/or any of their respective representatives who, from time to time, may act as directors, officers or agents of the Company and no such Person shall be liable to the Company or any of its subsidiaries for breach of any fiduciary or other duty, as a director or officer or otherwise, by reason of the fact that such Person pursues or acquires such business opportunity, directs such business opportunity to another Person or fails to present such business opportunity, or information regarding such business opportunity, to the Company or its subsidiaries unless (i) in the case of any such Person who is a Board Designee, such business opportunity is offered to such Person in his or her capacity as a director of the Company or such business opportunity is identified by such Person as a result of any information obtained by such Person during the course of his or her performance of duties as a member of the Company Board or as a result of Confidential Information furnished to such Person pursuant to the Transaction Documents and (ii) in the case of the Purchaser or members of the Sponsor Group or any of their respective officers, representatives, directors, agents, stockholders, members, partners, Affiliates, subsidiaries, or any of their respective designees on the Company Board (other than a Board Designee) and/or any of their respective representatives who, from time to time, may act as directors (other than a Board Designee), officers or agents of the Company or who may be furnished Confidential Information pursuant to the Transaction Documents, such business opportunity is identified by such Person as a result of any such Confidential Information so furnished to such Person. Any Person purchasing or otherwise acquiring any interest in any shares of Common Stock of the Company shall be deemed to have notice of and consented to the provisions of this Section ‎8.15. Neither the alteration, amendment or repeal of this Section ‎8.15, nor the adoption of any provision of the Certificate of Incorporation or the Indenture inconsistent with this Section ‎8.15, nor, to the fullest extent permitted by Delaware Law, any modification of Law, shall eliminate or reduce the effect of this Section ‎8.15.This Section ‎8.15 shall not limit any protections or defenses available to, or indemnification or advancement rights of, any director, officer, employee or agent of the Company under its Certificate of Incorporation, the By-Laws, any other agreement between the Company and such director, officer, employee or agent or applicable Law.  The Company shall not maintain, adopt or impose any code of conduct, by-law, organizational document or other binding rule or policy that is inconsistent with Section ‎8.15 or Section ‎8.16. Nothing in this Section 8.15 shall be deemed to in any way to limit or modify the obligations of the Purchaser Parties and their Affiliates and representatives or any Board Designee to comply with Section ‎6.13 of this Agreement and the Confidentiality Agreement, to the extent applicable to any such Person.

		
	8.16
	Sponsor. The Purchaser Parties and the Company hereby agree, notwithstanding anything to the contrary in any other agreement or at Law or in equity, that, to the maximum extent permitted by Law, when the Purchaser Parties take any action under this Agreement to give or withhold their consent, the Purchaser Parties shall have no duty (fiduciary or other) to consider the interests of the Company or the other stockholders of the Company and may act exclusively in their own interest; provided, however, that the foregoing provisions of this sentence shall in no way affect the obligations of the Parties hereto to comply with the provisions of this Agreement. For the avoidance of doubt, the foregoing sentence shall not limit or otherwise affect the fiduciary duties of any Board Designee.

38

IN WITNESS WHEREOF, the Purchaser and the Company have caused this Agreement to be duly executed and delivered.
	
			
	 
	 
	 

	PURCHASER:

	 

	WP BRONCO HOLDINGS, LLC

	 
	 

	By:
	 
	/s/ Robert B. Knauss

	Name:
	 
	Robert B. Knauss

	Title:
	 
	Secretary

	
			
	 
	 
	 

	COMPANY:

	 

	WEX INC.

	 
	 

	By:
	 
	/s/ Roberto Simon

	Name:
	 
	Roberto Simon

	Title:
	 
	Chief Financial Officer

	 
	 
	 

1

EXHIBIT A
FORM OF INDENTURE

[Exhibit A to Purchase Agreement]

EXHIBIT B
FORM OF REGISTRATION RIGHTS AGREEMENT

[Exhibit B to Purchase Agreement]

EXHIBIT C
FORM OF OPINION OF WILMER CUTLER PICKERING HALE AND DORR LLP

[Exhibit C to Purchase Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}]]